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ABSTRACT 
Antiretroviral therapy (ART) is effective in reducing HIV morbidity and mortality as well as 
improving patients' quality of life. However, because of several hurdles, resource-poor 
countries have provided treatment to only a few people in need. Thailand is unusual in having 
opted to offer universal coverage for therapy. This thesis aims to understand the process by 
which ART reached the Thai Government agenda, and to explore the lessons learned from the 
design and implementation of the publicly-organised treatment programme. 
This study suggests that Thailand's ART programme was influenced by the networks and 
learning of several actors which evolved over time. During a period of policy continuity 
between 1992 and 2000, the policy process developed within a relatively closed subsystem 
dominated by health officials in the Disease Control Department and HIV experts. The cost of 
antiretrovirals was the major factor restraining treatment coverage. The dramatic shift in ART 
service towards universal access took place in 2001, as a consequence of drug price reduction 
and political transformation that allowed participation of new Health Minister, health 
financing reformists, and an alliance of non-governmental organisations (NGOs). Apparently, 
local and external treatment experiences inspired these actors to pursue similar paths in 
Thailand. The rapid policy formulation process was facilitated by common interests, shared 
experience, previously established collaboration, as well as awareness of interdependency 
among members of the Ministry of Public Health's Technical and Administration Panels. 
Learning about the intricacy in ART administration, especially from existing programmes and 
research studies in the country, played a crucial role in devising treatment expansion plans. 
The individual expertise of clinical specialists, researchers, health officials, NGOs and 
PL WHA helped to accelerate lesson drawing from policy feedback, anticipating future 
obstacles and selecting appropriate policy options. 
At the sub-national level, the process by which the universal ART policy was translated into 
action involved another set of actors, comprising hospital administrators, health professionals, 
officials in the Health Ministry's Regional and Provincial Offices, local NGOs and PLWHA 
groups. A key feature of policy in this phase was that the front-line workforce struggled to 
carry out the tasks prescribed by national policy makers. The discrepancy between the 
programme's expectation and actual therapy delivered in two study provinces was significant, 
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resulting from insufficient number of experienced health personnel, increased workload as an 
effect of parallel reforms in the health and public administration systems, and stigma attached 
to HIV. To counter these impediments, treatment execution networks of government staff and 
civic groups were instigated. Collective learning among service providers, supporters and 
clients had an important role in ART scaling up. Different coping strategies were 
implemented in study hospitals, aiming to balance the contradictory goals of achieving the 
allocated targets while maintaining treatment quality. 
This thesis demonstrates that to understand policy development in such a complex 
circumstance governments cannot unilaterally deal with particular problems. Employing a 
policy network concept to address the partnership between state and non-state actors is not 
only useful but essential as the policy environment has expanded beyond merely state actions, 
to depend, to some extent, on non-state actors. Moreover, the integration of policy learning 
model into policy analysis framework can provide insights into the increasingly dynamic 
interactions between actors, context and processes of public policy in focus. 
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'While we must move ahead boldly, making use of the best current knowledge, there 
is much to be learned in the process. Systematic learning while doing will be 
critical to the ultimate success of these historic initiatives to scale up antiretroviral 
therapy. Such learning must be accomplished through rigorous monitoring and 
evaluation of the diversity of programmes employed from country to country and in 
countless villages, towns, and cities. Targeted evaluations and a rigorous 
programme of operational and applied clinical and behavioural research to answer 
specific questions must be thoughtfully designed, well coordinated, and funded from 
the beginning with ample dedicated resources. ' 
Curran and Debas (2001 :xi) 
'To gain support and maintain co-operation, collaboration and even solidarity, the 
key leaders had to learn and to implement new ways of doing things. Ultimately, 
advocacy was a very valuable learning process. Among other things, actors learned 
perseverance, patience, flexibility and adaptability to change in dynamic 
conditions. They also learned to work with others in an effective manner. ' 
Vichit-Vadakan and Anukansai (2004:89) 
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CHAPTER 1: INTRODUCTION 
The devastation caused by human immunodeficiency viru~ (HIV) and acquired immune 
deficiency syndrome (AIDS) is recognised as a global crisis. Over the two decades of its 
emergence, the disease has afflicted a large number of people. In addition to the infected 
individuals and family members, many components of society are affected by the epidemic. 
While HIV/AIDS is so far incurable, several approaches to disease prevention, treatment, and 
care exist and are being implemented at different levels. Among the medical interventions, 
antiretroviral therapy (ART) is the most effective in increasing survival time and improving 
the quality of life of infected persons. 
This thesis aims to understand better the introduction of antiretroviral medication in Thailand. 
In 200 I, the Thai government opted for a policy to provide universal coverage for treatment, 
an unusual move for a middle-income country, with almost one million people living with 
HIV/AIDS (PLWHA). Although the country had succeeded in curbing the disease from the 
early 1990s, treating all infected persons became the next challenge for the government and 
health system. Given the high cost of the drugs, this thesis seeks to get answers to the 
questions: how and why Thailand decided to roll out nationwide therapy. It also explores the 
features of the national ART initiative during the first three years of scaling up. 
To provide a background to the issue, this chapter describes the global HIV epidemic and its 
implications. Critical elements, caveats and potential externalities of ART as well as the 
integration of therapy into health systems are also discussed. In addition, it reviews the 
resources needed, advocacy and debates in relation to treatment scaling up in poor countries. 
1.1 The Global HIV epidemic: the disease, epidemiology and impact 
HIV is the causative agent of AIDS. The virus transcribes its genetic materials in infected 
host cells, after which the newly-replicated viral particles are released in the blood (Rubbert 
and Ostrowski 2003). The infection develops slowly with long intervals between the initial 
phase and the onset of serious clinical manifestations, varying from 1 to more than 15 years in 
adults but only 2 years in children. When the infection reaches the full-blown stage, the 
immune system does not function and patients are vulnerable to several opportunistic 
- 13 -
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infections (OIs), malignancies and neurological disorders, which define AIDS status 
clinically (Bartlett and Gallant 2003). Many of these complications are life threatening and 
require hospitalisation and expensive medicines. 
Transmission of HIV occurs by contact with contaminated secretions, blood and other 
biological fluids from infected persons. Sexual relationships, sharing needles and syringes, 
and blood transfusions spread the virus in adult populations (CDC 2003). The virus can also 
pass from mothers to newborns during gestation, delivery and breastfeeding. Health workers 
may be infected from needle pricks tainted with infected blood or secretions or coming into 
contact with these fluids through open wounds or mucous membrane. Transmission can be 
prevented through various means, for example condom use, blood product screening, 
exercising universal precautions in health facilities, and antiretroviral (ARV) prophylaxis and 
breast milk substitution in infected mothers and the neonates (Phoolcharoen and Detels 2002). 
HN vaccine trials are being conducted in many countries, but are not expected to be useful 
for many years (Peiperl and Buchbinder 2005). 
The global H/V epidemiology 
The first report of HIV -related illness was published in 1981 in the United States (US) (CDC 
1981). The epidemic in most regions started during the late 1970s to early 1980s, except in 
North Africa, Middle East, South and South East Asia, and East Asia and the Pacific where 
the extensive distribution of the virus commenced in the late 1980s (UNAIDS 1996). The 
global figures indicate that about 40.3 million people were living with HIV in 2005, while 25 
million had died of the disease since it was first identified (UNAIDS 2005). Cases and deaths 
continue to rise: increasing in 2005 by 4.9 million, with 3.1 million deaths. HIV affects 
different regions unevenly, with 95% of the infection occurring in developing countries. Sub-
Saharan Africa is the most heavily affected, with two thirds of the world's HN cases. The 
epidemic is expanding in Eastern Europe, Central Asia, and South and South-East Asia where 
previously little HN was observed (UNAIDS 2004a). In high-income countries such as 
France, Sweden, and United Kingdom (UK), prevalence has grown steadily as a consequence 
of new infections (UNAIDS 2003a). Wide coverage for ART which substantially prolongs 
patients' life is another reason for the increase in the numbers of PL WHA in these settings. 
- 14-
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Despite geographical variation, two features are common to all countries: first, infections are 
overwhelmingly among young adults, with individuals of 25 to 49 years of age the major 
group affected (UNAIDS 2004a). By 2003, this group made up 94% of the total world 
population with HIV/ AIDS. Second, the most vulnerable to HIV infection are the 
marginalised and underprivileged (Bloom et al. 2004). Owing to several barriers, these groups 
have poor access to public services including disease prevention and health care programmes. 
Implications of the epidemic 
HIV is well recognised for its negative effects on economies and development efforts. At 
household level, in addition to the morbidity and mortality of the infected persons, there is a 
loss of economic security, rising expenditure on health care, depleted household earnings, 
savings and holding assets (United Nations 2003). The epidemic has major implications for 
children and the elderly in HIV-affected families (Barnett and Whiteside 2002). Many school-
age orphans cannot continue their education. Some children are forced to take on a premature 
role, for example providing care to the sick and the younger brothers or sisters, leading the 
family, and starting their work life very early (Egero, Hammarskjold, and Munck 2001). 
Ironically, the elderly who have given care to their infected children while they live with the 
illness, may also be responsible for orphaned grandchildren (Knodel and VanLandingham 
2002). In the most extreme cases, HIV infection in an adult breadwinner can result in the 
migration and dissolution of the household. 
Since the majority of PL WHA are in their most productive years of life, in countries with 
high HIV prevalence the epidemic also affects the national economy. An estimated 26 million 
workforce participants worldwide lived with the disease in 2004 (ILO 2004). HIV-related 
absenteeism, debilitation and deaths have notable direct and indirect effects on the costs and 
productivity of manufacturing industry (Greener 2002b). The destructive impact on public 
service sectors such as the education, health and social welfare and its consequences on the 
services provided has also been noted (United Nations 2004; World Bank 2002). 
HIV also afflicts a country's economic development. As suggested by the Commission on 
Macroeconomics and Health (2001), apart from the damage to particular agencies and 
businesses, production loss and cost escalation may lower confidence among investors, 
subsequently resulting in less investment and possibly, economic recession. In addition, the 
- 15 -
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increase in demands for foreign currency spending on imported healthcare goods including 
ARVs and other anti-HIV drugs may deter economic growth and even increase the poverty 
level (Dixon, McDonald, and Roberts 2002). Some reports have suggested that in some 
African countries, the effects of HIV may delay the capacity to recover their macroeconomies 
for many decades (United Nations 2004). 
The most effective way to avoid the effects of HIV is to act before the epidemic starts 
(UNAIDS 2002a). For many countries, however, large numbers of people have already been 
infected before a policy response has been made. In such cases, the most reasonable strategy 
is to provide care in addition to prevention in order to reduce morbidity and delay premature 
death. Comprehensive care for PL WHA, as recommended by international organisations, 
involves a wide range of services, including voluntary counselling and testing for the 
infection, prevention of further viral transmissions, prevention and treatment ofOls and HIV-
related cancers, ART, and palliative care (WHO 2004d). Although antimicrobials can reduce 
the risk of major opportunistic diseases such as tuberculosis and Pneumocystic carinii 
pneumonia, the drugs are notably less effective than ART in prolonging survival of HIV-
positive persons (Lee et al. 2001). 
1.2 Antiretroviral therapy 
It was in the late 1980s when the first antiretroviral (ARV) was approved in the US. 
Thereafter, substantial benefits of ART have been documented and its clinical consequences 
have shifted the general attitudes towards HIV from a rapidly life-threatening infection to a 
manageable chronic disease (Siegel and Lekas 2002). At the same time, the use of ARVs has 
drawbacks as the drugs may cause serious adverse effects (Volberding 2003). There are also 
serious concerns about resistance to ARVs (Lange 2002). This section reviews different 
facets of medications including important precautions and caveats in therapy administration. 
1.2.1 Critical issues in ART: biomedical aspects and associated factors 
Antiretroviral drugs act by controlling HIV replications or intervening in the viral fusion to 
host cells (Pomerantz and Hom 2003). The first ARV - zidovudine was approved for HIV in 
1987. By July 2004, the US Food and Drug Administration had authorised the use of 19 
ARVs and related fixed-dose combinations as shown in table 1.1 (US FDA 2004). The drugs 
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can be classified by their phannacological actions into 4 classes, namely nucleoside reverse 
transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), 
protease inhibitors (PIs), and fusion inhibitors. 
Table 1.1: Antiretrovirals approved by the US Food and Drug Administration, as of July 2004 
Categories Generic name Approval date 
1. Non-nucleoside Reverse Delavirdine (DLV) 4 April 1997 
Transcriptase Inhibitors Efavirenz (EFV) 1 7 September 1998 
(NNRTIs) Nevirapine (NVP) 21 June 1996 
2. Nucleoside Reverse Abacavir (ABC) 17 December 1998 
Transcriptase Inhibitors Abacavir + lamivudine + zidovudine 14 November 2000 
(NRTIs) Didanosine (ddI) 9 October 1991 
Didanosine EC (ddI EC) 31 October 2000 
Emtricitabine (FTC) 2 July 2003 
Lamivudine (3TC) 17 November 1995 
Lamivudine + zidovudine 27 September 1997 
Stavudine (d4T) 24 June 1994 
Tenofovir DF (TDF) 26 October 2001 
Zalcitabine (ddC) 19 June 1992 
Zidovudine (AZT or ZDV) 19 March 1987 
, 
3. Protease Inhibitors (PIs) Amprenavir (APV) 15 April 1999 
Atazanavir (A TV) 20 June 2003 
Fosamprenavir (FPV) 20 October 2003 
Indinavir (IDV) 13 March 1996 
Lopinavir + ritonavir (LPV/r) 15 September 2000 
Nelfinavir (NFV) 14 March 1997 
Ritonavir (RTV) I March 1996 
Saquinavir (SCV) 6 December 1995 
4. Fusion Inhibitors Enfuviride (T -20) 13 March 2003 
.. 
Source: US Food and Drug Admlll1stratlOn (2004) 
I NNRTIs bind to and disable reverse transcriptase, a protein that HIV needs to make more copies of 
itself. NRTIs are faulty versions of building blocks that HIV needs to make more copies of itself. 
When HIV uses an NRTI instead of a normal building block, reproduction of the virus is stalled. PIs 
disable protease, a protein that HIV needs to make more copies of itself. Fusion inhibitors work by 
blocking HIV entry into cells. 
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ART is a highly toxic and complex medication. Initially, zidovudine, didanosine and 
zalcitabine were prescribed singly as mono therapy or as dual drug combinations, but by 1996, 
it was found that a more effective treatment was to combine three or more ARVs - the so 
called highly active antiretroviral therapy (HAART) - became common. The use of multi-
drug protocols has increased the difficulties not only in individual case management but also 
programmatic administration. Critical issues in ART as discussed below are major challenges 
for large-scale treatment delivery, especially in resource-poor settings. 
Treatment regimens, therapeutic outcomes and adverse reactions 
Since the mid-1990s, the efficacy of ART has improved progressively; however, it cannot 
eradicate the virus. Studies suggest that combinations of ARVs from different classes help to 
delay drug resistance and sustain viral suppression. Currently, recommended treatment 
protocols - known as HAART - include three drugs, 2 NRTIs and a NNRTI or PI, which can 
hinder the disease progression and restore immunological functions for significant periods 
(Enanoria et al. 2004; Smith et al. 2003). With these actions, treatment has contributed to a 
substantial decline in mortality, reduction in hospitalisations due to Ols, and lowered the need 
for palliative care (Detels et al. 2001; Lee et al. 2001). In addition, therapy has changed the 
public perception of HIV/AIDS from a highly fatal acute illness to a chronic disease. As 
argued by Kobayashi (1997:161, quoted in Siegel and Lekas, 2002:569), the medication 
availability 'was said to have reinserted the word 'hope' into the discussion about AIDS for 
the first time in a decade of treatment trials'. However, the effectiveness of ART varies, due 
to multiple factors - insufficient adherence, prior use of particular ARV s, and the clinical 
condition of patients at the time of treatment (Mocroft and Lundgren 2004). 
ARVs have different adverse drug reactions which result in both therapeutic and public health 
implications. Some unwanted effects are uncommon but serious and life-threatening, while 
others are moderate or mild but may lead to inadequate adherence and treatment interruptions 
(Volberding 2003). PLWHA who are aware of the serious side effects may hesitate to 
commence therapy (Phillips et al. 2003). Serious adverse reactions are mostly generated by 
the toxicities of ARVs on metabolism, for example lactic acidosis and its consequences such 
as hepatic dysfunctions, lipodystrophy, insulin resistance, and cardiovascular diseases 
(Montessori et al. 2004). Morphological abnormalities due to the redistribution of fat from 
face, limbs and buttocks; and accumulation in the abdomen and breast are among patients' 
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concerns. ARVs commonly recommended in ftrst-line regimens, such as didanosine, 
nevirapine, effavirenz, and stavudine, may induce signiftcant changes in hepatic histology 
and enzyme levels. Most of these undesirable effects are predictable and indicate the need for 
close monitoring of patients' signs and symptoms. Dosage adjustment or change in regimens 
can be expected in most patients (Volberding 2003). In this light, regular laboratory assays to 
monitor CD4+ cell counts2, viralload3, and drug resistance is necessary during the follow up 
period (Chaisson et al. 1998). 
Drug resistance 
Treatment efftcacy is time-limited since HIV resistance to ARVs can develop as a 
consequence of incomplete viral replication and mutation under selection pressure (Rubbert 
and Ostrowski 2003). Various factors encourage resistance, for example inappropriate 
regimens, treatment interruption and inadequate adherence to medications (Lange et al. 2004). 
Sub-therapeutic levels of one or more drugs owing to poor absorption, metabolic disorder, or 
drug-drug or drug-food interactions may trigger resistance in some cases (Kuritzkes 2004). 
Incomplete viral suppression which leads to resistance has been reported in patients with low 
CD4+ cell counts and high viral load at the time of therapy initiation (Saag 2003). 
When resistance has emerged as indicated by persisting viraemia during the course of 
treatment, changing the drugs to non-resistant agents of similar or new classes IS 
recommended (Darbyshire 2000). However, such measures may not be effective if the 
resistance is associated with patients' poor adherence. To avoid resistance and select suitable 
drugs, a good infrastructure for therapeutic outcome monitoring and testing of resistant strains 
is essential (Kuritzkes 2004). Though ARV resistance assessment is recommended as an 
integral part of therapy in developed countries, high costs and lack of skilled personnel are 
the major obstacles in routinely assessing drug resistance in poor settings (Geretti and 
Easterbrook 2001; Hirsch 2002). 
2 CD4 or CD4+ T lymphocytes are a type of white blood cells that coordinate the immune system's 
functions. When infected with HIV, CD4 are destroyed by the virus. The assessment of serum CD4 
concentration is essential for monitoring of the course of HIV infection and the response to therapy. 
3 Viral load is the amount of HIV in blood circulation. Similar to CD4 count, viral load test is a 
necessary part of HIV and treatment monitoring as the amount of virus in the blood is correlated with 
disease severity 
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Medication adherence 
Patients' adherence to ART at rates of over 95% is required to maintain adequate viral 
suppression (Paterson et al. 2000). As with many chronic diseases, poor adherence to therapy 
is widespread in both developed and developing countries (Chesney, Morin, and Sherr 2000). 
Starting treatment at the early-stages of infection, when the patients remain asymptomatic 
may result in poor adherence, especially where the drugs can induce toxicities or disturbing 
side effects (Moatti and Spire 2000). Even in those with advanced infection, perfect 
adherence to life-time medication is difficult to achieve. Patients' concerns that taking the 
medicines regularly will disclose their HIV status is another barrier to adherence (Roberts and 
Mann 2000). 
Adhering to ART is so complex that it requires integrated behavioural and biomedical efforts 
(Ickovics and Meade 2002). Adherence promotion strategies comprise wide ranging 
interventions, focusing on patient, treatment regimens, health care providers, and institutional 
elements (Simoni et al. 2003). For instance, providers are recommended to spend sufficient 
time with patients and also introduce measures, such as use of support groups or peer 
educators to monitor ongoing adherence; to intensify management during periods of 
suboptimal adherence; and to identify a family member, friend, or partner who will help and 
encourage the patient to adhere to therapy (Dybul et al. 2002). As Simoni and colleagues 
(2003) point out, adherence-enhancing measures need providers' leading advocacy as well as 
patients' and caregivers' cooperation. The effectiveness and feasibility of these strategies are 
context-specific, and the success usually declines over time (Howard et al. 2002). 
ART experiences elsewhere suggest the need for healthcare providers to have sufficient 
knowledge and experience, as well as sufficient infrastructures to deliver safe and efficient 
treatment. However, many aspects of ART remain unclear, especially when it is introduced in 
the developing world (Neaton 2005). This is because studies to inform medication guidelines, 
systems arrangement and implementation have been mainly conducted in industrialised 
countries where the HIV context differs from resource-constraint settings. Neaton (2005) 
argues that in poor health systems, HIV-related morbidity and mortality rates are extremely 
high, so that the adoption of simplified drug protocols and low-cost laboratory tests is 
necessary, but some of these 'practical' interventions have not been sufficiently assessed for 
their benefits or adverse effects in well-designed trials. 
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1.2.2 Public health spill-over of ART 
In addition to the effectiveness of ART and associated medical benefits to infected 
individuals, the introduction of treatment in the health systems has broader positive and 
negative effects. Many of these spill-over effects remain controversial and require further 
examination. 
Positive externalities 
ART may have significant preventive implications for the reduction of sexual transmission 
because it reduces infectiousness by decreasing viral loads in plasma and seminal fluid 
(Kashuba et al. 1999; Quinn et al. 2000; Royce et al. 1997). Since the levels of HN in body 
fluids is a contributing factor of transmission, it is expected that any interventions able to 
decrease the viral load can have a role in HIV prevention for all transmission routes (Blower, 
Scwartz, and Mills 2003). Modelling analyses indicate that ART, when used at a high rate, 
can reduce annual AIDS deaths and prevent a number of new infections at popUlation level. It 
has been argued that, however, despite a decrease in the rate of transmission owing to 
treatment, the incidence rale may not fall because unsafe sexual behaviour of population has 
more profound effects on the reduction of HIV incidence than does ART (Blower, Scwartz, 
and Mills 2003; Gray et al. 2003). 
Another positive effect of ART is that the awareness of such benefits may encourage 
PLWHA to seek institutional care from proper settings (Volberding 2003). For those with 
unknown sero-status who feel hesitant about obtaining HIV counselling and testing because 
of the absence of effective treatment, ART implementation may motivate them to seek the 
services which in turn may contribute to safer sex behaviour (Moatti et al. 2003a; Vermund 
and Wilson 2002). Further, the availability of therapy is likely to have psychosocial benefits 
for infected persons since it may alleviate feelings of stigma and isolation (Piot and ColI-Seck 
2001; WHOIUNAIDS 2004). Some assert that when treated individuals perceive their lives 
are valued, they will increase adherence to prevention practices (Lancet Infectious Disease 
2003). However, the relationship between ART access, people's perceptions, and their care 
seeking behaviour is complicated. For instance, a study in South Africa indicated that the 
availability of therapy encouraged uptake of HIV testing among only a small fraction of 
subjects (Day et al. 2003). The authors suggested that the fear of uncovering HIV status and 
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stigma might have counterbalanced the perceived benefits of therapy. In the same vein, 
Brannstrom et al (2005) demonstrate that although ART has been widely accessed in Sweden 
since 1996, the proportion of PL WHA unaware of their HIV status before AIDS develops -
the so-called late testers - increased significantly, from 22% in 1996 to 58% in 2002. 
The literature also discusses the positive effects of ART delivery on overall health system 
improvement which benefits non-HIV related conditions in resource-poor settings (Attawell 
and Mundy 2003). Though the epidemic has overridden the national healthcare system, the 
World Health Organisation (WHO) (2004e) maintains that scaling-up treatment will upgrade 
laboratories, human resources, and research capacity. Some stress that, however, such 
externalities can be developed only when additional resources are adequate and well-
organised (Attawell and Mundy 2003; Holmes 2004). 
Negative externalities 
It is inevitable that widespread use of ARVs will increase the chance of viral mutations and 
also promote distribution of resistant HIV strains (Blower and Volberding 2002). Following 
Blower and Volberding, treatment should be introduced concomitantly with strategies to 
encourage rational prescribing practices and patients' behaviours in order to avoid resistance, 
and then to promptly manage drug resistance at the time of its emergence. 
ART may also undermine HIV prevention efforts. As Siegel and Lekas (2002) point out, 
living longer with the disease may increase the likelihood of viral transmissions. Moreover, 
the perception that the disease is treatable can induce the adoption of risky practices. When 
patients become healthy and live longer, they may be less likely to maintain safe sex practices, 
and some may want to have children. Studies of sex behaviour among male homosexuals and 
intravenous drug users in developed countries suggest the rise of risky practices since ART 
became widely available (Kalichman and Rompa 2003; Katz et al. 2002; Tun et al. 2003). 
However, unchanged sex behaviour among PL WHA on therapy has also been reported in 
other settings (Moatti et al. 2003b; Stephenson et al. 2003). 
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1.3 Integrating ART in health systems: resources needed and barriers 
Integrating ART in health systems requires considerable care to ensure service quality and 
programme efficiency (WHO 2000). This includes training health workers in treatment . 
administration; adequate drug supply; reliable laboratory facilities, and access to related 
services such as counselling, HIV diagnosis, and management of opportunistic diseases 
(WHOIUNAIDS 1998). See table 1.2. As therapy is just one component of a comprehensive 
HIV care package, referral arrangements as well as collaboration between health providers, 
patients and their families and communities are crucial. Moreover, clear, accurate and 
appropriate guidance on programme administration and linkages between national agencies, 
local authorities and implementing units have to be well operated (Harries et al. 2001). 
Table 1.2: Minimum requirements for introducing ART to the health system 
Access to voluntary and confidential counselling and diagnostic testing. 
Reliable, long-term drug supply 
Laboratory facilities to monitor clinical outcomes and adverse drug reactions. 
• Management of opportunistic infections. 
Appropriate training for clinicians and paramedics. 
Support of a social network to help patients adhere to the regimen. 
• Strengthening of health and social services in a continuum of care. 
Source: adapted from WHOIUNAIDS (1998) 
Common problems faced by health delivery systems in poor countries include inadequate 
facilities and workforce to deliver even basic services such as immunisation; maternal and 
child care and nutrition (Lee 2003; Victora et al. 2004). Given that ART is clinically and 
socially complicated, rolling out therapy in these settings is even more difficult (Mugyenyi 
2004; Ruxin et al. 2005). Furthermore, the demands for HIV prevention, treatment and care 
strain the already limited health resources, especially staff, medicines and hospital beds 
(Mukherjee et al. 2003; Nielsen and Melgaard 2004). 
In addition to the increased workloads, the epidemic exacerbates workforce ~hortages as 
many health workers have been infected and died of the disease (Chen and Hanvoravongchai 
2005). Difficult working conditions, stress and fear of viral contamination result in 
discouragement, bum out, and absenteeism. In sub-Saharan Africa, growing outward 
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migration of doctors and nurses both within the region and to Europe and the Middle East has 
also affected the workforce (Eastwood et al. 2005). In South Africa, for instance, an estimated 
29,000 health worker positions are vacant, while an additional 12,000 posts are required in 
order to achieve the national ART target of 1.5 million in 2009 (Kober and Van Damme 
2004). As Marchal and colleagues (2005) argue, however, the staff crisis in the South is not 
confined to deficiencies in numbers but also to performance and accountability. The literature 
suggests that knowledge, experience, and attitudes of health personnel are crucial in ensuring 
high quality treatment (Hsiung et al. 2001; Kitahata et al. 1996; Souville et al. 2003). Tmining 
of respective workers can meet some needs - but many other changes inside and outside the 
health systems are also necessary (Hongoro and Mcpake 2004). 
1.3.1 Costly drugs and treatment monitoring 
Among the barriers to ART, the high prices of ARVs and laboratory reagents and machines, 
as well as associated costs of nationwide implementation have been cited as dominant 
(Bertozzi et al. 2004; Razum and Okoye 2001; Sendi and Gafni 2003). When triple-drug 
protocols became standard treatment in the late 1990s, first-line regimens cost between 
US$lO,OOO and US$12,000 per patient per year. By 2001, prices of the drugs had fallen to 
US$350 (UNAIDS 2002b). A decrease of over 50% in drug costs was reported in Latin 
America and the Caribbean between 2001 and 2002 (Bautista et al. 2003). However, most of 
new drugs used in advanced protocols, necessary for patients with drug-resistant HIV 
infections are sold at very high prices (Steinbrook 2003). 
Costs of ARVs vary across settings and time, depending on many factors such as price 
regulations, negotiations, patent laws, and generic competition (Hogg et al. 1998; Reich and 
Bery 2005). In Brazil, owing to the competency of domestic drug laboratories and 
negotiations between the Health Ministry and transnational companies, ARV prices dropped 
markedly once the national treatment programme started in 1996 (Teixeira, Vitoria, and 
Barcarolo 2003). The price reduction was partly due to the Government's ability to produce 
generic versions irrespective of patent status (Ortells 2003). By contrast, the decrease in drug 
costs in some countries, for example Cameroon, Kenya and Uganda began much later, and 
was due to generic importation; global initiatives including those fostered partnerships 
between international organisations, governments and drug manufacturers; as well as pressure 
from non-governmental organisations (NGOs) such as Medicins Sans Frontiere (MSF) and 
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AIDS Coalition to Unleash Power (ACT-UP) (Martinez-Jones and Anyama 2002; National 
AIDS Control Committee Cameroon 2004). A few African countries - Congo, South Africa 
and Tanzania for example - obtained ARVs from generic production, enabled by technology 
transfer from Brazil and Thailand (Chirac 2002; Steinbrook 2004b). 
However, although relatively low-priced drugs are now more available, ART remains costly 
due to expensive laboratory tests (Diomande et al. 2003; Stephenson 2002). Standard CD4+ 
and viral load assessment test cost over US$I,OOO per patient per year in the industrialised 
world, and may be higher in developing countries since most reagents and machines are 
patented (Kumarasamy et al. 2002). Owing to the high costs of monitoring, simplification of 
methods or exclusion of some assessment from routine practices is recommended (Grubb, 
Perriens, and Schwartlander 2003). 
1.3.2 Improving access to ART: estimated costs and feasibility 
The financial burden of HIV treatment on governments, private sector and households 
changes over time and differs from setting to setting. Costs of HIV programmes are affected 
by several elements, for example the number of clients, unit prices of drugs and other supplies, 
logistic and management features of particular services (Hutubessy, Bendib, and Evans 2001). 
Spending on ART is the major part of the overall resource needs for HIV response (Gutierrez 
et al. 2004). Owing to expensive ARVs, in many countries with high HIV prevalence and low 
national income, the costs of nationwide treatment cannot be met by existing domestic 
resources. 
In Latin America and the Caribbean the estimated costs of ART and related laboratory testing 
account for 51 % of US$937 million required for the comprehensive HIV service package in 
2005 (Opuni et al. 2002). In contrast, expenditure on therapy represented only 17% of the 
requirements of US$3 billion to finance HIV programmes in Asia-Pacific countries in the 
same period (ADB/UNAIDS 2005). The variation in the proportions of resource allocation 
for ART reflects the difference in HIV policy of countries in the two regions: i.e. in Latin 
America and the Caribbean policy is to provide wide access to therapy, while in Asia other 
services are emphasised. 
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At the global level, to achieve the goal of an initiative organised by WHO to get 3 million 
PLWHA on ART by 2005, the estimated funding requirements range between US$5.1 billion 
and US$5.9 billion, which cover ARVs, treatment monitoring, counselling, HIV testing, 
management of complications, palliative care, and support activities (Gutierrez et al. 2004). 
Such projections are based on the best use of the existing health system resources; advocacy 
to lower the costs of ARVs and diagnostics; and cooperation ofPLWHA and communities. 
However, the resources needed for the scale up of treatment includes expenditure on routine 
services, and also workforce and infrastructure development. Introducing ART in settings 
with structural inadequacies and weak management means that the health system has to be 
upgraded and large investments are therefore indispensable (Kumaranayake 2002b; 
Schwartlander et al. 2001). 
Although the resources required for HIV prevention and care are immense, surpassing 
financing capacity of governments and people in many settings, it has been argued that 
scaling up ART is affordable and feasible if resources are properly mobilised and well 
allocated (ADBIVNAIDS 2005; Bertozzi et al. 2004). In this respect, the strategies proposed 
comprise not only mobilising funds from high-income countries and other sources such as the 
Global Fund to Fight AIDS, Tuberculosis and Malaria (GF ATM), but also using every effort4 
to bring down the costs of ARVs and treatment monitoring. Importantly, it is emphasised that 
treatment cannot be sustained unless HIV prevention measures are introduced effectively. 
This is because the growing number of infected cases implies resources for therapy in the 
future which continue to rise. 
1.4 Treatment advocacy 
Improving 'ART coverage in the developing world during the past decade has been attributed 
to multisectoral efforts to mobilise resources, overcome impediments, and encourage political 
commitment (UNAIDS 2002b). HIV activism which has long promoted the rights to care and 
medical services among PLWHA has played, and continues to play an important role in ART 
access at the global and country levels (Ammann and Nogueira 2005; von Schoen Angerer et 
al. 2001). For example, in Honduras, treatment organisations of HIV-infected people and 
AIDS activists, strongly supported by the general public, influenced the Health Ministry to 
4 For example, use of generic products; differential pricing; price negotiation; voluntary license 
agreements; compulsory licensing; bulk purchasing; and donations (Reich and Bery, 2005). 
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establish an ART programme in 2002 (Ortells 2003). Likewise, the creation of an AIDS drug 
fund - FONSIDA - in Mexico, and the adoption of a national policy to ensure medication 
access in South Africa in 2003, was the result of pressure from local and international NGOs 
(Abdool Karim 2004; del Rio and Sepulveda 2002; Willan 2004). 
Apart from organising policy campaigns, coalitions of NGOs, academic, and professional 
associations have taken part in providing technical, financial and other support to therapy 
delivery (Paiva et al. 2002). An example can be drawn from MSF prevention and treatment 
programmes which cover over 13,000 PLWHA in 25 countries (MSF 2004b). Furthermore, 
civil society networks have been actively involved in making cheap ARVs and laboratory 
reagents available by accelerating product approval, negotiating with research-based and 
generic drug companies, and promoting the use of compulsory licensing and parallel 
importation to mitigate the impact of patents on drug prices and accessibility (Reich and Bery 
2005; von Schoen Angerer et al. 2001). 
The activities of international agencies have also been vital (Piot and ColI-Seck 2001; 
UNAIDS 2002b). The first international attempt to improve access to ARVs and drugs for 
opportunistic diseases - so called the HIV Drug Access Initiative (DAI) was founded by the 
Joint United Nations Programme on AIDS (UNAIDS) in 1997 (Saba 1998). The Initiative 
encouraged collaboration among key stakeholders to address treatment barriers. Five 
research-based drug companies were involved in the discussions regarding price reductions. 
However, the project was limited to 4 countries: Chile, Cote d'Ivoire, Uganda and Vietnam 
(UNAIDS 2000). The effort to expand HIV treatment was maintained through a collaboration 
- known as the Accelerating Access Initiative (AAI) launched in 2001 - between the United 
Nations (UN) agencies and pharmaceutical industry (UNAIDS 2001a). The same year the UN 
Secretary General called for intensifying pUblic-private partnerships to increase access to HIV 
treatment. Through the initiative, drug price reductions and donations made ART feasible in 
pilot-scale programmes in 26 poor countries. 
The UN also took on a stronger advocacy role in early 2000s, encouraging its members to 
address the epidemic and its consequences. For example, in 2000, reversing the spread of 
major infectious diseases including HIV was included as a component of the Millennium 
Development Goals (United Nations 2002). Following the United Nations General Assembly 
Special Session (UNGASS) Declaration of Commitment to tackle HIV/AIDS (United Nations 
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2001), all countries agreed to scale up response to HIV epidemic including treatment 
extension. Funding for ART was also increased through several multilateral and bilateral 
initiatives (WHO 2002a). 
In January 2002, the GFATM was established to mobilise funds for HIV programmes in the 
South. This financial mechanism attracted, managed and disbursed additional resources 
through a partnership between industrialised and less developed countries, WHO, UNAIDS, 
private sector, and civil society (GFATM 2003). As of January 2005, US$754 million had 
been disbursed for HIV which enabled 130,000 people to receive ART and more than 1 
million to access voluntary HIV testing (GFATM 2005b). Apart from the GFATM, other 
sources of treatment funding include the World Bank's Multi-country AIDS Programme 
(MAP), the US President's Emergency Programme for AIDS Relief (PEPFAR), and 
philanthropic organisations such as Bill & Melinda Gates, and Clinton Foundations (WHO 
2002a). Donor countries, for example Canada, France, Germany, the Netherlands, Norway, 
the UK and the US, also increased their contribution to HIV initiatives in resource-poor 
nations through the GF A TM and bilateral mechanisms (UNAIDS 2004a). All international 
commitments to HIV/AIDS resources in 2005 amounted to US$5.1 billion (GFATM 2005a). 
Another step to extend ART was taken in September 2003, as the WHO in collaboration with 
the GFATM and UNAIDS announced a programme known as '3 by 5' to provide ARV 
treatment to 3 million people in the developing world by 2005 (Lee 2003). The campaign 
aimed not only to ensure quality ART access, but also to promote disease surveillance and 
integrated treatment-prevention activities, all of which were expected to have spill-over 
effects for strengthening health systems as a whole (WHO 2004e). Although the 3 by 5 
Initiative is acknowledged for improving therapy access, its ambitious target is unlikely to be 
achieved (The Lancet 2005). 
1.5 Debates on ART provision in developing countries 
Previous sections illustrate the major financial and organisational impediments to scaling up 
ART in resource-poor settings, as well as the concerted efforts to overcome such obstacles 
and facilitate treatment extension over the first half of 2000s. However, the quest for 
increasing access to therapy has not been consensual. The next section looks at some of the 
debates around expanding ART. 
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1.5.1 When to instigate treatment programmes? 
As low-cost medicines and funding for ART have become increasingly available, attention 
shifted from the problems of affordability to the readiness of health systems to instigate 
treatment and expand coverage (Beattie 2003; Kasper et al. 2003). Some have argued that to 
avoid 'ART anarchy', i.e. poor compliance with therapy protocol on both demand and supply 
sides, drug resistance development, and disinhibition among treated patients - well-prepared 
healthcare providers and sustainable fmancing are necessary (Harries et al. 200 I; Stevens, 
Kayne, and Corrah 2004). For example WHO, prior to the 3 by 5 Initiative, emphasised the 
readiness of health systems as the prerequisite of ART delivery: 'Due to the high cost of 
antiretroviral drugs, the complexity of the regimens and the need for careful monitoring, 
specific services and facilities must be in place before conSidering the introduction of ART 
into any setting. '(WHO 2000: 16). 
On the other hand, some have argued that therapy should be rolled out immediately since 
delays hamper the opportunities to save lives, stabilise productivity, and revitalise the 
economy (Binswanger 2003; Piot and ColI-Seck 2001). Arguments include the proposition 
that treatment delivery will have positive spill-over effects for health systems as a whole 
(Buve, Kalibala, and McIntyre 2003; Piot and ColI-Seck 2001). When WHO launched its 3 
by 5 Initiative, it supported the latter view, in spite of earlier statements about the need for the 
health system to be secure. For example, Lee (2003:2086) argued that the attempt to improve 
ART coverage in the South would facilitate the development of workforce and infrastructure. 
In addition, in order to achieve the 3 by 5 goals the organisation advocates simplified, adapted 
therapeutic regimens and monitoring techniques which suit implementation environment in 
resource-poor settings (WHO 2002c). Others have warned, however, that such interventions 
may lead to a trade-off between sub-standard practices and quality (Schechter 2003). 
1.5.2 Valuing costs and outcomes of ART 
Economic assessments of health interventions provide useful information for resource 
allocation (Hutubessy, Bendib, and Evans 2001). Many arguments against scaling-up ART in 
the developing world are based on its poor value for money. Although ARV prices have 
dropped dramatically, medication remains prohibitive and less cost-effective than most HIV 
prevention measures (Creese et al. 2002; Marseille, Hofmann, and Khan 2002). It is therefore 
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suggested that scarce resources should be allocated to prevention rather than treatment. 
Respecting cost-minimisation, Brazil's ART programmes demonstrate that substantial 
resources could be saved from therapy-attributed reduction in OIs (Marins et al. 2003). 
However, the economic impact of treatment is setting-specific, noticeably depending on how 
well the programmes are organised (Hutubessy, Bendib, and Evans 2001). Where poor 
adherence and drug resistance are prevalent, the benefits of ART tend to be trivial compared 
to costs. 
The proponents of therapy extension respond to such arguments in different ways. Some 
criticise existing economic studies as biased, since positive externalities of medication have 
been excluded from the models (Boelaert et al. 2002; Yazdanpanah 2004). Others maintain 
that despite the immense costs of ART, the costs of not providing therapy are enormous 
because leaving people sick and dying in the prime of their productive life will result in 
severe psycho-social and economic devastation (van Dam and Hutchinson 2002). The 
Commission on Macroeconomics and Health (2001) argued that HIV treatment is vital for 
economic stabilisation and restoring economic development in highly-afflicted areas. 
The context of implementing ART in the developing world is subject to rapid changes in 
ARV prices and uncertainty in its outcomes, which makes economic analysis of HIV 
programmes difficult, unavoidably limited, and controversial in its role of informing policy 
(Hutubessy, Bendib, and Evans 2001; Kumaranayake 2002a; Mills and Shillcutt 2004). ART 
advocating organisations including the WHO, UNAIDS and OF ATM have found themselves 
more comfortable making policies on the grounds that economic assessment and utilitarian-
based concepts are important, but insufficient for those involved in policy and priority-setting 
processes (Boelaert et al. 2002). Thus, current mainstream policies tend to propose 
simultaneous investment in ART and HIV prevention (Lee 2003; United Nations 2001). 
1.5.3 Roles of ideologies in ART 
ART advocates use different ideologies in the campaigns for increasing treatment coverage 
around the world, often covering notions of human rights, equity and ethics (Annas 2003; 
Heywood 2002; Schneider 2002). 
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Many argue that 'health is a human right', and all parties have obligations to promote health 
for all people irrespective of their illness conditions (Patterson and London 2002). Some 
make the point that because of limited access to effective treatment and care, HIV infection 
equals a death sentence thus global apathy and inaction should be regarded as a crime against 
humanity (Hogg et al. 2002). The right to obtain proper HIV medications has been adopted as 
part of many international frameworks. As stated in the International Guidelines on HIV and 
Human Rights, for instance, 'access to HIVIAIDS-related treatment is fundamental to 
realizing the right to health. ' (UNAIDS 2003b: 13). Following Patterson and London (2002), 
there is an increasing body of international agreements, treaties and law drawn on a human 
right basis which benefits treatment access. Examples are the Declaration of Commitment 
issued by the United Nations General Assembly Special Session on HIV/AIDS, the Doha 
Declaration, and the Inter-Parliamentary Union's Handbook for Legislators on HIV/AIDS, 
Law and Human Rights (UNAIDS and IPU 1999; United Nations 2001; World Trade 
Organization 2001). 
Paradoxically, the values of ethics have been used for and against ART in the South. 
Ethically-oriented concepts are introduced to oppose policy decisions developed on economic 
grounds. Boelaert and colleagues (2002) argue, for example, the rationale for treatment in 
industrialised societies is not based on its cost-effectiveness but the contribution to health and 
quality of life of PLWHA. The authors (2002:1002) also maintain: 'Sound and democratic 
decision making is not only grounded on technical evidence, but also on ethical principles, 
respect for and fair representation of the interests of patients, their families and communities '. 
According to many activists, despite unsatisfactory cost-effectiveness ratios, access to a 
health intervention should be strongly encouraged if it is life-saving (von Schoen Angerer et 
al. 2001). 
However, ethics-guided discourses, based on the clash between individual rights to life-
saving services and the public interest, have also opposed large-scale medication in resource-
poor settings (Sills 1994). Some suggest to withhold therapy to patients who are potentially 
poor adherers, for example homeless and transient persons, drug addicts, and the mentally ill 
(Eckenwiler 1999). These assertions are supported by the fact that inadequate adherence may 
lead to drug resistance. This not only wastes resources but may also release unmanageable 
drug resistant viral strains to a wider population. Others contend that restraining access to 
ART is unethical as it may force these people to seek sub-standard and un-supervised use of 
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medicines from the black market (Buve, Kalibala, and McIntyre 2003; Friedman, Wainberg, 
and Drucker 1998). 
With respect to a fundamental professional ethic of 'doing no harm,5, it has been argued that 
healthcare providers are obliged to deliver HIV treatment and to ensure best practice 
including facilitating adequate adherence and offering prevention interventions (Friedman, 
Wainberg, and Drucker 1998; Popp and Fisher 2002). As Von Schoen Angerer (2001) 
emphasises, failing to provide the most feasible, available treatment to patients is also an act 
against physicians' ethics. This argument goes on to propose that, it is the mutual obligation 
of all social institutions including families and infected individuals, to foster adherence 
through all feasible measures, rather than resist expansion of ART coverage. 
The above contentions are contradicted by others. Pronyk and colleagues (2001) simply raise 
the question 'Is antiretroviral treatment a solution or merely a further complication for 
countries in sub-Saharan Africa and elsewhere? '. The 'doing no harm' norm, when applied 
to the case of ART in incompetent health systems, may harm the public, and so implementing 
therapy should be avoided. Instead, policy should be to prescribe 01 prophylaxis which is less 
complicated, more affordable, and to some extent effective in prolonging patients' lives. 
Finally, there are concerns about equity. Inequitable access to ART between the North and 
the South, as well as in-region and in-country inequities suggest the need to increase 
treatment coverage, especially in poor settings. Practically, however, the expansion of ART 
which cannot meet the demands in all countries has led to inequities. The limited success of 
international plans such as the Accelerating Access Initiative in lowering drug prices in some 
areas offers an illustration: 
'Prices for antiretroviral medications in Honduras dropped 85%, down to about 
US$l, 300 yearly. Yet in bordering Nicaragua, ... , the price for ART remains above 
US$5, 000 yearly for most cocktails. This phenomenon occurs because UNAIDS 
implemented its Accelerating Access programme in Honduras, successfully, and 
multi-national companies reduced their prices dramatically. ' (Stem 2002) 
5 Hippocratic Oath: " .. .I will do so to help the sick, keeping myself free from all intentional wrong-
doing and harm, .... " (http://www.wwwl.wnn.edulphnnloaths/oathl.html; accessed 29 October 2004) 
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From an extreme view, some note that ART programmes should not be launched unless 
equitable access for all clinically-eligible PL WHA is guaranteed (Binswanger 2003; von 
Schoen Angerer et al. 2001). The literature also illustrates the assertions that providing 
medication in less developed societies can undermine existing inequitable levels of access to 
health care (lDRC 2004). For instance, financing ART may drain resources needed for 
primary care services which usually benefit a wider range of people (Holmes 2004; von 
Schoen Angerer et al. 2001). Under pressure from international advocacy that supports 
responses to a particular disease the government may re-prioritise national health problems 
accordingly, distracting attention, resources, and management efforts away from other needs. 
1.6 Summary 
This chapter provides background information on HIV and ART. Despite substantial 
prevention efforts, between 1980 and 2000 the virus spread progressively throughout 
different parts of the world, affecting developing countries in particular. From the mid-1990s 
the use of antiretroviral drugs as combination regimens proved effective in reducing viral load 
and restoring immune functions. Experiences in the North illustrate significant benefits of 
therapy as well as several caveats. Integrating ART into a health system requires sufficient 
resources to assure service quality. For most settings in the South, the immense costs of 
ARVs and treatment monitoring and lack of experienced health workers are great 
impediments in delivering this life-saving medication. Over the past few years, advocacy for 
treatment expansion has been substantial, through the movement of civil society organisations 
and several initiatives at the global level. However, scaling-up ART programmes in poor 
countries has not occurred with consensus, and there continues to be considerable debate 
within discourses on ARVs and AIDS. 
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CHAPTER 2: ART IN RESOURCE-POOR SETTINGS 
Chapter 1 discusses the barriers to antiretroviral therapy (ART) of people in the developing 
world, and the global movement to deal with such obstacles. This chapter reviews treatment 
programme implementation in poor countries, focusing on how treatment is integrated into 
the health delivery system. It sets the context of this study, by reviewing Thailand's health 
delivery system, human immunodeficiency virus (HIV) problems and government policy 
responses including the evolution of the national treatment programme. 
2.1 ART in resource-limited countries: diffusion and coverage 
When zidovudine monotherapy was initially introduced, the high price of the drug restricted 
access among most patients even in industrialised societies (Peck and Bezold 1996). 
Information on the coverage of zidovudine medication in resource-poor settings in the same 
period is scant. Evidence suggests that it was not until the early 1990s that treatment was 
provided outside the developed world as Brazil and Thailand began small-scale zidovudine 
programmes in 1991 and 1992, respectively (Chequer et al. 2002). 
In 1996, Brazil became the first developing country to offer universal and free access to 
antiretrovirals (ARVs) (Galvao 2002). The number of treatment clients in Brazil steadily 
increased to 106,000 in 2002, representing over half of people living with HIV/ AIDS 
(PLWHA) on medication in the developing world (Chequer et al. 2002). The improved 
survival rates and cost savings due to the reduction in opportunistic infections as well as 
related hospital admissions were dramatic (Levi and Vitoria 2002; Marins et al. 2003). Owing 
to such success, the Brazilian ART programme has been acknowledged as a model for 
settings in the South (UNAIDS 2002b). Following Brazil, small-scale medication was 
initiated in several countries between the late 1990s and early 2002 (del Rio and Sepulveda 
2002; Desclaux et al. 2003; Katzenstein, Laga, and Moatti 2003; Laurent et al. 2002; 
Okubagzi and Singh 2002). Promising therapeutic outcomes comparable to the North were 
observed in pilot and community-based programmes in Ethiopia, Haiti, Mexico, Senegal, 
South Africa and Uganda (MSF 2004b; Walton et al. 2004; Weidle et al. 2002; WHO 2003a). 
However, access to HIV treatment and care including ART in poor settings is limited. In 2001, 
global ART coverage reached only 2% of an estimated 5.4 million population in need (WHO 
- 34-
CHAPTER 2: ART IN RESOURCE-POOR SETTING 
2002b). Although therapy has expanded steadily - the number of people receiving ARVs in 
low- and middle-income countries increased from 440,000 to 970,000 in 2004/2005 
(WHOIUNAIDS 2005b) - the service remained inadequate covering only 15% of people 
needing therapy in 2005. 
ART expansion varied across regions and countries. Latin America and the Caribbean made 
the most significant progress as by 2002 some countries such as Argentina, Brazil, Chile, and 
Cuba had achieved almost universal coverage (Chequer et al. 2002; WHO 2002b). By June 
2005, the World Health Organisation (WHO) and Joint United Nations Programme on AIDS 
(UNAIDS) (2005b) estimated that in the whole region, 290,000 or 62% of clinically eligible 
PLWHA were receiving treatment. In the same period the lowest ARV coverage of 5% was 
reported in North Africa and the Middle East, of an estimated 80,000 population in need. By 
contrast, the highest HIV prevalent area is sub-Saharan Africa, even on that continent the 
number of people on medication grew considerably from 310,000 to 500,000 in 2004/2005. 
However, almost 90% of people needing treatment could not access ARVs. 
In summary, although ARV combinations have been in use for therapeutic purposes since the 
mid-1990s, treatment extension in the developing world has developed only slowly. As a 
result, only small fractions ofPLWHA have access to life-saving medication. 
2.2 ART programme configurations in an era of scaling-up 
From 2000, substantial progress has been made in ART extension in resource-poor countries. 
The emphasis of stakeholders has shifted from how to obtain adequate funding for drugs and 
related services to how to deliver therapy effectively (Gilks 2001; Marchal, De Brouwere, and 
Kegels 2005). The literature illustrates the variation in patterns of ART programme 
arrangement, participating organisations and individuals, and financing components. 
2.2.1 Models of ART delivery in the public sector 
In the North, ART is mostly offered through specialised centres for HIV treatment and care 
(Bogaards and Goudsmit 2003). In areas with low density populations such as Australia, 
treatment is primarily provided by general practitioners in community care units, as part of 
comprehensive referral systems. In contrast, the models of medication delivery in resource-
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poor settings are diverse (Stewart, Padarath, and Bamford 2004). ART may be managed as a 
vertical scheme; may be integrated into existing programmes such as those for HIV I AIDS, 
other sexually-transmitted infections and tuberculosis; or may be delivered through normal 
health delivery services including hospitals and primary health centres (Jaffar et al. 2005). 
Although in many settings ART has been recognised as a component of prevention and care 
for PL WHA, therapy is prescribed and followed-up in limited certified sites, while general 
care is often provided through broader health services. This is the case in Botswana, 
Cameroon, India and Indonesia (Day 2005; de Korte, Mazonde, and Darkoh 2004; National 
AIDS Control Committee Cameroon 2004). Kenya is perceived to have a well-coordinated 
system of care, with certified facilities determined on the basis of geographical coverage and 
HIV burden (Mundy 2003). These ART-delivery sites also offer other HIV services, and act 
as referral centres for patients from several entry points, for example tuberculosis clinics, 
prevention of vertical HIV transmission centres, and voluntary counselling and testing units. 
In the countries with prevalent HIV infections among injecting drug users (lDUs) such as 
Indonesia, Malaysia and Vietnam, therapy is also integrated into drug dependence treatment 
programmes (Ali, Rahmad, and Yaakob 2005; WHO/UNAIDS 2005a). 
Since ART coverage has improved, the needs for long-term hospitalisation have fallen 
markedly (Sabin 2002). Some settings make use of existing home-based care programmes to 
reduce the burden on the health delivery system. In Cambodia and Uganda, caring for 
PL WHA in their home with support from health workers is seen to enhance the effectiveness 
of counselling and education for patients and their families (Dejong 2003; Sano 2005). It is 
maintained that, furthermore, home care model benefits patients in remote areas where 
travelling and accommodation costs are expensive. 
2.2.2 Range of partners involved in treatment scaling up 
Substantial numbers of ART programmes in the developing world have evolved from pilot-
scale initiatives organised by multiple partners, ranging from gov~rnment agencies, private 
corporations, non-governmental organisations (NGOs), international organisations and donors. 
The public-private-civil society partnership notion remains vital in the treatment scaling-up 
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period, and is usually incorporated in national HIV I AIDS plans of many countries (Stewart, 
Padarath, and Bamford 2004). 
The private sector is included in many national frameworks to improve treatment access. But 
the nature of such involvement is extremely diverse. Some private hospitals have been 
certified by the government to deliver ART as part of extended treatment plans in Cameroon 
(National AIDS Control Committee Cameroon 2004). On the other hand, the South African 
Government has no policy to oversee treatment and care for HIV in private facilities, though 
attempts have been made to ensure standard service quality in both public and private sectors 
(South African Ministry of Health 2003). Transnational and local corporations in Botswana, 
Cote D'Ivoire, India, Rwanda, and South Africa playa role in ART provision to their 
employees and dependants (Global Business Coalition on HIV/AIDS 2003; UNAIDS 2004a). 
In many African, Asian, Latin American and the Caribbean settings, ARVs are also offered 
through private clinics and pharmacies (Brugha 2003; Macharia et al. 2003; Wheeler et al. 
2001). 
Pilot projects in Haiti, Uganda and elsewhere demonstrate the effectiveness of community 
approaches in HIV prevention and care (Dejong 2003; Farmer et al. 2001; Wendo 2005). 
Among the key activities prior to rolling out large-scale ART, is targeting and mobilising 
communities to raise awareness about the benefits and vital elements of treatment, as well as 
their potential role in supporting treatment administration (WHO 2002c). The involvement 
and solidarity of lay people and community-based organisations in partnership with other 
NGOs has been rising, especially in Africa, as witnessed in the creation of the Partnership for 
Access to Antiretrovirals in 2002 (WHO/UNAIDS 2005a). In some settings, these 
organisations import ARV s and deliver medication to people in need, and also take part in 
organising campaigns for access to treatment at the national level. 
PL WHA - those formed into 'self help' groups - have also had a role in hospitals and 
communities: offering mental support, reducing stigma, promoting adherence and facilitating 
uptake of therapy, as well as counselling and testing among people with unknown HIV status 
(Dejong 2003). A global initiative - the so called Collaborative Fund for HIV Treatment 
Preparedness - was launched in 2003, aiming to provide support for different preparedness 
activities through small grants to NGOs and PL WHA groups in Africa, Latin America, the 
Caribbean, Asia and Eastern Europe (WHO/UNAIDS 2005b). 
- 37 -
CHAPTER 2: ART IN RESOURCE-POOR SETTING 
2.2.3 Financing ART 
An important feature of ART provision is how treatment is financed. Government budget and 
health benefit plans are responsible for the major HIV expenditure in many middle-income 
settings, for example Panama (73%), Mexico (87%), and Chile (99%) (UNAIDS 2004b). In 
other countries where medication is inadequately offered through public programmes, some 
PLWHA access treatment is funded through NGOs and private business (Global Business 
Coalition on HIV/AIDS 2003; UNAIDS 2004a). Whether treatment comes from the public or 
private sector, the main burden of care for PL WHA in many societies falls on households -
many of which cannot afford treatment. 
In the scaling-up era, 'new money' from several international funds and philanthropic 
organisations has poured into poor countries. From 2002, multilateral and bilateral donors 
have also had an increasing role in therapy extension (MukheIjee et al. 2003). Rwanda is an 
obvious illustration. In 2000, total HIV expenditure was US$5.6 million, 41% of which came 
from afflicted households (Partners for Health Reform plus 2005). In 2002, overall costs for 
HN response amounted to US$9.9 million, and the share of out-of-pocket payments dropped 
to 16%, while external and public resources accounted for 75% and 9%, respectively. Funds 
committed for scaling up ART in the South during 2004 to 2005 came from the Global Fund 
to Fight AIDS, Tuberculosis and Malaria (GFATM), World Bank, the US President's 
Emergency Programme for AIDS Relief (PEPFAR), Clinton Foundation, and governments of 
Belgium, Italy, Luxembourg, the United Kingdom and the United States (WHO 2005c). The 
role of international initiatives in this period was significant, especially in highly endemic 
areas such as many southern and eastern African settings where the fmancial support for HIV 
prevention and treatment from outside accounted for over half the countries' total health 
budgets (Bennett, Boerma, and Brugha 2006). 
The analysis of resource flow and funding recipients within particular countries illustrates the 
configurations of ART delivery. In Mexico, for instance, treatment costs are subsidised 
through 5 social security institutions, while the uninsured access the service through the 
government's National Fund for Persons Living with HIV/AIDS (Bautista et al. 2003). In 
contrast, in South Africa the government budget for ART implementation is allocated directly 
from the National Treasury to provincial governments, down to public hospitals and district 
health centres (South African Ministry of Health 2003). Fragmented financing patterns can be 
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observed where there are several donors, as each funding agency focuses on different 
activities, for example drug procurement, treatment delivery, community- and home-based 
care, prevention, and development of infrastructure (WHO 2005a; WHO 2005c). 
2.3 Implementing ART in the developing world: the on-going challenges 
A growing body of literature on the introduction of ART in low- and middle-income 
countries suggests that the success in organising pilot projects is not easily replicated when 
treatment is brought to a large scale. While clinical effectiveness, acceptable adherence rates 
and low resistance are experienced in many parts of the developing world, unsatisfactory 
outcomes and threats of negative consequences in broad respects have also been reported in 
some settings (de Korte, Mazonde, and Darkoh 2004; Kasper et al. 2003; Marins et al. 2003). 
The ART initiative in China offers a good illustration. The Chinese government launched free 
medication programme in poor areas in April 2003, and experienced many difficulties 
including a drop out rate of almost 20% in the first seven months (Pan 2003). 
At the global level, despite the unprecedented increase in resources for HIV over the past few 
years, the gap between the amount pledged by donors and requirements remains immense. As 
ART provision in most developing countries is reliant on external funds, this raises a difficult 
question about service sustainability (GFATM 2005a; WHOIUNAIDS 2005b). The 
uncertainties of treatment programme financing and long-term support from international 
initiatives are well recognised. For instance, a WHO senior official pointed out, 'We're going 
to reach a crisis in terms of supply very very soon ... of antiretrovirals throughout the 
developing world because the scale-up is happening very very quickly. ' (Jim Yong Kim 
interview in Zarocostas 2005: 1104). Poor coordination between funding agencies and 
individual projects; conflicting interests of donors; and donor-driven agendas have been 
reported in recipient nations (National AIDS Control Committee Cameroon 2004; State 
Council AIDS Working Committee Office-China 2004; Taegtmeyer and Chebet 2002), all of 
which threatens the efficiency of ART implementation. 
As suggested elsewhere, impediments in delivering quality ART are also attributed to 
inadequate staff, infrastructure and drug and reagent supply. In Malawi, for example, staff 
shortage is so severe that 'in the event of loss of the only clinical officer at a treatment site, 
many patients and families could be negatively affected leading to cessation of therapy ... ' 
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(Muula 2004:418). Resource and management constraints, poor geographical distribution of 
ARVs and other medical services for PLWHA are reported (Day 2005; de Korte, Mazonde, 
and Darkoh 2004). For instance, although the sites to offer medication have been extended, 
essential laboratory tests are available only in urban areas or large cities (Muula 2004). 
During the scaling-up era, governments request technical assistance in many areas such as 
training, management, planning, monitoring and evaluation from the WHO and other United 
Nations specialised agencies (WHOIUNAIDS 2005a; WHO/UNAIDS 2005b), requests which 
are not always met. Slow progress in recruitment and capacity building of health personnel 
and community workers has been highlighted concomitantly with the problems of internal 
and external brain drain in sub-Saharan African settings (WHO 2005b; WHO 2005d). 
Evaluations also report high levels of stigma which act as a barrier to treatment access and 
adherence among people in need (WHO 2005b; WHO 2005d). Variation and inconsistency in 
regimens prescribed are prevalent, even though national guidelines have been established 
(Bautista et al. 2003). 
Although ARV prices have fallen considerably, treatment remains unaffordable for large 
numbers of PL WHA, particularly where there is a lack of support from government or social 
insurance. The high costs of ART and complementary services are said to be the major factor 
impeding treatment access and adequate adherence in Malawi, Mexico, and Nigeria (Bautista 
et al. 2003; Partners for Health Reform plus 2004; van Oosterhout et al. 2005). Shortage of 
ARVs, drugs for opportunistic infections (Ols) and other supplies owing to over-enrolment of 
clients, delays in budget release and poor performance in procurement are also evident in 
these settings. 
In some countries, mismanagement in the drug system has resulted in the leakage of donated 
ARVs to unauthorised health facilities and black markets, as well as re-exportation of the 
drugs to industrialised countries (Desc1aux et al. 2003; Siringi 2004). Within official 
treatment delivery networks, studies in African settings illustrate the use of substandard and 
counterfeit drugs that reflect unreliable selection, procurement, logistics as well as ineffective 
drug regulation (Ahmad 2004; Pau et al. 2005; Penzak et al. 2004). In addition, as the cold 
chain system does not always work well in areas where ART programmes are implemented, 
high temperature and humidity are common factors accelerating drug decomposition (Pau et 
al. 2005). 
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There are also significant challenges to individual case management resulting from clinical 
conditions of PL WHA, as many access institutional care and start treatment at advanced 
stages, with low CD4+ levels and OIs (Bautista et al. 2003; de Korte, Mazonde, and Darkoh 
2004). Standard practice guidelines suggest that such complications should be treated before 
ART initiation; however, therapy is infeasible in some countries because of the lack of 
appropriate medicines (Muula 2004). Moreover, HIV patients in many areas are commonly 
infected with tropical or sub-tropical diseases, for example amoebiasis, leishmaniasis, malaria, 
strongyloidiasis, and trypanosomiasis (Grant and DeCock 2001; Harms and Feldmeier 2002), 
comorbidities which increase the complexity of ART and costs of treatment provision. 
Specific expertise and extra resources are needed to address such problems. 
As the goal to deliver universal coverage for HIV treatment and care is difficult to achieve, 
governments face other challenges in allocating scarce resources across interventions, groups 
of population, and geographical areas. While the literature on the effect of ART introduction 
for resource diversion from other public programmes is limited, inequity in access to ARV 
medication has been observed in many countries (Bautista et al. 2003; Day 2005; Msellati et 
al. 2003; Partners for Health Reform plus 2004). The poor, uninsured, IDUs, men having sex 
with men, and remote or isolated populations often have less opportunity to receive therapy 
than others, as a consequence of existing vulnerability; stigma and fear attached to 
HIV/AIDS; inadequate information; and poor commitment of government. In HIV-prevalent 
settings with scarce resources, rationing ART in accordance with the criteria other than 
clinical eligibility is almost always inevitable, and debates around issues of ethics and equity 
continue (Bennett and Chanfreau 2005; Daniels 2005). 
2.4 Introduction to Thailand's health system 
Thailand's health system is pluralistic, involving various organisations in public, private and 
civil society sectors. The Ministry of Public Health (MOPH) is the national health authority 
responsible for implementing and coordinating programmes on health promotion, disease 
prevention and medical service delivery (Ministry of Public Health 2005). In addition to the 
Health Ministry, some disease control activities including HIV prevention and treatment are 
jointly carried out through the collaboration of many public agencies, private business and 
CSOs. 
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Many MOPH departments have regional offices in the 12 health regions. These offices 
include, for example, the Regional Disease Control Offices, Regional Centres for Health 
Promotion, Regional Centres for Cancer Treatment, and Regional Medical Laboratory 
Centres (Ministry of Public Health 2002b). These agencies are in charge of vertical 
programme implementation. Some, for example the Regional Centres for Cancer Treatment 
and Regional Medical Laboratory Centres, have sufficient resources to carry out all of the 
activities in charge. For others including the Regional Disease Control Offices and Regional 
Centres for Health Promotion, some of their responsibilities are to execute the programmes 
which target wide population, such as immunisation, health promotion and family planning. 
These programme activities are integrated into provincial health delivery system, carried out 
by health workers in hospitals and other health care settings. In such cases, the Regional 
Centres/Offices take a coordinating role, and provide technical and management support to 
Provincial Health Offices (PHOs), hospitals and local administrations. 
The MOPH also delegates some functions and authority to PHOs in 75 provinces. Primarily, 
the PHOs are responsible for provincial planning, budget allocation, disease surveillance and 
reporting, consumer protection of food and health products, medical premise registration, and 
monitoring health professional practices. They also supervise and coordinate all MOPH 
health delivery facilities in the province. For the national programmes those require health 
workers to be implementers: the PHOs act as collaborators between Regional Offices and 
implementation units. Special arrangement is introduced in the capital city of Bangkok, where 
health programme development and implementation are responsible by local government -
the Bangkok Metropolitan Administration. 
2.4.1 Health service facilities 
Thailand has a relatively well-established health delivery system in terms of specialisation 
and geographical coverage of health care facilities. By the early 1990s, the health service 
network in the public sector had expanded to cover all urban and rural areas, i.e. in sub-
districts and villages. Disease prevention interventions and medical services are mainly 
organised and delivered by MOPH facilities (table 2.1). 
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Table 2.1: Number of health facilities by type and administrative level, 2003 
Bangkok Regional Provincial District Sub- Villages 
Metropolis district 
Medical schools 5 4 - - -
Specialized 19 40 - - - -
hospitals (a) 
General hospitals 
Public (MOPH) 5 25 70 - - -
Public (others) (b) 24 - 57 - - -
Private 100 - 246 - - -
District hospitals 5 - - 725 - -
Health centres 61 - - 214 le) 9,765 -
Primary health 
- - - - - 66,223 
care centres 
Private clinics 3,100 - 11,853 - - -
Pharmacies 3,393 - 4,832 - -
Drug stores (d) 565 - 4,088 - -
Source: data from Ministry of Pubhc Health (2005). 
Note: (a) For example, psychiatric hospitals, cancer prevention and control centres, communicable 
disease hospitals and drug dependence treatment centres; (b) organised by non-MOPH agencies 
such as Ministries of Interior and Defence, Bangkok Metropolitan Administration, and state 
enterprises; (e) municipal health centres; (d) managed by non-pharmacist professionals such as 
nurses and midwives 
In 2003, primary health care centres, run by community health volunteers, existed in over 
66,000 villages. These settings provided basic treatment for minor illnesses, and also 
offered essential information on healthy practices for health promotion and disease 
prevention (Ministry of Public Health 2005). At sub-district level, 9,765 MOPH 
health centres are first-line health care units at which services are delivered by midwives 
and technical nurses. The other 214 health centres are located in urban areas, organised by 
local administrations including municipalities and the Bangkok Metropolitan 
Administration. At these facilities, services are provided by medical doctors and other 
health professionals. In 2003, there were hospitals with at least one general practitioner 
established in 725 out of 795 districts (91 % coverage). Secondary and tertiary care, 
emphasising curative treatment, is delivered by specialists in specialised centres and 
general hospitals at provincial, regional or metropolitan levels, largely by the MOPH 
(Ministry of Public Health 2005). 
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The private sector also has a role in health care delivery, especially through clinics, 
pharmacies and drug stores which offer primary services for minor illnesses. In 2003, there 
were some 15,000 private clinics, 8,200 pharmacies and 4,600 drug stores, mostly located in 
Bangkok, provincial capitals and districts (Ministry of Public Health 2005). In addition, 
people could seek institutional care from 346 private hospitals, most of which were 
concentrated in the capital city and urban areas of some provinces. The share of hospital beds 
in the private sector was 20% of the total 133,245 beds available in 2003 (Bureau of Policy 
and Strategy 2004c). 
2.4.2 Workforce In the health delivery system 
Thailand has sufficient capacity to produce health personnel of different professions and 
specialisation. Seventy institutes are responsible for health workforce education and skill 
development (Ministry of Public Health 2005). The number of health professionals and 
paramedics has increased over time. In 2002, there were 18,987 medical doctors, 84,683 
professional nurses and 7,350 pharmacists, working in the health service sector (Bureau of 
Policy and Strategy 2002). Twenty-one percent of doctors, 12% of nurses and 11 % of 
pharmacists practiced in private facilities. The country's ratios of population to doctor, nurse 
and pharmacist were 3,295, 739 and 7,350, respectively. Compared with many HIV-prevalent 
countries such as Ghana, Uganda and Zimbabwe, where the ratios are one doctor to 11,100, 
21,300 and 17,500 people, respectively (WHO 2004c), Thailand is better off. However, 
inequitable distribution of human resources in health across geographical areas is an 
important problem in the Thai health system. Figure 2.1 suggests that doctors, nurses and 
pharmacists are mostly clustered in Bangkok and the Central Region, while the Northeast 
Region has the highest popUlation to health workers ratio. The disparity of workforce 
distribution can also be observed at the provincial and district level. 
2.4.3 Health system financing 
In 2001, Thailand's health expenditure amounted to 170 billion baht at constant price (2,732 
baht per capita), which was 3.2% of Gross Domestic Product (Tangcharoensathien, Vasvid, 
and Patcharanaumol 2004). The government budget, allocated to the Health Ministry, other 
public agencies, and health benefit plans, was the major source of health finance, accounting 
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Figure 2.1: Distribution of doctors, professional nurses and pharmacists by region, 2002 
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for 54% of the total, while private funds , mainly came from household spending on medical 
services and personal care, were responsible for 46%. The share of foreign money was only 
0.1 % of the national health expenditure. 
Before 2001, there were four categories of publicly-subsidised health benefit programmes: 
Medical Welfare Scheme for low-income groups; Civil Servant Medical Benefit Scheme for 
government officials, state enterprise workers and dependants; Social Security Scheme for 
private-sector employees; and Voluntary Health Card Scheme (Tangcharoensathien, 
Srithamrongsawat, and Pitayarangsarit 2002). These plans varied for their benefit packages, 
payment mechanisms, costs of care, efficiency and equity across groups of beneficiary with 
regard to the level of government subsidy as well as quality of services provided. The four 
schemes covered around 60% of 63 million population, while private health insurance 
coverage was 10%, and the rest 30% were uninsured . 
Considerable changes in health care fmancing were introduced in 2001, when the government 
instigated the Universal Health Coverage (UC) Scheme. Three main objectives of the reforms 
were to provide universal access to health care including disease prevention, health promotion 
and medical services; to improve health system efficiency; and to standardise the benefit 
package across different government-organised health benefit programmes (Jongudomsuk 
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2004). In 2003, the UC was the largest health benefit plan, as it covered the low income and 
the previously uninsured, which accounted for 75% of the Thai population (Vasvid et al. 
2004). Meanwhile, the coverage of Civil Servant Plan and Social Security Scheme was 9% 
and 10%, respectively, and the fraction of those who had no benefit coverage declined to 5%. 
Despite the success in improving health access, variations between the three public schemes 
in terms of sources of finance, payment mechanisms to providers and benefit coverage remain 
(Tangcharoensathien and Jongudomsuk 2004). The UC and the Civil Servant Schemes are 
subsidised through general tax revenue, while the Social Security Plan is funded through 
public revenue, plus employers' and employees' contributions. Health services provided to 
Social Security Scheme members are subsidised on a capitation basis, according to the 
number of beneficiaries registered in each hospital. Meanwhile, the UC finances ambulatory 
care, health promotion and preventive care on a capitation basis, and has adopted Diagnosis 
Related Groups as a tool to subsidise in-patient services. In contrast, fee-for-service subsidy is 
employed in the case of government officials and dependants. 
2.4.4 Health system and policy research 
Apart from health facilities, equipment, medical supplies and manpower, Thailand's health 
system regards knowledge, scientific evidence and different sorts of information as crucial 
resources (Ministry of Public Health 2005). As research, knowledge management and 
evidence-based policy decisions are key strategies of the five-year National Health 
Development Plan (National Economic and Social Development Board 2002), many related 
activities such as programme monitoring and evaluation, research studies, information system 
development and dissemination of information derived from research findings, are integral 
parts of strategic and operational plans of all MOPH departments. 
The effort to create a conducive environment for knowledge generation and utilisation in 
policy making began in late 1970s, when the National Epidemiology Board was instigated as 
a technical advisory body in the Health Ministry (Wasi 2004). Over the past three decades, 
this group of clinicians, public health experts and reformists has evolved and established 
many autonomous agencies, which play a crucial role in producing evidence to inform 
policies and also strengthening health system research capacity. These include: for example, 
the National Health Foundation (established 1990), Health Systems Research Institute (1992), 
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and Thai Health Promotion Foundation (2001). See table 2.2. Owing to the shared visions and 
strong attempts of several persons involved in these agencies, there has been significant 
development in the country's health policy and system research including the expansion of 
research networks through the collaboration between researchers in health with academics 
and professionals of different disciplines, as well as civil society organisations (CSOs) and 
communities. 
Table 2.2: Objectives and strategies of selected health research promotion agencies 
Objectives Strategies 
The National To encourage • to create research networks to support a wide range of 
Health knowledge generation biomedical, health system and policy studies 
Foundation and utilisation as an • to disseminate research findings to the public or target 
(NGO) integral part of health populations 
system development 
The Health To promote and • to foster research and knowledge management to 
Systems support research support health system reforms 
Research studies to inform • to strengthen research networks for rational public 
Institute health policy health policies 
(autonomous, formulation and • to promote learning from research findings through the 
government implementation local participation of health providers and communities 
agency) • to organise political and social movement to advocate 
health system reforms 
The Thai To advocate changes • to campaign, support and provide funding to Thai 
Health in behaviour and organisations involved in health promotion 
Promotion environment in order • to create awareness of hazardous behaviour and to 
Foundation to reduce ailments create belief in health promotion amongst people 
(autonomous, and premature deaths • to conduct studies and research, or encourage the 
government as well as to improve conduct of the study and research, training or 
agency) quality of life organisation of meetings with regard to health 
promotion 
• to develop the ability of a community in fostering 
health promotion by the community or other 
organisations 
Source: Wasl, 2004 ; Health Systems Research Institute, 2005; Slwaraksa, 2004 Thal Health 
Promotion Foundation Act, 2001 
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2.4.5 Pharmaceutical industry and the Government Pharmaceutical Organisation 
The local pharmaceutical industry plays an important role in Thailand as it is the major source 
of drugs used in the health delivery system. The relatively low prices of generic products 
make most essential medicines accessible to the Thai people. In 2002 the value of generic 
drugs produced by 178 local laboratories in the private sector accounted for 55% of the total 
value of drugs distributed in the market (40,000 million baht, current prices) (Ministry of 
Public Health 2005). However, the Thai pharmaceutical industry has limited capacity. First, 
the industry is preparation-based, as it relies on raw materials imported from foreign 
countries: few of the chemicals, active ingredients and pharmaceutical necessities, can be 
synthesised locally. Second, most local manufacturers cannot produce drugs which require 
high technologies such as control-released products, biological and biotechnology-derived 
preparations (Commission on Thai Drug System Study 2002). Although academic institutes 
have succeeded in preparing some of these drugs in laboratories, there are many obstacles to 
scaling-up the production in industrial sites (Umprayn and Reungrungsi 2000). Given that 
most new chemical entities are patented and the production processes of new drug 
preparations increasingly require complex technologies, it is predicted that the share of 
locally-produced pharmaceutical products in Thailand will decrease over time. 
The Government Pharmaceutical Organisation (GPO) is a state enterprise under the MOPH. 
It is responsible for the production and supply of drugs including vaccines, and diagnostic 
reagents for the public sector (Government Pharmaceutical Organization 2004b). It aims to 
reduce government spending on imported drugs and reserve essential drugs for national 
emergencies. According to the Government Procurement Regulation, all government agencies 
and state enterpnses including national programmes, hospitals and other health facilities have 
to purchase drugs, if they are listed on the essential drug lists, from the GPO as their first 
priority (Commission on Thai Drug System Study 2002). Essential drugs can be bought from 
private companies only when they are not produced by the government laboratory, or if those 
manufactured by private firms are sold at a price lower than median price set by the MOPH. 
This government laboratory manufactures over 400 products, emphasising the drugs on the 
National Essential Drug List (Kraisintu 2001). The sales volume of the GPO products is 
approximately 4,000 million baht a year. 
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The GPO's Institute for Research and Development was established in 1992, with the 
mandate to conduct research to develop suitable formula and quality assurance methods of 
pharmaceutical products for industrial-scale production (Government Pharmaceutical 
Organization 2004c). Since its conception, the Research and Development Institute has 
worked on the formulation of many ARVs and drugs for OIs (Kraisintu 2001). By 2004, the 
GPO had produced 22 ARV products in different strengths, dosage forms and combinations, 
containing 5 ARV entities: zidovudine, didanosine, stavudine, lamivudine and nevirapine 
(Government Pharmaceutical Organization 2004a). Compared with the original products, 
prices of GPO's drugs were significantly lower (table 2.3). The launch of cheaper generic 
versions has resulted in a price reduction of some originals. However, until 2001, the GPO 
had only produced a small number of ARVs and certainly not sufficient to meet the needs of 
PLWHA. 
Table 2.3: Comparison of ARV cost per day, original products and GPO's products (baht) 
2000 2001 2002 2003 2004 
Original GPO's Original GPO's Original GPO's Original GPO's 
d4T+3TC 382 382 106 382 27 382 27 382 27 
AZT+3TC 387 387 126 387 48 387 44 387 44 
AZT+d4T 278 278 86 278 20 278 20 278 20 
d4T+ddI 292 292 78 292 55 292 55 292 55 
NVP 324 83 50 54 30 55 30 55 30 
EFV 300 107 107 107 107 111 111 111 111 
Source: MSF-BelglUm, ThaIland (prepared by Sarowat and Siriwong, June 2004) 
Note: d4T, stavudine; 3TC, lamivudine; AZT, zidovudine; ddI, didanosine; NVP, nevirapine; 
EFV, efavirenz .. 
2.5 HIV and ART in the Thai context 
The HIV epidemic in Thailand reached the generalised6 stage in the early 1990s. Although 
public programmes for disease prevention and impact mitigation including small-scale ARV-
6 Generalised epidemic refers to an HIV epidemic in a country in which 5% or more of women 
attending urban antenatal clinics are infected; infection rates among individuals in groups with high-
risk behaviour are also likely to exceed 5% in countries with a generalised epidemic (World Bank. 
1998. Confronting AIDS: Public Priorities in a Global Epidemic. Geneva: World Bank.) 
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based therapy had been established since the problem became apparent, it was not until late-
2001 that the nationwide ART initiative began. This section explores the country's response 
to the HIV epidemic, as well as the evolution of the national treatment programme. 
2.5.1 Features of the epidemic 
The first HIV case in Thailand was diagnosed in a university hospital in 1984 (Phanuphak et 
al. 1985). In the beginning, the disease was concentrated in homosexual men and IDUs 
(Kunanusont 2000). In the early 1990s, heterosexual relationships became a major mode of 
viral transmissions, driving the infections into the general population. According to the 
national registry, by the end of 2003 HIV/AIDS cases reported from healthcare settings had 
accumulated to 317,000, of whom 73,000 had died. Ninety percent were 15 to 49 years of age 
(Deewong and Chitnumsub 2003). The highest number of 28,000 cases and 8,000 deaths was 
reported in the single year of 1998. Thereafter, there was decline in both morbidity and 
mortality? 
Findings of sentinel sero-surveillance also illustrate the falling trend of the epidemic (Plipat et 
al. 2003). Between 1989 and 1995, prevalence escalated, and was followed by a decline in all 
high-risk groups (figure 2.2), except the IDUs (Bureau of Epidemiology 2004b). The 
prevalence among brothel-based sex workers, for instance, rose from 4% in 1989 to 33% in 
1994, and then steadily dropped to 11% in 2003. On the other hand, disease rates among 
IDUs8 reached 50.8% in 1999, and fluctuated between 44.9% and 50.0% during 2000 to 2003. 
Meanwhile, the estimated number of IDUs in the country was between 100,000 and 250,000 
(Kaplan 2005). 
Following a study commissioned by the national planning agency - the National Economics 
and Social Development Board, the accumulated HIV cases and deaths in 2001 were 700,000 
and 358,000, respectively (Thai Working Group on HIV/AIDS Projections 2001). The 
projections also suggest that, based on the profiles ofpeople's behaviour and national HIV 
7 The figures from the disease registry more or less represent the number of PL WHA who could access 
institutionalised health services; however, the case reports were disproportionately submitted by 
hospitals under the Health Ministry. Underreporting is commonly associated with this type of 
monitoring system and has been witnessed in many settings (Division of Epidemiology 2002). 
8 HIV testing in injecting drug addicts was carried out in those sought care from public drug addiction 
treatment clinics. 
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Figure 2.2: HIV prevalence in high-risk populations, 1989 to 2003 
Source: Bureau of Epidemiology 
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Note: CSW, commercial sex worker; direct CSW, brothel-based sex workers; indirect CSW, sex 
workers who are based in non-brothel establishments, for example restaurants, night clubs and 
massage premises; male STD, male attendants of clinics for sexually-transmitted diseases. 
policies in 20009, the number of new HIV and AIDS cases and overall PL WHA tend to 
decline until 2020. This means that if ART access has been promoted, the number of HIV-
infected persons at a particular time will be larger than estimated in the baseline scenario 
owing to the extended survival. 
2.5.2 National responses to HIV epidemic 
After the fIrst AIDS case was reported, the Thai government reacted slowly because HIV was 
believed to be a problem of limited groups of male homosexuals, especially those in contact 
with foreigners, thus was not a threat to the whole population (Tarantola et al. 1994). 
Although later evidence indicated the coming endemic, public information and other means 
of HIV education was suppressed due to the concerns about adverse effects on foreign 
investment and tourism, major sources of the country's income (Ungphakorn and Sitthitrai 
1994; Viravaidya 2001). During this phase, the HIV policies developed and implemented by 
9 ART in the national programme was provided to only 2,000 PL WHA; and the prevention of mother-
to-child HIV transmission was in its initial phase. 
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the Health Ministry were mostly 'health-focused', emphasising risk group education, disease 
surveillance, and blood screening (Thongcharoen 1991). 
Informed by the first-round HIV sero-surveillance in 1989, which demonstrated high 
prevalence in IDUs and sex workers, HIV rose on the government policy agenda 
(Phoolcharoen et al. 1999). A new national framework was introduced in 1991, integrating 
disease prevention, treatment and alleviation into the National Economic and Social 
Development Plan, which aimed at fostering multisectoral participation to address the 
emerging epidemic and its implications (Porapakkham, Pramampol, and Athibhodhi 1995). 
The five-year National AIDS Plan for 1992 to 1996 comprised four major elements: (1) 
public information and education, (2) medical treatment and care, (3) human rights 
protection, and (4) social support, and research, monitoring and evaluation (Ungphakom and 
Sitthitrai 1994). Many prevention programmes implemented in this period changed sexual 
behaviours and contained new infections (Nelson et al. 1999; UNAIDS 2001b). They 
substantially altered the course of the epidemic. In this period, in addition to the public sector, 
NGOs and business coalitions had an increasing role in HIV policy making and 
implementation. 
During the first half of the 1990s, HIV treatment mainly comprised 01 drugs, though they 
were perceived to be inefficient since medication was expensive and could prolong life for 
only a short period (Sawanpanyalert 1997). Owing to scarce resources, HIV inevitably 
competed with other health problems for budget, personnel and supply allocation in health 
facilities. As the number of patients escalated, the impact on the health systems became 
clearer. The strategies employed to reduce the burden were to facilitate the collaboration 
between healthcare settings, communities and NGOs through the establishment of day care 
services and self-help groups. Such collaboration has been claimed to have provided the 
foundation for introducing a holistic care package in the subsequent period (Thanprasertsuk 
1997; Tsunekawa et al. 2004). 
In the late 1990s, HIV policy direction shifted again: the 1997-2001 National AIDS Plan was 
formulated to harmonize with the current National Economic and Social Development Goals, 
i.e. sharing the concepts of 'people-centred' development (Kampisit 2000). Empowering 
people as members of families and communities was the main strategy. The plan called for 
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operationalisation through community-based civil society movements, while all sectors were 
expected to take active roles (Phoolcharoen et al. 1998). 
During this phase, the MOPH's AIDS Division launched two national-scale initiatives: the 
Comprehensive Care Continuum for PL WHA in 1997 and the Prevention of Perinatal HIV 
Transmission in 2000. The former aimed to offer timely, holistic medical services and 
psychosocial support to infected persons and their families (AIDS Division 2000). The 
programme's activities were carried out in healthcare settings and communities (Simmons 
and Uthis 2002). For the vertical transmission prevention, the programme was developed on 
the evidence and experience from clinical trials and pilot projects conducted in Thailand 
between 1996 and 2000 (Kanshana et al. 2000; Thaineua et al. 1998). After the process of 
counselling and testing, short-course zidovudine regimen and breast milk substitution formula 
were offered to all pregnant women who voluntarily joined the initiative. The Health Ministry 
claimed that due to high uptake this intervention could halve new-born infections (UNDP-
Thailand 2004). 
The holistic approach principle was maintained to the National AIDS Plan for 2002 to 2006: 
fostering people-centred strategies and participation of all sectors (Kampisit 2000; National 
AIDS Committee 2002). Three main targets to be achieved included (1) reduction of HIV 
prevalence among the 15-49 year-old population to less than 1%; (2) providing access to 
appropriate care and services to least 80% of PL WHA and affected persons; and (3) HIV 
prevention and alleviation activities to be initiated and implemented by local administrations 
and communities. Apart from encouraging afflicted people, families and communities to be 
self-reliant in disease prevention and care delivery, this plan aimed to modify the health 
delivery system for PL WHA in order to guarantee full and fair healthcare and social welfare 
for the afflicted population. 
2.5.3 Overview of civil SOCiety organisations in HIV field 
Alongside the development of HIV control programmes, civil society organisations took an 
important part in the policy processes. At national level, NGO leaders started their role in the 
campaign for prompt government response to the disease in mid-1980s (Ungphakom and 
Sitthitrai 1994). Despite this, NGOs were first integrated into the national HIV control 
framework when there was a change in the administration in 1991, and Mechai Viravaidya -
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Chainnan of a renowned NGO for family planning, the Population and Community 
Development Association (PDA) - was appointed to be the Minister to the Prime Minister's 
Office. The long-standing relationship between PDA and public agencies allowed NGO 
participation in the country-level policy making (Seckinelgin 2002; UNDP-Thailand 2004). 
Representatives of people's organisations fonnally joined government policy decisions from 
1991, as they were appointed to be the National AIDS Committee members. 
Civic participation in HIV prevention and care at peripheral level began in 1984, at least 50 
NGOs were working in the field in that year (Denduang and Charusomboon 1993 quoted in 
UNDP-Thailand 2004). Apart from the PDA, well-established NGOs such as the Thai Red 
Cross Society and the Parenthood Association of Thailand were among the first civic groups 
launching HIV prevention and education interventions (World Bank Thailand Office 2000). 
The number of associations and foundations registered as not-for-profit HIV-related 
organisations markedly increased in 1992 and onwards (Rujjanavet and Chinchotikasem 
1995). In 2004, more than 650 NGOs including community-based organisations were 
working in the area of HIV / AIDS, mainly located in Bangkok and disease-prevalent 
provinces in the north of the country (Ministry of Public Health 2005). When HIV burden to 
health care providers became visible in certain areas, groups of persons afflicted by the 
infection were instigated, mostly with support from health facilities or NGOs (UNDP-
Thailand 2004). By 2005, over 700 PLWHA groups had been established (ATSI 2005). 
HIV NGOs carried out several activities, ranging from education, prevention, care, support 
and advocacy: for example, providing care for PL WHA, offering social and financial support 
to afflicted families, organising education programmes on HIV prevention, reducing stigma 
and discrimination attached to the disease in workplaces and communities, and campaigning 
to improve AIDS rights (UNDP-Thailand 2004). In many instances, NGOs collaborated 
closely with government agencies and patient groups to carry out their tasks (Panichpak 
2002). PL WHA in 'self-help' groups also contributed to prevention and care delivery, 
psychosocial support and other impact mitigation programmes, especially in communities. 
Since 1992, CSOs involved in HIV services could apply for budgetary support from the 
MOPH (ATSI 2005). However, government budget could meet only a small fraction of the 
amount demanded. In 2004, for instance, 24% of the requested 290 million baht was allocated 
(Ministry of Public Health 2005). 
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2.5.4 Evolution of the national ART programme 
The ARV medication programme in Thailand can be traced back to 1992, when a small-scale 
initiative was established by the Health Ministry to provide zidovudine monotherapy to low-
income patients (Kunanusont, Phoo1charoen, and Bodaramik 1999). The drugs used in this 
initiative were subsidised by the government, procured centrally by the MOPH's Disease 
Control Department, and then supplied to participating hospitals, which were small in number, 
and mostly located in Bangkok. Treatment coverage was insignificant, compared to the size 
of the epidemic. The number of clients was only 350 in the first year though it increased to 
3,600 by 1995 (Tangcharoensathien and Teokul 2002). Despite an increase in treatment, the 
proportion of those covered declined as the epidemic extended dramatically (Punpanich, 
Ungchusak, and Detels 2004). 
In 1995, the Health Ministry terminated its ART service because an economic evaluation 
suggested that the programme was inefficient and considerably less cost-effective than 
vertical transmission prevention (Kunanusont, Phoolcharoen, and Bodaramik 1999; Prescott 
and Thai Antiretrovirals Study Team 1998). The economic evaluation study also suggested 
that many factors contributed to the undesirable costs and outcomes: for example expensive 
drugs, low-efficacy regimens, and poor compliance with treatment protocols on both supply 
and demand sides. From 1996 the MOPH's ARV budget was relocated to support a newly-
established clinical trial project - the so-called Clinical Research Network - which aimed to 
strengthen health care providers' capacity to deliver ARV medication as a component of 
comprehensive care for PLWHA (Thanprasertsuk, Lertpiriyasuwat, and Chasombat 2004). 
Introduced as an operational research project, this initiative assessed the effectiveness of 
different dual-ARV protocols. By 1999, 58 MOPH hospitals, teaching institutes, and NOOs 
had joined the network. The number of treatment recipients as research subjects was 
maintained at 2,000 per year from the Network initiation till 2001 (Tangcharoensathien and 
Teokul 2002). However, during this period some PL WHA accessed antiretroviral medications 
through other research initiatives as well as through services organised by NOOs and through 
private providers (Phanuphak 2004; Punpanich, Ungchusak, and Detels 2004). 
Based on experience and information gained from the Clinical Research Network, the 
MOPH's policy to provide service-based ART was reformulated as part of the Access to Care 
Initiative in 2000 (Siraprapasiri 2002). The Access to Care Initiative aimed to develop a 
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comprehensive HIV treatment delivery system, and to improve medication access among 
infected persons (Ministry of Public Health 2001 b). Highly active antiretroviral therapy 
(HAART) was first introduced in MOPH hospitals in this period. To address the obstacles 
found in the past, three main strategies included: (1) ARV price negotiation undertaken by the 
Disease Control Department; (2) selection of participating hospitals on the grounds of their 
competency in health service delivery, financial status, pharmacy administration, voluntary 
counselling, HIV testing, referral network, as well as community support; and (3) 
standardization and development of clinical guidelines (Ministry of Public Health 200 I b). 
All regional, provincial and district hospitals in 8 upper northern provinces were invited to 
join the programme on a voluntary basis (Satasit, Kuaykiatikul, and On-Nom 2002). By the 
end of 2001, the Access to Care facilities had extended to include 109 hospitals and 16 
laboratories, most of which were located in the northern region. In its first year, the Initiative 
targeted 1,200 adults and 500 children, who were enrolled by a local panel comprising 
government officials, NOO staff, representatives of communities and PL WHA in accordance 
with centrally-set criteria. Apart from new enrolees, it was the Health Ministry policy to 
continue to support ARVs to study subjects in the clinical research network, after it had been 
replaced by Access to Care Initiative. 
The first-year programme evaluation of the Access to Care Initiative suggested several 
problems in the preparation and implementation. Only 1,400 clients were enrolled, and as of 
January 2002, over 30% were lost to follow up (Satasit, Kuaykiatikul, and On-Nom 2002). 
Poor adherence to therapy was also prevalent. The obstacles in delivering treatment included 
inadequate experience and knowledge of doctors, counsellors and other health personnel, 
ARV and laboratory reagent shortages, a lack of laboratories in some areas, and the short life-
span of some drugs which resulted in complicated inventory and storage management. A 
study conducted in 6 northern provinces in the same period demonstrated similar difficulties 
reported by clinicians, nurses and pharmacists in the execution of the Initiative (Punpanich et 
al. 2002). 
In November 2001, the new government pledged to gradually expand ART coverage to 
achieve universal coverage (The Nation 2001). According to the new Health Minister, 
medication would be included in the benefit package of the newly established UC Plan 
(Matichon 2002). This represented a change from initially limited support for treatment for 
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PLWHA to a pledge to make ART universally available. After the adoption of the new 
treatment policy, access to ARV service in public programme increased dramatically. In 
September 2004, the number of patients on therapy was 50,750, 83% of projected AIDS cases 
in the country (data from Bureau of AIDS, Tuberculosis and Sexually-transmitted Infections) . 
However, it was not until late 2005 that ART was integrated into the UC scheme, and 
financed through the National Health Security Office. During 2001 to 2005, the national 
treatment initiative continued to be subsidised by the Health Ministry's budget. 
Figure 2.3 summarises the development of the publicly-organised ART programme from its 
instigation in 1992 until 2004, when therapy was scaled up to meet universal access goal. 
Figure 2.3: ART programme development, 1992-2004 
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2.6 Summary 
The first section of this chapter suggests that in the era of treatment scaling-up, ARV 
medication in resource-constrained countries has expanded rapidly owing to support from 
international agencies, donors and CSOs. However, in most HIV -afflicted areas service 
coverage remains limited. In some settings where therapy has expanded, many challenges 
emerge, and are likely to hinder treatment quality and programme efficiency. In addition, 
there are major differences in ART coverage across regions as well as divergence in treatment 
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programmes the developing world. These situations reflect the roles of several factors that 
shape policy decisions and implementation. 
Thailand is a country with a relatively high HIV prevalence. The swift government response 
to the epidemic, especially in prevention efforts, led to a decline in new infections from the 
mid-1990s. National HIV strategies evolved rapidly between 1991 and 2000, addressing the 
growing demand for medical services in the public sector, by establishing collaboration 
between healthcare providers, private corporations, communities and NGOs, and promoting 
holistic prevention and therapeutic approaches through a variety of initiatives. 
Despite the progress in healthcare arrangement for PL WHA, Thailand struggled to introduce 
ART, starting with publicly-subsidised treatment for some from 1992. However, the service 
failed for many reasons, and the MOPH embarked on a number of operational research 
projects to assess and improve implementation. Throughout this decade of national 
programme implementation, only a small fraction of PL WHA benefited. The adoption of the 
universal ART policy in 2001 was therefore regarded as a radical shift in treatment delivery. 
This study explores the scale up of Thailand's antiretroviral programme to meet the universal 
coverage goal. It describes the reasons why the government decided to expand treatment, and 
how such intention was translated into action. This thesis is organised into eight chapters: 
Chapter 1 provides the overview of the global HIV epidemic and its consequences, the key 
elements of ART, the integration of treatment into health systems, and controversial issues on 
treatment expansion in resource-poor countries. 
Chapter 2 reviews documents on the introduction of ART in the developing world, including 
medication coverage in different regions, treatment programme configuration, and problems 
experienced in programme scaling-up. This chapter also introduces Thailand's health systems 
and the past development of its HIV problems, policy response and ART provision. 
Chapter 3 reviews literature on models and approaches in public policy analysis, focusing on 
the use of two concepts: policy networks and policy learning, to understand actors' 
involvement in the processes of agenda setting, policy formulation and implementation. This 
chapter also sets the framework, objectives and the methods used in this study. 
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Chapter 4 examines agenda setting and policy adoption processes, including the shifts in 
policy networks and the perceptions of network members of the large-scale ART programme, 
transformation of political context, and changes in the administration which led to health care 
financing reform and ARV price reductions. 
Chapter 5 addresses policy formulation by analysing the structure and interests of the Health 
Ministry's advisory panels responsible for devising the national ART programme 
configuration, including the process of drawing lessons from past experiences of the panel 
members as well as treatment implemented in other countries. 
Chapter 6 sets the context of case study provinces: Phichit and Rayong. It reviews HIV 
epidemiology, health system resources, relationships between health providers and CSOs, 
HIV treatment and care before ART expansion, and the decisions to participate in the national 
treatment programme of the six study hospitals. 
Chapter 7 examines the process of implementation of universal ART policy in study hospitals, 
including arrangements of staff for service delivery, targets and achievement, constraints and 
coping strategies. It explores the collaboration between hospitals and networks with CSOs 
sought by health workers as well as the providers' learning motivated by the desires to meet 
the hospitals' targets and assure treatment quality. 
Chapter 8 discusses the thesis findings against the conceptual framework and existing 
literature on ART introduction in resource-poor settings. It also highlights lessons learned 
from the Thai experience on treatment expansion. Conclusions are drawn on the contribution 
of policy analysis approaches to understand ART policy development in the Thai context, and 
the potential utilisation of such understanding to inform policy in other developing countries. 
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Chapter 2 illustrates that although human immunodeficiency virus (HIV) is a vital public 
health problem in many societies in the South, there are variations in national antiretroviral 
therapy (ART) policy. In most areas ARV medication is available for only limited numbers, 
and extensive treatment coverage is relatively rare. Given the real difficulties in rolling out 
ART initiatives in poor countries, understanding why some governments have commenced 
universal coverage for this service, and how they developed the programmes and strategies to 
overcome impediments is important and will have lessons for other countries. Thailand has 
been selected as a case study to explore policy development and implementation of ART. As 
seen in chapter 2, the national HIV control policy long emphasised prevention elements, but 
in late 2001 there was a dramatic shift as the government decided to increase treatment 
coverage from a small-scale programme to meet universal needs. 
This chapter reviews theoretical literature and related empirical studies in public policy. An 
analytical framework is generated to provide an approach for analysing the policy process. 
Based on this conceptual framework, specific objectives for the study have been developed, 
which focus on the different roles of actors and their influence on three policy stages: agenda 
setting, formulation and implementation. The context within which these interactions take 
place is also explored. Then, two notions of policy networks and policy learning are discussed 
for their utility in explaining policy in particular phases. Finally, methods employed in this 
thesis and research limitations are illustrated. 
3.1 Study of public policy: general conceptual framework 
The term 'public policy' has been presented with several definitions, ranging from simple to 
complex formulations (Parsons 1995). However, they all centre around some key aspects: 
public policies are originated through the decisions of governmental agencies including 
legislative institutes to retain the status quo or to introduce changes in a policy domain 1o 
10 Policy domain refers to fields of public activities, for example health, education, agriculture and 
transportation (John 1998). Such a notion denies the existence of singular political system structures, 
and suggests a variety of political processes in each area. Particular policy domains differ in several 
aspects, for example the influence and cooperation of actors; resources and instruments available to 
policy makers; practice of decision making; balance of power; and likelihood of policy success. 
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(Howlett and Ramesh 2003). Leichter (1979:38) suggests that public policy analysis has its 
central role in addressing the question 'Why do governments do what they do?' 
In general aspect, policy sciences aim to get insight into policy making and executing 
processes (Lasswell 1951: 14-15 quoted in Parsons 1995: 19). Theories and models developed 
in particular disciplines contribute to empirical studies of policy in different ways. For 
example, economics approaches emphasise the rationality, efficiency and equity of public 
programmes, while sociological frameworks mainly focus on social problems, social structure 
and power in society, organisations and institutions (Parsons 1995). By contrast, 
psychology's cognitive theories seek to explain how problems are recognised, how policy 
alternatives are searched, and how policy decisions are made. However, scholars maintain 
that in many instances, a policy is so complex that it requires a multidisciplinary framework 
in the analysis. Among others, Wildavsky (1979:15 quoted in Parsons 1995:29) points out 
'Policy analysis is an applied subfield whose contents cannot be determined by disciplinary 
boundaries but by whatever appears appropriate to the circumstances of the time and nature 
of the problem. ' 
Concerns of policy analysts vary. Some pay attention only to government activities, 
bureaucracy and outcomes of public interventions, while others look at the roles of different 
stakeholders and explore why they pursue certain solutions (Parsons 1995). To address the 
increasing complexity in developing countries' health systems, Walt and Gilson (1994) 
suggest that apart from exploring the policy content", three interrelated elements need to be 
taken into account, namely the actors engaged in the policy; the processes as the paths to 
policy choices and consequences; and the context in which the policy evolves. This 'policy 
triangle' framework 'can be applied in any country, to any policy, and at any policy level. ' 
(Buse, Mays, and Walt 2005:2). 
Actors 
The policy triangle approach considers actors as individuals, or people who form temporary 
groups such as groups of parents who campaign for nutritious school lunch, or members of 
permanent organisations, for example political parties, government departments, private 
'I Policy content is defined as substance of a particular policy which details its constituent parts (Buse, 
Mays, and WaIt 2005:4) 
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companies, and civil society organisations (CSOs) (Walt and Gilson 1994). Actors as 
individuals hold different roles and positions such as politicians, civil servants, academics, 
and professionals. Meanwhile, individual and group actors can also be differentiated by 
sectors they belong to: public, private for-profit and private non-profit or civil society. In 
addition, actors may seek to influence policies at certain levels so that they are classified as 
domestic, national, regional and international. Buse and colleagues (2005) argue that on the 
one hand, individuals cannot be separated from the organisations or groups they affiliate as 
they share some interests and destinations. On the other hand, however, any organisation is 
not homogenous, but consisting of many individuals who may have different ideas and 
positions towards particular policies. For instance, the Ministry of Health is a key actor in 
health protection, and at the same time, it is made up of several departments and large 
numbers of officials, professionals and paramedics. 
In the health sector, CSOs such as philanthropic foundations, professional associations, faith-
based organisations, and communities are groups of actors those play an increasingly 
important role in different policy stages (WHO 2001). Civil society refers to the institutional 
form of voluntarily collective action, distinctive from governmental agencies and private 
corporations 12 (Centre for Civil Society 2004). Since it exists alongside the state and the 
market, civil society is often defined as the 'third sector '. CSOs' action may support or 
oppose particular policies of the regimes (Post and Rosenblum 2002). The civil society notion 
is ideologically-oriented, based on a range of ideals about politics, organisation and 
citizenship (Van Rooy 1998 quoted in Lewis 2001:3). For example, civil society in the United 
States is developed on the values of voluntarism, liberty, community spirit, and efforts to 
keep the government accountable and effective (Lewis 200 I). Seckinelgin (2002) stresses that 
civil society movements represent the 'politics of people' - the underlying ideal of many 
community organisations in Western countries. However, CSOs in the South may developed 
on different ideals that affected their involvement in public policies in particular ways. 
The roles, position, interests and power of policy participants are important. Actors with 
different attitudes towards goals and means, may have unequal levels of power (Harrison 
12 In this sense, the tenns non-governmental organisation (NGO) and CSO can be used 
interchangeably. However, in some instances, NGO is viewed as the CSO with particular features. For 
example, the United Nations Development Programme defines NGOs as the CSOs which are involved 
in the contractual delivery of development goods or services (UNDP 2006). 
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2001). Along the policy process, actors interact with each other, and often those with more 
power playa leading role in shaping policies to enhance their interests (John 2002). Power 
and influence of actors are associated with policy resources they command (Howlett and 
Ramesh 2003). In some developing countries, policy decisions are made within a closed 
circle of few technocrats and professionals (Grindle and Thomas 1991). Power in policy 
making of the influential civil servants is based on different elements, for example their 
authority provided by laws and regulations, their knowledge and skills in special areas, and 
their ability in access to a wide range of information (Hill 1992: 1-11 quoted in Howlett and 
Ramesh 2003:69). However, the distribution of power in a society depends on policy issues 
and context (Buse, Mays, and Walt 2005). As Walt (1994) suggests, the extent of actor 
participation in health may differ according to whether an issue is considered low-politics or 
high-politics 13. Moreover, since an organisation is not seamless, power of different 
departments may be unequal. For instance, Buse et al (2005) argue that in government system 
of low-income countries, the Ministry of Health usually has less power than many others such 
as the Ministries of Finance, Defence, Foreign Affairs and Industry. 
Context 
Public policies also depend on the context within which they develop. They are affected by 
their environment, and vice versa - some may cause changes in context. Williams and 
colleagues (2004), for instance, argue that national malaria control policies that suggest the 
use of particular antimicrobials, especially in the settings with poor treatment administration, 
may result in widespread resistance of Plasmodium parasites. Leichter (1979) classifies 
policy context into four categories. First, situational factors are transient or impermanent 
conditions such as wars, technological changes, economic recession, and natural disasters. 
Second, structural factors, relatively more permanent conditions, including political, 
economic, social, and demographic structure. Third, cultural factors are political and general 
social values of groups in the society, such as religion. Finally, environmental (or exogenous) 
factors are events, structures and values existing outside the domestic political system such as 
13 Low politics issues are defined as ordinary issues those neither involve core values nor affect 
important groups in the political system. The policies to address low politics problems are seen as 
micro, sectoral policies, of which the processes tend to be open for broad participation. On the other 
hand, high politics issues are connected with macro-level ideals or values. Changes in the policies of 
high politics often develop in relatively close processes, and involve small groups of actors (Walt 
1994). 
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international collaboration, agreements or pressure. Contextual factors differently motivate 
and enable actors to recognise problems and also to support or oppose particular solutions 
(Considine 2005). 
Processes 
Policy in a broader sense does not focus on only the decisions to carry out particular actions, 
but looks at the complex, repetitive processes that create the outputs and produce changes 
from such decisions (Gordon, Lewis, and Young 1977; Harrison 2001). Developed as a 
heuristic device, the stagist approach has been introduced to disaggregate such messy 
processes into a series of phases. Among others, Hogwood and Gunn (1984) propose a 
framework of discrete stages, beginning with agenda-setting and option analysis, going on to 
policy formulation; implementation; monitoring; and evaluation. Although such 
simplification helps to facilitate studying public policies, it has been argued that the approach 
may be misleading as it cannot reflect what actually operates in the political systems (Parsons 
1995). Policy processes are not sequential, but comprise feedback loops between different 
stages: government agendas are continually set and reset, and policies may be reformulated 
while they have got implemented (Hill 1997). 
3.2 Conceptual framework for studying antiretroviral policy in Thailand 
The policy triangle framework suggests that to understand the development of Thailand's 
antiretroviral policy, the issues to be examined in this thesis include the interactions between 
actors, processes of agenda setting, policy formulation and execution and the context in which 
those processes took place. However, over the past decade significant changes in policy 
making have been observed: shifting dominant roles and power from traditional institutions 
such as governments and political parties to groups of multi-sectoral actors with different 
interests, resulting in the increased dynamics, uncertainty and interdependence (Hajer and 
Wagenaar 2003). This shift suggests that the relatively static policy triangle needs exploration. 
To enhance the explanatory power of the policy analysis framework, the notions of policy 
network and policy learning are introduced to the conceptual framework of this study. By this, 
it is expected to allow close exploration into the roles of actor coalitions and the extent to 
which their policy learning played a part in policy development. 
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3.2.1 Policy networks: framing the interplay between key actors 
'Networks are an organisational form with extraordinary capacities for innovation, 
managing risk, building trust, facilitating joint action and gathering information .... 
When networks include the active participation and involvement of decision makers 
they have the potential to influence policy. ' Stone (2001: 13) 
Although governments are officially responsible for policy making and execution, in reality 
public policies are shaped by clusters of representatives from politicians, bureaucrats and 
organised interests (Marsh 1998a). The policy network approach has been developed to 
understand the relationships between these actors, especially when decision making in public 
sector becomes so complex and fragmented that it cannot be explained by the older institution 
and state theories (Smith 1993). This approach argues that in a policy arena, state and non-
state actors are interdependent. This is because they have incentives to create networks 
whereby the former can achieve specific policy goals with assistance from the latter, while 
the interest groups can take part in policy making to pursue their benefits (Rhodes 1988). 
Bressers and O'Toole (1998:215) assert that the increasing attention to policy network 
concept 'has been fuelled in part by recognition of the complex array of actors involved in 
policy choices as well as the inability of contemporary government to move unilaterally 
without incorporating the constraints, preferences, and resources of other social actors. ' 
Others such as Hajer and Wagnaar (2003) argue that to address globalisation and increasingly 
fragmented sources of political power in the network society, both government and non-
government sides recognise the needs for shared perspectives on problem definitions and 
collective policy making as new modes of problem solving. 
Policy networks differ in terms of number of participants, types of interests, cohesion, 
resources and power (Marsh and Rhodes 1992). Resources can be finance, knowledge, 
expertise, technologies, or capacity to mobilise support from members and outside. Through 
their networks, participants are enabled to create collaboration, exchange information, share 
resources, and construct common knowledge (Stone 2001). The extent to which particular 
networks can influence policy processes and meet their ultimate goals relies upon the capacity 
to manage and maintain such collaborative practices (Hajer and Wagnaar 2003). Policy 
networks can be classified into two hypothetical categories: policy communities and issue 
networks (Marsh and Rhodes 1992). 
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A policy community refers to a tightly-integrated group with a limited number of members 
who share fundamental values and goals. The community is stabilised by persistent balance 
of power among members though one or two interests may dominate. A policy community 
usually involves only one government department, and if two or more agencies participate, 
only one of them has to be accepted by others to playa leading role (Smith 1993). Smith 
further argues that as well as the dominant department, on many occasions individual 
politicians may be involved, and that the policy community may comprise only one or two 
interest groups. In highly-technical areas such as those relating to some scientific or health 
issues, the roles of experts and professionals inside government or academic institutes are 
crucial. For example, in late 1990s clinicians and researchers were dominating actors in 
changing national malaria policies in many developing countries (Williams, Durrheim, and 
Shretta 2004). The networks of experts and professionals with recognised expertise in 
particular areas, who have a common set of beliefs, norms and policy projects, and attempt to 
use their technical competence to influence public policies are referred to as 'epistemic 
communities' or 'knowledge communities' (Haas 1992). 
By contrast, an issue network comprises large numbers of members with broad values and 
interests (Marsh and Rhodes 1992). As Smith (1997:81) points out, 'membership in an issue 
network is extremely large. There are likely to be several government departments, agencies 
or subcommittees. The range of interest groups could be in the hundreds .... ' In the case of 
smoking policy in the United Kingdom, for instance, the opponents of the tobacco industry 
which formed part of an issue network between the 1960s and 1990s included the British 
Medical Association, Action on Smoking and Health, and Department of Health including its 
departmental agencies such as the Health Education Council (Read 1992). These 
organisations created links with several government officials and medical doctors to 
encourage anti-smoking policies. 
Marsh and Rhodes (1992) maintain that issue networks have limited access to the policy 
process, and that they rarely exist at the inner circle of policy-making and therefore have an 
insignificant role in the policy process. However, on exceptional occasions members of issue 
network can influence policy though they are not consulted by the government, but act 
peripherally. For example, in the early 2000s a South African NGO-academic alliance led by 
the Treatment Action Campaign challenged the government to improve access to 
antiretrovirals (ARVs) (Schneider 2002). In 2002, the civic organisations won a court case 
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they filed against the administration: the Constitutional Court ruled that the National HIV 
Control Programme must offer nevirapine to all HIV -positive mothers in order to prevent 
vertical transmission (Willan 2004). Some observe that, however, despite the absence of 
political involvement, networks may affect policy decisions as their values and desires 
generate particular opinions and public debates (Stone 2001). 
Marsh and Rhodes (1992) stress, however, that no network conforms exactly to this 
categorisation, and that the policy community and issue networks are better perceived as the 
two ends of the policy subsystem continuum. For them the term policy network is used 
generically. In addition, the typology is not exhaustive as there may be two tiers within a 
policy network: a core and a periphery, and the difference between the members with and 
without resources is distinctive (Marsh and Rhodes 1992). Empirical studies show that even 
in well-integrated policy communities, different levels of participation and influence in policy 
decisions can be identified (Read 1992), and that economic and government interests usually 
dominate policy networks (Marsh 1998b). 
A policy network develops and changes in its beliefs, rules and strategies over time 
(Richardson 2000; Sabatier 1988). In some instances, the tight-knit communities become 
more open and less integrated, and vice versa (Smith 1991). As Marsh and Rhodes (1992) put 
it, transformation of policy networks is prompted by the il)ternal and external environment, 
such as economic and social change, new knowledge and technology, and public opinion. For 
example, when HIV-related problems became overwhelming and governments' response was 
considered inadequate, many countries including Thailand experienced increasing 
participation of CSOs in national policy processes (Sills 1994; Ungphakorn and Sitthitrai 
1994). Network members do not respond to contextual factors directly, but choose whether or 
not to respond and how to respond in accordance with their understanding of the issues and 
circumstances (Marsh 1998b). The literature suggests that, for instance, technical changes 
may be mediated by economics and professional interests (Marsh and Rhodes 1992). 
In a policy domain, two or more networks may exist and interact with each other (Marsh and 
Rhodes 1992). These policy networks may operate at different levels: global, national and 
sub-national (Richardson 2000; Shiffman, Stanton, and Salazar 2004). Competition and 
negotiations between networks and among members of the same network who command 
different ideas can be expected, with those with more resources and power dominating the 
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processes, either by retaining the status quo or fostering radical shift (Marsh and Rhodes 
1992). Substantial evidence demonstrates the important roles of policy networks in agenda 
setting, policy formulation and implementation. An illustration is the partnership between 
international agencies, the drug industry, national governments and NGOs those contribute to 
research & development, donation and distribution of essential drugs and vaccines in many 
poor countries, for example the Stop TB Initiatives, the Global Alliance for Vaccines and 
Immunization, the Gates Foundation/Merck Botswana Comprehensive HIV/AIDS 
Partnership, and programmes involving donations of albendazole, Malarone® (atovaquone 
and proguanil combination) and Mectizan® (Ivermectine) (Widdus 2001). 
However, although a series of case studies illustrates the existence of policy networks, and 
their effects on policy processes and outcomes in many policy domains, it is emphasised that 
solely analysing the policy network cannot provide insight into policy decisions and their 
consequences (Marsh and Rhodes 1992). This is because networks are merely one of the 
elements responsible for any policy innovation. Marsh and Rhodes (1992) point out that to 
understand better the policy processes, changes in the networks' environment and its 
influence on networks' features should be taken into account. In order to develop a more 
dynamic model to portray the association between policy networks and outcomes, Marsh 
(l998b) proposes the inclusion of the concept of policy learning among actors, as a factor 
influencing network interaction. As Marsh (1998b) suggests, skills of network members to 
interact with each other and with actors outside the network are not only inherent, but also 
acquired from their learned experiences. 
3.2.2 Policy learning: acquiring knowledge for policy decisions and action 
Learning refers to cognitive processes of attaining skills and knowledge which can be 
retained and used as necessary (Smith 2005). It is also applied to the course of interpreting, 
understanding and making sense of abstract elements such as values, goals and perspectives. 
Bernard and Armstrong (1998:46) note: 
'Most broadly understood, learning is the process by which people make sense of 
their social and physical environments in progressively more intricate ways, derive 
meaning, develop guiding principles, and become better able to predict the 
consequences of their own and others' actions. ' 
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Many scholars have tried to establish the explanations of policy change based on the notion of 
policy learning. Following Hall (1988:6, quoted in Bennett and Howlett 1992:276), policy 
learning refers to 'a deliberate attempt to adjust the goals or techniques of policy in the light 
of the consequences of past policy and new information so as to better attain the ultimate 
objects of governance. ' In the public policy literature, different terms such as lesson drawing, 
policy learning, policy-oriented learning, policy transfer and social learning are used with 
overlapping definitions (Bennett and Howlett 1992; Dolowitz and Marsh 1996; Stone 2001). 
Although these terms share the concept that policy decisions are made on the basis of 
knowledge of past experiences and knowledge-based speculations of policy outcomes, they 
are not interchangeable (Bennett and Howlett 1992). Rose (1991), for instance, defines lesson 
drawing as a particular type of policy learning in which policy makers draw lessons on 
experiences in other settings. By contrast, Dolowitz and Marsh (1996) maintain that policy 
transfer has broader definitions than lesson drawing as the latter refers to the policy transfer 
which occurs on the voluntary basis, while the term policy transfer covers both voluntary and 
coercive actions. A study of Ogden and colleagues (2003) suggests that, for example, directly 
observed therapy, short course (DOTS) - a strategy for tuberculosis treatment developed by 
the World Health Organisation (WHO) - was perceived as coercively transferred to low- and 
middle-income countries in the early 1990s. As the authors point out, DOTS transfer in some 
settings was viewed as intimidation since the treatment was pushed through influential 
international donors and sometimes against the wishes of national actors. Despite the 
variation in definitions, assuming Hall's (1993) and May's (1992) assertions, this thesis 
defmes policy learning as a form of learning which involves the use of experience, new 
information and other feedback that leads to either policy continuation or policy change. 
Policy learning may develop consciously and unconsciously, through different mechanisms: 
experience, observation, or systematic study such as evaluation and experimentation (May 
1992; Rose 1993). It can take place at any policy stage, among individuals, groups of actors, 
policy networks and organisations in policy subsystems. According to Bennett and Howlett 
(1992), the learned objects as emphasised by different scholars may be policy interventions, 
processes, goals and ideologies, each of which results in particular effects: if not the status 
quo, changes in organisations, programmes, and paradigms. 
Policy networks, policy learning and therefore policy outcomes are affected by contextual 
elements within and outside policy subsystems (Sabatier 1988). For instance, the transfer of 
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safe motherhood policy from global agencies to Honduras, followed by successful 
implementation during the 1990s was facilitated by collaborative advocacy of domestic health 
officials, donors, and representatives from international organisations such as the World Bank, 
WHO, United Nations Population Fund (UNFP A) and United States Agency for International 
Development (USAID) (Shiffman, Stanton, and Salazar 2004). Apart from depicting the 
influence of the health system context, the Honduran safe motherhood initiative reflected the 
involvement of multiple partners as members of a policy network. 
Following Peterson (1997), policy learning can be classified into two types: substantive and 
situational. Substantive learning comprises the results of practice, experimentation, analysis, 
observation, and adjustment in policy, argued on the basis of facts and objectivity. As shown 
by Williams et al (2004), for example, the replacement of chloroquine by sulfadoxine-
pyrimethamine combination for malaria treatment in many African settings in the late 1990s 
was driven by the evidence on parasitic resistance to the former regimen and the effectiveness 
of the latter. On the other hand, situational learning is the process by which lessons mostly 
derived from perceptions of norms, purported cultural differences, and measures of public 
attitudes through focus groups and surveys are subjectively interpreted. For instance, the 
introduction of policies on needle exchange and condom programmes is hindered in some 
societies owing to conflicts in social norms and religious beliefs (Rochefort and Cobb 1994a). 
Peterson's (1997) model also illustrates that different sets of actors are involved in, and 
different outcomes are developed from policy learning of particular type. However, as the 
author asserts, there is no clear border between the two types of learning, and in practical 
policy processes substantive and situational learning operate concomitantly. Sabatier (1988) 
argues that alterations in the political and economic context can affect the core beliefs of 
actors in policy networks, which subsequently results in a shift in policy learning from 
substantive to more situational. 
Policy learning is presented through social construction, interpretation and understanding of 
problematic conditions, potential solutions and context (May 1992). It is noted that policy 
makers may adjust their perspectives on and logical explanations of the problems they 
address and the preferred policy options on the grounds of their experience, study, and 
professional training (Grindle and Thomas 1991). In this light, as Klein (1997) points out, 
learning among those involved in the policy process is not a neutral intellectual exercise, but 
influenced by selective perception and arguments about the interpretation of evidence. Since 
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different actors have different perspectives and concerns, variation in patterns of policy 
learning and outcomes can be expected when particular interests have a leading role in a 
policy subsystem (Klein 1997; Peterson 1997). For example, bureaucrats tend to focus more 
on policy feasibility than do their academic counterparts. Therefore, learning among civil 
servants is process-related and likely to result in incremental organisational change rather 
than paradigm shift (Bennett and Howlett 1992). 
3.2.3 Agenda setting 
In studying policy, the process by which problematic conditions and concerns come to 
receive governments' attention, i.e. rise on the government agenda, and thus have the 
potential for policy alteration is represented by the term agenda setting (Nelson 1978). As 
Marsh and Rhodes (1992) suggest, policy change and continuity are determined by the 
structure and action of policy networks. Baumgartner and Jones (1993) have proposed a 
punctuated equilibrium model which argues that the shifts in policy networks are a vital 
factor leading to policy innovations. They suggest a policy domain comprises long periods of 
stability with policy continuity and intermittent phases of instability with dramatic policy 
changes. Both dramatic changes and stability in the system are influenced by two interacting 
elements: policy venues and policy image. 
'Policy venues are the institutional locations where authorative decisions are made 
concerning a given issue. ' (Baumgartner and Jones 1993:32). Such institutions can include 
government agencies, private organisations, local authorities, consumer groups, the family, 
including policy communities (Baumgartner and Jones 1993). It is maintained that which 
institution will make the decisions about particular issues depends on how the issue is 
understood and discussed, in other words: 'how it comes to be associated with one set of 
images' (Baumgartner and Jones 1993:32). A condition may be recognised as a public policy 
problem if it has an image that indicates a demand for the government's intervention 
(Baumgartner and Jones 1993). The authors point out that such a perspective resembles what 
other scholars call 'problem definition'. In addition, Baumgartner and Jones (1991: 1047) note 
that policy image and policy venue are closely related: 'as venues change, images may 
change as well; as the image of a policy changes, venue changes become more likely.' For 
instance, when HIV in Thailand was considered as a communicable disease in late 1980s, 
national HIV policy making involved only government officials in the Health Ministry. In 
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contrast, from 1992, after the epidemic was recognised as associated with several 
socioeconomic factors, the policy decisions in HIV area have been influenced by multi-
sectoral actors as members of the National AIDS Committee (Porapakkham, Pramarnpol, and 
Athibhodhi 1995). 
During stable periods, the same group of privileged elites dominate as members of policy 
communities and gain political and economic benefits (Baumgartner and Jones 1993). 
System stability is maintained through shared understandings, preferences and values towards 
particular issues, while the differences and opposition are excluded from policy making. As 
Marsh and Smith (2000:6) argue, ' ... tight policy networks persist, in large part, because they 
are characterised by a large degree of consensus, not necessarily on specific policy but 
rather on policy agenda, boundaries of acceptable policy. ' Actors who have expertise in 
particular areas attempt to convince others that the issues are so technically complex that the 
outsiders are unable to make appropriate decisions (Baumgartner and Jones 1993). Moreover, 
they may use their knowledge to articulate the definitions of the problems and policy options 
to support policy monopolies and continuity. 
Apart from the tightly-integrated arrangements of policy communities that discourage 
dramatic reforms, patterns of policy learning among participants playa role. May (1992) 
points out that it is the dominant interest's specialisation and unwillingness to challenge core 
beliefs of the network that constrains policy learning. Similarly, as Sabatier (1988) argues, 
policy coalitions usually resist information that confronts their fundamental beliefs thus the 
policy learning during this period is instrumental and merely results in incremental changes. 
An illustration can be drawn from the global tuberculosis treatment strategy between 1970s 
and early 1980s, where experts in the field preferred 18-month regimens to the newly 
researched 6-month protocols since the latter was believed as unsafe and might result in 
multi-drug resistance development (Ogden, Walt, and Lush 2003). 
In the instability phase, the existing privileged members of the network are challenged as new 
ideas disseminate throughout policy subsystems, allowing a wider range of actors with have 
different interests, values and expertise to permeate the policy-making arena (Baumgartner 
and Jones 1993). This may be because politicians, government officials and members of 
interest groups who hitherto paid little or no attention to specific issues, are encouraged to 
participate in decisions by a new understanding about the nature of the problems and 
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solutions (Baumgartner and Jones 1993). 'When they are portrayed as technical problems 
rather than as social questions, experts can dominate the decision-making process. When 
ethical, social or political implications of such policies assume centre stage, a much broader 
range o/participation can suddenly become involved. '(Baumgartner and Jones 1991:1047). 
For example, when HIV in Thailand was considered as a 'health issue' in the early phase of 
the epidemic, those who played a central role in devising national HIV strategies included 
clinicians and specialists in the Health Ministry and universities. From the early 1990s when 
growing evidence suggested HIV distribution and its consequences were socially-oriented, 
the range of policy participants expanded to involve private business, NGOs and communities 
(UNDP-Thailand 2004). The transfer of key participants in policy decisions does not always 
develop without conflicts between those who support different interpretations of policy issues. 
Contests between the proponents and opponents of a policy innovation are dynamic and may 
occur in either stability or instability phases, but are more likely in the latter (Baumgartner 
and Jones 1993). 
Although the subsystems are tightly restricted with technical expertise and other resources, 
these advantages may be disturbed in certain situations that enhance redefinitions of the 
policy issues (Baumgartner and Jones 1993). This is what Richardson (2000: 1017) observes: 
'New ideas and knowledge have a virus-like quality and have the ability to disrupt existing 
policy systems, power relationships and policies. ' Monopolies may be broken down because 
of the changes in the policy networks' features such as shifts in individual network members, 
cohesion and reallocation of resources and power. For instance, a study in Victoria, Australia 
between 1991 and 1993 suggested that the main issues on the governmental agenda shifted 
from health care-oriented topics including prevention and health promotion to those on 
rational funding, economic reforms and cost escalation. It was observed that in parallel, there 
was increasing influence in the policy network from people with an economics background, 
while the role of medically-trained academics and civil servants declined (Lewis and 
Considine 1999). Change in the regime and turnover of key personnel in the policy 
community such as chairpersons of government commissions and leading politicians in the 
Congress can encourage the rise and fall of certain agenda items (Kingdon 1984). 
Agenda setting may be influenced by surrounding circumstances of the policy subsystems, for 
example economic stability, political conditions and international and pressures (Grindle and 
Thomas 1991). The international context may play an important role in the agenda setting of 
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health policies in developing countries (Shiffman 2003; Williams, Durrheim, and Shretta 
2004). Dramatic changes in the government's agenda may also be associated with rapid 
dissemination of new issues triggered by focusing events l4, campaigns of organised interests, 
publications of the issues in the media, and surges of public opinion (Baumgartner and Jones 
1993; Kingdon 1984). Evidence elsewhere suggests that, for instance, the WHO's 3 by 5 
Initiative and fmancial support from the Global Fund to Fight AIDS, Tuberculosis and 
Malaria drew considerable attention of resource-poor countries' governments to ART 
programme commencement (Steinbrook 2004a). 
In a given environment, the chance for an issue to be perceived as a problem and matching 
solutions to be considered by policy community members may be enhanced by the efforts of 
particular individuals or groups of participants - policy entrepreneurs, who actively promote 
their proposals to the government for attention and action (Kingdon 1984). Several strategies 
have been employed by policy advocates to convince the administration and general public to 
consider particular social conditions as problems, for example by framing debates, crafting 
arguments, building coalitions, and brokering their ideas and proposals to political supporters 
and the public (Mintrom 1997). 
Actors who desire to influence policy may define and redefine problematic conditions and 
policy options in rhetorical ways (Rochefort and Cobb 1994b). For instance, a group of policy 
advocates in the United States successfully changed the government's child-abuse policy by 
labelling it as 'battered child syndrome' to legitimise the involvement of medical 
professionals (Nelson 1978). The effort of ART advocates to articulate delayed treatment 
provision as a death sentence to PL WHA or a crime against humanity (chapter 1) offers 
another illustration. 'By dramatising or downplaying the problem and by declaring what is at 
stake, these descriptions help to push an issue onto the front burners of policymaking or 
result in officials' stubborn inaction and neglect. ' (Rochefort and Cobb 1994b:3). In the same 
14 A focusing event is 'an event that is sudden; relatively uncommon; can be reasonably defined as 
harmful or revealing the possibility of potentially greater future harms,' has harms that are 
concentrated in a particular geographical area or community of interest; and that is known to the 
most informed members of the policy community and the public virtually simultaneously' (Birkland 
1998). Following Kingdon (1984), focusing events are not confined to negative occurrences such as 
crisis and disaster but also include personal experience or powerful symbol. In some cases, obvious 
events not harmful by themselves, highlight the issues to which the government pay attention, for 
example international conference organized by highly accepted organizations, may be considered as 
focusing events (Shiffinan 2003). 
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vein, Baumgartner and Jones (1993) have maintained that the distribution of particular policy 
ideas within the policy communities may trigger substantial changes in policy image, and 
raise new issues on the government agenda. 
Focusing on the policy choices, along with the recognition and conceptualisation of 
problematic conditions, a shift in agenda items requires corresponding policy options to be 
identified (Baumgartner and Jones 1993; Kingdon 1984). From several competing proposals 
for a given problem only a few will be seriously considered (Kingdon 1984). As Kingdon 
further points out, the interventions are most likely to reach governmental agendas if they 
meet the criteria of technical feasibility; conformity with social values; and the anticipation of 
future impediments including fmancial constraints, public acceptability, and political 
receptivity. However, the technicalities and anticipated impediments in implementing 
particular policies are subject to actors' interpretations (Rochefort and Cobb 1994a). In 
addition, Grindle and Thomas (1991:73-74) have illustrated the influences of system 
circumstances of crisis or non-crisis for decision making: 'Certain kinds of policy issues - a 
devaluation, say - tend to get on decision makers' agendas only when crisis conditions exists. 
Other kinds of policy - to decentralise, for example - emerge almost uniquely under politics-
as-usual circumstances. ' 
3.2.4 Policy formulation 
When a problematic issue reaches the government agenda, the next policy stage involves the 
decision to find solutions to the problem. The course of action to explore, assess and accept or 
reject a given policy option is defined as policy formulation (Howlett and Ramesh 2003). 
Particular public policies may come from the proposals posited in the agenda-setting process, 
or may be developed later in government offices. As policy formulation involves instrumental 
and evaluative activities, the concepts of policy learning and issue definition may provide 
understanding to how programmes are designed. 
According to Rose (1991), in most situations policy makers tend not to invest their time and 
resources in seeking fresh knowledge, i.e. commissioning research to inform policies, but to 
search for lessons from their own organisations including past experiences, neighbouring 
agencies and also foreign countries. Learning among policy formulators may involve learning 
from implementers. As Stone (1999:53) points out, 'Policies sometimes develop on particular 
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local practices - either through pilot schemes, including drug trials, or the innovations of 
street level bureaucrats ... '. To address the problems which are confined to a few settings of 
similar characteristics, such as those that share socioeconomic features or face a unique 
problem, alternative policy models are limited (Dolowitz and Marsh 1996). Lessons may also 
be drawn across policy domains as illustrated in the case of the United Kingdom's National 
Health Service reforms where the government partly learned from its own market-based 
model established in the education sector (Greener 2002a). Furthermore, as argued by 
Dolowitz and Marsh (2000), an organisation may be forced implicitly or explicitly by others 
to adopt particUlar policies. Such pressure may be significant in highly aid-dependant 
countries that may be obliged to follow the directions issued by international agencies and 
donors (Grindle and Thomas 1991). 
When the information on potential policy prototypes has been gathered, policy makers need 
to consider whether or not, and how to introduce such lessons in their settings. Policy 
learning may involve not only copying but also different degrees of adaptation therefore the 
policy innovations may be different from its template (Bennett 1991; Rose 1991). This is 
because the adoption of a policy is contingent on several conditions, especially the internal 
factors of the policy importer setting, such as the effects of policy legacies, political context 
and socioeconomic status (Rose 1990). Similar to the agenda setting stage, policy options 
may be assessed for their technical feasibility, affordability and social acceptability (Cobb, 
Ross, and Ross 1976), and as a result, undergo some transformation. As observed by Grindle 
and Thomas (1991), as policy formulation usually involves government officials, their 
concerns, including bureaucratic implications, for example individuals' career objectives, 
competitive positions and budgets between governmental units, as well as administrative 
capacity, compliance and responsiveness may affect how far policies are adapted. 
Since the actors involved in this policy stage are required to search, examine and justify the 
appropriateness of competing policy options, they have to have a minimal level of knowledge 
and skills on problems and solutions in the subject domain (Howlett and Ramesh 2003). In 
addition, given that the policy formulation process is complex, iterative and often long 
lasting, the participants have to be motivated by enduring interests. Policy networks may be 
important for policy in this stage. According to Stone (2001: 13), ' ... the interaction of official 
decision makers (politicians and bureaucrats) with relevant stakeholders and experts, helps 
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to reinforce the credibility and legitimacy of network participants in the formulation and 
implementation of policy. ' 
The role of policy learning among network members in the policy formulation stage has been 
depicted in Sabatier and Jenkins-Smith's (1993) advocacy coalition framework. The authors 
argue that continual learning operates throughout policy formulation and implementation 
stages. Apart from common interests, knowledge and values shared by members of particular 
coalitions as suggested in such a framework, the influences of available resources and 
external elements in their learning and related policy change are emphasised. 
While advocacy coalitions include a range of state and non-state actors, Rose (1991) has 
observed that policy makers, especially politicians, often rely upon advice from expert or 
professional networks - so called 'epistemic communities'. Learning within such networks is 
prompted by scientific knowledge, which is usually, but not always consensual, systematic 
and professionally constituted (Stone 2001). In addition to academics and specialists, other 
actors such as elected officials, bureaucrats and organised interests can lead the policy 
networks (Marsh and Rhodes 1992). However, as Howlett and Ramesh (2003) suggest, those 
who are appointed by the authorities, such as scientists or government experts in some policy 
domains, gain advantage over others in policy formulation. 
Owing to the variation in the types of learning, dominant actors shape policy outcomes 
differently (Peterson 1997). Policy learning among specialists is classified as substantive, 
based on integrated information and knowledge derived from scientific procedures. If experts 
take a leading role in policy design, policy change focuses on developing policy instruments 
for the implementation phase. On the other hand, if politicians are in the lead, they may opt to 
design policies which are not only feasible to implement, but also attractive among voters. 
Therefore, policy learning among politicians is more situationally oriented, and can result in 
reforms. Interest groups with widely ranging goals and positions may emphasise scientific-
based learning rather than pursuing reputation among their clients, and vice versa, depending 
on type of interests. 
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3.2.5 Policy implementation 
'An understanding of how and why public policy is put into effect can be conceptualised 
under the heading of implementation' Schofield and Sausman (2004:235). As the literature 
suggests, action is a key moment in the policy process as it significantly affects policy 
outcomes (Hudson and Lowe 2004). This is because policy content may be adjusted, 
elaborated or even rejected during implementation (Hill and Hupe 2002). The analysis of 
policy in this phase aims to understand the process and factors influencing the discrepancies 
between policy intention and action. Substantial literature in this field discusses two 
distinctive 'top down' and 'bottom-up' models (Parsons 1995). 
The top-down approach sees implementation as the process whereby policy makers at the top 
of an administrative hierarchy, such as the government and parliament, expect bottom-level 
bureaucrats to carry out the policy as formulated (Hill and Hupe 2002). Following Walt 
(1994), such a concept stems from the perception that the implementation stage involves 
administrative or managerial activities, and is completely separated from the politically-
oriented policy formulation. Some studies employing top-down approaches focus on the gaps 
between policy intention and actual policy implementation. They often aim to provide 
information on 'best practice' conditions to programme administrators to enhance the 
complete control over the process and therefore its outcomes (Hudson and Lowe 2004). For 
instance, Hogwood and Gunn (1984) propose a model comprising ten preconditions required 
for achieving perfect implementation. This includes, for example, the absence of constraints 
from external circumstances; adequate time and resources; effective coordination between 
participating units; and complete understanding of, and agreement upon the objectives to be 
achieved. However, such a model is ideal since it is almost always impossible to achieve all 
the listed preconditions, which suggests that implementation will always be flawed (Walt 
1994). 
By contrast, the bottom-up alternative seeks to explain the process and actors involved in 
translating policy into action (Hill and Hupe 2002). This approach perceives the 
implementation stage as part of a policy-making continuum: the policy is remade and fine 
tuned by those expected to be implementers (Barrett 2004). As Walt (1994:155) maintains, 
'the bottom-up view is that implementers often play an important part in policy 
implementation, not merely as managers of policy percolated downwards, but as active 
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participants in an extremely complex process that informs policy upwards too. ' Many have 
pointed out that implementation is an interactive process, characterised by negotiation and 
conflict among participating networks, and therefore as political as the policy formulation 
stage (Grindle and Thomas 1991). 
Assuming a bottom-up perspective, Lipsky's (1980) work on public servants' behaviours 
suggests that street-level bureaucracy is where implemented policy is diverted from its 
prescription. His study illustrates the discretionary freedom in service delivery and distortion 
of such practices from policy intention. Developed by public officials, these informal 
practices aim to address implementation constraints and complexity, excess demands, 
conflicting and ambiguous policy objectives, uncertainties about new jobs, and occupational 
stress (Lipsky 1980). Eventually, such coping mechanisms become routine and then 
established practices in the organisations. Lipsky further argues that programme managers 
and superior officials have found some difficulties in controlling the street-level bureaucrats' 
behaviours and fostering policy compliance. 
The roles of knowledge, skills and understanding among public servants on policy 
innovations, such as their meaning in relation to service delivery and appropriate ways of 
executing them, is important since they affect the services offered to clients (Hardiker and 
Barker 1999; Rees et al. 2004). Hill (2003) has suggested it is essential to explore further how 
implementers understand policy in order to do it. Implementation involves endless learning of 
implementers as they are obliged to search for the strategies to meet new policy goals and 
programme instruments including new technologies (Browne and Wildavsky 1984). As Hill 
(2003) emphasises, inadequate knowledge and misunderstanding of implementing units may 
lead to policy failure. Getting better insight into policy implementation, especially in complex 
contexts, is therefore to conceptualise it as an ongoing learning process (Behets, Miller, and 
Cohen 2001). 
With the attempt to integrate the two major approaches in implementation - the top-down and 
bottom-up, Sabatier (1986) has embedded policy learning in the model for policy study (Lane 
1987). Sabatier's advocacy coalition framework highlights the role of evaluation feedback of 
policy while it is being implemented as an input to the policy learning process. According to 
Hudson and Lowe (2004), however, such learning develops among elite policy makers and 
affects policy formation rather than implementation. 
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The model of learned implementation (Schofield 2004) suggests that the practices of front-
line officials are influenced by policy learning as a function of bureaucrats' motivation, 
competency, acquired knowledge, and latitudes of discretion. In implementing a policy, 
bureaucrats require technical and procedural knowledge and motivation. Learning about new 
knowledge, capacity building, and subsequently trying out technical operational solutions 
continue over time. In this sense, learning among street-level officials aims not only to gain 
the knowledge on how to get new policy into action but also to acquire the capacity to deal 
with the undesirable effects of the initiatives, i.e. to develop effective coping strategies. 
Schofield (2004) also maintains that the learned objects involved in this policy stage can be 
classified into technical and procedural. The latter type of knowledge helps to examine, 
refine and adapt the knowledge in the former category. The cognitive process that produces 
procedural knowledge - the so called generative learning - also results in increasing 
competence and capabilities of service providers to develop solutions to implementation 
obstacles. The invented policy execution strategies become routinised as it is recorded into 
job tasks as well as individual workers' and organisational memories. According to the 
learned implementation model, the learning process of front-line bureaucrats is facilitated by 
organisational capacity, resources and expertise, and constrained by problem complexity, 
inadequate resources and insufficient information. Although such learning is motivated by the 
possibility to exercise discretion, Schofield (2004) stresses that it does not develop liberally, 
but is bound by bureaucratic regulations, the bureaucrats' sense of organisational 
accountability and professional responsibility. 
Although Lipsky's street-level bureaucracy concept and Schofield's model of learned 
implementation focus their attention on the implementing agents, empirical evidence in health 
sector shows that translating a policy into practice involves several actors outside 
implementing units, for example politicians, representatives from a range of multi-level 
government agencies, business corporations, and CSOs including professional organisations 
(Beyer 1998; Kajula et al. 2004). Rhodes (1996) points out that policy subsystems within 
which the discussion, negotiation and bargaining operate among these participants exist in 
this policy stage. Barrett (2004:253) argues: 'the political process by which policy is mediated, 
negotiated and modified during its formulation continues in the behaviour of those involved 
in its implementation acting to protect or pursue their own values and interests. ' 
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According to Marsh (l998b), the obstruction in implementing a policy may be originated by 
implementation actors who have not been involved in policy making, i.e. policy networks that 
shape policies are not the same as implementation networks those get the policies into action. 
Implementation gaps may stem from the differences in the interpretation and understanding 
of problems, policy goals and prescribed instruments between central-level policy makers and 
peripheral actors (Hill 2003). An example can be drawn on HIV policy in the Russian 
Federation: in addition to the political and socioeconomic context, varying interpretations of 
criminal codes and federal orders relating to HIV/ AIDS, as well as the behaviours and 
attitudes of health administrators and staff influenced priority setting, policy pursued and 
activities carried out in particular regions (Atun et al. 2005). 
3.3 Analytical framework for the thesis 
The previous section reviews theoretical literature on the development of three stages of 
policy cycle: agenda setting, policy formulation and implementation, and suggests that the 
concepts of policy networks and policy learning, in combination can help to explain the 
processes by which a policy is shaped and translated into practice. Assuming these notions, a 
conceptual framework for the analysis of Thailand's antiretroviral policy is constructed as 
shown in figure 3.1. 
Figure 3.1: Framework for analysing Thailand's antiretroviral policy 
Actors Policy networks Context 
• state Policy learning • endogenous 
• non-state • exogenous 
• international ! 
Policy process 
,....- Agenda setting4-
* t 
Formulation 
* t Policy outcomes ---+ Implementation- r---. 
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The diagram captures the interaction between three factors central to public policy: the actors, 
context and process. The actors and context shape the agenda setting, policy formulation and 
implementation through the networking and learning of participants. Throughout the three 
policy stages, networks of politicians, government officials, private corporations, CSOs and 
international agencies in a policy domain evolve and intersect. Elements of change occur: (1) 
in the features of policy networks such as the members, resources, interests, ideologies, 
cohesion and positions in relation to particular issues as well as other network clusters, and 
(2) in the process by which these networks acquire knowledge about problems, solutions, and 
related environment. A result of the overall processes - the policy outcomes, may affect the 
contextual factors that lead to further policy making and implementation. 
Note that although the above description largely presents policy processes as consisting of 
sequential, discrete stages, as portrayed in the diagram, the analysis of Thailand's ART policy 
takes into account the complex features of actual public policy which involves back and forth 
movements of particular issues through different overlapping phases. Moreover, it has been 
kept in mind that there may be interactions between the networking and learning among key 
actors across policy stages. 
3.4 Objectives of this thesis 
Based on the literature on ART policy in developing countries and the conceptual framework 
described in the previous section, the objectives of this thesis are developed as follows: 
(1) To describe the shift in the Thai government agenda towards universal ART access, 
and succeeding adoption of such policy. 
(2) To explain the process to design the national treatment programme in order to achieve 
the universal coverage goal. 
(3) To explore the process by which ART was integrated into the health delivery system 
and subsequently provided to the targeted population 
(4) To identify the key actors and analyse their involvement in each stage of the policy 
processes. 
(5) To assess the context that influenced policy development and implementation. 
(6) To explore the extent to which learning was an important part of the policy process. 
(7) To identify whether policy processes were affected more by the actions of individual 
actors or by networks of actors coming together to promote particular policies. 
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3.5 Methods 
This study focuses on national ART programme development since the policy to provide 
universal treatment access was adopted in 2001 until December 2004. The field work of this 
thesis was carried out in Thailand between October 2003 and December 2004. To explain the 
national-level policy processes, i.e. agenda setting and policy formulation, data were collected 
from the Ministry of Public Health (MOPH) and other governmental agencies; academic 
institutes; private companies; PLWHA groups and NGO offices located in Bangkok and 
Nonthaburi. To gather information on ART programme implementation, the field work was 
primarily conducted at Health Ministry hospitals and Provincial Health Offices in two case-
study provinces: Phichit and Rayong. Provincial interviews and documentary reviews also 
covered agencies involved in the translation of treatment policy into practice, i.e. Regional 
Disease Control Offices and CSOs, established in the areas nearby. 
3.5.1 Justification of case study approach and selection of study provinces 
Case studies are a research strategy used in many fields of social sciences where there are 
demands for thorough understandings of contemporary, complex phenomena, such as in 
policy and politics areas (Yin 1994). As Yin (1994:3) further notes, such an approach helps to 
illustrate 'holistic and meaningfUl characteristics of real events '. In policy analysis, case 
studies are valuable to understand the processes of policy change and the factors associating 
with policy success and failure (Keen and Packwood 1999:51). Following Stake (2002), case 
studies can be used to test hypotheses, and their exploratory and explanatory power on 
intricate events as well as contextual conditions is also vital. 
As case studies seek to address the 'why' and 'how' questions, they mainly rely on qualitative 
methods such as interviews and documentary analysis, which are sometimes criticised for 
their lack of objectivity, precision and generalisability (Hammersley and Gomm 2002). 
However, several strategies have been introduced to reduce subjectivity and improve 
precision of qualitative approaches (see section 3.5.4). Research employing case-study design 
may contain one case or a small series of cases (Yin 1994). While multiple-case studies need 
extensive resources and time, in comparison to applying the single-case, the advantage is that 
they offer more compelling explanation, and therefore more robust conclusions (Herriott and 
Firestone 1983). To understand the processes of policy changes and outcomes, a study of a 
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particular policy in many settings with different situations would be useful as it can reflect the 
policy development and influence of several factors those do not exist in every setting. 
Nevertheless, although research fmdings drawn from a single case cannot be generalised to a 
population, some scholars argue that generalisability is not an essential goal for qualitative 
research (Cronbach 1982 quoted in Schofield 2002:75). Even single case studies are 
intrinsically interesting and do not mean that findings in one situation cannot help to form 
hypothesis on what will occur in other situations (Schofield 2002). Analysis of similarities 
and differences between settings makes it possible to judge the extent to which the findings 
can be transferred from one situation to another (Kennedy 1979 quoted in Schofield 2002:76). 
Owing to resource and time limitation, this thesis includes only two provinces in the analysis 
of ART programme implementation. 
The two provinces were selected according to 3 criteria. First, both provinces had relatively 
high HIV prevalence. Phichit and Rayong were among the top five provinces in term of HIV 
prevalent rates among pregnant women at antenatal clinics in 2003 (Bureau of Epidemiology 
2004a). Second, both provinces had little experience of ART delivery before treatment 
scaling up: only one out of nine MOPH hospitals in Phichit, and two out of six MOPH 
hospitals in Rayong delivered ARV medication before 2001 (data from ATSI database). Third, 
one province had stronger NGO and PLWHA groups than its counterpart. Given that CSOs 
were recognised by policy makers as important partners who would support ART delivery in 
particular areas during the scale up era, significant questions arise over the circumstances in 
and processes by which the providers and civic networks interacted to influence the 
expansion of the services. Rayong was the province with many well-established NGO-
PL WHA networks since the early HIV epidemic. In contrast, a smaller number of AIDS 
NGOs in Phichit had been recently instigated, and had a small role, compared to those in 
Rayong, in collaborating with health care providers and providing support to patient groups. 
3.5.2 Data collection 
To meet the objectives of this thesis, qualitative approaches, including in-depth interviews 
and documentary analysis were utilised. According to Denzin and Lincoln (1998), qualitative 
inquiries seek answers to questions on how social experience is created and given meaning. 
The objectives are to explain behaviours; social relationships, processes and situations; and 
the meanings people give to their activities and the activities of others (Blaikie 2000). As 
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qualitative research aims to interpret social interactions, behaviours and events in terms of the 
meanings constructed by people, it is usually referred to as social constructive or 
interpretative research (Patton 2002). Patton also notes that constructivists focus their 
attention on understanding specific cases in particular circumstances rather than on 
generalisations to others in different contexts. A key feature of qualitative investigation is that 
it adopts a multi-method approach in one study (Pope and Mays 1999). In the same way, 
although this thesis largely involved in-depth interviews and documentary review, other 
approaches such as direct observation of actors' behaviours, informal communication with 
knowledgeable persons and lay people, field notes and a personal diary were also used to 
gamer primary data as well as to verify information from other sources. 
Semi-structured interviews 
The interviews were conducted as face-to-face conversations on specific topics between the 
investigator and key informants - people knowledgeable about the issues in focus. This 
method has been used in cases where the studied subjects cannot be directly observed, for 
example to obtain intentions, opinions, perceptions, attitudes and past experiences or 
behaviours (Patton 2002). The semi-structured interview employing a set of open-ended, core 
questions as an interview template, is a useful technique in seeking explanations to specific 
issues (May 1997). Interviewers have to be open-minded, introducing divergent questions at 
times, and also take into account any new concepts and frameworks proposed by the 
interviewees (Britten 1999). 
In this thesis, generic interview guides were developed and then adapted for particular groups 
of key informants with potentially different patterns of policy involvement, for example 
policy makers, treatment advocators, patient group leaders and service providers of various 
disciplines (see generic interview guides in Appendix 1). The interviews were carried out in 
Thai and taped by the investigator, and then transcribed by experienced research assistants. In 
some cases, key informants were re-interviewed via telephone. Only quotes used in the thesis 
were transcribed into English. At the beginning, a number of potential interviewees were 
purposively selected by the investigator on the basis of related public policy documents and 
literature on the scale up of ART in developing countries. The list of key informants 
interviewed was eventually extended to cover persons mentioned by other respondents or 
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emerging from other sources of information during fieldwork. In this study, 80 persons listed 
in Appendix 2, were interviewed. 
Documentary analysis 
Documents are products of structured and informed social practices deriving from the 
decisions which people make as individuals and members of groups or organisations (May 
1997). Documentary sources contribute to the information on past social phenomena and 
individual behaviours which operated in particular political, economic and socio-cultural 
contexts (Prior 2003). Documentary analysis provides the evidence explaining why and how 
particular policies were made and carried out (Buse, Mays, and Walt 2005). Information from 
documents can be utilised either straightforwardly or interpretively, to produce primary 
research findings or for verification purpose (Mason 1996; Patton 2002). 
The documents mainly explored in social research are written texts collated and recorded by 
organizations and individuals for particular purposes (Mason 1996). There are several sources 
of information, written and unwritten, to be explored in analysing health policy, for example 
journals, reports, documents, statistical databases and the media including the Internet (Buse, 
Mays, and Walt 2005). Useful evidence can also be retrieved from unpublished documents 
including letters, email messages, 'internal' materials, as well as grey literature. Documents 
of all sorts are social products therefore they should be selected and analysed with caution, 
taking into account not only their content but also other features such as the production and 
functions (Prior 2003). 
In this thesis, a wide range of documents, in Thai and English, were perused. They principally 
comprised government documents and statistics from central departments, sub-national 
agencies and study hospitals; they included reports, conference proceedings, work plans and 
pamphlets produced by NGOs and PL WHA networks at national level and in study 
provinces. Moreover, articles and other forms of research reports published in domestic and 
international journals were reviewed for the background information on HIV epidemiology, 
related policies and ART programmes in the developing world including Thailand. A 
substantial part of documents analysed in this study were produced by international 
organisations in particular WHO, UNAIDS, and HIV-related civil society alliances. In 
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addition, a number of news and commentary articles from national newspapers were included 
in the review. See the outline of documents reviewed in this study in Appendix 3. 
This thesis is a tribute to the learning environment of the Thai health system. At the time of 
study, there were several research reports on public ART service and health care financing 
reforms, produced not only by health officials in central departments and academics, but also 
by front-line professionals and NGOs. Apart from the findings of these studies from which 
helpful information was excerpted, the investigator synthesised a considerable fraction of this 
thesis from other researchers' insights and experiences. 
Other means for gathering information 
Much of this study was carried out while the investigator was an employee of the 
International Health Policy Programme - a research body of the Ministry of Public Health -
which has been involved in the development of policies in the health system including the 
reforms of health care financing and economic evaluation of health programmes and 
interventions. Before starting the PhD study in September 2002 and during the fieldwork 
between October 2003 and December 2004, the investigator participated in conferences, 
meetings and discussions on many HIV/AIDS and health financing reform topics, among 
others, for example national HIV policies, ART scaling-up processes and implications for 
health delivery facilities. For instance, the investigator represented the International Health 
Policy Programme on the MOPH's Administration Panel, which was responsible for devising 
management strategies for the National ART Programme while therapy was expanded in 
2002. Experience gained from attending the meetings of this Panel contributed to better 
understanding of the roles and networks of actors in policy formulation. 
As the International Health Policy Programme had developed close connections with Health 
Ministry departments, the National Health Security Office, Bureau of AIDS, Tuberculosis 
and Sexually-transmitted Infections, and many of the MOPH's sub-national agencies 
including hospitals, this facilitated the investigator in her contacts with health officials, 
specialists, health workers as well as researchers in the field. A good deal of information was 
accessed through personal communications. In particular, exchanging experience with other 
HIV researchers provided insights into many important facets of treatment expansion in the 
Thai context. For example, the investigator learned about psycho-social factors hindering 
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ART seeking and ARV administration from a group of social scientists from Chulalongkorn 
University. Moreover, such relationships helped to understand the features of knowledge 
generation and utilisation as well as networking patterns between stakeholders in HIV area. 
As an employee of an autonomous research institute contributing to knowledge 
generation in the health sector, the investigator experienced good cooperation from key 
informants and their organisations. However, working with the International Health 
Policy Programme may also have been a source of possible biases. Since this research 
institute had been involved in economic evaluation of many health interventions and 
provided policy recommendations based on the efficiency of resource utilisation, the 
investigator believed strongly that ART should not be included in the universal health 
coverage plan, until the treatment programme was assessed for its financial consequences 
in relation to public health outcomes. However, throughout the course of this thesis, the 
investigator tried to be objective, and employed several methods to reduce bias (see 
section 3.5.4). Accessing information from various sources, especially from people who 
promoted and disagreed with treatment expansion, helped to balance the analysis, and to 
enhance the thesis quality. 
3.5.3 Data analysis 
In this study, quantitative data on epidemiology, resource availability, programme enrolees 
and services delivered were utilised to reveal some contextual elements and outputs of the 
policy. For the documentary review, the content analysis approach illustrated by May (1997) 
and Ericson (1991 quoted in May 1997: 173) was employed. The investigator read, 
conceptualised and interpreted the text according to specific themes, picking out pieces of 
information relevant for understanding treatment policy processes in particular stages. 
Afterwards, such information was assembled and shaped to narrate the policy development 
and implementation, linked with the thesis' conceptual framework. Throughout the process, 
the documents were examined for not only their content but also the contexts in which they 
were produced and functioned. 
Regarding interview data, the framework approach was introduced in the analysis. As Pope 
and colleagues (1999) maintain, this method has been developed for studies for which the 
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objectives are set in advance and guided by a conceptual framework. This approach is 
deductive, differing from the inductive process used in grounded theory where analytical 
concepts emerge from the data. In this thesis, transcripts of individual interviews was 
explored for key concepts as informed by the conceptual framework. These thematic 
keywords were highlighted and rearranged under relevant headings and sub-headings. 
Finally, the information under particular headings was reviewed and interpreted, by 
considering the actors and their involvement in the policy processes; searching for patterns of 
relationship with each other; and seeking explanations for these elements within the data. 
3.5.4 Quality control of research 
A significant body of literature illustrates a wide variety of criteria and positions to judge the 
quality of qualitative inquiries, some of which fit a constructivist perspective while others are 
located within a positivist paradigm (Spencer et al. 2003). Lincoln and Guba (1985 quoted in 
Spencer et al 2003:40) reject scientific criteria usually applied to appraise the validity, 
generalisability, reliability and objectivity of quantitative studies, and instead propose a set of 
naturalistic criteria defined as credibility, transferability, dependability and confirmability for 
interpretivist research. In contrast, other scholars such as Morse et al (2002) stress that the 
usual concepts used to assess reliability and validity can be applied to qualitative 
investigation. The differences in these criteria and underlying assumptions affect the 
approaches employed to ensure the rigour of research to a certain extent. Despite the variation, 
these quality-assurance methods share basic principles: reducing the biases and accounting 
for the predispositions of researchers as well as data sources, i.e. interviewees and documents 
(Morse et al. 2002; Patton 2002). 
This thesis adopted the approach to improve the validity and reliability of investigation as 
suggested by Mays and Pope (1999). This included triangulation of data across sources; 
considering the characteristics of key informants and documents which might influence the 
information provided; clear illustration of methods of data collection and analysis; attention 
to deviant or negative cases; and incorporating a wide range of different perspectives. In 
addition, this thesis was embedded with verification mechanisms. As Morse and colleagues 
(2002) suggest, verification strategies should be introduced throughout the course of 
qualitative study, and include systematic and constant monitoring of the fit of data and 
conceptual work of analysis and interpretation. This can help researchers to determine when 
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and how to modify research process in order to ensure quality. Wherever possible, the 
investigator tried to use triangulation and verification methods to assure the quality of this 
thesis. 
3.5.5 Consent procedures and ethical clearances 
Key informants participated in this study on a voluntary basis. The investigator sent them an 
invitation letter with the information on the aims, objectives, methods and expected benefits 
of this research, as well as the outline of interview questions in advance. Those who agreed to 
take part were informed about their rights to refuse to answer any particular questions or to 
leave the study at any time. Every interviewee was asked to sign a consent form before the 
interview started. 
This thesis received ethics approval from Thailand's Ministry of Public Health on 13th 
January 2004 and the London School and Tropical Medicine's Ethics Committee on 3rd 
February 2004. 
3.5.6 Research limitations 
One of the limitations of this thesis was the case study approach introduced in the analysis of 
programme implementation. As only two provinces were studied, and they cannot represent 
all provinces of the country, findings about the policy process at this stage cannot easily be 
generalised or transferred to other provinces. Even in the same province, it could be seen that 
the policy responses of hospitals and professional practices varied across districts. Although 
the case study approach is an appropriate method for the examination of complicated policy 
events and their circumstances, the results of this thesis should be interpreted and used with 
caution. Transferring the lessons learned from these two provinces requires understanding the 
differences and similarities in the context of study settings and others. However, some of the 
fmdings may be useful to inform ART implementation in provinces where most elements of 
the health delivery system are similar to the study provinces. Even in the areas with different 
environment, this thesis may contribute to some aspects of treatment introduction. 
The aim of this thesis was to get insight into the changes in the national ART policy which 
mainly involved service provision in Health Ministry hospitals. Therefore, another weakness 
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is that the picture of treatment delivery in non-MOPH public facilities and the private sector 
is missing. Evidence from the Government Pharmaceutical Organisation suggests that in 2003 
approximately 70% of its first-line ARVs was distributed through the MOPH-organised 
national programme, which meant that other public providers as well as private clinics and 
hospitals had a significant role in ART provision. ARV recipients outside Health Ministry 
hospitals included Social Security Scheme members, Civil Servant Medical beneficiaries, and 
self-financed patients. 
Another important problem in conducting this research was the difficulty in finding 
comprehensive, systematic data. Some of the existing databases of Thai research reports as 
well as part of provincial and district statistics were incomplete, and not updated. As a 
consequence, some explanations about ART programme development and its context in this 
thesis relied on key informants. This was crucial for some particular issues the interviewees 
tended to conceal such as their failure, mismanagement, poor practices, and embarrassing 
experiences. Moreover, clients and beneficiaries of public programmes might hesitate to 
criticise their service providers. 
In spite of these limitations, this study can provide a synthesis of available information, useful 
insights into the policy making process, and lessons for other provinces as well as other 
developing countries. 
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CHAPTER 4: UNIVERSAL ACCESS TO ART: AGENDA SETTING AND POLICY 
ADOPTION 
Thailand launched its first antiretroviral treatment (ART) programme with limited coverage 
in 1992, and adopted the policy to offer medication to all eligible people living with 
HIV/AIDS (PLWHA) in late 2001. Despite a substantial decline in new human immune-
deficiency virus (HIV) cases, at the time of the policy shift almost one million of the 
population were living with the disease. The literature reviewed in chapter 2 suggests that 
even for a middle-income country, introducing such a costly, complicated intervention on a 
massive scale was unusual, and raises many questions on the government's decisions and 
action. This chapter explores the agenda setting phase that drove the universal treatment issue 
on to the Thai government agenda. 
4.1 The national ART programme before 2001: incremental policy changes 
Although adjustments were intermittently introduced to the national ART programme's 
targets, strategies and drug regimens between 1992 and 2001, treatment coverage never 
increased over a few thousand beneficiaries, representing only 3% to 9% of PLWHA 
(Tangcharoensathien and Teokul 2002). Changes in the programme features during the first 
ten years of its implementation can be regarded as incremental. This section reviews the roles, 
positions and interactions of policy participants, as well as the ways they defined ART in this 
policy continuity phase before 2001. 
4.1.1 Interactions between policy makers and civil society 
During this incremental period, HIV strategies and plans were dominated by government 
officials in the Ministry of Public Health (MOPH), especially the Disease Control Department 
as evidenced from documents and interviews. Despite the fact that the country's HIV policy 
development and planning were the responsibility of the National AIDS Committee (NAC) 
(established in 1991), which comprised representatives from several public agencies, private 
corporations, individual experts, non-governmental organisations (NOOs) and PLWHA 
networks, an evaluation of the national HIV control programmes suggests that the role of the 
Disease Control Department was critical in steering the policy direction (Chalamwong et al. 
1997). This partly resulted from frequent turnovers of the administration and associated time 
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spent on bureaucratic processes to appoint a NAC. Chalamwong and colleagues (1997) 
suggest that during 1991 to 1997 period, the gap between NAC meetings was typically 5 
months to 1 year. Even when the Committee existed, the Prime Minister as the chairperson 
called for few meetings (Khoaw Sod 1993). As a result, some urgent policy decisions were 
left to government officials in the MOPH as their positions were relatively permanent. Also, 
Teokul (1998:5) asserts that the Health Ministry's technocrats and professionals had a 
comparative advantage, in comparison to NAC members from the private sector and NGOs, 
in learning about new knowledge and technologies in this area so that the MOPH became 'the 
country's front-line agency in HIVIAIDS control campaigns'. This was because health 
officials and specialists had relevant training background and had access to updated 
information more easily than others. 
Although NGOs and PLWHA played a crucial role in encouraging the governmental response 
to the early epidemic, and their representatives were appointed to be NAC members, their 
involvement in HIV mainly focused on implementing prevention and care programmes 
(Phoolcharoen et al. 1998; Porapakkham, Pramarnpol, and Athibhodhi 1995). However, this 
does not mean that the civil society movement at the national level absolutely declined. 
Documents and interviews suggest that NGOs and also individual activists occasionally made 
proposals to the Health Ministry to revise, enact and enforce laws to curb the illegal 
distribution, advertisements and clinical trials of vitamins, traditional medicines, herbs, 
vaccines and many other products claimed to cure HIV, as well as to regulate the quality and 
marketing of HI V screening test kits (Eaow-sriwong 1991; Intrajitr 1994; Ungphakorn 1991). 
Meanwhile, some NGOs and patient groups appealed for fewer drug control measures and 
medicine practice regulations in order to provide more choices in treatment and care for 
PLWHA since there was no cure for the disease and the approved anti-HIV products and 
services were fmancially prohibitive (Asavaroengchai 1994; Dahlan 1994; Tangjai 1994). 
In particular with the adoption of ART and other medical services, it was the bureaucrats and 
experts as members of ministerial task forces who made the decisions on the interventions to 
be included, and the strategies to have them delivered in the national programmes, while the 
NAC provided a broad policy framework (interview NlO). For instance, the shift in ART 
provision from service-based to research-based treatment in 1995 (chapter 2) was decided by 
health officials and specialists (Kunanusont, Phoolcharoen, and Bodaramik 1999). 
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Treatment advocacy of the NGO alliance started in the early 1990s, and the first campaigns 
were launched in 1991, with NGOs urging the government to reduce import taxes of 
zidovudine, as well as to consider the implications of patent regulation for drug prices 
(Commission on NGO Coordination for Primary Health Care 1991; Matichon 1991). 
However, civic participation in national ART policy only became significant in the late 1990s 
when they began campaigns for improving access to generic antiretrovirals (ARVs) and drugs 
for opportunistic infections (Ols) (Wilson et al. 1999). As noted by Wisartsakul (2004), this 
happened after 53 PLWHA groups throughout the country formed into the Thai Network of 
People Living with HIV/AIDS in 1995. The author also points out that the PLWHA network 
collaborated with the pre-existing National AIDS NGO Network, and jointly participated in 
several campaigns. In the didanosine case lS, for example, the coalition employed multiple 
strategies: urged the Health Ministry to issue compulsory licensing l6 to allow local drug 
industry to produce a generic version; encouraged the Government Pharmaceutical 
Organisation (GPO)'s research and development of ARV products; communicated with the 
United States (US) Presidency not to retaliate with trade sanctions when generic drugs were 
locally produced; and filed a petition to the Intellectual Property Court to revoke the disputed 
patent held by Bristol-Myers Squibb (Ford et al. 2004; Wisartsakul 2004). 
Apart from the local HIV NGOs and PL WHA, movements for treatment expansion were 
supported by several other actors: health professionals, intellectual property lawyers, 
scientists of the government laboratory, school of pharmacy lecturers, and consumer 
protection organisations, as well as international NGOs such as Medicins Sans Frontiere 
(MSF) (interview N13, N15 and NI9). As the literature and key informants suggest, these 
groups and individuals brought with them different resources, for example strategic advice 
and expertise in filing court cases of the lawyers; information and knowledge of the 
academics; proficiency in clinical trials and practices of the medical specialists; capability in 
producing cheaper medicines commanded by the scientists; and information on foreign 
15 Didanosine (ddI) was an antiretroviral, patented in Thailand, with a specified a dose range, since 
1992 (Ford et al 2004). In 1998, Bristol-Myers Squibb - ddI manufacturer - applied for patent 
extension to all doses. NGOs organised Didanosine Working Group in 1999 and campaigned against 
such amendment since it was considered to hinder treatment access among PLWHA. The Working 
Group also encouraged generic production of ddI by mean of compulsory licensing. 
16 Stated under Article 31 of the TRIPs Agreement, country governments may issue compulsory 
license - a mechanism to limit patent or intellectual property rights in order to protect public health of 
their people. The license will allow local drug industry to manufacture particular patented drugs, of 
which a percentage of sales must be returned to compensate the patent holders. 
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experiences and fmancial assistance from international NOOs. Many of these non-state actors 
approached the state counterparts directly in meetings and discussions, as well as publicised 
their proposals through the media, while others provided distant support. In so doing, apart 
from forming into networks, the treatment advocates learned from others' experiences 
(Wisartsakul 2004). For example, two NGO leaders pointed to their participation in a 
campaign for drug price reduction: 
'Before this time, NGOs were only involved with campaigning and training, but 
with this issue, I had to familiarise myself with ARV medicines, patents, TRIPS 17 
and WTOIB. 'and, 'We had to catch up on the legal details. We had to know what 
the academics mean. We had to be precise about the medicine formula and its 
effects. '(Treemanka and Tienudom, respectively, quoted in WisartsakuI2004:46) 
Although the Health Minister and bureaucrats were mostly amenable to interaction with the 
NOOs, the imbalance of power between politician-bureaucrat policy makers and the civic 
alliance counterparts could be observed. The didanosine case offers a good illustration. 
Although urged to do so by NGOs, the Health Minister refused to issue a compulsory license 
to produce the drug domestically (Ford et al. 2004; Wisartsakul 2004), and instead sought to 
procure low-priced original products of didanosine and other ARVs through the government's 
tendering mechanisms (Chitwarakorn 2001). The Minister also allowed the state laboratory to 
manufacture didanosine in powder, instead of the patented tablet form (Wisartsakul 2004). 
This reflected the power (even if only perceived) of Big Pharma in the US. 
As in other countries, the pharmaceutical industry was an important actor in the HIV area. In 
Thailand, transnational companies were accused of using drug patents and other monopolistic 
measures l9 to set unreasonably high prices of ARVs - the major barrier to treatment (Drug 
Study Oroup 2001; Limpananont 2002), in spite of the fact that the local drug industry had 
the capacity to bring down the prices through marketing of generic versions. A report of the 
17 The Agreement on Trade-related Aspects ofIntellectual Property Rights 
18 World Trade Organisation 
19 In 1980s, the Thai government was forced by the US Trade Representative to enact an 
administrative measure - known as Safety Monitoring Programme - to grant market exclusivity to 
research-based companies for marketing pharmaceutical products those were not eligible for the 
protection under the Patent Act. The programme required original products to be tested for safety in 
clinical settings for 2 to 4 years after approval by the Thai authority. During this 'safety monitoring' 
period, corresponding generic products could not be applied for registration (Limpananont 2002). 
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International Centre for Trade and Sustainable Development (2000) suggests that the fear of 
trade sanctions was the main reason why the MOPH was reluctant to implement compulsory 
licensing measures even though the US administration declared no official opposition. In the 
same report, the Director General of the Disease Control Department argued that, 'We must 
be very, very careful: considering the livelihood of our 62 million people, not just the 1 
million HIV patients. ' 
Some key informants said that apart from making use of international trade agreements, 
research drug corporations employed several tactics to restrict local ARV production and 
generic prescription in the national programme (interview N13 and NI9). As revealed by one 
scientist, her office was often visited by foreign executives of major pharmaceutical 
companies and the US Embassy officials to make sure that the government laboratory did not 
violate patent regulations (The Nation 2002). She went on to note that 'Death threats were 
common when I began producing these drugs a decade ago. '. Another example of the action 
of drug industry was illustrated by Wisartsakul (2004:32): 
'Bristol-Myers Squibb made an offer to the Director of the Government 
Pharmaceutical Organisation to become the distributor for two Bristol-Myers 
Squibb products, didanosine and stavudine. Bristol-Myers Squibb proposed a 
reduced price for didanosine of around 29 baht per tablet, still very expensive 
compared to the one produced by the Government Pharmaceutical Organisation. 
Th .. d'd d . ,20 ... e negotzatzon 1 not en In success. 
However, the.involvement of transnational drug companies in the national ART policy during 
this period, and their relationship with, and influence on, Thai politicians and health officials 
is unclear as the evidence is limited. 
4.1.2 The attitudes of key actors towards ART 
During the 1990s large-scale ART delivery was commonly perceived as unaffordable 
(Chitwarakorn 2001; Dahlan 1994; Patanasingha 1996). For example, in a press conference in 
20 This was to prevent the government drug finn to produce generic didanosine. As maintained by a 
key infonnant, the offer was based on the condition that if the government laboratory accepted this 
proposition, it would not sell generic version at the same time. 
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1992, the Director General of the Disease Control Department emphasised that, 'AZT 
(zidovudine) - the only antiretroviral offered in public programme - is very expensive: 50 
baht per tablet. As the usual dose is 12 tablets a day the total cost is 600 baht per head. ' 
(Naew Naa 1992). The Director General also maintained that, 'Free drugs are available for 
only 300 low-income patients. The wealthier who can afford the cost will be asked to pay by 
themselves. The government cannot support all PLWHA since very large amount of budget 
would be required in such case. ' (Khoaw Sod 1992). For the bureaucrats responsible for 
resource allocation across HIV interventions, the 1995 programme evaluation which 
suggested that ARV-based treatment was significantly less cost-effective than the use of the 
drugs to prevent mother-to-child HIV transmission also led to another commonly-held official 
view (see chapter 2): ART did not provide the best value for money, especially in comparing 
prevention programmes which had been well-established and proved effective (Kunanusont, 
Phoolcharoen, and Bodaramik 1999). 
Gradual changes in the attitudes towards ART of the two networks could be observed with 
the growing numbers of publications on the effectiveness of highly active antiretroviral 
therapy (HAART) and the associated cost saving in the West and Brazil after 1996. 
Treatment advocate coalitions and expert activists deliberately distributed such information: 
passing on the success stories to health officials, professionals and the general public 
(Matichon 2001). In addition to the clinical outcomes of medication, NGOs' campaigns for 
ART access through generic production were motivated by two elements: the introduction of 
relief strategies for public health implications of the Word Trade Organisation's Intellectual 
Property Right Agreements and the NGOs' experiences on the unsatisfactory results of 
treatment for opportunistic diseases (interview N15 and N16). Furthermore, the notions of life 
saving medication and human rights were increasingly highlighted to encourage treatment 
extension (Ungphakorn 2001; Wisartsakul 2004). However, owing to the limited capacity of 
the local drug industry, threats of international trade sanctions, and the absence of global 
mechanisms to foster ARV price reduction, nationwide treatment remained infeasible in 
Thailand throughout the 1990s. 
4.2 The introduction of universal health coverage and the exclusion of ART 
The shift in the national ART policy towards universal coverage developed in the midst of 
substantial changes in politics and health system reform. After a long period of political 
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instability as reflected by short life-span regimes and military coups, the Thai Rak Thai party 
gained a landslide victory in the general election in January 2001 (Nelson 2001). Given its 
strong majority in parliament and popular support after the election, the administration 
implemented several initiatives as pledged in the electoral campaign (Phongpaichit and Baker 
2004). This included the introduction of the universal health coverage plan (UC). Rolled out 
in all 76 provinces by October 2001, the publicly-funded scheme making health care 
available to everyone was regularly rated as the government's best initiative (National Health 
Security Office 2004b; Phongpaichit and Baker 2004). 
Before the UC was instigated, several health benefit plans existed for different groups of 
people (Tangcharoensathien, Srithamrongsawat, and Pitayarangsarit 2002). However, there 
was a significant fraction (30%) of the population who had no benefit coverage (chapter 2). 
The feature of Thai health insurance system at that time included fragmentation, duplication 
and inadequacy, and led to inefficiency of resource use and inequity among beneficiaries of 
different schemes. The introduction of the UC aimed to tackle such problems by 
consolidating the existing schemes for low-income groups and also expanding health benefits 
to cover the uninsured (Jindawattana and Pipatrojkomol 2004). The newly established plan 
allocated funds to health providers for ambulatory care, health promotion and preventive care 
on a capitation basis, and adopted Diagnosis Related Groups as a tool to subsidise in-patient 
services (Siamwala 2002). The coverage for health interventions in the UC was restricted to 
those selected to be part of the scheme's benefit package (Ministry of Public Health 2001a). 
For treatment advocates the establishment of the UC underpinned the likelihood of improving 
ART access (interview N16 and NI7). However, although NGO staff expected treatment 
expansion as one of the UC benefits, ART was actually excluded. The status of ART was 
officially discussed at a meeting to prepare for the rolling out of the new health insurance 
initiative convened on 17th March 2001 (Ministry of Public Health 2001f). In the meeting 
chaired by the Prime Minister, the competing proposals of two policy networks: the 
technocrats and NGOs were presented. Sanguan Nitayarumphong - the Deputy Health 
Secretary responsible for UC implementation21 - proposed to exclude ART (interview N02). 
This proposal was supported by Viroj Tangcharoensathien - a health economist with 
21 Later, Nitayarumphong became the first Secretary General of the National Health Security Office-
an autonomous public agency with a mandate to oversee the UC when the National Health Security 
Act was effective in early 2003. 
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expertise in healthcare financing. It was the economist and his research fellows22 who worked 
out the projections and related policy recommendations on the financing facets of the UC 
such as the capitation rate and benefit package (Tangcharoensathien, Wibulpolprasert, and 
Nitayarampong 2004). Health officials and researchers closely involved in formulating the 
initiative explained that the reason for the exclusion was the high cost of ARVs and 
insufficient information on the long-term financial implications for the health plan (interview 
N02 and NIl). 
While ART was labelled by the UC officials as costly, the NGO-expert alliance held different 
perspectives. They accepted that owing to the high ARV prices, it was infeasible for the 
government to subsidise ART for all afflicted people immediately (interview Nl5 and NI6). 
They argued, however, that treatment should be adopted as a component of the UC for two 
reasons. First, as suggested in clinical studies in several settings, ART could significantly 
reduce morbidity and mortality, as well as improve the quality of life. Second, the exclusion 
of therapy would be regarded as discrimination against people with a particular health 
condition which violated the Constitution and human rights (interview N15, Nl6 and NI7). 
As Ungphakom (2001:75) asserts: 
Those who can afford it are now able to have a good quality of life for a long 
period of life. This raises the question whether drugs should be considered in the 
same terms as a commodity .. , or should it be considered an essential part of 
people's needs and therefore a right. Should it be a right to people in the world to 
receive the drugs needed in order to support their life?' 
.-
The NGOs raised the Brazilian and Indian experiences in producing low-priced generic drugs 
and pointed out that the universal coverage for ART would be possible if a similar strategy, 
i.e. local ARV manufacturing, was introduced. In addition, they proposed that the government 
commission economic and fmancial evaluations of treatment in order to inform policy23 
(interview Nl5 and NI6). This proposition, as noted by NGO leaders, was based on the 
22 Tangcharoensathien was a researcher of the Health Systems Research Institute. He also ran a 
capacity strengthening programme in health economic & financing research. The health economist and 
fellows focused their works on the implications of and impediments in implementing different health 
insurance schemes in Thailand. 
23 This demonstrates the culture of respecting evidence-guided policy processes in Thai health 
systems. Even though the NGOs emphasised the justice and human rights as their major arguments, 
many of them agreed that the benefits of ART should be proved in empirical studies. 
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positive cost-saving and cost-benefit parameters of ART programmes in forerunner settings 
such as Brazil and developed countries (interview N13 and NI5). In this regard, the meeting 
assigned the Health Ministry's research agency - the Health Systems Research Institute 
(HSRI) - to estimate the financial costs of nationwide ART compared to its potential benefits 
(Ministry of Public Health 2001f). 
While the potential financial burden of ART to the early phase of the UC plan was the centre 
of debates, other aspects were not taken into account: for example the infrastructure to 
support rational prescribing, dispensing, administration and monitoring as well as other 
critical issues like medication adherence and drug resistance (interview N02 and NIl). In 
interview, health officials - mostly health economists or related disciplines - who were 
involved in the UC establishment, admitted that they had had no experience in HIV and ART 
areas, thus their concerns focused only on a single element: ARV costs. On the other hand, 
their treatment advocate counterparts maintained that they considered other potential 
obstacles, but believed that the treatment was manageable in the Thai context (interview NI5 
and N16). This suggests that the decision to exclude ART from the UC scheme was not 
determined by the speculation on the inadequacy of infrastructures and other resources in the 
health delivery system but rather on affordability. 
4.3 Agenda setting and adoption of universal ART policy 
The previous section illustrates the roles of the government official cluster and the civil 
society coalition in ART policy making and the justification proposed by the technocrats that 
led to the exclusion of the treatment from the UC in March 200 I. Yet a mere 8 months later, 
in November of the same year, the government offered medication to all eligible PLWHA 
through the newly founded health plan. This section explores the evolution of the national 
ART policy during this eight-month period in order to understand the factors that account for 
the provision of nationwide treatment, as well as the process and context in which the policy 
was innovated. 
4.3.1 Stepping towards universal ART access 
The NGO network began communicating with the Thai Rak Thai cabinet even before the 
discussion about the UC benefit package took place. In February 2001 an important event 
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relating to ART provision in resource-poor settings developed. Cipla - an Indian generic drug 
company - announced an offer of ARV s to developing countries at a price between 1,200 and 
2,050 baht24 per patient per month (Reuters 2001). As the monthly cost of the drugs in 
Thailand was between 7,000 and 10,000 baht, the NGOs promptly conveyed this message to 
the government. Following the same report, the NGO alliance encouraged the Health 
Ministry to deal with Cipla for cheaper medicines. 
On 5th March, NGO leaders met Surapong Suebwonglee - the Deputy Health Minister - and 
asked him to enact appropriate strategies to lower the prices of all anti-HIV drugs marketed in 
the country (Bangkok Business 2001c). The Minister was informed about the advantages of 
purchasing Cipla products and that the drugs had been adopted by HIV programmes in many 
African countries. The NGOs also urged the Health Ministry to support the GPO to produce 
non-patented ARVs on an industrial scale. They expected that either the importation or local 
manufacture of generic drugs could result in a price reduction to 1,000 baht per patient per 
month. The Minister responded positively: the policy was to strengthen the government 
laboratory to produce more anti-HIV items and also to extend its facilities for industrial-scale 
production (Bangkok Business 200 1 b). 
Although local ARV manufacture had never been declared as a government policy before, the 
Health Minister's vow to encourage its laboratory to produce low-cost drugs was not 
rhetorical. The GPO's Research and Development Institute had succeeded in formulating a 
number of anti-HIVs since the early 1990s, so that it could respond promptly to the 
ministerial request (Kraisintu 2001). Approved by the Governing Board of the GPO on 15th 
March, the proposal to upgrade ARV production from laboratory into industrial scale was 
submitted to the cabinet and was finally approved in May (Ministry of Public Health 2001e). 
It was expected that the first batch of drugs could be launched by January 2002. The monthly 
price of first-line regimen drugs was anticipated to decline to 4,000 baht in the beginning 
phase and later to 2,000 baht, which would be affordable for inclusion in the DC. 
After the exclusion of ART from the UC in March 2001, the network of NGOs and 
activists continued campaigning for treatment extension. Parallel to the Thai movement 
were significant milestones in international efforts to attain similar objectives. In April, 
24 US$1 equalled 41 baht in early 2001 
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the South African government's triumph over 39 transnational pharmaceutical 
companies25 raised attention worldwide, and was brought to the Thai government, as a 
role model to address the impediments in large-scale ART delivery (The Nation and 
Deutsche Presse Agentur 2001). The NOO coalition urged the government to act upon its 
policy on making generic drugs more available and accessible. This action was 
immediately undertaken after three NOOs, namely the MSF, Treatment Action Campaign 
and Oxfam jointly delivered a press release acknowledging the end of the lawsuit in 
South Africa as a 'powerfUl precedent set for other developing countries' (MSF, T AC, 
and Oxfam 2001). The influence of this particular event on Thai ART policy is unclear; 
however, it demonstrates a possible influential role of the global AIDS NOO network in 
policy making in the South. 
The relationship between the politician-bureaucrat and civil society networks became closer 
as it seemed they shared a common destination: improving ART access. A series of 
discussions to extend publicly-subsidised treatment were convened between the Health 
Minister; health officials from both the Disease Control Department and those involved in the 
UC commencement; and NOO-expert alliances (interview N15 and N16). During this period, 
the major focus of concern of all parties remained on the high drug costs. A NOO leader 
notes that, in an important meeting organised in May 2001, the Health Minister pledged to 
integrate ART into the UC benefit if drug costs had decreased to less than 2,000 baht a month 
(interview NI5). 
Alongside the development of the public-civic partnership, the context of the national ART 
policy changed to allow cheaper drugs to be available. After the government laboratory's 
ARV project had been approved, notable progress was made in accordance with the 
timeframe. Serious attention was paid by the Health Ministry to implement this initiative as 
reflected in press releases, speeches and presentation at national conferences and meetings 
(Ministry of Public Health 2001e; Suebwonglee 2001), and when the Minister visited the 
laboratory to reaffirm the policy to its governing board and administrators (interview N13). 
This demonstrated the strong intentions of the government to increase treatment coverage. 
25 In 1998, 39 pharmaceutical companies filed a lawsuit against South African government over its 
Medicines and Related Substances Act, which would allow compulsory licensing and parallel import 
of medicines in a health emergency. On April 19, 2001, the pharmaceuticals companies withdrew their 
case owing to mounting international pressure mobilised by NOOs. 
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In this period, many medical and laboratory experts had a supporting role in facilitating 
access to ART. They provided related information, advice and training to PLWHA and NGO 
staff. Some were closely involved in formulating the Health Ministry's Access to Care 
Initiative which was in its first year of implementation. On some occasions, these specialists 
expressed their views to the general public. In October 2001, for instance, a Thai Professor of 
Immunology who led an international HIV research network made an assertion through the 
media that despite higher drug costs in Brazil than Thailand, Brazil had started its nationwide 
ART programmes (Matichon 2001). Furthermore, he mentioned the net benefits of therapy in 
Brazil as a consequence of the opportunistic infections averted, hospitalisation reduction, and 
increased quality oflife, as well as recurrent productivity among ARV recipients. 
The success of the government laboratory was publicised in October 2001, and it was 
announced that the first batch of ARV fixed-dose combinations would be launched in 
December, and that the increased manufacture volume would result in a drug price reduction 
which allowed a ten-fold increase in treatment coverage from 5,000 to 50,000 PLWHA 
(Bangkok Business 2001a; Manager 2001). As noted by the GPO Director, two cocktail 
formulas26 mainly prescribed in such a programme, could be marketed at the cost of 2,300 
baht per patient per month, while the corresponding brand products cost 16,400 to 21,800 
baht per patient per month. According to the Director, two other fixed-dose combinations 
would be launched by April 2002. 
The dissemination of such information was critical. Immediately, the NGO coalition urged 
the government for further action. On 5th November, a letter co-signed by the presidents of 
the Thai Network for PLWHA and Thai Non-governmental Coalition on HIV/AIDS was sent 
to the Health Minister as well as circulated to the media, proposing the Ministry to designate 
bilateral task force to oversee treatment extension (Tan-ud and Panichpak 2001a). The letter 
not only illustrated the ambitious goal proposed by the ART advocates, but also reflected 
their knowledge and experiences in the HIV field. It was stressed that the task force should 
have the following responsibilities: (1) to work out a plan to integrate therapy into the UC 
scheme that would benefit 150,000 PLWHA within five years; (2) to design programmes for 
human resource and infrastructure development; (3) to supervise HIV prevention campaigns 
in order to reduce future demands for medication; and (4) to foster research on the 
26 Zidovudine + lamivudine + nevi rapine and zidovudine + didanosine + nevirapine 
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consequences of treatment extension such as the decline in public spending on opportunistic 
infections and welfare services for PLWHA27• 
In addition, the letter suggested that to achieve the target of treating 150,000 individuals the 
budget must increase over five years, i.e. from 500 million baht for fiscal year 2002 to 3 
billion baht for 2006. The NODs claimed that these figures were justified as it had been 
expected that drug prices would further reduce owing to negotiations with private drug 
companies and the capacity of the government laboratory. The estimated budget covered the 
costs for twice-a-year CD4 testing. Moreover, to develop the training curriculum for health 
workers and the plan to improve infrastructure, the civic alliance recommended that the task 
force should take into account the past experiences in providing therapy to 3,000 patients 
under the first-year Access to Care Initiative. Finally, the letter stated that a thousand 
PLWHA and NOD representatives from 5 regions of the country would gather at Government 
House in Bangkok to hear the government's decision on World AIDS Day eve - 30th 
November 2001. At the same time, another letter was sent to the Prime Minister asking the 
government to adopt the policy to provide free access to ART in the UC (Tan-ud and 
Panichpak 2001b). 
The NOD network also employed other means in their campaigns. Thai NGDs and worldwide 
partners, for example the International Oay and Lesbian Human Rights Commission, MSF, 
and Global Treatment Access, called for support from other NODs and the general public. A 
draft letter provided as a prototype was posted on these NODs' websites persuading 
audiences to endorse and forward it to the Thai government (International Oay and Lesbian 
Human Rights Commission 2001). The letter requested the Prime Minister to ensure the 
government's commitment to include ART in the UC. Several arguments including those on 
human rights, discrimination, equity, and the matters of life and death of PL WHA were 
presented to convince the politicians and the public. The NODs' proposal emphasised the 
obligations to uphold and exercise the principles of many international conventions, as well 
as agreements and guidelines adopted by the Thai governments in the past. The successful 
ART programme in Brazil was also highlighted as the best practice. 
27 This proposal indicates that, on the one hand, the importance of research had been recognised by 
different parties involved in Thai health policy, and the NGOs believed ART's benefits exceeded the 
costs, on the other. 
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In response to such movement, on 28th November, a government-NGOs meeting was 
organised. Those who took part in the discussion included the Health Minister, Deputy Health 
Secretaries28, the Director General of the Disease Control Department, the Director of the 
Government Pharmaceutical Organisation, HIV experts, NGOs and PL WHA representatives 
(Ministry of Public Health 200Ic). Prior to the meeting, the NGOs prepared information on 
many facets of a publicly-funded ART programme, such as the potential number of PL WHA 
currently eligible for therapy and the magnitude of financial implications for the UC plan 
(interview Nl5 and NI6). With these projections, they tried to convince the Health Minister 
that integrating ART into the UC would be fmancially feasible. 
Subsequent to the discussion, an agreement was attained. The key resolution was that the 
Health Ministry agreed in principle to include ART in the UC package, phasing it in 
gradually. A memorandum was developed to cover all issues concerned by the participants of 
both sides. First, a remark was made that studies including operational research in different 
fields were required to support efficient integration of treatment into the health scheme 
(Ministry of Public Health 2001c; Wibulpolprasert 2001). Second, a task force consisting of 
health officials, academics, clinicians, NGOs and PL WHA representatives would be 
designated to formulate a comprehensive work plan. In order to enhance patient adherence to 
therapy and to assure clinical outcomes as well as programme efficiency, the task force would 
set up guidelines on drug selection, patient enrolment, treatment regimens, and clinical 
monitoring. Finally, it was emphasised that multi sectoral collaboration would be pursued to 
maintain the well-established programme for HIV prevention. 
Despite the Health Ministry's pledge to integrate ART into the UC plan, the treatment 
advocates felt the settlement made at the 28th November meeting was uncertain (interview 
N15, N16 and NI7). NGO leaders pointed out in interviews, they did not believe that the 
government would keep the promise, thus they carried on a public demonstration planned 
before the agreement was reached. On 30th November, the Health Minister made a declaration 
before a thousand PL WHA that the government would expand the UC benefit package to 
cover ART (Manager 2001; Noikorn 2001). 
28 There were four deputy health secretaries. The two who participated in the 28th November 
discussion included Sa-nguan Nitayarumphong and Suwit Wibulpolprasert 
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4.3.2 Extending ART coverage versus integrating ART in the UC 
The above discussions illustrate a straightforward process that led to policy innovation: ART 
had been excluded from the UC package in March 2001 owing to the prohibitive ARV costs. 
Eight months later treatment was pledged to be included in the health plan after substantial 
drug price reductions. In fact, both policy makers and NGO networks recognised that there 
were different issues to consider: extending ART coverage and integrating ART in the UC. 
This section explores the meanings of these two aspects as perceived by each group of policy 
participants, as well as their implications for the policy development. 
Policymakers' perspectives 
According to a senior official responsible for the UC instigation, fmancial feasibility and the 
implications of integrating ART into the emerging UC plan, was a major concern, making 
him reluctant to facilitate such development (interview N02). This was shared by politicians 
and other technocrats. Since the universal health coverage policy was in the early phase of its 
formulation and implementation, these personnel felt that the programme had not yet been 
well established. Thus, they were unwilling to bear the increased risks from ART. For 
instance, Suebwonglee - the Deputy Health Minister stated that: 
'Not only UC implementation but also the extension of ART coverage under the new 
scheme resembled the 'Long March' - if the first pace had been unevenly 
performed, both initiatives might fall down before reaching the destination. 
Therefore, the initial period must be well prepared. ... ART provision is a really big 
issue - we have to consider carefully how to maintain the steps forwards' 
(Suebwonglee 2001) 
On the other hand, the Health Minister and bureaucrats thought that the government could not 
refuse to improve medication access for two reasons (interview N2 and Nll). First, the 
administration had to keep its promise that treatment would be delivered on greater scale if 
ARV prices decreased to an acceptable level. Second, the concurrent global initiatives to 
encourage ART access could not be ignored; otherwise it would result in an undesirable 
image that the country, and the impression that the Health Ministry, was left behind. A high-
ranked MOPH official revealed that he had many opportunities to discuss with the minister 
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about the global mainstream policies and related campaigns, for example the joint declaration 
issued by the United Nations General Assembly Special Session (UNGASS) on HIV/AIDS in 
June 2001 (interview N02). Such international policy developments indicated that Thailand 
could not afford the embarrassment if the government chose the status quo. This official 
maintained that he also raised the successful case of nationwide ART programmes in Brazil 
to the Minister. 
The attitudes towards the potential burden of ART on the UC budget played a key role not 
only in the exclusion of treatment from benefit package at the beginning, but also in the 
policy decisions after ARV prices fell. In the fonner phase, another factor was involved: 
technocrats felt the urgency to move the UC scheme forward. One said that he saw the 
window of opportunity opened to refonn the country's health care financing system as this 
issue had failed to catch the government's attention in spite of his efforts to do so for the past 
ten years (interview Nll). Therefore, he and his refonnist colleagues did not want to divert 
attention to study the financial burden of ART because it would delay the UC 
implementation. 
Actually, the projected resources required for the UC were derived from existing data on the 
total medical care costs of services provided in a number of hospitals (Tangcharoensathien, 
Teerawattananon, and Prakongsai 2001). None of particular health interventions covered by 
the new scheme had been assessed for its costs and financial impact on the health scheme. As 
revealed by an official, owing to the limited timeframe, the preparatory process of the UC 
was disorganised, especially in the formulation of the fundamental components of programme 
financing (interview N02). This assertion has been reaffinned by Siamwala (2002:225): ' ... 
while the UC committee envisages a more leisurely pace of implementation, this has to be 
confronted with the political drive to show the result quickly, ... ' Because of this haste, 
treatment and care enlisted to the first version of benefit package were transferred from the 
benefits provided under the Social Security Scheme without reappraisal of their economic and 
fmancial consequences (Jindawattana and Pipatrojkomol 2004; Ministry of Public Health 
2001 f). That ART had not been covered by the Social Security Scheme was another factor 
legitimising treatment exclusion from the UC (interview N02). 
The perception about the high costs of ART among the UC technocrats remained important 
even though the government laboratory showed it could produce low-priced generic dugs. At 
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that time, the Health Ministry's UC task force was occupied by day-to-day problem solving 
(interview NIl and NI2). None of the health economists in this team paid attention to 
estimate the potential costs of ART and its fmancial implications. An official who led the 
management of the health care financing reform said he supported a policy for the 
government to subsidise ART as a component of the UC package (interview N02). This 
official further argued that, integrating therapy into the health plan in 200 I or even one to two 
years later, was infeasible since it would severely afflict the constrained budget29 • Since the 
additional burden from the anti-HIV medication was seen as 'overwhelming and intolerable', 
he suggested that the Health Minister adopt the universal ART coverage, but only gradually 
integrate it into the UC, without setting up an exact timeframe. 
Treatment advocates' perspectives 
NGOs and other activists too paid much attention to the status of ART in the UC. Although 
treatment could be extended to achieve universal coverage by employing the existing 
management processes of the Disease Control Department, they insisted that the service 
should be funded as a UC component. NGO leaders argue that the financing mechanism was 
vital because it affected the sustainability of ART provision (interview N15, Nl6 and NI7). 
As the Health Ministry's negotiating power with the Budget Bureau was considered to be less 
powerful than other ministries, leaving any interventions outside the benefit package and 
funding them as non-UC items would be uncertain, since it meant that the budget item and 
amount would have to be negotiated year by year. Since the universal health coverage policy 
proposed in the electoral campaign was one of the most high-profile elements of the Thai Rak 
Thai's triumph, it was argued that the administration must be accountable to meet the 
resource needs for any essential services (Kulsomboon, Thanaviriyakul, and Pinyowiwat 
2003). Some activists also claimed that excluding HIV therapy from the health benefit 
scheme would discriminate against PL WHA. 
Others pointed out that as ART could reduce medical care costs, ensuring access by 
integrating treatment into the UC would benefit the health plan itself. The Thai Red Cross 
Society (2002), for example, argued that the government should include treatment in the UC 
since it would offer better value for money than the services for many other diseases such as 
29 This argument is supported by many documents such as Jindawatana and Pipatrojkomol (2004), 
NHSO (2004), Jongudomsuk (2004). 
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hypertension, heart diseases, and renal failure. The Red Cross officials compared the quality 
of life of the elderly patients with chronic conditions with PLWHA on ARVs and concluded 
that the latter group would gain more. Some academics asserted that ART was more cost-
effective than many interventions covered by the UC, especially in comparison with treatment 
interventions for other chronic conditions. With these perceptions, the NOO coalition 
maintained to pursue the goal of financing ART in the UC through the policy formulation 
phase as will be discussed in the next chapter. 
4.3.3 What others thought about the new policy 
The above discussion illustrates a relatively consensual policy process, resulting in the 
extension of the national ART programme coverage, and ending the integration of treatment 
into the UC. However, the discussion was largely confined to the interaction and perceptions 
of the policy makers and NOO coalition. 
Synthesising the information from documents and key informants, it appears that the issues of 
delivering nationwide ART and including medication in the UC package did not catch the 
public's attention. Although the evolution of the new policy was published in newspapers and 
in other media, it could draw little attention of the general public and even journalists 
(interview N09 and N18). The result of reviewing a range of newspapers suggests that ART-
related information disseminated during March to November 2001 mostly came from NOOs 
and the Health Ministry's or the GPO's press releases. There were only a few analyses in two 
English-language newspapers which were accessed by a small number of people. Interviews 
with health officials and NGO leaders also suggested that though it was likely that some 
people disagreed with the policy, none of them liked to raise conflicting arguments publicly 
(interview N03, N04 and N19). This is because denial or merely expressing unsympathetic 
views towards the sick or the underprivileged including PL WHA was an action against social 
norms of the society where most of the population were Buddhists. 
As key informants maintain, the debates for and against the universal ART policy adoption 
developed within a limited circle - among academics, HIV experts, and AIDS officials 
(interview N04, N09 and N19). More importantly, the discussions did not aim at absolutely 
opposing the treatment provision, but focused mainly on the anticipated negative externalities 
of the national-scale medication programme, especially given the plan to expand rapidly. The 
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literature and interviews with health personnel in the field suggest that many officials in the 
Health Ministry and sub-national offices, as well as health workers involved in implementing 
the Access to Care Initiative articulated their concerns about the undesirable consequences on 
the health delivery system, owing not only to inadequate preparation but also to 
administrative hurdles caused by the newly introduced health financing reform (AIDS 
Division 2001; Kulsomboon, Thanaviriyakul, and Pinyowiwat 2003). However, these caveats 
were conveyed to particular audiences such as those attended technical meetings or 
conferences which normally caught neither politicians' nor the public attention. 
4.4 Why was the universal ART policy adopted? 
The availability of low-priced ARVs and the NGO movement were generally recognised as 
the major factors of ART policy innovation in 2001 (Phanuphak 2004). Based on the 
literature and interview data, however, the government's decision to adopt the new policy was 
predisposed by many elements internal and external to the health system. According to the 
Health Minister, in addition to the price reduction, the policy to scale up ART was supported 
by the notion of human rights: 'the right to equally and universally access health services of 
Thai people' (interview NOl). Another motivating factor was the potential public interest 
concerning the desirable implications of treatment for HIV patients, their families and the 
society. The Minister went on to maintain that Thailand had a well-established health 
infrastructure and management system, as well as sufficient financial and human resources, 
compared with many other developing countries. In sum, she stressed that the strong political 
resolve - which came from this combination of factors - played a crucial role in the policy 
making. However, she admitted in interview that treatment advocates' campaigns encouraged 
the cabinet to make the decision. At the same time, she argued that the inclusion of ART in 
the UC package was in line with other treatments and care adopted under the umbrella of the 
Thai Rak Thai Party's universal health coverage policy. In response to the question on 
whether international ART experiences such as Brazil's large-scale treatment programme had 
had any influence, the Minister denied the role of established models in other countries and 
emphasised that the policy adoption was solely subject to endogenous factors: the potential 
benefits to the public, technical feasibility and political commitment. 
However, other sources of information provided broader explanation for the policy change. 
In term of political desirability, it appears that the government as well as the Thai Rak Thai 
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party might have been concerned about their domestic reputation. Some interviewees 
illustrated the political importance of the policy, by maintaining that ' ... at least, over 50,000 
PL WHA who would be on government-subsidised ART and their family members would vote 
for the party in the 2005 national election. ' This argument was reafftnned by a journalist who 
also pointed out that universal access to medication could bolster the country's prominence in 
the international HIV arena. 
'Politically, the Health Minister knows exactly how to play the game and how to 
make use of the Bt30 medical scheme30, touted as one of the major policies that put 
the Thai Rak Thai Party into government. The decision is sure to win Thailand 
praise from the international community again after the globally-recognised 
success of its programme to reduce the rate of new HIV infections. ' (Sakboon 
2001). 
However, it could also be argued that, the Health Minister was forced to adopt the policy. The 
government's pledge to expand ART coverage if drug prices declined to a certain level had 
been publicised through ministerial statements and other media (Ministry of Public Health 
200Ie). This allowed the administration very limited choice in responding to the demand 
made by the NGO alliance when the state laboratory declared the price reduction. Given that 
it was not unusual for politicians to disregard their own promises, the government's actions 
were closely watched by treatment advocates who kept up pressure on the cabinet. One senior 
health official recognised that the political pressure would continue and even increase, and 
therefore he often reminded the Minister about her promise and the potential consequences of 
ignoring it (interview N02). 
In addition to the domestic circumstances, and in spite of the Minister's denial, the global 
movement to encourage ART in resource-poor settings played a crucial role. Among several 
inter-state agreements and affirmations endorsed by Thai government, the declaration of 
commitment issued by the UNGASS on HIV/AIDS in June 2001 was critical. This set of 
statements illustrates the commitments of state leaders to address HIV epidemic by every 
effort to ensure the access to prevention, care, support, and treatment among affected 
populations (United Nations 200 1). At the United Nations Assembly, the Deputy Prime 
30 The UC was usually called the '30-baht scheme' since patients were required to pay 30 baht per visit 
or per admission to hospitals 
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Minister who was the head of Thai delegates asserted that the government fully supported the 
adoption of this declaration (lntrawityanunt 2001). Key informants argued that the 
government had to respect the declared commitment to improve ART access as part of their 
international obligations (interview NIl and personal communication with a Deputy Health 
Secretary). The mechanism to evaluate the progress in implementing the UNGASS 
commitments was acknowledged to be an inducement to the administration. This was because 
the level of national achievement for each of the measure would be regularly appraised and 
reported to the Annual UN General Assembly. Prior to the UNGASS on HIV/AIDS, Thailand 
had declared its obligations on HIV prevention and treatment at several regional and 
international meetings, but the 2001 UN forum was the first high-level intergovernmental 
conference dedicated to this specific issue (Ministry of Foreign Affairs 2003). There is little 
doubt that the Thai Government's commitment to treatment extension was in part encouraged 
by the global trend (Phanuphak 2004). 
To be fair, an argument can be made that the ART policy innovation in Thailand was not 
under domestic or international political pressures but, to some extent, motivated by true 
public interests. In other words, the government had a strong commitment to improve 
treatment access. This was reflected in ministerial policies and actions, for example the 
programme to strengthen the GPO's capacity in order to extend generic ARV production was 
implemented immediately after the Thai Rak Thai cabinet came to power as aforementioned. 
Such effort indicates that the government had had clear objectives and strategies to address 
the treatment impediments. Drug price reduction - a vital factor of the adoption of universal 
ART coverage - was partly the outcome of the administration's advocacy. 
4.5 Summary 
The process of HIV policy making in Thailand comprised a long period of policy continuity 
followed by a radical policy shift. Over the first decade of national ART programme 
implementation, incremental changes resulted in limited treatment coverage. When the 
Government pledged to scale up treatment in late 2001, there were transformations in both the 
policy network and policy image. Health financing reformists and civil society organisations 
replaced groups of Disease Control Department officials who had dominated the policy 
decisions concerning ART delivery since 1992. At the same time, nationwide treatment was 
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considered feasible owing to the local production of generic ARVs and the associated price 
reduction. 
Reflecting Kingdon's explanation of how issues reach the policy agenda, universal ART 
coverage took place at a critical moment when problem, politics and solutions came together. 
The HIV epidemic and its devastating effects had long been recognised as a problem; the 
Thai Rak Thai administration was elected and committed to universal health care with strong 
civil society support for political change to improve access to treatment; and affordable drugs 
were one of the solutions that made scaling-up a feasible national policy. 
The 2001 programme renovation could also be seen as an outcome of learning among several 
groups of policy actors. The Health Minister, reformists, health officials and HIV experts got 
the information on ART expansion in different parts of the world from many sources, local 
and international. Meanwhile, NOOs and PL WHA alliance including health professionals in 
some hospitals obtained direct experiences on service provision through their projects such as 
the Buyer's Club. Lessons drawn by members of these policy networks had an important role 
in inspiring and inducing policy change. 
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CHAPTER 5: MOVING TOWARDS UNIVERSAL ART ACCESS: NATIONAL 
POLICY FORMULATION 
When the Thai government agreed to provide universal coverage for antiretroviral therapy in 
late 2001, it was understood that the relevant agencies, led by the Ministry of Public Health 
(MOPH), had the obligation not only to get many more people living with HIV/AIDS 
(PL WHA) on therapy but also to arrange the integration of treatment into the recently 
launched health benefit scheme. To achieve these two goals, the national antiretroviral 
therapy (ART) programme configuration was subjected to modification in several aspects. 
This chapter provides the overview of the gaps and achievements in improving treatment 
access in the beginning phase of the programme scale up. Moreover, it sheds light on the 
concomitant revisions of key elements of the medication delivery and associated resource 
mobilisation in this period. 
5.1 Treatment expansion: targets and achievements 
Extending HIV medication on a national scale required a substantial preparatory period and 
this was initially underestimated. Although the MOPH received extra resources, which would 
double the target of people on ART for fiscal year 2002, i.e. from 3,000 to 6,000 clients, 
when the fiscal year ended in September 2002 only half the expected number were on therapy 
(Chitwarakom 2003). In the process to draft the budget proposal for 2003, the Health 
Ministry planned to deliver ART to 12,000 PLWHA (Sirisuthom 2002). As a result of the 
continual drug price reductions, the final proposal stated that treatment coverage could be 
doubled, i.e. to benefit 23,000 patients (Administration Advisory PaneI2002c). However, the 
national programme was able to meet only 57% of this target by September 2003. Despite 
the unsatisfactory achievement for 2004, the Health Ministry aimed to have 50,000 PL WHA 
on therapy. As maintained by a senior official, the Ministry was confident that the 
programme's perfonnance could be improved and therefore the target could be met by 
learning from the first-two-year experience of treatment extension (Teeratantikanont 2004). 
5.2 Major changes in programme configuration 
As the national ART programme was expected to meet the challenge of broadening services 
for all eligible PL WHA, the policy instruments to achieve the new goal were amended 
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accordingly. Developments in the initial phase of treatment scale up can be categorised into 6 
facets: integrated management; resource mobilisation; designations for the Health Ministry 
agencies; changes in treatment protocols; revisions of enrolment criteria; and extension of 
therapy to hospitals external to the Health Ministry. 
5.2.1 Integrated management of the national programme 
Before the scale up of ART in 2002, treatment delivery had been organised in a fragmented 
manner, involving several government agencies and non-governmental organisations (NGOs). 
The Health Ministry had a leading role in providing the medication through many of its 
departments, but all had different target populations. This included the Department of Disease 
Control's Access to Care programme for adults and children; the Department of Health's 
ART for post-delivery women and their family (so called 'PMTCT plus'); and therapy 
offered under clinical trials and research projects jointly conducted by the Health Ministry 
and other institutes (ATSI 2003b). To facilitate efficient scale-up, in July 2003 the Disease 
Control Department's Bureau of AIDS, Tuberculosis and Sexually-transmitted Infections 
(ATSI) integrated all previously disjointed programmes under an overarching umbrella, 
entitled 'National Access to Antiretroviral Programmes for People Living with HNIAIDS 
(NAPHA)' (ATSI 2003b). A steering committee, comprising representatives from MOPH 
departments, other ministries, local administrative authorities, publicly-funded health benefit 
schemes, and civil society organisations (CSOs), was appointed to set up administration 
guidelines and coordinate different programme components (ATSI 2003b). This aimed to 
encourage information exchange through the inauguration of common reporting system, 
standardisation of clinical and management practices, and resource sharing, as well as to 
improve referral of patients between programmes. However, this move did not cause 
significant conflicts, which might be because there was no substantial change in programmes' 
management structures and resource allocation to responsible departments (interview N05). 
5.2.2 Resource mobilisation 
The increase in the number of targeted clients required additional resources, including 
funding, personnel, and infrastructure. Promptly after the universal ART policy was 
announced, the Health Ministry submitted a proposal to the cabinet for an additional budget 
of 250 million baht for the first-year treatment extension (Assavanonda). At that time, the 
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fiscal year 2002 had started and the financial allocation to all budget lines had been 
established. Since ART was not classified as urgent according to the public finance regulation, 
the Health Ministry received an extra amount of only 50 million baht (Administration 
Advisory PaneI2002c). However, future budgets were met in full. 
The budget required to meet targets for 2003 and 2004 rose sharply to 350 million baht and 
one billion baht, respectively. But there was no difficulty in getting funding approval from the 
Budget Bureau and House of Representatives, as there was no dissension on the rationale, and 
these amounts did not exceed the overall fmance for the Disease Control Department's pre-set 
budget ceiling (Teeratantikanont 2004). The consensus on budget allocation to the treatment 
programme was likely to have been facilitated by the government party's majority in the 
legislative institute. Apart from public finance, Thailand got a grant of US$192 million from 
the Global Fund to Fight AIDS, Tuberculosis and Malaria (OFATM) for HIV programmes 
including ART between 2002 and 2006 (OFATM 2004). However, the public component 
accounted for the major portion of treatment programme funding, i.e. 80% of the total in 2003 
(Teokul et al. 2004). With this budget, antiretrovirals (ARVs) and laboratory supplies were 
centrally purchased in bulk and distributed to hospitals through the regional disease control 
offices (Ministry of Public Health 2003b). In 2004, matching resources from the OF ATM 
facilitated the accessibility to CD4+ cell measurement as the grant included setting up an 
additional 20 well-equipped laboratories with flow cytometres to make a total of 39 sites 
throughout the country (WHO-SEARO 2004). However, other tests necessary for ART 
monitoring such as viral load and drug resistance assays were very limited - available in 
Bangkok and a few other provinces (Phanuphak 2004). 
The demand for qualified hospitals and health personnel to serve more patients also escalated 
considerably. From its first launch in 2000, the Access to Care programme had been 
integrated into the existing health delivery system, predominantly run by the Health Ministry 
(Satasit, Kuaykiatikul, and On-Nom 2002). The Disease Control Department had invited 
some hospitals, especially those located in HIV -prevalent provinces of the north, to 
participate. A number of settings volunteering to join the initiative were selected according to 
the competency of key personnel, including physicians, nurses, counsellors, pharmacists, and 
medical scientists (Ministry of Public Health 2001 b). The principle of voluntary hospital 
participation ended in 2004 when the Health Ministry issued the policy demanding all its 
hospitals to provide ART under the national programme. 
- 116 -
CHAPTER 5: POLICY FORMULATION 
Regarding human resource development, consultation sessions and training courses were 
organised for health administrators, hospital directors, and health workers at different levels 
from 2000 (interview N08). Policy communication was also set out on several occasions 
including national meetings chaired by the Health Minister or Deputy Minister (interview 
NOS and N09). These aimed to deepen the understanding and strengthen cooperation between 
responsible agencies and also to ensure treatment quality. By December 2004, ART in the 
national programme had been extended to 914 out of 980 government hospitals, with over 
3,300 health workers and laboratory scientists trained under newly developed curriculum to 
deliver the therapy nationally (Thanprasertsuk, Lertpiriyasuwat, and Chasombat 2004). 
During 2002 to 2004, the role of NGOs in the national ART initiative was significant. As 
illustrated in Access to Care guidance from 2002 (Ministry of Public Health 2002a; 2003b), 
the civic groups were recognised as important partners, and also vital resources, to provide 
necessary information and mental support to HIV patients before and during therapy 
administration in order to encourage adherence. Many NGO staff and PL WHA were invited 
to take part in training courses as consultants and speakers as well as participants (interview 
N08 and NlS). Moreover, with administrative and financial support from the Health Ministry 
and GF ATM, in July 2002 the NGO alliance initiated projects to develop the role of infected 
persons in providing care for PL WHA as part of an existing Comprehensive and Continuous 
Care framework (Kumphitak et al. 2004). By May 2004, Comprehensive and Continuous 
Care centres funded by GFATM monies had been established in lOS hospitals or 12% of the 
national ART programme settings. 
5.2.3 Designations for responsible MOPH-affiliated agencies 
Between 2000 and 2003, while the Health Ministry hospitals were being persuaded to join the 
Access to Care programme on a voluntary basis, these settings were allowed to set their own 
targets in accordance with their capacity and demands for medication in the catchment areas 
(Satasit, Kuaykiatikul, and On-Nom 2002). However, owing to the insufficient management 
of drug procurement, inventory and logistics at the national and peripheral levels, drug 
shortages occurred in many provinces so that a 'quota' system was introduced to restrict the 
numbers of treatment enrolees in particular hospitals (Punpanich et al. 2002; Satasit, 
Kuaykiatikul, and On-Nom 2002). Ironically, there were some un-used ARVs at the central 
department, and the national targets were not achieved. The revision of the arrangement 
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commenced in 2004 as the national target of providing 50,000 PLWHA with therapy was 
shared between 12 health regions according to the number of HIV cases previously reported 
from each region (Ministry of Public Health 2002b). This meant that the 'voluntary targets' 
set by participating hospitals and the 'quota' employed in ARV allocation were superseded by 
what was perceived as a 'coercive target' - a programmatic goal that each regional disease 
control office and hospital was expected to attain. 
5.2.4 Changes in treatment protocol 
A crucial shift in therapy delivery in the Access to Care scheme was the introduction of new 
standard treatment regimens in 2002. After the universal ART policy was announced, 
responsible advisory panels advised the Disease Control Department to replace eight existing 
ARV combinations for adults with three regimens: stavudine + lamivudine + nevirapine, 
stavudine + lamivudine + efavirenz, and stavudine + lamivudine + indinavir and/or ritonavir 
(Ministry of Public Health 2001b; 2002a). See table 5.1. Recommended regimens for children 
also changed, reduced the number from 12 to 6 formula. Triple-drug formula were first 
regimens of choice. Dual therapy would be prescribed in the cases hypersensitive to both 
nevirapine and efavirenz. 
The drug administration protocol, for adults and children, including dosages, warning and 
precautions in the treatment guidelines were amended accordingly, and were also clearly 
illustrated in the operational manuals and training documents. The recommendations on 
suitable strategies to change regimens were developed and circulated to respective institutes 
and heath professionals (ATSI 2004b). 
In addition to ART, the national HIV programme recommended the prophylaxis and 
treatment of major opportunistic infections (Ols): tuberculosis, Pnuemocystic carinii 
pneumonia, and cryptoccocal meningitis among PL WHA, especially for those who had not 
met the enrolment criteria to start ARV medication (Thanprasertsuk:, Lertpiriyasuwat, and 
Chasombat 2004). Corresponding guidelines on drug administration, case management and 
related laboratory testing were developed at the national level. However, hospitals were 
responsible for procurement of these drugs and chemical reagents as they were not funded by 
the Disease Control Department. 
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Table 5.1: ART regimens prescribed in the national programme before and after the adoption of 
universal access policy 
Before policy shift (2000-2001) After policy shift (from 2002) 
Adults • AZT+3TC+NVP • d4T+3TC+NVP 
• AZT +ddI+NVP • d4T+3TC+EFV 
• AZT+3TC+EFV • d4T+3TC+IDVlRTV 
• d4T+ddI+EFV 
• AZT+3TC+SQV/RTV 
• d4T+ddI+ SQVIRTV 
• AZT+3TC+IDVIRTV 
• d4T+ddI+IDV/RTV 
Children • AZT+ddI+EFV • AZT+3TC+NVP 
• AZT+3TC+EFV • d4T+3TC+NVP 
• d4T+ddI+EFV • AZT+3TC+EFV 
• d4T+3TC+EFV • d4T+3TC+EFV 
• AZT+ddI+IDV • d4T+3TC 
• d4T+ddI+IDV • AZT+3TC 
• AZT+ddI+RTV 
• d4T+ddI+RTV 
• AZT+ddI 
• AZT+3TC 
• d4T+ddI 
• d4T+3TC 
.. Source: MImstry ofPubhc Health (2001b; 2002a) 
Note: AZT, zidovudine; 3TC, lamivudine; NVP, nevirapine; d4T, stavudine; ddI, didanosine; 
EFV, efavirehz; IDV, indinavir; RTV, ritonavir; SQV, saquinavir. 
5.2.5 Revisions of enrolment criteria 
In 2001, patient enrolment for adults in the Access to Care Initiative was locally carried out in 
accordance with the Health Ministry-recommended inclusion and exclusion criteria, which 
included both clinical and social elements as shown in table 5.2 (Ministry of Public Health 
200Ib). Following the official guidelines, a panel comprising government officials and 
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representatives from communities, NGOs and PL WHA groups was expected to make 
collective decisions on patient enrolment. 
Table 5.2: Enrolment criteria for adults in the national ART programme, 2000-2001 
Inclusion criteria 
CD4+ cell count < 250 cells per mm3 or viral RNA> 30,000 copies per mm3 by b-DNA 
technique or > 50,000 copies per mm3 by RT-PCR technique 
The patient understands the treatment objectives and expresses hislher willingness to 
participate and cooperate in the follow-up process 
• The patient who is likely to benefit or contribute to the family, community, or society 
Exclusion criteria 
• The patient with a history of hypersensitivity to at least one ARV in every available regimen 
• The patient with high tendency to exercise unsafe practices such as mus (for the mus, they 
must be treated for the addiction before commencing ART) 
The patient with poor adherence and who is unlikely to cooperate in the follow-up process 
Source: Ministry of Public Health (200 1 b) 
When treatment protocols for adults were cut down to 3 combinations in 2002, new 
enrolment criteria were introduced. Therapy was suggested for patients in three categories: 
infected persons with AIDS-defining illness; symptomatic HIV cases3 I with CD4+ cell count 
less than 250 cells per mm3 and asymptomatic cases whose CD4+ cell had dropped under 200 
cells per mm3 (Ministry of Public Health 2002a). 
Another revision was the cancellation of the 'social criterion' which favoured individuals 
who were considered likely to make a contribution to family, community and society. 
Moreover, it was the first time the Health Ministry spelled out that only treatment-naIve 
patients were eligible beneficiaries of therapy. Later, in early 2004, this criterion was 
removed and the national programme began to cover treatment-experienced cases. As the 
31 HIV-infected individuals with unknown chronic fever, diarrhoea with unknown cause longer than 
14 days, and/or weight loss more than 15% within 3 months 
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drug regimens were limited to three combinations, the patients who had been treated with 
other ARV s prior to the enrolment had to meet another set of conditions on the CD4+ cell and 
viral load levels, non-resistance to particular drugs, and clinical signs and symptoms to ensure 
that the regimens could be switched properly (ATSI 2004d). 
By contrast, the enrolment of children to receive ART, before and after the policy change, 
was mainly subjected to clinical justification. In 2000 and 2001, the national programme 
guidelines suggested that all children aged under 12 months were eligible for treatment 
irrespective of clinical stage of HN infection (Ministry of Public Health 200 1 b). Those 
between 1 and 12 years old were enrolled if they had mild, moderate or severe symptoms, or 
if their immune levels indicated moderate to severe suppression, according to the US Centre 
for Disease Control and Prevention's classification system32 . Criteria were also set to exclude 
those with the history of ARV hypersensitivity, potential failure to adhere to medication, or 
inability to perform normal activities (e.g. bedridden). From 2002, the criteria slightly 
changed: children of one year of age and over with mild symptoms were not eligible, while 
other conditions remained the same (Ministry of Public Health 2002a; 2003b). 
5.2.6 Spill-over effects to other agencies 
Along with the growing participation of MOPH hospitals in ART delivery, the Health 
Ministry convinced and provided support to the Bangkok Metropolitan Administration - the 
local government for the capital city - to establish ART clinics in its affiliated hospitals 
(Ministry of Public Health 2003b). A study in mid 2002 documented the increasing number 
of local authority hospitals which were supported by the Disease Control Department to 
deliver treatment as part of the national programme (Administration Advisory Panel 2002d). 
At the same time, the Health Ministry's AIDS Division sought new partnerships with the 
Social Security Office33 through several meetings in 2003 and 2004 (ATSI 2003c; Social 
Security Office 2004). Dialogue between the two agencies aimed to improve ART coverage 
among the Social Security Scheme beneficiaries and also to standardise the treatment 
protocols across the initiatives. Moreover, subsidising treatment in Social Security Plan was 
expected to help to diminish national programme expenditure as this scheme was funded 
32 Center for Disease Control and Prevention. 1994 Revised classification system for human 
immunodeficiency virus infection in children less than 13 years of age. MMWR 1994;43: 1-10 
33 Health insurance manager for private-sector employees - Social Security Scheme (SSS) 
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through 3 sources: government, employers and employees. With technical, management and 
other support from the MOPH, Government Pharmaceutical Organisation (GPO), academic 
institutes and NGOs, the Social Security Office agreed to extend its medical benefits to cover 
ART in late 2004 (Manager 2003; Treerutkuarkul 2004). 
5.3 Designing the new programme configuration 
The aforementioned changes in the programme features subsequent to the adoption of the 
universal access goal demonstrate that the government's pledge was not merely rhetorical. 
The administration also kept its promise to allow the participation of NGOs and PL WHA in 
policy formulation, and a new form of policy network was formed - appointed by the 
government. On 4th December 2001 - promptly after the declaration of the public 
commitment to medication - the Health Ministry established an Advisory Committee to 
develop administrative strategies and technical guidance to facilitate the inclusion of ART in 
the Universal Health Coverage (UC) benefits (Ministry of Public Health 2001 d). Chaired by 
the Director General of the Disease Control Department, the committee consisted of 21 
members, half of whom were from government agencies: including Health Ministry 
departments; the GPO; HIV experts and academics, and the rest from NGOs and PL WHA 
networks. 
5.3.1 Advisory Panels for treatment extension 
In February 2002, the Advisory Committee delegated its functions and responsibilities to 4 
Advisory Panels (Ministry of Public Health 2002c). As illustrated in the Ministerial Order, 
the first tw~ Panels were assigned to revise the clinical guidelines on ART in adults and 
children. Mainly, they comprised experts and physicians from medical schools and public 
hospitals. The third Panel principally encompassed scientists from university and Health 
Ministry laboratories, and was appointed to work out the detailed procedures of essential tests 
for ART instigation and outcome monitoring. The appointment of these experts and scientists 
was not swprising because their expertise had been well recognised, and was task-relevant. In 
addition, most of them had been involved in rolling out the Access to Care scheme from its 
first launch. The fourth [Administration] Panel was asked to draw recommendations on the 
preparation strategies and administrative aspects of the country-scale ART as part of the 
universal health coverage scheme. The Panel was chaired by Nitayarumphong - the Deputy 
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Health Secretary who led the establishment of the UC scheme. Crucially, the majority (8 of 
15) of the panel members were NOOs and PLWHA leaders, most of whom had played a 
leading role in the campaigns for universal ART access. AIDS officials, NOO and PLWHA 
representatives were appointed to be members of all Panels. This included, for instance, the 
designation of MSF physicians who had experience in treatment delivery in civic-organised 
programmes in the country. 
This collaboration between the Thai government and civil society in health was not unusual. 
Documents suggest the involvements of NOOs and community-based volunteers in rolling 
out several public health activities, for example the Primary Health Care initiative34 and the 
Family Planning programme from 1970s (Ministry of Public Health 2002d; Nitayarumphong 
and Mulada 2001). Between the late 1980s and early 1990s, civil society associations such as 
those previously focused on family planning and sexually-transmitted diseases campaigned 
for government response to the HIV epidemic. HIV NOO representatives were appointed as 
members of the National AIDS Committee since its conception in 1991. At the peripheral 
level, these NOOs played important roles in providing care and support to PL WHA. Close 
cooperation between civil society, MOPH agencies and hospitals as well as its benefits to 
HN patients and families were reported in many parts of the country. 
The state and civil society connections developed continually and reached a crucial stage 
when nationwide campaigns were organised to support the formulation of the National Health 
Bill during 2000 to 2002 (National Health System Reform Committee 2002). The social 
mobilisation to facilitate health reforms was extensive, and the participation of the general 
public as well as the CSOs through series of public hearings was acknowledged as an 
important element of change (Phoolcharoen 2001). NOOs and PLWHA had been involved as 
active partners in many fora before and after the National Health Bill was endorsed and put 
forward through the legislative process. The HIV NOO's participation in these events 
enhanced the relationships with other NOOs in health and related areas such as consumer 
protection and human rights organisations (interview N15 and NI6). Importantly, they also 
had many opportunities to meet and discuss their issues with the reformist network at which 
Nitayarumphong was the forefront. 
34 The strategy employed by Thai government to achieve 'Health for All by the Year 2000' 
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In addition to the partnership strengthening through the collaborative movements for health 
system reform, health officials recognised the capacity ofNGOs and PLWHA owing to these 
civic groups' past experiences, for example in rolling out Buyers' Clubs35 and co-trimoxazole 
prophylaxis campaign36 since 2000 (Thanprasertsuk, Lertpiriyasuwat, and Chasombat 2004). 
As argued by Kumphitak and colleagues (2004), the two initiatives demonstrated the NGOs' 
capability to improve HIV treatment and care through patient participation, in collaboration 
with healthcare providers and well-organised training programmes. A former Director of the 
MOPH AIDS Division acknowledged that the learned lessons and accumulated skills of the 
civic groups were helpful in rolling out nationwide ART and thus their representatives were 
embraced to join the Health Ministry's Technical and Administrative Panels (interview N05). 
5.3.2 Decisions on the programme's new design 
The role of the Administration Panel in introducing the national ART programme revision 
was crucial. As assigned by the Advisory Committee, its responsibilities were to work out the 
strategies and guidance on broad issues of the universal ART management - for instance the 
fmancing and budgeting; patterns of treatment delivery, logistics, and procurement of low-
priced ARVs and laboratory reagents (Ministry of Public Health 2002c). In the single year of 
2002, there were regular meetings and substantial outputs from this Panel. The discussions, 
recommendations, and resolutions made by the Administration Panel had spill-over effects on 
others as well. 
The Administration Panel took into account both the integration of ART into the DC and the 
improvement of treatment access; however, it made more significant progress in the latter 
than the former (Administration Advisory Panel 2002c). The decisions made by this Panel 
were affected by the health system environment, especially the difficulties experienced in the 
recently-launched DC as provincial and district hospitals struggled with the new healthcare 
35 A project organised by the Thai Network ofPLWHA to support private, collective ARV purchasing 
from India and delivery of the medications by HIV specialists. 
36 This campaign aimed to increase access to co-trimoxazole for the prophylaxis of Pneumocystic 
carinii pneumonia (PCP). The Thai Network for People Living with HIV/AIDS organised training 
programmes for representatives from 157 interested PLWHA groups to provide information on drug 
administration, and general knowledge in relation to PCP and other OIs. These trained PL WHA were 
responsible for screening their group members for signs and symptoms which indicated the needs for 
PCP prophylaxis, and referring them to receive the drugs in hospitals. They were also expected to offer 
first aid if common symptoms, such as cough, diarrhea, fever and rash, developed, and refer the 
patients to health workers if the symptoms persisted (Kumphitak et aI2004). 
- 124-
CHAPTER 5: POLICY FORMULATION 
financing arrangements (Administration Advisory Panel 2002b). During the period of ART 
programme design, complaints about the UC made by health providers focused on fmancial 
constraints and a substantially increased workload (National Health Security Office 2004b). 
These were considered potential impediments in introducing other radical changes, especially 
expecting them to deliver additional services to PL WHA. 
One of the successes of the Administration Panel was that its proposals, for instance those on 
the engagement with new partners for ART delivery, revisions of therapy provision profile 
and human resource development component, were accepted by the authorities, i.e. the 
Advisory Committee and Disease Control Department, and finally got implemented. 
Persuading the Bangkok Metropolitan Administration and Social Security Scheme to take 
part in delivering and financing the medication was one of the recommendations from this 
Panel (Administration Advisory Panel 2002c; 2002d; 2002f). The motivation to approach 
these agencies was that their responsibilities could fulfil existing gaps, i.e. the small Health 
Ministry hospital network in the capital city and the limited ART coverage among private 
firm employees who were the Social Security Scheme beneficiaries. Another clear illustration 
of the Panel's role was that its proposals to provide the opportunities for NGOs and PLWHA 
participation in training and care delivery were adopted by the Health Ministry. Moreover, the 
extension of ART to treatment-experienced patients in 2004 could also be claimed as a result 
ofthis Panel's advice (Administration Advisory PaneI2002f). 
The above does not suggest the other three Panels' roles were less important. All shared the 
ultimate goal to renovate the national programme to suit the massive service delivery. The 
major revisions of treatment regimens and enrolment criteria were informed by the feedback 
from previous policy implementation. The Access to Care programme evaluation in 2001 
indicated several weaknesses including inefficient procurement, poor inventory and allocation 
of ARVs to participating hospitals, because as many as eight complicated combinations had 
been adopted (Punpanich et al. 2002; Satasit, Kuaykiatikul, and On-Nom 2002). This led to 
frequent drug shortages and health providers' mistrust. See chapter 2. The two Panels for 
clinical guideline development therefore sought to simplify the protocols, to lessen the 
problems in treatment administration and drug management (interview NOS and NlO). 
Although most of the members of the Panel for Clinical Guidelines Development were HIV 
experts, the discussions to identify the most suitable first- and second-line regimens focused 
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not only on the clinical outcomes but also on implementation feasibility on a national scale. 
The Drug Selection Panel considered that the fixed-dose combination stavudine + lamivudine 
+ nevirapine was not the best regimen from the clinical aspect (interview N05 and NlO). 
Despite the drug being effective, local studies had demonstrated that severe side effects 
developed in 20% of Thai patients. However, as this combination was the cheapest and was 
well tolerated by 80% of treated individuals, it was selected to be the first-line formula. One 
Panel member pointed out that the drug was selected because of its acceptable efficacy, 
safety and potentially good adherence (interview NIO). Another advantage of this 
combination was that it could be locally produced by the GPO under the brand 'GPO-Vir' at 
an affordable price (interview N05 and NlO). NGO members of the Panel, for example MSF 
representatives, supported GPO-Vir choice as this product had been prescribed to hundreds of 
PLWHA in their projects and caused no serious problems (Kapranis quoted in Agence 
France-Presse 2002). 
Findings from clinical studies in Thailand37 were seen to have had more legitimacy in the 
drug selection choice than western-based trials. As asserted by the Panel for Clinical 
Guidelines Development, there were many reasons indicating that findings from drug studies 
could not be transferred across settings (interview N05 and NlO). For instance, most Thai 
PL WHA sought institutional care when they were seriously ill, i.e. with CD4+ cell levels 
much below 200 - the clinical stage which was unacceptable for subject recruitment to 
clinical trials in western countries. Meanwhile, another two formulas, i.e. effavirenz- and 
protease inhibitor-containing regimens, aimed to be GPO-Vir alternatives in intolerant and 
resistant cases were also selected, though they were more expensive. 
The modification of the criteria to start ART in adults was a shared responsibility of the 
Advisory Panel members and officials in the AIDS Division. One official argued that, the 
change in the CD4+ cell levels as the indicators to commence therapy - from 250 to 200 cells 
per mm3 in asymptomatic cases - was recommended by World Health Organisation (WHO) 
(2002c), and suggested by clinical evidence that the outcomes would be as promising as 
employing the existing criteria (interview N05). He also observed that starting therapy at 
lower CD4+ cell levels would significantly decrease the financial burden to the programme 
37 Studies conducted by Thanomsak Ake-patananon, Siriraj School of Medicine and series of clinical 
trials of different HAART regimens done by Kiat Ruxrungtham and colleagues under HIVNAT. 
Ruxrungtham was the chairperson of the technical panel on ART delivery in adults. 
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because of a smaller number of eligible clients. Unsurprisingly, this assertion was never used 
as the rationale for the criterion modification. 
Regarding the 'social contribution' inclusion criteria, all parties agreed to its cancellation 
although the issue had not been raised on the agenda of any Panel but discussed in many 
formal and informal ART-related meetings (interview N05). Eventually, it was the Access to 
Care programme manager who decided to remove it. This action was mainly justified by the 
fact that the criterion had been discriminatory (personal communication with a former 
Provincial Chief Medical Officer and a Regional Disease Control Official). In addition, 
feedback from health providers and provincial health officials suggested that this selection 
measure was hardly used in practice due to the difficulties in making the judgement on 
whether an individual could or was willing to contribute to the society, and how to compare 
treatment candidates. 
Despite the difference in the responsibilities of the Technical and Administration Panels, they 
shared a fundamental principle in their decision making that treatment would be delivered 
with adequate quality. The analysis of meeting records suggested that vital issues in ARV 
administration such as adverse drug reactions, patients' tolerability, and medication 
adherence had often been discussed. However, individual members addressed particular 
concerns, which varied widely from clinical- to system-oriented issues. Competitions 
between different ideas were occasionally evident (personal observation). Two examples on 
drug procurement and service delivery facilities illustrate this. Some members proposed 
shifting ARV procurement from national to hospital level in order to solve the problems of 
delayed logistics and drug shortages, which usually occurred in the early-phase Access to 
Care Initiative (Administration Advisory Panel 2002a). Others suggested transferring certain 
ART delivery functions to sub-district health centres, aiming to ease the burden on district 
hospitals, and to lift the geographical barriers of the treatment access (Administration 
Advisory Panel 2002b). Agreement could not be reached on these proposed strategies so the 
two elements remained unchanged. However, as perceived by Panel members, even the 
discussion on these and other controversial issues, was relatively consensual (interview N04 
and N05). 
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5.3.3 Termination of the policy formulation network 
Apart from the influence of contextual factors on the programme modification, the policy 
formulation network itself was affected by the shift in the policy subsystem's environment. 
The activities of the four Advisory Panels faded out in late 2002 though they were not 
officially terminated by the Health Ministry. The major cause of the interruption was the 
bureaucratic system reform implemented in October 2002 and subsequent reorganisation and 
staff reallocation in all government agencies, including the MOPH and its departments 
(interview NOS, N08 and NlS). The AIDS Division was integrated into a newly founded 
organisation - the Bureau of AIDS, Tuberculosis and Sexually-transmitted Infections (ATSI) 
- with a new Director (Ministry of Public Health 2002b). Many AIDS officials who had 
undertaken the secretariat role in the Advisory Committee and four Panels took new positions 
with different duties. Some were transferred from technical supervisory to service delivery 
posts in hospitals (interview N08 and N09). Importantly, when the National Health Security 
Office - an autonomous agency responsible for UC management and implementation - was 
established and fully functioning in early 2003, Deputy Health Secretary Nitayarumphong 
moved to become its first Director General. 
5.3.4 Who really made the changes? 
As maintained by Marsh and Rhodes (1992), some members of particular networks may play 
more significant roles than others in policy making. Following the Panels' minutes, ART 
programme formulation in the scale-up phase intensively involved the NGO network and 
HIV experts from MOPH and universities. The civic actors as the Administration Panel 
members actively joined in the process by developing the meeting agendas, drafting strategic 
plans, and providing ideas in the discussions (Administration Advisory Panel 2002a; 2002b; 
2002c; 2002d; 2002e; 2002f; 2002g; 2002h). The meeting records also indicate that many, 
though not all, NGOs' suggestions were well responded to and accepted by other members. 
Although NGOs had worked closely with Health Ministry officials and peripheral health 
providers since the nascent phase of HIV epidemic, interviewees maintained that these actors' 
participation in the treatment extension period had a more 'forceful' pattern (interview NOS 
and N09). 
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At the same time, many significant changes in the ART programme configuration reflected 
the crucial role of specialists and scientists of different areas. With their expertise and long-
term engagement in treatment delivery since the implementation of the Clinical Research 
Network in the mid-1990s, the policy making process to roll out countrywide treatment was 
well informed with not only scientific evidence but also the insights from experience, and the 
difficulties of balancing treatment quality and practicality. Although expert members of each 
Advisory Panel did not officially represent groups or organisations, their competence and 
experience had been gained from work and research done in their institutes, and in 
collaboration with each other. For instance, Kiat Ruxrungtham - chairperson of the Panel to 
develop the guidance for treatment in adults - was a leader in clinical trials of different ARV 
combinations as parts of a multi-country network - the so-called HIV-NAT. He was also a 
key person in the Thai AIDS society which was a non-governmental association of HIV 
clinicians and other health professionals with the main objective to improve access to quality 
medication among Thai PLWHA (interview NlO). In addition, HIV specialists had formed 
connections with and offered support to NGOs in several ways. Therefore, although the 
recommendations made by the Technical Panels were likely to be dominated by experts, 
members of non-specialist networks also had some influence. 
Despite the vital roles of civic groups and experts in the policy formulation process, the final 
decisions were guided and made by bureaucrats. Key informants revealed that every meeting 
of the Advisory Panels was attended by at least one high-ranking official, such as the Deputy 
Director General of the Disease Control Department or the Deputy Health Secretary -
Nitayarumphong - who facilitated the discussions towards consensus (interview N04 and 
N05). As the civil servants had insights into all facets of ART delivery including how the 
service was located in the health and administrative system context, they could influence their 
civic counterparts with internal information. NGO representatives admitted that it was the 
first time they learned about the impediments and limitations to organising a large-scale 
programme in the public sector (interview N15 and NI7). A NGO leader asserted in interview 
that, 'the meetings looked like consultations between partners, and the health officials used 
these stages to convince others to agree with their proposals. '(interview N15) 
Officially, an Advisory Panel must be accountable to its instigating authority. In this light, 
the four Panels reported to the Advisory Committee which then forwarded all agreed 
recommendations to the Disease Control Department and Health Ministry for final decision. 
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However, for particular resolutions of these Panels - for example the suggestions to revise 
training curriculum and materials - some formal processes were bypassed (interview N05 and 
N09). The reasons given by responsible officials included that improving ART access was 
recognised as the government's priority thus any unnecessary delay in arrangements should 
be avoided. In addition, owing to the delegated system of Thai bureaucracy, decisions could 
be made at different levels depending on the degree of their importance. Therefore, either 
Nitayarumphong, the Deputy Director General of the Disease Control Department, or the 
AIDS Division director could endorse many proposed changes in ART strategies and 
commanded their subordinates to have them implemented (interview N05). In other words, 
the fact that high level officials attended meetings was very important - not only showing 
government commitment, but also facilitating the process - making it faster. 
5.4 FinanCing ART through the UC: the unfinished agenda 
Since the national ART programme was established in 1992, treatment had been subsidised 
by the Health Ministry through the Department of Disease Control bUdget. When civil society 
alliances campaigned for universal access to ARVs in 2001, they aimed not only for service 
scale up but also to include therapy in the UC package. Although the government promised to 
gradually expand the UC benefit to cover ART, as of December 2004 the treatment 
advocates' goal had not been met. 
While the Administration Panel was functioning in 2002, representatives of civic coalitions 
often raised the issue of financing on the meeting agenda (interview N15 and NI6). NGO 
leaders observed that the Panel members from the Disease Control Department were 
apparently not paying sufficient attention to this issue, but focusing only on the national 
programme expansion. Excepting the chairman Nitayarumphong, most bureaucrat 
participants, as well as specialists, academics and health providers who sat on the Panel, were 
unfamiliar with health financing arrangements and thus should have little interest in it. Some 
officials and researchers argued that the MOPH and Disease Control Department were not in 
favour of the change in ART programme funding because it would result in a substantial 
decline in their annual budgets. For example, once the National Health Security Office 
became the treatment purchaser the Disease Control Department's role would shift from 
programme manager to technical supporter, which meant fewer resources and less power 
(personal communication, anonymous). This was the experience of the Health Ministry when 
- 130-
CHAPTER 5: POLICY FORMULATION 
a significant portion of its budget was diverted to the UC plan from fiscal year 2002, which 
was claimed to be a major cause of severe resource shortage in peripheral healthcare settings 
ever since (National Health Security Office 2004b). Meanwhile, officials in the Bureau of 
AIDS, Tuberculosis and Sexually-transmitted Infections focused differently: they would have 
liked more time to prepare infrastructure and health personnel in order to ensure treatment 
quality before all public hospitals were obliged to deliver ART as part of the UC. 
Since Nitayarumphong was one of the founders of the emerging health plan and most likely 
to get the National Health Security Office Secretary General title, he was the sole government 
official who had an obvious interest in the alteration of ART financing strategy. Projected 
demands for the enormous amount of 40 to 50 billion baht to support next-ten-year universal 
ART access (Administration Advisory Panel 2002t), was of major concern to the Deputy 
Health Secretary, because of the magnitude of the treatment burdens and implications on the 
UC's stability. His hesitation might have also been fuelled during that period because protests 
against the health financing reform among hospital directors, physicians, and medical 
professional organisations had increased over time (Assavanonda 2002a; Assavanonda 
2002b; Khwankhom, Sukin, and Sakboon 2002). However, in spite of all this, he had not 
shown any sign or attempt to delay the treatment integration until the role of the Advisory 
Committee and its Panels came to the end in December 2002. 
The NGOs' campaigns for financing ART under the UC continued throughout 2003 and 2004, 
while the Health Ministry's and National Health Security Office's positions became clearer 
(interview N15 and N16). A public hearing on the UC implementation and performance 
organised in June 2004 indicated the popular preference that ART should be covered by the 
UC (Manager 2004a). The National Health Security Office responded positively to this 
suggestion. Along with these movements, the Health Ministry designated a new Advisory 
Committee in late 2003 to consider the change in ART financing mechanism (Ministry of 
Public Health 2003c). The ATSI as the Advisory Committee's secretariat amended the 
working process - organising a series of consultation sessions which were attended by the 
committee members and a wide range of stakeholders including NGOs, PL WHA groups, 
academics, HIV experts, regional and provincial health officials, and health professionals. 
Mounting feedback on the impediments in ART expansion and UC implementation resulted 
in increasing concerns of all parties that the integration of treatment into the health benefit 
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plan should be carried out cautiously. In 2004, the discussions among policy actors mainly 
addressed the question 'how to ensure quality and sustainability of ART provision in the 
UC?' For instance, in a consultation meeting on 14th September 2004 the issues in focus 
were long-term sources of funding, growing demand for second-line ARVs, variation in 
therapy offered in the national programme and 3 health benefit plans, capacity and role of 
CSOs, the need for strengthening HIV prevention, and generic production of new-generation 
ARVs (personal observation). 
Fed with lessons learned from a couple of years of both the UC and national-scale ART, the 
consultation led to the recommendations that funding ART under the UC would be feasible if 
the problem of fmancial uncertainties could be solved, while service quality and programme 
efficiency must be concomitantly enhanced. Finally, in December 2004 the National Health 
Security Board agreed to finance ART as a component of the UC benefit package by 2005 
(Manager 2004b). 
5.5 Summary 
In 2002, there was a transformation in the treatment policy network, allowing Disease Control 
Department officials and HIV specialists, who had a minor role in universal ART policy 
adoption, to take part in the policy formulation process. It was not surprising that these public 
servants, health systems reformist and treatment advocacy coalitions were appointed as 
Advisory Panels members to work out new programme features, because the tasks required 
both technical and management expertise as well as practical skills necessary for synthesising 
lessons from past experiences, anticipating future impediments and selecting appropriate 
policy options. Importantly, all members of the Panels might have been expected by the 
Health Ministry to steer service expansion and provide support to sub-national offices and 
hospitals in the policy implementation phase. 
The policy development in this period suggests the important role of collective policy 
learning. Representatives from the MOPH, Disease Control Department, universities, 
research institutes, hospitals, NGOs and PL WHA groups formed into a network to devise 
new programme strategies. The experience of network members was a crucial factor 
accelerating the policy development process: helping the Advisory Panels to reach rapid 
decisions. Collaboration between health officials, academics, health professionals, and staff 
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of CSOs had been established since HIV problems became obvious in the late 1980s. The 
interrelationship was occasionally strengthened through events that demanded multi-sectoral 
cooperation. Information exchanges across networks were beneficial to learning from each 
other. 
The transfer of lessons from the previous phase of national ART service reaffirms the 
complexity of policy making, as policy formulation and implementation stages overlapped, 
rather than ran discretely. Feedback on the obstacles in delivering treatment through the 
Clinical Research Network and the Access to Care Initiative, as well as the problems faced by 
health care providers in introducing the UC plan played a considerable role in shaping the 
new ART programme configuration. In this way, the Thai HIV policy formulation process 
could be considered to have been influenced by 'bottom-up' policy implementation process. 
A key feature of policy formulation in this period was that the level of consensus was high. 
The harmony of Panel members of different backgrounds might have stemmed from the long-
term connection between their own networks, prior to joining the MOPH Panels. In addition, 
these state and non-state actors shared the same goals and interests: to get more PL WHA on 
quality therapy. Their awareness of the interdependency among Panel members might also 
have had a role in fostering agreements upon the issues being discussed. The attendance of 
high-ranking officials in the meetings and even the leadership of the health system reformist 
who chaired the Administration Panel, were other factors facilitating the process. 
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CHAPTER 6: SETTING THE CONTEXT OF CASE STUDY PROVINCES 
Antiretroviral (ART) policy innovation between 2001 and 2004 was expected to benefit 
people living with HIV/AIDS (PLWHA) nationwide. To understand how the policy was 
activated, two provinces with relatively high human immunodeficiency virus (HIV) 
prevalence were selected as case studies. In each province, 3 hospitals implementing the 
national treatment programme are analysed - one provincial, two at district level. This 
chapter describes the context of the policy execution in the study settings: HIV epidemiology 
and the features of health delivery systems as well as the responses to the epidemic before 
ART scaling up. It also appraises the roles of different actors in the hospitals' decisions to 
sign up to the national initiative in the early phase of expansion. The analysis sheds light on 
the factors affecting treatment instigation in the study provinces and provides some insight 
into the evolution of the universal ART policy implementation. 
6.1 Introduction to case studies 
Pichit and Rayong - the study provinces, are located in different parts of the country. The 
literature suggests that HIV has long been an important problem in both provinces (Bureau of 
Epidemiology 2003). However, the features of each province differ in several aspects. 
6.1.1 Phichit 
Phichit is a medium-size province located in the lower northern part of the country, 350 
kilometres from Bangkok (Phichit Provincial Administration Office 2004). The province is 
divided into 9 districts, namely Muang; Bang Mun Nag; Pho Prathap Chang; Pho Tha Le; 
Sam Ngam; Taphan Hin; Thapkhlo; Vajira Baramee and Wang Sai Phun. In 2003, the 
provincial population was 590,476, the rural portion of which accounted for 80% 
(Department of Provincial Administration 2003). Most people work in agriculture. The 
province is relatively poor: its gross product in 2002 was 33,489 baht per capita - ranked 53 rd 
of the country's 76 provinces38 (National Economic and Social Development Office 2002). 
38 The per capita gross domestic product for 2002 was 85,951 baht 
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Health delivery system 
Phi chit is one of 6 provinces which make up Health Region 9, which comes under the 
supervision of the Regional Offices of the Ministry of Public Health (MOPH), located in an 
adjacent province, Phitsanulok. In 2003, public health facilities in Phichit comprised 9 
MOPH hospitals, 109 health centres; and in the private sector, 4 hospitals and 45 clinics 
(Phichit Provincial Health Office 2004). The ratio of beds in public to private facilities was 
855: 150 (Bureau of Policy and Strategy 2004a). The number of doctors, professional nurses 
and pharmacists in the public sector was 64, 638, and 54, respectively (Bureau of Policy and 
Strategy 2004b). In addition, there were 10 doctors and 25 nurses working in private settings 
in the same year. In 2003, 93% of the provincial population were covered by health benefit 
plans (Universal Health Coverage plan 75% of total population, Social Security Scheme 13%, 
and Civil Servant Medical Benefit Plan 5%). The poverty of the general population, as well as 
a very small business sector and therefore few formal-sector employees, have limited 
investment in private hospitals in Phichit (interview R06 and S 11). 
HIVepidemiology 
Phichit's first acquired immune-deficiency syndrome (AIDS) case was diagnosed in 1987 
(interview S 11). Like many other provinces, evidence suggests that the provincial HIV 
incidence reached a peak in the early 1990s (Bureau of Epidemiology 2003). The number of 
new HIV and AIDS cases diagnosed in healthcare settings and reported to the Health 
Ministry declined from 285 in 1999 to 106 in 2003. The total number of cases ever recorded 
between 1987 and 2003 amounted to 2,237, of whom 667 had died by 2003 (Phichit 
Provincial Health Office 2004). Fifty-five percent of HIV patients were labourers, while 
farmers and other agriculturalists accounted for 16% of the total. The rest included merchants 
(6.1 %), government workers including civil servants, arm forces and police officers (3.2%), 
children under 5 years old (3.1 %), housewives (2.7%), unemployed (2.5%), and others (11 %). 
HIV in Phichit has spread widely in the general population. Sentinel sero-surveillance 
indicated a prevalence rate of 2.8% among pregnant women at antenatal clinics in 2003, 
against the national figure of 1.3% (Bureau of Epidemiology 2004b). The prevalence rate in 
commercial sex workers in this province was 6.2%, lower than the corresponding rate of 
11.4% of the national average, but HIV officials felt the Phichit figure was an underestimate 
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because surveillance did not cover indirect sex workers, who were believed to be 
substantially afflicted (interview R06 and S07). In addition, interviewees pointed to the rising 
trend in some sexually-transmitted diseases such as syphilis and gonorrhoea in 2003 and 2004 
which indicated that HIV infections might also rise. 
6.1.2 Rayong 
Rayong province is located at the centre of the east coast region, 179 kilometres from 
Bangkok (Department of Provincial Administration 2003). It comprises 6 districts: Muang, 
Ban Chang, Ban Kai, Klaeng, Pluag Dang, and Wangchan. In 2003, the provincial population 
was 523,518, one-third of which were agriculturalist (Rayong Administration Centre 2004). 
Rayong has maintained high economic growth for many years. In 2002, the per capita 
provincial product was 515,577 baht - the highest in the country (National Economic and 
Social Development Office 2002). The economy is boosted by manufacturing industries such 
as chemical, petrochemical and metallic production, all of which accounted for 56% of the 
provincial output. Large industrial estates and deep-sea ports expanded during the 1990s, 
requiring an increased workforce, from other provinces and also neighbouring countries -
Cambodia and Myanmar (Interview R07). Almost 60% of the total 1,400 industrial sites in 
this province are located in 2 districts: Muang and Klaeng (Rayong Administration Centre 
2004). Rayong is also famous for tourism thus the province is open to large number of 
visitors as well as migrant labourers who work in tourism facilities. 
Health delivery system 
Rayong and 6 other provinces in the east fall under Health Region 3. Chonburi is the principal 
province of this region, where the Regional Disease Control Office and Medical Testing 
Laboratory are located. In 2002, public healthcare facilities in Rayong included 1 provincial 
and 6 district hospitals and 127 health centres under the MOPH direction; and 6 private 
hospitals and 111 private clinics (Rayong Administration Centre 2004). There were 128 
doctors, 772 professional nurses and 55 pharmacists practising in the government sector in 
the same year (Bureau of Policy and Strategy 2004b). Meanwhile, 51 doctors, 143 nurses and 
15 pharmacists worked in the private sector. The total number of hospital beds in 2003 was 
1,194 (public 868 and private 326) (Bureau of Policy and Strategy 2004a). As the province is 
home to many private establishments such as factories and business facilities, a significant 
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portion of the population, i.e. the formal-sector employees are beneficiaries of the Social 
Security Scheme. 
HIVepidemiology 
The first symptomatic HIV patient in Rayong was identified in 1987. The number of new 
cases reported from healthcare settings escalated considerably at the beginning of 1990s - the 
same period as the expansion of industrial estates and sea ports (interview R07 and SI6). 
Case reports per annum peaked at 1,177 in 1998, followed by a decline to 979 and 682 in 
2000 and 2003, respectively (Rayong Provincial Health Office 2004a). In 2003, the morbidity 
rate in this province was the highest in the country. The accumulated HIV cases reported 
between 1987 and 2003 amounted to 9,687, while 2,147 had died by 2003. Over half of these 
patients resided in the main town, and 66% were general labourers. Seventeen percent of 
PL WHA treated in government and private health facilities in 2003 were migrants from other 
provinces. 
Findings of sentinel surveillance illustrated that Rayong's HIV prevalence in subpopulations 
such as pregnant women at antenatal clinics and commercial sex workers was amongst the 
top five in the country over many years (Bureau of Epidemiology 2003). In 2003, despite a 
declining trends in all monitored groups, disease rates in pregnant women (3.1 %) were still 
the highest compared with other provinces (Bureau of Epidemiology 2004b). Apart from sex 
workers, fishermen were a population with a high risk to the infection. Labour migration and 
tourism were seen to be responsible for the sustained HIV epidemic in this province 
(interviewR07 and SI6), although HIV officials pointed out that the disease was also 
prevalent among immigrants from neighbouring countries. Similar to Phichit, the rising trend 
of gonorrhoea and syphilis was apparent in 2003 and 2004, indicating unsafe sex practice and 
potential increase in HIV infections (interview S13 and SIS). 
In suminary, both study provinces are afflicted by HN (table 6.1). However, the problem in 
Rayong is more severe than its Phichit counterpart. The numbers of HIV -positive persons 
who are still alive suggests higher demand for medical services including ART in Rayong. 
Compared to Phichit, Rayong is better off for its health care resources. 
- 137-
CHAPTER 6: THE CONTEXT OF CASE STUDY PROVINCES 
Table 6.1: Selected parameters on HIV and health care resources, Phichit and Rayong 2003 
Phichit Rayong 
Population 590,476 523,518 
HIV prevalence in pregnant women at ANC, % 2.8 3.1 
Accumulated HIV cases (1987-2003)* 2,237 9,687 
Accumulated HIV deaths (1987-2003)* 667 2,147 
Bed: population 1:588 1:439 
Doctor: population 1:7,979 1:2,925 
Nurse: population 1:891 1:572 
Pharmacist: population 1:10,935 1:7,479 
... Note: * as reported by hospItals and other health faclhtles 
6.2 The context of study hospitals 
A total of six MOPH hospitals in Phichit and Rayong were analysed for their ART 
implementation. Apart from the two provincial facilities, 2 district hospitals were selected 
from each province - i.e. Sam Ngam and Thapkhlo in Phichit and Klaeng and Wang Chan in 
Rayong. Sam Ngam hospital signed up to the Access to Care Initiative, which started in 2001, 
shortly before the obligatory participation was imposed in 2004. Provincial health officials 
asserted that treatment delivery in this hospital had been well organised and responsive to 
clients (interview R06 and Sl1). In contrast, it was suggested that Thapkhlo hospital which 
joined the national programme earlier - in 2002 - experienced difficulties in therapy 
provision in the beginning phase. In Rayong, both Klaeng and Wang Chan hospitals 
instigated ART service as part of the national programme in 2002. 
This section reviews the demand- and supply-side factors relating to HIV and ART delivery 
in the six study hospitals. This includes the statistics on HIV patients who accessed 
institutional care; public resources available for treatment provision; steering and supervisory 
roles of MOPH's regional offices; and the relationship between non-governmental 
organisations (NGOs), PLWHA groups and healthcare providers. 
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6.2.1 Demands for HIV treatment and care 
The information on reported HIV/AIDS cases and deaths suggested that the magnitude of 
HIV burden in the 6 study settings during the ART scaling up differed considerably between 
the settings (table 6.2). Large numbers of HIV cases had been identified in Rayong town and 
Klaeng district before the national treatment initiative started in 2001, while the number of 
HIV patients who received institutional care in Phichit town was much smaller. In the other 
three districts, the number of newly diagnosed cases was only 10 per year, on average. By 
2003, the accumulated number of deaths among PLWHA in Phichit town, Sam Ngam and 
Thapkhlo was 179, 55 and 43, respectively. The information on the number of deaths by 
district in Rayong province was not available. 
Table 6.2: Reported symptomatic HIV and AIDS patients in study settings, 2000-2003 (cases) 
District 2000 2001 2002 2003 Accumulated Accumulated 
HIV/AIDS HIV / AIDS deaths 
(1987-2003) (as of2003) 
Phi chit Town a 71 49 81 52 599 420 
Sam Ngam a 17 24 12 10 181 126 
Thapkhlo 8 19 10 8 14 159 116 
Rayong Town 0 476 421 415 309 5,252 n.a. 
Klaeng I) 237 141 92 109 1,488 n.a. 
Wang Chan 0 20 22 17 22 186 n.a . 
• a • I) Sources. Phlchlt Provmclal Health Office (2002g), Rayong Provmclal Health Office (2004a) 
The information in table 6.2 was derived from spontaneous case reporting - the disease-
monitoring approach generally known to have the major drawback of underreporting. 
Although more accurate HIV epidemic numbers can be drawn from data from sentinel sero-
surveillance, the former's advantage is that it suggests the rough number of infected persons 
who access health delivery systems. The annually reported cases and accumulated figures at a 
point of time offer a picture of the extent of the HIV burden in particular hospitals. This helps 
to project the trend of service utilisation which is essential in responding to policy 
formulation and planning. For instance, hospital directors needed to compare the demands for 
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services across different diseases in their decision making on the adoption of new treatments 
and allocation of resources. 
6.2.2 Health care resources 
Phichit and Rayong provincial hospitals are located in the main towns. In addition to serving 
people in their catchment areas, they are obliged to provide secondary and tertiary care to 
patients referred from district hospitals. Apart from general practitioners (GPs), there are 
specialists in medicine, paediatrics, and obstetrics practising in these provincial facilities 
(Phichit provincial hospital 2003; Rayong Provincial Health Office 2004c). The health 
delivery system in Rayong possesses more resources than that of its Phichit counterpart. 
According to the MOPH hospital categories, Rayong provincial hospital is classified as a 
regional hospital owing to the number of beds (550), range of subspecialties and services 
provided. The demand for institutional care in Rayong town is shared with 6 private hospitals 
with a total of 250 beds (Rayong Administration Centre 2004). 
Klaeng hospital - 47 kilometres from Rayong town - is a large district-level facility of 120 
beds, with 3 GPs and 7 doctors trained in major sub-specialties such as medicine, obstetrics, 
paediatrics, orthopaedics, and general surgery (Rayong Administration Centre 2004; Rayong 
Provincial Health Office 2004c). In contrast, Wang Chan is small and remote - 70 kilometres 
from the main town. However, Wang Chan is adjacent to Chonburi - the major province of 
Health Region 3, and people can seek care from the regional hospital. The 30-bed district 
hospital of Wang Chan is operated by 3 GPs and paramedics including a significant number 
of nurses (Wang Chan hospital 2003). Like many other small and distant districts, frequent 
in- and out-movement of doctors is a problem in Wang Chan (interview DI9). 
Sam Ngam district hospital is 18 kilometres from the main town (Phichit Provincial 
Administration Office 2004). It is located on the border of Phichit and Phitsanulok - the 
regional headquarters. In contrast, Thapkhlo is a remote district, 68 kilometres from the main 
town and 110 kilometres from Phitsanulok. Both Sam Ngam and Thapkhlo hospitals are 
small, with 30 beds and 2 GPs (Phichit Provincial Health Office 2004). Frequent movement 
of doctors in and out of these district settings has been common. Although it takes longer 
from Sam Ngam to Phitsanulok than to Phichit town, some people including those living with 
HIV prefer seeking care from the regional hospital and regional medical centres for some 
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diseases such as tuberculosis and sexually transmitted infections (interview R06 and S04). 
Thapkhlo's remoteness is a barrier for its residents to travel to visit health providers in the 
provincial and regional healthcare settings. 
Table 6.3 summarises selected health care resources of the public sector in study districts. It 
suggests that, on the whole, the government health service system in Rayong is better 
resourced, compared to its Phichit counterpart, especially in relation to the doctor to 
population ratio. 
Table 6.3: Selected government's health resources in study settings, 2003 
District Population Bed: population Doctor: Nurse: 
population p~ulation 
Phichit Town 142,786 8 1:353 (405)8 1:4,7608 1:357 8 
Sam Ngam 45,306 8 1:1,510 (30)8 1:22,653 a 1 :1,225 8 
Thapkhlo 53,015 8 1:1,767 (30) 8 1:26,508 8 1:1,433 8 
RayongTown 206,249 b 1 :375 (550) c 1:3,683 c 1:441 c 
Klaeng 127,127° 1:1,059 (120) Q 1:11,557 a 1:1,271 a 
Wang Chan 23,873 0 1:770 (30) e 1:7,958 e 1:468 e 
Note: the figure In () IndIcates the number of hOSPItal beds 
Sources: 8 Phichit Provincial Health Office (2004); b Rayong Administration Centre (2004); c 
Rayong provincial hospital (2004); dKlaeng hospital (2004b); e Wang Chan hospital (2003) 
6.2.3 Direction and supervision for ART implementation 
According to the Health Ministry's sub-national administration structure, the Department for 
Disease Control has Regional Offices in 12 health regions. Each Regional Office is 
responsible for the prevention, surveillance, and control of communicable and non-
communicable diseases (Ministry of Public Health 2002d). To carry out these tasks, these 
offices collaborate with and oversee provincial health authorities and hospitals to implement 
some programmes, for example the Expanded Programme for Immunisation, and prevention 
and treatment campaigns for infectious diseases including HIV, tuberculosis and malaria. 
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When ART was gradually extended during 2002 to 2003, the normal supervision and steering 
system for disease control was deployed. In addition, the Disease Control Department 
provided a range of support such as health personnel training and supervision through its 12 
regional offices (Ministry of Public Health 2002a; 2003b). Since provincial and district 
hospitals were under the direction of the Health Ministry's Health Service Department, the 
connections between the Regional Offices and hospitals usually involved Provincial Health 
Offices (PHOs) which were in charge of overseeing the health delivery system within 
provinces. 
As the universal ART policy became high priority in 2004, the Disease Control Department 
introduced intensive supervision and monitoring over the treatment delivery units (Ministry 
of Public Health 2003a). There were regular visits of senior officials of the Health Ministry 
and the central Departments to its regional centres, provinces and hospitals, aiming to 
promote the national ART initiative and to get feedback from health workers in hospitals 
(interview R04 and R07). The visits were also to facilitate the development of strategies to 
deal with any recognised obstacles. 
In 2004 the Disease Control Department established an advisory board to provide 
recommendations to improve treatment extension in each region (interview R01, R04 and 
R06). Chaired by the Ministry Supervisor, the board members consisted of the directors of the 
Regional Offices for Disease Control and Health Promotion; Provincial Chief Medical 
Officers; hospital directors; HIV experts; academics; and NGO and PL WHA representatives. 
This advisory body was expected to develop programme directions in collaborative ways for 
the entire region. Administrators of regional and provincial offices were involved because it 
was considered an effective strategy to promote two-way communications and cooperation 
among these peripheral agencies. 
6.2.4 Relationship between NGOs, PLWHA groups and healthcare providers 
The development of partnerships between the public sector and NGOs in Phichit and Rayong 
was markedly different, probably reflecting the magnitude and burden of HIV epidemic in 
each area. The very first HN NGOs founded in the east-coast region from the mid-1990s 
were faith-based organisations such as the Camillian Social Centre and San Maria Foundation, 
both of which were in Rayong (interview R08 and SI6). Later, this area was relatively 
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crowded with local, national, and international NGOs offering several sorts of care and 
assistance for infected persons and families. 
With support from the Camillian Centre, the Eastern Regional Network for PLWHA was 
established in 1999, and thereafter became an active member of the National PLWHA 
Alliance and also coordinator ofPLWHA groups in 7 Eastern provinces (interview R08, R09 
and S 16). The close collaboration between these NGOs and government agencies especially 
MOPH hospitals developed some time before the universal ART policy (Contarin 2004; 
Disease Control Office for Health Region 3 2004a; Eastern Region PL WHA Network 2003). 
Evidence for links between civil society, private business, and government organisations was 
apparent in the establishment of, for example, the Provincial HIV Prevention and Control 
Committee and the Regional Advisory Board on ART Extension (interview R07 and SI6). 
By contrast, the involvement of HIV NGOs in healthcare delivery in Phichit was only 
observed from about 2002, and seemed to be less organised than in Rayong. Three CSOs, 
namely Ruam Pattana Phichit, Phichit PLWHA Network, and PLWHA Network of the 
Lower-Northern Region, were suggested in interviews as having active roles in Phichit 
(interview R06, SII and SI2). The first, which mainly focused on agriculture and community 
development, provided financial support to hospital-based PL WHA groups for occupational 
training and encouraged group leaders to take part in HIV education activities in secondary 
schools and communities. For the two PLWHA networks, their substantial role emerged after 
the national ART programme was instigated. Similar to Rayong, official coordination among 
actors from different sectors was partly managed through provincial and regional panels 
(interview R-D 1 and R06). Interviewees asserted that in both provinces, these panels were 
dominated by government officials. 
As delivering healthcare for PL WHA demanded the understanding and cooperation of 
patients, an important strategy was to offer them essential information (interview SOl and 
SII). To facilitate this process, Phichit provincial hospital set up a PLWHA group, as early as 
1992, aimed at organising education fora and information exchanges among members. The 
hospital funded group activities which mostly emphasised meetings of patients and with 
health providers. Later, the group extended its interests to wider areas such as practising self-
employed occupations in order to improve income-earning opportunities (interview S04 and 
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SI2). The relationship built among patients, and between patients and health workers through 
this arrangement was perceived as useful for HIV care in this setting. 
In Rayong, the first patient group was established in Klaeng hospital in 1999 (Klaeng Kow 
Naa Club 2003). Later, in 2000, HIV patients in the provincial hospital formed into a small 
organisation. The group formation was acknowledged as a product of the cooperation 
between the hospital and Camillian Social Centre (interview S16 and S17). The analysis 
suggests that this initiative was underpinned by the remarkable increase in demands for HIV 
services in this region. The management was similar to that in Phi chit in terms of support and 
range of activities. However, the Rayong group got substantial assistance from the Regional 
PLWHA Network so that it was relatively stronger and more independent than the former. 
The success in coordinating ART provision through the Buyers' Club 39 was claimed as 
empirical evidence for the effectiveness of the group (interview S23 and S24). Furthermore, 
the patient organisation was well accepted by hospital administrators as witnessed in two 
observations - the inclusion of the patient group in the hospital's organisational structure on 
HIV service delivery (interview S16), and the hospital providing a permanent office and 
meeting room for the group members (Koh Kaew Club 2002). In contrast, the establishment 
of PL WHA group in Phichit provincial hospital was less formal as it was not recognised as a 
component of HIV care provision. As of July 2004, the group leaders were still negotiating 
with the hospital director for a room to organise group activities (interview S04 and SI2). 
In the district settings, at the time of data collection in july 2004, the establishment of a 
patient group in Sam Ngam hospital was under consideration (interview 002). The hospital 
director maintained that since ART had been inaugurated in this facility for only 10 months, 
there were many uncertainties such as the extent of PL WHA participation, volunteer leaders 
and demand for incentives, and financial implications for the hospital. By contrast, patient 
groups were organised and led by health workers in Thapkhlo and Wang Chan, after ART 
service instigation in the hospitals. PL WHA leaders claimed there were connections between 
these patient groups and provincial and regional PL WHA organisations as well as other 
NGOs (interview 011 and 023). Through such linkages, the capacity of the groups was 
39 Buyers' Club was a programme to promote ART access, offering medicines together with 
appropriate information and counselling. In June 2002, approximately 1,000 PL WHA received 
treatment from 21 Buyers' Club sites across the country (MSF 2004). Thereafter, the number of clients 
continually declined as a result of the National ART Programme extension. 
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strengthened by the Regional PLWHA Network through many education and training 
sessions on HIV care, group management, and home visits. In addition, the group leaders 
learned from the Regional NGO to develop proposals to seek funds from different sources 
such as the Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM). A grant from 
this global initiative was allocated through the two regional PL WHA networks in late 2004. 
With this support, patient groups could ran their projects such as prevention and education, 
home visits, and occupation training. However, the analysis of interview data and personal 
observation suggest that group activities predominantly depended upon health workers in 
each hospital. 
Regarding the provider-client relationships, Klaeng's HIV clinic was the only study setting 
criticised for its undesirable approach. The interviews with health officials, NGO and 
PL WHA leaders suggest poor relations owing to the responsible health workers' personality; 
lack of cooperation between departments and poor connection with other hospitals (interview 
R07, R09 and S23). ART and other HIV services offered in this facility left the clients 
dissatisfied and in some instances, provoked perceptions of stigma and discrimination. 
Interviewees claimed that these phenomena encouraged PL WHA in this district to seek care 
from other hospitals. 
Although all hospitals, except Sam Ngam which had no group, encouraged patient 
involvement through group mechanisms, participation was voluntary (interview D07, Dl3 
and D20). For those who refused to participate in groups, the counselling, information, and 
other services were offered on an individual basis. In 2004, the largest hospital-organised 
PL WHA group existed in Rayong provincial hospital (table 6.4). The small proportion of the 
group members compared to the total treatment clients was said to be because most of the 
patients resided in the main town, and were afraid of coming across familiar persons in the 
patient group who might unveil their HIV status (interview S04 and SI6). Thapkhlo was the 
only study hospital where the number of PL WHA group members exceeded that of the 
current ART clients. However, interviewees in all settings suggested that large numbers of 
members were not associated with active participation, and many patients joined group 
activities only when they came to visit health workers in HIV clinics. 
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Table 6.4: Patient groups in study hospitals: year of formation and number of group members 
comparing with the number of ART clients in 2004 
Hospital Year of group Number of group Number of current 
formation members ART clients 
Phichit, provincial 1992 a 25 a.(I) 46 b.(2) 
Thapkhlo 2003 8 30a. II 19 b.(2) 
Sam Ngam n.a. a n.a. a.(I) 11 1).(2) 
Rayong, provincial 1999 c 151 d.(j) 261 C.(2) 
Klaeng 199g e 50 d.(3) 99 c.(L) 
Wang Chan 2002 a 30 d,(j) 37 c.lLI 
• b Sources of mformatlOn: a key mformants m study hOSPItals, DIsease Control Office for Health 
Region 3 (2004b); C Koh Kaew Club (2002); d Eastern Region PLWHA Network (2004); e Klaeng 
Kow Naa Club (2003) 
Note: (I) as of July 2004; (2) as of September 2004; (3) as of March 2004 
6.3 Health delivery systems' responses to HIV before ART era 
Soon after the first HIV case in Phichit was reported, the PHO in collaboration with the 
Disease Control Office for Health Region 9 and hospitals in the province developed a system 
for disease prevention and control, which comprised activities to be undertaken in 
communities and healthcare settings (interview S 11). The first HIV clinic in Phichit was 
founded as. a unit under the Medicine Department in the provincial hospital in 1992 
(interview SOl). At that time, a counselling service had only recently been introduced to the 
country's health delivery system, especially in MOPH hospitals. All nurses including those 
working in district facilities were trained in basic counselling courses annually, which were 
run at the provincial level (interview S08 and SII). Some counsellors attended the advanced 
counselling programmes for HIV regularly organised by the Disease Control Department in 
Bangkok. 
In the mid 1990s, the HIV clinic in Phichit provincial hospital offered counselling, testing, 
and prophylaxis and treatment of opportunistic infections (Ols) (interview S04). Infonnation 
& education, follow-up, and monitoring were also carried out. The clinic also provided 
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condoms to clients not only to prevent further infections but also for contraception purposes 
(interview S08). When zidovudine and breast-milk substitutes for the prevention of mother to 
,child viral transmission became available through the national initiative in 2000, a connection 
was established between the HIV clinic and antenatal clinic to deliver counselling and testing 
for pregnant women (interview SOl). Family planning services including contraceptives were 
offered to HIV patients in the Obstetric & Gynaecology clinic. 
HIV prevention and control programmes in Rayong had been developed from the late 1980s 
(interview S 15 and S 16). Strategies and activities were adjusted over time in accordance with 
the national policies as well as changes in local HIV epidemic features. The Disease Control 
Office for Health Region 3, PHO and MOPH hospitals created close collaboration in the areas 
of disease surveillance, research projects, and the implementation of HIV programmes such 
as the 100% condom campaigns, information & education, and vertical transmission 
prevention (interview S 16 and S 17). 
The number of symptomatic HIV and full-blown AIDS patients admitted to Rayong 
provincial hospital increased markedly from 1993, reaching 40 to 50 cases per month in 1997 
(interview S15 and SI6). The burden of HI V in Klaeng and Wang Chan became visible a few 
years later. However, similar to other provinces, the health delivery system in Rayong began 
preparing to deal with the growing demands for treatment and care in the early 1990s and 
established anonymous clinics in the provincial and district hospitals in 1992. Following the 
Health Ministry's policy, all nurses had to be trained in basic HIV counselling irrespective of 
clinics or wards they were working in, so that they could manage HIV -suspected and infected 
cases properly. 
In 1996, Rayong provincial hospital started a collaboration with Camillian Social Centre 
(Tangsurakit 2000). With this relationship, bedridden cases who had been rejected by families 
and communities were referred from the hospital to this NGO's hospice for palliative and 
terminal-stage care (interview S16). The Camillian Centre also organised training sessions 
targeting students, civil servants, community members, and factory workers on disease 
prevention and many aspects of care (Contarin 2004). The provincial hospital also sought 
partnership with other NGOs in the Eastern region to provide assistance to PL WHA and 
families (interview S16 and SI7). 
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A different feature of HIV treatment and care provision observed in the two study provincial 
hospitals is that in Rayong case, there was strong coordination between doctors, nurses and 
social workers in preventive and outreach activities from the early epidemic. Through this, 
holistic and multi-sectoral approaches had long been employed to address HIV problems in 
Rayong town and nearby districts before the national ART programme was extended in 2001. 
The analysis of the interview data suggests that medical and psycho-social interventions were 
introduced by the provincial hospital through the partnership with other provincial-level 
government agencies and local administrations, private companies, NGOs, and PLWHA 
networks. However, medical services within the hospital and clinical trials in Rayong 
provincial setting were fragmented, even those activities which were supposed to be well 
integrated under the supervision of the hospital's Infectious Board (interview Sl3 and S22). 
In this hospital, there was no special clinic for HIV, and ART was prescribed by specialists in 
the Medicine and Paediatrics Departments. Interviewees argued that as these specialists had 
different subspecialties such as cardiology, nephrology, and gastroenterology, some of them 
did not pay much attention to national treatment protocols (interview Sl3 and SI8). In 
contrast, HIV -related activities in the provincial hospital of Phichit in the same period were 
cohesive since they were led by the sole doctor and more focused on medical care delivered 
in the facility. 
District hospitals in the two study provinces could deliver HIV counselling & screening; 
however, treatment and care for PL WHA was limited to symptomatic relief in these settings. 
For expensive 01 drugs such as amphotericin B and fluconazole, which were unavailable at 
district level, patients were usually referred to provincial hospitals (interview D03, D06 and 
D22). Klaeng hospital was exceptional as this district facility provided a wider range of drugs 
for 01 prophylaxis and treatment (interview Dl3). This was because according to the Health 
Ministry's regulations, the number and categories of drug items on hospital drug lists 
depended on hospital size and specialties of doctors (Commission on Thai Drug System 
Study 2002). Interviewees in both provinces believed that some PL WHA who could afford 
the costs sought care in nearby provinces such as Chonburi and Phitsanulok respectively as 
well as in Bangkok owing to stigma and perception of better services. Stigma also led to HIV 
patients seeking health services from different districts. 
Wang Chan hospital was perceived as an outstanding district facility among other district 
hospitals in Rayong province, because of its development and quality of HIV service 
- 148 -
CHAPTER 6: THE CONTEXT OF CASE STUDY PROVINCES 
provision (interview R07 and R09). Despite limited capacity in some services, treatment and 
care for PLWHA had been well integrated before ART delivery instigation. In 2001, the 
hospital signed up to a pilot programme of the Disease Control Department aiming to provide 
integrated, holistic HIV care - the so called 'Comprehensive and Continuum of Care 
programme' (interview D20). All health workers from different departments were trained in a 
course organised by the Disease Control Department to understand the objectives and 
concepts of the medical services and psycho-social care offered to PL WHA at particular 
stages of the disease, in both hospital and community. The programme evaluation in 2002 
indicated the success of the Comprehensive and Continuum of Care programme in this 
hospital in many aspects including patients' satisfaction and improved quality of life 
(Yachompoo 2003). 
6.4 First introduction of ART in study provinces 
In Phichit, ART was first delivered as dual-drug regimen in the provincial hospital in 2000 
through a multi-centred clinical trial coordinated by HIV-NAro (interview SOl). The study 
was managed and funded as a project under the Clinical Research Network. Before the 
research started, all investigators and respective health workers were trained by the project 
coordinators in two main aspects, namely ART provision and Good Clinical Practice41 • They 
learned about treatment administration and crucial caveats including the importance of 
medication adherence and drug use monitoring; programme management; data handling and 
analysis; and techniques for laboratory testing (interview S04, SIO and SII). Fifteen patients 
were enrolled in this treatment trial according to preset criteria. Close supervision from the 
HIV -NAT and intensive audit were undertaken throughout the 96-week study period. 
It is unclear when ART was first introduced in Rayong. However, it was believed that a 
number of PLWHA might have been treated with ARVs of different regimens in private 
hospitals and clinics before the medications were offered in government facilities (interview 
R07 and S 16). Interviewees claimed that treatment was prescribed in Klaeng hospital from 
1996 (interview D12 and Dl3). At that time, the hospital had only 60 beds and a small 
40 HIV research collaboration between the Netherlands, Australia and Thailand, jointly coordinated by 
the Thai Red Cross Society and other foreign institutes. 
41 Good Clinical Practice is an international code of conduct in biomedical studies in humans. It covers 
a wide range of elements aiming not only to assure research quality but also to safeguard subjects from 
unnecessary adverse effects and other unethical treatments. 
- 149-
CHAPTER 6: THE CONTEXT OF CASE STUDY PROVINCES 
number of doctors. Twenty PLWHA received dual ARV regimens, zidovudine + didanosisne 
or zidovudine + zalcitabine, through a clinical trial under the Clinical Research Network. 
Treatment was prescribed by a GP whose important role in HIV service delivery continued 
when the Access to Care Initiative commenced in Klaeng in 2002. 
In the non-governmental sector, ART access was encouraged by the Camillian Centre. From 
1997, the NGO funded some patients in its hospice to receive medications from the Thai Red 
Cross HIV clinic in Bangkok (interview S16 and S17). At the same time, it supported the 
establishment of the network of PL WHA groups in Rayong, which was further extended to 6 
other provinces in the east-coast region (St. Camillus Foundation of Thailand 2002). Later, 
the eastern PLWHA association became a member of the Thai Network for PLWHA 
(interview R09). When the national network, AIOS Access Foundation and Medicine San 
Frontier (MSF) established the 'Buyers' Club' in October 2000, the eastern network signed 
up to the programme, through which ARVs were purchased and prescribed to self-funding 
patients (interview SI6). 
Rayong and Chonburi provincial hospitals were the major hubs of ART provision through the 
Buyers' Club in the eastern area. Focusing on Rayong province, health providers in the 
provincial hospital, Klaeng hospital and a Royal Thai Navy medical centre volunteered to 
deliver therapy for the programme members (interview S16 and 012). The estimated number 
of patients who received medication through this mechanism during 2000 to 2002 was 
between 350 and 400. This included PLWHA not only from different districts but also other 
provinces. A Wang Chan nurse revealed that since ARVs had not been provided in small 
hospitals like hers, one of her patients whose C04+ count was 6 cells per mm3, who it was 
anticipated would not survive until the government's 'programme was established, sought 
therapy from the Buyers' Club in the provincial hospital (interview 020). 
The Buyers' Club was commented on positively and negatively. NGOs and other treatment 
advocators praised its ability to provide ART, since treatment was not initially available in the 
public sector (interview R09 and S24). Moreover, the programme in some way encouraged 
collaboration and information exchange between health professionals of the Red Cross 
Society, MSF, Camillian HIV Centre, and the public hospitals (interview S16 and S17). The 
relationship was also claimed as firm foundation for the scaling up of the national ART 
programme (MSF 2004a). On the other hand, the project was criticised for many drawbacks 
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(interview S13). First, therapy was based on personal judgements, in the absence of 
established guidelines42. Second, there was no proper system to guarantee the service quality, 
i.e. to promote medication adherence and monitor clinical outcomes. Finally, since the 
Buyers' Club members had to absorb the whole financial burden, occasional income deficits 
resulted in drug shortages and subsequent treatment interruptions. Interviewees asserted that 
these pitfalls and the fear of development of drug resistance led many doctors in Rayong 
provincial hospital to refuse to take part in this programme (interview S 13 and S 15). 
Along with ART prescription in the Buyers' Club, therapy was offered by Rayong Obstetrics 
& Gynaecology Department under the Perinatal HIV Prevention Trial Project (PHPT)43 . 
Rayong provincial hospital and Klaeng hospital participated in this multi-centre study from 
1997 (interview SI3 and DI2). Excluding a small number of those with contra-indications 
and dissenting cases, all HIV -positive pregnant women were recruited to receive zidovudine 
for preventive purposes. For ethical reasons, the subjects were promised follow-up over their 
lifetime and provided with care and dual-ARV therapy, which shifted to triple-drug regimens 
as recommended by the national ART guidelines later. 
In summary, before the government issued the policy to scale up the ART programme in 
2001, three study hospitals had had some experience of dual-ARV therapy provision. The 
largest group of patients received the medication in Rayong provincial hospital through the 
Buyers' Club. In the other two settings, namely Phichit and Klaeng hospitals, treatment was 
provided to a small number of infected persons who were enrolled as subjects in clinical trials 
under the supervision of the Health Ministry's Disease Control Department. Health providers 
of Klaeng hospital were also involved in treatment delivery through the patients' self-
financing initiative, the Buyers' Club. 
6.5 Introducing universal ART coverage: peripheral-level policy adoption 
After the government adopted the policy to extend its ART programme to meet universal 
coverage in 2001, the national treatment target gradually increased to 50,000 in 2004. The 
voluntary participation of hospitals in the programme was maintained during the first two 
42 Several dual-ARV regimens were prescribed through Buyer's Clubs in different hospitals. 
43 The study was conducted by an international collaborative research group based in Thailand which 
involved multidisciplinary researchers, experts and health workers from the MOPH, universities in 
Thailand and the United States, and four institutes in France. 
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years of scaling up; after that participation became obligatory. This section explains how and 
why study hospital directors decided to instigate ART service in the national initiative in the 
early extension period. 
6.5.1 Persuasive role of sub-national MOPH offices 
As stated in the national ART programme guidelines, Regional Disease Control Offices were 
responsible for identifying competent hospitals and convincing the directors to join the 
initiative (Ministry of Public Health 2001 b; 2002a; 2003b). Since there were no explicit 
criteria to assess hospitals' competency, large facilities including regional and provincial 
hospitals, especially those with experience on HIV care were considered priority (interview 
ROI and R04). Smaller district hospitals were invited to participate when the programme had 
been launched for a year (interview D02 and D20). 
To scale up ART in Phichit and Rayong, similar arrangements for policy communication 
were employed by the two Regional Disease Control Offices. Information on the national 
treatment initiative was circulated through the meetings of hospital administrators and health 
workers on different occasions (interview ROI and R04). After this, hospitals were invited to 
join the national programme. Prior to treatment start, three-day training workshops were 
arranged for health workers who would be involved in the service delivery, namely 
physicians, nurses, counsellors, pharmacists, and laboratory scientists, from all hospitals in 
the regions. It was also the Regional Offices' responsibility to organise specific skill-
development courses for each profession and also for the staff ofNGOs and PLWHA groups. 
The education, information and training programmes aimed to encourage efficient therapy 
provision among participating hospitals and also to enable the non-participants to take part in 
the Initiative later. 
Although the guidelines had not suggested that PHOs should have a promotional role in 
persuading hospitals to join the national programme, in practice provincial-level officials 
helped to identify the potential hospitals and to convince them to sign on. This was because 
PHOs and hospitals were under the direction of the Health Secretary's Office and they had 
had close collaboration with each other in general health service delivery aspects (Ministry of 
Public Health 2002d). A HIV official observed that since Phichit PHO recognised the 
importance of the policy to scale up treatment, many elements of the national programme 
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such as the targets and activities were included on the agendas of the monthly meetings of 
health administrators within the province (interview R06). 
However, the task of convincing hospitals to join the national programme became 
increasingly difficult over time as most of the competent hospital settings had been enrolled. 
In late 2003, almost all of the non-participants were 10- and 30-bed district hospitals (ATSI 
2004c). Following the universal ART policy in 2004, all MOPH hospitals were obliged to 
deliver the medication under the national initiative. As a consequence, the role of the 
Regional Disease Control Centres and PHOs shifted from persuaders to supervisors, 
collaborators, and 'trouble shooters'. 
Interviews suggested that there was a real need to persuade many smaller hospitals to join the 
national ART programme before 2004 (interview R01, R06 and R07). Reluctance arose from 
the fear of treatment implications for the hospitals, for example in the incurred expenditures 
on ARVs, chemical reagents and staff training. It was also possible that some facilities with 
few HIV patients hesitated to start the service because the problems were not acute for them. 
These issues are explored in the next section. 
6.5.2 Perceptions of healthcare providers on universal ART policy 
The interviewees illustrated that in the early phase of the national treatment programme, 
directors and health workers of study hospitals were positive to ART extension since it would 
reduce the burden from repetitive HIV -related admissions and associated medical care costs 
(interview Sl1 and SI3). In particular, health providers who had got involved in therapy 
provision showed their support for the government programme owing to their direct 
experience (interview SOl and 012). For instance, a social worker of Rayong provincial 
hospital said: 
'Since we had worked with the MSF and PLWHA network to coordinate patient 
group activities, we witnessed significant changes. Some of them were bedridden, 
with CD4 levels of as low as zero. They became healthier ... got up from beds and 
played football with friends ... they could return to work. This made us consider that 
ART delivery would enhance overall carefor PLWHA as well. ' (interview S16) 
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A specialist from the same hospital asserted that ART was essential especially in the settings 
with large numbers of HIV patients. 
'In some wards, most of the admitted patients were HIV positive. We only treated 
OIs and other complications ... then let them home. They usually came back to us 
within 2 to 3 days or a couple of weeks at the longest. Ifwe hadn't offered ARVs, as 
we all know, they would come back and forth - visited us frequently. This cost us 
enormous resources ... ' (interview S 13) 
As suggested by key informants, however, the decisions to participate or not in the national 
ART programme were influenced by many factors other than the clinical outcomes in 
infected persons and associated medical care cost reduction. One of the impediments to 
therapy delivery was the workforce shortage. The inadequate number of health workers and 
disproportionate workload were chronic problems in many provinces especially in rural areas 
(interview R04, R06, and S07). In addition, this problem was exacerbated by the reform of 
healthcare financing including the UC launched in 2001. The UC reform required the 
reallocation of doctors and paramedics, who also had increased workloads, such as the health 
promotion campaigns and 'close-to-home' healthcare delivery in community-satellite centres 
(Srithamrongsawat and Torwatanakitkul 2004). Among the reform's consequences was also 
the growing number of people seeking institutional care, as well as inefficient budget 
management and subsequent deficits in financial incentives such as over-time allowances 
(National Health Security Office 2004a). Evidence suggests that the impact of the UC for 
health delivery system affected all levels of health facilities; however, the effects on the ART 
programme .participation varied across study hospitals. For instance, in Rayong provincial 
hospital where the Social Security Scheme was a substantial source of the service budget, 
financial constraints originating from the UC implementation might have been less severe 
than hospitals in Phichit. However, the financial consequences of the UC on health facilities 
of different levels were complicated and involved many administrative and economic factors. 
Regarding the subsequent increase in workloads, it was argued that before the 2004 national 
ART programme, hospitals were allowed to set their own targets; and in some settings like 
Phichit provincial hospital the number of clients to be treated was decided by considering 
workforce capacity (interview SOl). Thus the additional burden originating from participation 
in the programme was considered to be manageable. Similarly, Wang Chan hospital was 
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invited to join the Access to Care Initiative in 2002, when only 20 PL WHA regularly visited 
the HIV clinic, so they could be absorbed in routine work. Responsible health workers 
therefore did not hesitate to start treatment delivery (interview D20). Interviewees maintained 
that despite lacking experience and knowledge, this hospital volunteered to sign up since the 
health workers expected the training programme organised by the Regional Disease Control 
Office would be able to fill the gaps. 
Sam Ngam was the only study hospital reluctant to take part in the national ART programme 
because of the concern about negative consequences. The director perceived that it was 
difficult for such a small facility to handle the potentially increased number of HIV patients 
and associated financial impact (interview DOl). The arguments related to the possibility that 
ART service would increase the health personnel shortage, since doctors, nurses, pharmacists 
and medical scientists had to allocate more time to deliver this complex therapy. Moreover, 
according to the national programme requirements, the Disease Control Department would 
merely provide ARVs to hospitals and subsidise laboratory costs for enrolees. Other 
categories of expenditure such as those on home visits, blood specimen transportation and 
other logistics, data management, and programme administration were left to hospitals. The 
recently initiated UC plan was also perceived to have had negative effects on the hospital's 
personnel and financial resources. 
An additional concern raised by Sam Ngam director was on the sustainability of the Access to 
Care Programme. In its beginning stage, the Initiative was perceived as 'another research 
project' (interview DOl). The Director had heard that an unpleasant effect for healthcare 
settings of joining the Clinical Research Network was that the Disease Control Department 
failed to continue its support to the participating hospitals when research projects had ended44• 
In the absence of assistance from the central level, it became a burden on the health providers 
to maintain ART for their patients who used to be study subjects, because of the huge 
expenditure on ARVs and other supplies. In many settings, medication was terminated owing 
to fmancial constraints. The Director also argued that he had consulted the respective 
Regional Disease Control Office about the long-term status of the Access to Care Initiative, 
yet received no definite answer. Although only one hospital director mentioned this, another 
44 This reflected the discrepancy between policy and practice - following national guidance, ART was 
supposed to continue in all study subjects with financial and technical support from the Disease 
Control Department. 
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interview with a former director of the MOPH AIDS Division suggested that this scepticism 
was prevalent among hospital administrators (interview NOS). This concern was justified: 
treatment interruption as a consequence of the change in the national ART policy was 
reported in certain parts of Thailand. For instance Phanuphak (2004) reveals that when the 
Health Ministry changed its policy to support the study of zidovudine + didanosisne and 
zidovudine + zalcitabine combinations in naive patients in 1998, many ARV-experienced 
cases could not get free drugs to maintain treatment. 
6.5.3 Decisions to join the national ART programme 
All study hospitals participated in the national ART programme before it became 
compulsory; however, the motivations to do so were different. The Sam Ngam hospital 
director revealed that he decided to take part in late 2003 because of implicit external pressure 
(interview DOl). He experienced the policy communication through the PHO as 'top-down 
command'. 
'We had problems of personnel shortage ... we were reluctant - not sure about our 
capacity; however, we signed up to the programme. It was the provincial 
administrators' policy - they demanded J 00% participation. It was a bureaucratic 
top-down command. I discussed this with friends - other district hospital directors 
'" we signed up because our hospital was the only non participant. ' (interview 
DOl) 
Although the Health Ministry asked for voluntary collaboration from hospitals, the Director 
of Sam Ngam hospital felt he was forced because at the monthly meetings of health 
administrators in the province, names of non-participating hospitals had been underscored, 
which to certain extent embarrassed the Directors of such facilities. One HIV official 
admitted that it was the PHO's strategy to put pressure on hospitals by naming the non-
participants (interview R06). Before the voluntary participation policy was officially lifted by 
the MOPH, the hospital obligation to deliver ART had been strongly promoted at the 
provincial level. Possibly, this was because the proportion of participating hospitals in a 
province reflected the performance of the PHO in some ways. 
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In Rayong provincial hospital, although there were almost 400 PL WHA on medication 
through the Buyers' Club when the scale up of the national programme began in 2001, the 
hospital did not decide to participate promptly (interviews S16 and SI7). The limited staff in 
the Medicine Department and special arrangements required in treatment delivery were the 
reasons given for the reluctance to make a long-term commitment. However, interviewees 
maintained that health professionals and social workers were willing to take part in the 
national ART programme (interview S13 and SI6). It was possible too that the decision made 
finally by the hospital director was partially influenced by NGOs and PL WHA concomitantly 
with the concern about the hospital's reputation as a regional facility. A key informant said: 
'It was not only health providers who got the information ... NGOs, patients and 
PL WHA group leaders got it too. They frequently reminded us that the drugs had 
been available and allocated to this province. We anticipated the consequences (if 
we didn't sign up to the initiative) since we were a regional hospital ... large 
numbers of PLWHA came to us to seek care. I informed the director that the group 
leaders knew a lot and consulted him on how to respond to their requests.' 
(interview S 17) 
For many, participation in the national programme was voluntary. Interviews in the other four 
study settings suggested strong support for patients' wellbeing. Health workers of Phi chit 
provincial hospital, Klaeng and Wang Chan asserted that the benefits of ART to patients was 
the major reason justifying their hospital's participation (interview SOl, 012 and 018). 
Likewise, a nurse in Thapkhlo observed that the hospital volunteered to instigate the service 
because the. director expected improved therapy access would benefit PL WHA and families 
(interview 007). The interviewee perceived no coercion on the part of the provincial or 
regional offices on her hospital. An argument can be made that, however, there might have 
been pressure on the hospital director but nurses and other health workers were distanced 
from such pressure. It is worth noting that at that time, there was no doctor practising in this 
district and the hospital was overseen by the Deputy Provincial Chief Medical Officer who 
was assigned to be the acting director. As this senior officer was normally responsible for 
policy-level issues, he might have signed on to the programme in order to further the profile 
of the provincial health delivery system. This may have taken precedence over the potential 
feasibility and costs of the service provision in this hospital. 
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From interviews, it seems that the decisions to start the ART service were voluntary or only 
indirectly coercive. Also the decisions involved very few: only the director and a small group 
of healthcare staff, led by physicians. In the two provincial settings, and Klaeng and Wang 
Chan hospitals, programme participation was initiated by health workers, who proposed the 
directors endorsed it (interview SOl, S16, Dl2 and 20). All interviewees said that they found 
no obstacle in convincing the directors to join the initiative. In contrast, the dominating role 
of hospital directors in decision making was mentioned in both Sam N gam and Thapkhlo 
cases (interview D02 and D07). Regarding Sam Ngam hospital, key informants revealed that 
the director did not consult staff about applying to join the Initiative but informed respective 
health workers that treatment delivery in the hospital seemed to be inevitable because he 
perceived this policy was going to be compulsory shortly (interview D02 and D03). 
Despite active involvement of PL WHA groups in HIV treatment and care in Rayong before 
ART coverage extension, the NGOs' role in deciding to instigate therapy provision in the 
three study hospitals was limited. As argued by key informants, it was unlikely that PL WHA 
would appeal for additional or improved hospital services because of the strong stigma 
attached to HIV (interview R07 and R09). Many hid their HIV status to avoid social isolation 
and discrimination. Also PL WHA may have perceived they had inferior knowledge about 
treatment than the health professionals. Given that most PL WHA groups were initiated by 
hospital staff, they may have been reluctant to make group demands. An interviewee 
maintained that: 
'We cannot expect PLWHA to challenge even they become increasingly cohesive 
when gathering in groups. ... it is impossible for them to challenge physicians and 
nurses because these patient groups have been established and managed by 
hospitals. ' (interview R07). 
From a health official's perspective, NGOs which were independent of the public sector 
should have been more successful than hospital-organised patient groups in reflecting 
PLWHA's demands (interview R07). In reality, however, NGOs played a minor role in 
encouraging programme participation. Although the Eastern Region PLWHA Network had 
collaborated well with government hospitals to provide support to HIV-infected people, the 
Network Director revealed that his organisation had largely tried to persuade and support the 
actions of the health providers, and admitted he had no planned action when the hospital 
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directors or physicians refused to join the Access to Care Initiative, or limited the number of 
ART clients (interview R09). In part, this might be because the response from the health 
authorities was considered justified by the fact that the human resources constraints in public 
hospitals was well known and affected not only HIV patients but also those with other 
diseases. In addition, it was accepted that such impediments were not solely encountered at 
sub-national levels. 
6.6 Summary 
Phichit and Rayong differed in terms of the demography, economic status, health care 
resources, and burdens of HIV in the health delivery system. The relatively severe afflictions 
from HIV in Rayong might have been a factor encouraging civil society participation in 
treatment and care delivery from the early days of the epidemic. Patient groups in provincial 
and district hospitals in this province were managed with support from faith-based 
organisations and regional-level PLWHA coalition. Networks to tackle HIV-related problems 
had connected Health Ministry hospitals with NGOs, PLWHA groups, and private business 
long before ART scaling up. The launch of several research studies ARVs, prophylaxis and 
therapeutics, and NGO-organised treatment through the Buyer's Club in Rayong and nearby 
provinces, provided many opportunities for health workers and staff of civil society 
organisations to learn together about the benefits, risks and proper administration of 
medication. In addition, the substantial fund from Social Security Scheme was an important 
factor shaping the allocation of the National ART Programme resources. 
A different picture was illustrated in Phi chit: there was lower prevalence of HIV, less 
fmancial support from the Social Security Plan and looser connection between government 
hospitals and NGOs including PL WHA groups which were fewer in number. However, 
learning to deliver ART developed in the provincial hospital when it joined the clinical trial 
project organised by a research institute as part of the MOPH's Clinical Research Network in 
2000. As this project was multi-centred, HIV clinic staff in this hospital acquired direct 
experiences of treatment implementation and also drew lessons from other settings. 
The notable improvement in patients' health gained from participating in research projects, 
apparently motivated some hospital staff to want to take part in the extended National ART 
Programme. However, concerns about possible failure owing to increasing workload as well 
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as inadequate resources made some hospital directors hesitate to sign on. This suggests that 
the policy process in peripheral public agencies resembles that at the national level: the 
adoption of new interventions relies on the perceived feasibility in the implementation and 
anticipated implications for the organisations. Information exchange among administrators 
and health professionals of different settings was an important part of the decision process. 
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CHAPTER 7: IMPLEMENTING UNIVERSAL ART POLICY 
Chapter 6 illustrated the circumstances relating to HIV burden and health services for people 
living with HIV/AIOS (PLWHA) including antiretroviral therapy (ART) before the universal 
treatment policy arrived in Phichit and Rayong. Employing the bottom-up policy 
implementation approach, the present chapter describes the roles played by sub-national 
actors to get the programme into action. It mainly focuses on how the hospitals reacted to the 
targets and directions set by national agencies. The issues explored in this respect comprise 
the integration of therapy into the existing service delivery structure and workforce 
allocation; hospitals' performance; impediments and coping patterns. The analysis also sheds 
light on the factors conducive to, and discouraging of, ART scale up in the two provinces. 
7.1 Integrating ART: structure and staffing 
The introduction of ART policy at national level in 2001 resulted in the restructuring of HIV 
services in particular study hospitals in one way or another. When the Access to Care 
Initiative was first introduced in 2000, all hospitals had HIV clients, but not all were offering 
antiretroviral (ARV) medication. The two provincial hospitals and Klaeng district hospital 
had already provided medication to a number of patients through other programmes at that 
time, but the 3 other study settings had not (table 7.1). 
In the three hospitals with ART delivery experience, health workers included enrolees in the 
Access to Care Programme in their routine clinics (interview S04, Sl6 and 012). As the 
systems already established in these facilities more or less conformed to the national 
programme's requirements, minimal changes were introduced. Interviewees indicated that 
there were attempts to transfer old ART clients from research projects and the Buyers' Clubs 
so that they could receive free medication in the national Initiative. However, this was 
contradicted in the enrolment criteria, which excluded those who had already taken ART 
(Ministry of Public Health 2001 b). The exceptional cases were the HIV-NAT study subjects 
in Phichit. Following negotiation between health providers and the Regional Disease Control 
Office, all eleven subjects were provided with appropriate ARV regimens on the Access to 
Care quota (interview SOl). The small number of treatment-experienced patients in this 
setting might have facilitated the regimen adjustment and management processes when they 
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Table 7.1: Number of ART clients at the time of treatment provision in the Access to Care was 
instigated (cases) 
Hospital No. ofnon-ATC ART clients 
CRN/ 
HIV-NAT 
Phi chit, provincial 11 
Rayong, provincial 0 
Klaeng 20 
Thapkhlo 0 
Wang Chan 0 
SamNgam 0 
Source: key mformants m 6 hospitals 
Note: 
Buyers' 
Club 
0 
382 
n.a. 
0 
0 
0 
YearofATC No.ofATC 
PHPT participation enrolees, first 
year 
0 2001 10 
50-60 2002 75 
n.a. 2002 30 
0 2002 3 
0 2002 5 
0 2003 10 
(1) ATC, Access to Care Initiative; CRN, Clinical Research Network project; HIV-NAT, the HIV 
Netherlands Australia Thailand Research Collaboration; PHPT, Perinatal HIV Prevention 
Trial Project 
(2) n.a., the data were not available. The best estimation for the number of the Buyers' Club 
clients in Klaeng hospital is 20. 
were transferred to the national initiative. On the other hand, the larger demands for 
medication among the Buyers' Club members in Rayong could not be met by the limited 
provincial quota applied in the first year of the programme. 
The scale up of ART in 2004 required staff mobilisation at hospital level: extending 
involvement to specialists and other health workers in Paediatric and Obstetrics & 
Gynaecology Departments (interview S04, S16 and D20). To guarantee service quality, 
Phichit provincial hospital appointed an ART Committee to oversee and integrate therapy 
delivered by different clinics and wards (interview SOl). The Committee issued treatment 
guidelines, some of which were simplified from the national directions and manuals. 
Similarly, in Rayong provincial hospital ART provision in different Departments was 
supervised by a committee on HIV prevention and treatment. By contrast, there was a lack of 
coordinating body for ART services in adults, children, and women after delivery in Klaeng 
district hospital. 
Different arrangements were introduced in the other three settings with no ART experience. 
However, the new systems aimed not only to integrate ARV-based treatment but also to 
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counter some existing problems - mostly involving workforce shortages and movements. In 
Thapkhlo, Sam Ngam and Wang Chan hospitals, health professionals who had been in charge 
of HIV prevention and care, were assigned to manage ART services, irrespective of their 
professional training or job description (interview D02, D07 and D20). A former HIV official 
said this was common in many other district hospitals owing to insufficient personnel 
(interview R07 and SII). 
Another similarity was that in these settings there were movements or changes in position of 
personnel as a result of the public administration reforms in 2002 and 2003. Before ART 
started in Thapkhlo, HIV prevention and treatment was fragmented. There was no focal point 
to manage the overlapping services, or to carry out the tasks on statistics and reporting 
(interview D07). When the hospital signed up to the Access to Care Initiative in 2002, an 
ART clinic was set up and run by a nurse of the In-Patient Department (interview D08). In 
the hospital reorganisation in 2003, this nurse was transferred to a new position in the Health 
Insurance Unit, while her responsibility as ART service coordinator was handed to a 
counselling nurse of the Mental Health Division (interview D07). By the end of the first year 
of ART, 5 out of6 health workers who had received the Access to Care Initiative training had 
resigned, or had been relocated to different jobs (interview D08). The newly-assigned 
treatment coordinator of Thapkhlo was responsible for coordinating the therapeutic and 
prophylactic ART services, as well as prevention and alleviation of drug addiction and mental 
disorders (interview D07). 
In Sam Ngam hospital, prior to ART adoption, a clinic was set up in the Sanitary Division to 
offer pre- and post-test counselling (interview D02). Those who were found to be HIV-
positive were referred to receive treatment and care from the Health Promotion Division, 
where the services to prevent vertical viral transmission were also offered. Almost at the same 
time as ART arrived in Sam Ngam, a nurse of the Family & Community Health Division was 
asked to take over HIV-related tasks from a sanitary officer (interview DOl). After attending 
a training workshop organised by the Regional Disease Control Office, this nurse became the 
coordinator of all activities under the National Treatment Initiative and also played the role of 
manager, counsellor, and nurse at the monthly ART clinic (interview D02). In addition to the 
HIV treatment and management, she was responsible to the Family & Community Health 
Division, and her job description covered health programmes such as mother and child health, 
nutrition, and prevention and care for chronic diseases in communities. 
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Compared to Thapkhlo and Sam Ngam, HIV services in Wang Chan seemed to be better 
organised and more cohesive as most health professionals involved in the prevention and care 
delivery had worked together for a long time. HIV -related activities in this setting had been 
coordinated by a nurse and counsellor of the antenatal clinic since 1999 (interview D20). 
When the hospital signed up to the national ART initiative in 2002, this nurse continued her 
role and also took the responsibility of managing therapy provision although she moved from 
the antenatal clinic to the Family & Community Health Division. 
In these three hospitals, one general practitioner (GP) was responsible for ARV prescribing; 
and importantly, the shift in the medication prescribers was a frequently-occurring 
phenomenon. Sam Ngam director revealed that between the instigation of ART provision in 
November 2003 and July 2004, his GP staff changed three times (interview DOl). The 
situation was even worse in Thapkhlo hospital. At the time of data collection, the hospital had 
a new director who had just moved in after it had been supervised by the director of a nearby 
district hospital for four months (interview D07). The other doctor in Thapkhlo in July 2004 
was newly graduated, recently transferred from another district setting, and had started 
working only two months before. In contrast, the GP who prescribed ART in Wang Chan in 
2004 had been trained in the Access to Care preparation programme in 2002 (interview D19). 
However, this doctor would leave to pursue a specialist internship in the near future. As 
argued by provincial health officials, the mobility and shortage of doctors in district hospitals 
had long persisted and was acknowledged as an important impediment to ART scaling up in 
the two study provinces (interview R06 and R07). 
7.2 ART scaling up in Phichit and Rayong 
The information on the national ART programme between 2001 and 2003 is too limited to 
indicate the provincial- and hospital-level achievement. When the treatment 'quota' turned to 
'targets' in 2004, systematic policy monitoring tools were installed including periodic 
reporting that captured the information from provincial and regional offices and hospitals 
(Thanprasertsuk, Lertpiriyasuwat, and Chasombat 2004). Based on the data available from 
the Bureau of AIDS, Tuberculosis and Sexually-transmitted Infections and interview 
information, this section examines the performance of study settings in expanding treatment 
coverage in two aspects - quantity and quality of the service provided. 
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7.2.1 The unmet targets 
In 2004, the national ART programme set the performance indicators on the number of 
treatment clients on two different bases - accumulated and current cases (Disease Control 
Office for Health Region 9 2004b; Rayong Provincial Health Office 2004b). The goal for 
each implementing setting was to achieve 100% of the target if the accumulated figures were 
employed, while it was set at 80% if the assessment was based on the numbers of current 
clients. The 2004 targets for Phichit and Rayong were 332 and 1,213, respectively (Disease 
Control Office for Health Region 3 2004b; Disease Control Office for Health Region 9 
2004c). Parallel to the national figures, the number of treatment enrolees in both provinces 
steadily increased; however, only about 76% of the targets on the accumulated-case basis 
were met by the end of September 2004 (figure 7.1). 
Figure 7.1: Accumulated number of the national ART programme clients as percent of the targets, 
Phichit and Rayong, fiscal year 2004 
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Source: Bureau of AIDS, Tuberculosis and Sexually-transmitted Infections 
At the sub-national level, the current-based figures were usually employed to monitor and 
assess programme development (interview ROl). Disaggregated by settings, none of the study 
facilities could meet their targets. The best performance was observed in the case ofThapkhlo 
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hospital where 67% of the target was achieved in September 2004. Table 7.2 illustrates the 
number of PL WHA on treatment at the time of data collection and three parameters: the 
number of referred-out, dead, and default cases, which impart broader aspects of the ART 
delivery by hospitals. Some patients were referred to receive therapy in other settings for 
different reasons. For instance, 6 migrant workers in Wang Chan asked for treatment in their 
hometowns, while 3 paediatric cases in Phichit were referred back to the hospitals at district 
level after regimen adjustments were made by specialist in the provincial hospital. The other 
two parameters - deaths and defaults are discussed in the next section. 
Table 7.2: National ART programme clients in study hospitals, 2004 (cases) 
Hospital Target Number of ART clients 
Current Referred out Dead Default Accumulated 
Phi chit, provincial 80 8.(1) 36D.(~) 3 0.(2) Ob.(2l 2 0.(2) 41 D.(l) 
Thapkhlo 30 8.(1) 19 b.(l) 1 b.(2) o b.m OD.\L) 20 b.(l) 
Sam Ngam 23 8.\1) 11 b.(Z) Ob.(2) 3
b
,f2T 1 D.lL) 15 b.(2) 
Rayong, provincial 449 c.(I) 2490.(3) 3 d.(J) 3 d.(3) 1 d.(J) 256 d.{JT 
Klaeng 220 C.P) 80 e.(4) 1 e.(4) g
e.(4) 4 e.(4) 94 e.(4) 
Wang Chan 120 c.(I) 28f,\'l) 6 t.(4) 4 1;(4) o t.(4) 38 f.(4) 
• 8 • D Sources of1Oformatton. DIsease Control Office for Health RegIOn 9 (2004c), key 1Oformants 10 
particular hospitals; C Disease Control Office for Health Region 3 (2004b); d Rayong hospital 
(2003 and 2004); e Klaeng hospital (2004a); f Wang Chan hospital (2004) 
Note: 
(1) Default cases included the loss to follow up and drop out or refusing to continue the 
medication after instigation 
(2) (I) as of September 2004; (2) as of July 2004; (3) between June 2003 and May 2004; (4) as of 
May 2004 
7.2.2 Beyond the number of enrolees 
In addition to the numbers of patients on medication, ART programme performance can be 
assessed in terms of treatment benefits and service quality (WHO 2003b). Healthcare 
providers in all study settings expressed their satisfaction with the low default rates and 
desirable clinical outcomes as indicated by the improved overall health status; escalated 
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CD4+ cell levels; weight gain; and lowered opportunistic infection (01) rates (interview SOl, 
S14, D02, D07, D13 and D20). Hospital admissions due to serious adverse drug reactions 
were required in only a few patients. After treatment instigation, a small number of clients 
were classified as default cases as they discontinued the medication or never visited the 
clinics for follow up. 
Although treatment adherence was recognised as a vital element in ART and the less-than-
perfect adherence suggests a service of deficient quality, there had not yet been any 
systematic evaluation conducted in study settings on this issue. Rayong Provincial Health 
Office (PHD) included the goal of assuring adherence in 80% of treatment recipients in its 
HIV/AIDS prevention and control plan; however, no detailed framework and methodology 
for the assessment was developed (Rayong Provincial Health Office 2004b). In interviews, 
health workers in all study settings argued that the improved therapeutic results indicated 
desirable adherence of their patients. 
As shown in table 7.2, deaths among ART clients were reported in 4 hospitals: 9 in Klaeng, 4 
in Wang Chan and 3 in Rayong (provincial setting) and Sam Ngam. As health workers 
explained, the common factor of the fatality was the patients' severe ill-health, as indicated 
by the very low CD4 cell counts and existing DIs at the time of enrolment (interview D02, 
D13 and D20). According to hospital database, 66% and 58% of ART recipients in Klaeng 
and Wang Chan, respectively, started the medication at CD4 cell levels of less than 50 cells 
per mm3 (Klaeng hospita12004a; Wang Chan hospital 2004). The enrolees' condition in these 
two district hospitals was relatively poor as the Health Ministry AIDS Division's data suggest 
the national corresponding figure was 53% on average. However, apart from initial low CD4 
cell counts there are many factors contributing to treatment outcomes including patient 
survival, for example experiences of providers, 01 manifestation, and medication adherence 
(Chaisson et al. 1998; Kitahata et al. 1996; Paterson et al. 2000). 
As the literature suggests, a potential negative consequence of ART is the sexual disinhibition 
in clients with improved health, and the magnitude of this problem to some extent indicates 
the quality of counselling services (Kalichman and Rompa 2003; Katz et al. 2002). Health 
officials and providers in both study provinces argued that it was difficult to explore sex 
practices (interview R04, S13, S14, D02). However, they suggested that disinhibition would 
be an unavoidable aftermath of treatment extension and would need systematic action at 
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national and peripheral levels to counteract it. A Regional Disease Control official noted in 
interview: 
' ... these patients get well - physically, some look nice. When they become healthier, 
they look like other people ... as if they have never got infected. Then, they have 
irresponsible behaviour. Some admit that they don't have protected sex .PLWHA 
Network asks us to organise educational programmes on this issue, but this relates 
to life skills and other elements ... it should be managed by the Department ~f 
Mental Health. We are going to coordinate necessary activities to deal with the 
forthcoming downside. '(interviews R04) 
Pregnancies, either intended or unintended, were another important issue mentioned by 
interviewees not only in ART clients but also in general HIV-positive persons. Although 
family planning services were offered to all HIV patients, some of them refused to comply to 
contraceptive instruction since they desired to have children and then got pregnant while they 
were on ARVs (interview SOl, S14 and DB). Some PLWHA treated in study hospitals did 
not inform their spouse that they were infected. In such cases, the providers asserted that it 
was patients' right to make their own decisions; and the health workers' responsibility was to 
provide proper counselling and prevent vertical HIV transmission (interview SO 1, S 13 and 
SI6). One doctor in Rayong provincial hospital revealed: 
'I keep considering we should take it more seriously to address unsafe sex practices. 
I often remind my patients when they come to the clinic: you must stop the disease 
at yourself - don't expand it further. It is really bad to destroy other people's lives. 
... even though we provide them with information, contraceptives and condoms, 
some get pregnant. They neither ask their husbands to use condoms nor take the 
drugs regularly, because they don't want to disclose their HIV status. ' (interview 
S14) 
7.3 Quantity and quality of treatment in the study context 
Since universal ART access became the Ministry of Public Health (MOPH) priority in 2004, 
the policy's progress was on the list to be reported to the monthly inter-departmental 
meetings of the Health Ministry (Ministry of Public Health 2003b; 2004a). Treatment 
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extension was closely monitored at different levels of the health system; and the performance 
indicators mostly emphasised were not about service quality, but the gap between targets and 
numbers of clients in certain settings (interview ROt, R06 and R07). Pressure was put on the 
regions and provinces where progress was relatively slow. As shown in Figure 7.1, from the 
beginning of2004, Phichit's and Rayong's performance in term of the number of ART clients 
by target could be considered moderate. This section describes the difficulties in enrolling 
eligible PL WHA to receive therapy in study settings and strategies introduced by these policy 
implementation units in order to achieve the programme targets. It also explores the 
perspectives of healthcare providers about the goals and associated measures established by 
the Health Ministry to scale up medication in this period. 
7.3.1 Moving patients: moving targets 
An important feature of the national ART programme was that the enrolees were not required 
to register in particular hospitals thus they could seek medication from any preferred setting. 
Given the HIV-related stigma and inadequate 01 drugs at district level, many PLWHA sought 
care from health facilities located far from their domiciles. For instance, some patients 
residing in Sam Ngam and Thapkhlo were willing to travel to get ARVs from Phichit or 
Phitsanulok provincial hospitals, or even from Bangkok (interview 002 and 007). Health 
workers argued that owing to the lack of effective HIV registration, responsible agencies 
could not have accurate data on the current disease status and other information such as 
address and heath provider of each infected person. Interviewees maintained that for these 
reasons, the number of their clients could change over time, and the treatment targets set on 
existing information were difficult to achieve if the patients had died or moved freely from 
one hospital to another. 
In contrast, none of the key informants in Rayong expressed the concern about unattainable 
targets. This does not mean that the information on the number of PL WHA residing in 
Rayong was considered reliable or no HIV -positive persons sought care from different 
districts and provinces. However, it might be because HIV prevalence in Rayong was so high 
that the pool of HIV patients in MOPH hospitals was sizeable and healthcare providers had 
no difficulties finding cases to be enrolled on the national initiative. 
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7.3.2 Strategies to boost programme uptake 
In order to meet ART targets, public relations campaigns were initiated in Phichit (interview 
RO land R06). This measure, with a corresponding budget, was put in the regional Access to 
Care operational plan for fiscal year 2004 (Disease Control Office for Health Region 9 
2004b). However, a key informant revealed some reluctance among health officials at the 
beginning (interview ROl). The concern was that the publicised information about ART 
availability and its efficacy might be misinterpreted, resulting in carelessness and negligence 
in safe-sex practices. However, when the increase in the number of new enrolees was 
apparently sluggish, the Regional Disease Control Office got the public relations plan 
implemented. 
The Phichit PHO established an information programme to target the national ART 
programme messages to people with high risk of HIV infections and PL WHA groups 
(interview R06). Other government agencies and local administrations were asked to 
distribute the information to their clients, for example PL WHA who received monthly 
financial support from the Provincial Social Welfare Office. Apart from the information 
campaigns organised by the regional and provincial offices, in fiscal year 2004, the Health 
Ministry allocated 15,000 baht to each hospital for the ART programme administration 
including public relation activities to encourage treatment demands among isolated or 
undisclosed PLWHA (ATSI 2003a). 
Although Rayong province did not face the same problems in finding HIV cases, the PHO 
and provincial hospital ran information campaigns about ART service provision in order to 
promote HIV counselling and testing for early case detection (interview R07). This also 
aimed to encourage clinical outcomes through prompt therapy initiation in the infected 
individuals. One interviewee revealed that, like its Phichit counterpart, the campaigns were 
initially opposed by senior provincial administrators because of the concern about 
misinterpretation of the content of the information distributed. 
'In a meeting at the Provincial Administrative Office, we proposed to encourage 
PL WHA to seek proper care, by disseminating the information that AIDS was 
treatable, but patients had to take medicines until the end of their lives. We were 
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criticised by senior officials - they argued that such information would be wrongly 
conceived, resulting in misbehaviour ... neglecting prevention. ' (interview R07) 
Directors and staff of study hospitals in Phichit were concerned about meeting treatment 
targets. Therefore, they too created mechanisms to boost service uptake, but some expressed 
professional ethical concerns. In the provincial hospital, health workers tried to verify the 
figures by reviewing retrospective epidemiological information in order to map the patients 
according to their current dwellings and also to identify the number of deaths among them 
(interview SOl). Sam Ngam hospital did the same, recognizing however, that this must be 
done with caution since it might be regarded as disrespectful of the rights of PL WHA who 
sought anonymity (interview DOl). The HIV nurse of this setting revealed that she asked her 
network, including sub-district health workers, officials of local administration authorities, 
community leaders and village health volunteers, to support case finding and provide 
information (interview D02). 
Thapkhlo hospital faced similar problems: the gap between the current demand and expected 
need for ART. The responsible nurse observed that in 2002 - the first year of treatment 
service, from the target of 10, only 3 clients who resided in the township and other districts 
were enrolled (interview D07). The interviewee argued that the obstacle arose from the lack 
of reliable HIV case reporting and there was a marked discrepancy between the information 
from different sources. The strategy employed to encourage patient enrolment in this district 
was not case fmding in communities but dispatching the programme's information through 
posters and brochures. 
7.3.3 Quantity versus quality: health workers' perspectives 
Although healthcare providers in study settings had been positive to the early-phase Access to 
Care Initiative, their attitudes became more pessimistic when the MOPH set the 2004 target to 
get 50,000 PLWHA on medication. It appeared that the demands of the Ministry on its sub-
national offices and hospitals to enrol more patients distressed responsible health workers 
since they anticipated a growing workload and threat to service quality (interviews R04 and 
D06). They feared that the crucial elements of ARV administration such as adequate 
counselling and follow-up measures to ensure adherence would be neglected if the number of 
clients surpassed capacity. A regional health official asserted: 
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'ART is presented as another routine, resembling simple antibiotic prescriptions. 
We cannot expect the services to conform to standard practices ... some essential 
procedures may fail to be carried out. Patients just come in and receive drugs from 
our clinics and that's it. When we have to treat a lot more patients, we do not have 
enough time to give comprehensive counselling - no follow up, no home visit ... ' 
(interview R04) 
Although health workers in Phichit worried about failing to meet the national programme 
targets and introduced corresponding strategies to enhance patient enrolment, they argued that 
the increase in the number of clients was not their ultimate or sole objective. The provincial 
hospital's HIV specialist, the Sam Ngam nurse, and the Thapkhlo counsellor all shared 
concerns that a larger caseload would undennine treatment quality, in particular given 
provision over a lifetime, complicated medication, and patients who felt stigmatised and 
isolated (interview SOl, D02 and D07). 
Despite apprehension about the unmet targets, these ART providers prepared a common 
explanation to the central department that they had put their best efforts to case finding, 
running information campaigns, justifying each case against enrolment criteria, and carefully 
taking care of their HN patients no matter whether they were or were not ART enrolees. In 
all study settings including those in Rayong, there were lists of PL WHA at different clinical 
stages; some of whom were ART eligible according to the enrolment criteria, but the 
medication had not yet started. Health workers asserted that they did not care about being 
blamed for not meeting targets and would not enrol the new batch, if treatment quality could 
not be ensured to their satisfaction. For instance, a Sam Ngam nurse said her hospital could 
deliver good quality ART to 10 patients at maximum, but the medication target for this 
setting was 23. 
'I told the director I couldn't bear the frustrations .I asked him to ignore the 
criticisms made in the provincial meetings when our performance was highlighted 
with 'red figure '/ Service like this couldn't be accelerated. If patients were 
unprepared, it would be dangerous. In some cases, I had to phone them in the 
morning and evening to remind them to take the drugs as I wasn't sure about the 
adherence... - definitely we would fail ... drug resistance would develop.' 
(interview D02) 
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In Thapkhio, the ART coordinator said that she was not actively searching for new cases in 
the communities, because a 30-bed hospital like hers could not handle more HIV patients 
(interview 007). She preferred providing the best to the small number she had on the list, 
which had been much expanded since she took over the task. This health worker welcomed 
walk-in cases, who she would add to the existing pool, and then systematically monitor their 
clinical condition until the Access to Care enrolment criteria were met. She argued that ART 
was not the best therapy for all PL WHA because of its adverse effects; and therefore, to her 
patients she recommended several health promotion and self-care activities. 
Similar concern about the quantity-quality trade off was expressed by treatment providers in 
Rayong. At the time of data collection in May 2004, none of the study hospitals had got close 
to the targets. However, ART coordinators in these settings showed no signs of distress about 
the unmet targets. Although there were a lot of patients on waiting lists, responsible health 
workers insisted that they would not enrol the next cohort unless both supply and demand 
side were well prepared (interview S16 and D20). In the interviews, the ways the doctors, 
nurses and pharmacists discussed specific issues such as case management, training needs, 
patient group coordination, and programme impediments principally reflected their attitude 
that service quality was vital. In addition, ART was seen as a component of integrated 
treatment and care for PL WHA, thus in the perspectives of these providers, the whole range 
of services and related activities should be concomitantly promoted. 
7.4 Dealing with constraints 
Respective healthcare providers pointed to many difficulties in maintaining service quality, 
although evidence suggested acceptable outcomes. This section analyses the overall context 
in which treatment policy was executed and how contextual factors hindered critical elements 
of therapy provision. It also explores the measures employed by hospital directors and staff to 
counter the constraints. 
7.4.1 The dynamics of change 
In addition to the inauguration of the Universal Health Coverage Plan (UC) in 2001, two 
national policies were launched subsequently: the public administration system reform in 
2002 and national-scale health promotion campaigns in 2004. Both were said to have had 
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negative implications for ART scaling up (interview R04, R07 and DO 1). Interviewees 
claimed that strategies of the former included organisational restructuring; reallocation of 
personnel within and across agencies; and early retirement opportunities for civil servants45, 
all of which resulted in significant loss of experienced health workers, not only in hospitals 
but also in the PHOs. The reorganisation of hospitals and changes in HIV clinic coordinators 
in Sam Ngam and Thapkhlo (section 7.1) were among the reform's consequences. 
In early 2004, another large-scale project titled 'Healthy Thailand' was launched by the 
Health Ministry46. This policy aimed to improve the health status of the general population as 
well as emphasising disease prevention in women and children, in line with the Millennium 
Development Goals for 2015 (Thaineua 2004). It comprised health promotion activities in 5 
areas: diet, exercise, emotion, environment and disease reduction, all carried out at different 
levels from national to provinces, districts, and villages. Although the project called for 
public and community participation, fostering these activities were extra tasks on an already 
overburdened range of health workers (interview S17, D02, D07 and D09). 
7.4.2 Providers' competency 
Other than the problem of health personnel shortage, inadequate knowledge and experience to 
deliver treatment was mentioned by key informants. Similar difficulties have been 
documented in many health systems when central departments start up new programmes at 
peripheral level (Gilson et al. 2003; Rees et al. 2004). In Phichit and Rayong, doctors, nurses 
and pharmacists revealed that ART issues had been discussed very briefly while they were 
undergraduates (interview S02, S05, S14, and D07). For most of them, the first time they 
learned about the medication, especially its critical elements, was from the Access to Care 
training sessions during 2001 to 2003. The exceptional cases included two Phichit provincial 
hospital specialists - one in Medicine and the other in Paediatrics, who had been trained to 
prescribe ARVs during internships in a university hospital in Chiangmai - a province with 
very high HIV prevalence (interview S02 and S03). On the other hand, a doctor who led ART 
service in Rayong provincial hospital argued that although he was a medicine specialist, he 
45 This strategy aimed to downsize the bureaucratic system. Government officials 50 years of age and 
over were encouraged to resign from public work and received a substantial payment, in addition to 
normal pensions, in return. 
46 The Healthy Thailand policy became national agenda in fiscal year 2005 and was extended to 
involve government officials from other ministries including Ministries of Interior and Education 
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had had no experience of prescribing ART during his internship in a medical school in 
Bangkok (interview SI4). 
Other providers such as the OP and nurse of Thapkhlo hospital had never received training on 
ART delivery (interview 006 and D07). The OP maintained that he had no difficulty in 
prescribing ARVs because he followed the national guidelines (interview 006). Despite this 
argument, problems arising from this inexperienced doctor were mentioned by other health 
workers in this setting (interview D07 and 009). By contrast, the nurse expressed her 
concerns about lacking competency when she first undertook the tasks (interview 007). She 
received training in the Access to Care course after having been involved in the programme 
for 6 months. Self study by consulting different sources of information was her coping 
strategy. 
'I was trained in Mental Health Nursing. I confess I knew almost nothing about 
ARVs in the beginning. The first six months, being unfamiliar with the drugs and 
regimens, I found really difficult. I was expected to know everything as I was a 
coordinator. Therefore, I had to read many books and review several documents. 
Partly, I learned from patients - the PLWHA Network. The pharmacist also guided 
me ... she taught me about the drugs and drug actions. Now, it's fine. ' (interview 
007) 
The problem of inexperienced doctors was also highlighted in Wang Chan. The OP who was 
responsible for the service had never been trained or got involved in ART delivery. She 
admitted lacking confidence when the director assigned her this task (interview 019). 
However, working in an area with very high HIV prevalence such as in Rayong, she was 
inevitably exposed to large number of cases. Furthermore, the doctor claimed that she gained 
more knowledge from the Access to Care training sessions as well as the continuing 
education programmes organised by an NOO - the Thai AIDS Society47. 
47 The Department for Disease Control outsourced the Thai AIDS Society to develop training 
curriculum and run education programmes for doctors involved in ART provision. 
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7.4.3 Integrating care in the province 
In 2004, as the national ART programme demanded hospitals enrol more clients, the 
obstacles in service delivery became apparent, and required system adjustment. In Phichit, the 
PHO and the provincial hospital established an inter-hospital network to provide support to 
district facilities: organising training and education programmes for district health personnel 
including medical scientists (interview SOl and S03). This aimed to complement the training 
workshops organised by the Regional Disease Control Office between 2001 and 2003, by 
offering new cohorts of health workers and those transferred from other positions with the 
national programme orientation and current information on the detailed technical aspects 
necessary for each discipline (interview S06, S08 and SIO). 
Special arrangements were integrated in the existing training programmes set for newly-
graduated doctors before they were allocated to district hospitals (interview SOl and S03). 
While rotating in different departments of the provincial hospital, the GPs were trained in 
ART administration in both adults and children. The network also allowed consultations 
between district-level doctors and specialists of the provincial hospital. Moreover, as 
paediatric ART was considered much complicated, the provincial hospital offered therapy 
initiation for children from districts and then referred the cases back when the regimens were 
adjusted and stable. Key informants revealed that the inter-personal connections established 
in the training period encouraged further collaboration among doctors as well as other 
professions of the two levels (interview S06, S08 and S10). 
While a HIV treatment network was established to coordinate health care providers in Phichit, 
less structured collaboration between hospitals was observed in Rayong's ART delivery. 
Interviewees said they used the existing, normal referral system set by the MOPH through 
which patients were referred from district settings to receive secondary or tertiary care in the 
provincial hospital (interview D19 and D20). With such a mechanism, paediatric cases and 
complicated adult patients in Klaeng and Wang Chan were transferred for ART and other 
HIV medications to the provincial facility. After that, these patients would be referred back to 
the district hospitals for maintenance therapy. Apart from this, there were case consultations 
between GPs and specialists in different hospitals. Technical support among doctors was 
needed not only by GPs at district level; a medicine specialist of the provincial hospital 
revealed that he consulted a specialist of Chonburi provincial hospital who had long 
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experience providing HIV medications in this region (interview SI4). Treatment advice was 
particularly requested in the cases in which drug-resistance had developed, for example 
among Buyers' Club members who had received ARVs for many years. 
Inter-hospital collaboration also played a role in inventory management of drugs used in the 
programme. In the early phase of the Access to Care initiative, shortages and oversupply of 
ARVs were reported to be prevalent in both Phichit and Rayong (interview S05 and S22). In 
the case of drug shortages, pharmacists sometimes had to borrow from other hospitals in the 
same province. Oversupply of nearly expired ARVs from the regional disease control office 
was also a problem in district hospitals with a small number of ART clients. In such cases, 
the provincial hospitals might be asked to exchange their newer batches with the older from 
the district counterparts. This was because in the provincial settings with higher HIV 
caseloads, drugs inventory turnover was more rapid. 
7.4.4 Crossing professional boundaries 
In addition to the collaboration between settings as a strategy to deal with workforce shortage 
in district facilities, each study hospital set its own mechanisms which to some extent shared 
common features. Key informants suggested that in addition to doctors, nurses and 
pharmacists played key roles in ART provision in all study settings, especially district 
hospitals (interview R01, R06 and Sl1). However, doctors and pharmacists appeared to be 
more bound by their professional territories, so that nurses who were more flexible ended up 
running the clinics and coordinating all treatment partners internal and external to the 
hospitals,as well as updating the programme's database and report-writing. When the 
national ART programme was considerably extended in 2004, the two study provincial 
hospitals allocated more nurses to support the service including related administration work 
(interview S04, S17, and S20). Even so, the providers argued that this did not meet the 
substantial increase in the caseload. In district settings, on the other hand, all management 
tasks of ART delivery remained undertaken, single-handed, by one nurse (interview D02, 
D07, Dl3 and D20). Since there were frequent turnovers of doctors in Sam Ngam and 
Thapkhlo, nurses and pharmacists were expected to assure the service quality including 
safeguarding patients from severe adverse effects of the medication (interview ROI and R06). 
The exceptions were Klaeng and Wang Chan hospitals where the GPs had had some 
continuity. 
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While it appeared to be a norm that health professionals would support each other, 
interviewees argued that nurses and pharmacists of district hospitals had to pay particular 
attention to newly-graduated GPs, by reviewing their prescriptions and providing second 
opinions in cases considered as irrational prescribing (interview D02 and D07). For instance, 
a Thapkhlo pharmacist revealed that: 
'It was a pharmacist's responsibility to review the prescriptions because the new 
doctors didn't know ... some of them had never attended training course - they 
didn't know what to do, what had changed, what was to be emphasised. A frequent 
mistake was on drug dosage ... ' (interview D09) 
In Phichit, interviewees maintained that since therapy was delivered by paediatricians some 
of whom were unfamiliar with not only ART but also the whole package of HIV treatment 
and care, some prescriptions were inappropriate (interview S06 and S08). For example, the 
drug dosage was not adjusted according to patients' weight, and drugs for 01 prophylaxis 
were not concomitantly prescribed with ARVs. In such cases, responsible pharmacists had to 
consult the prescribers before dispensing. Although such pharmacy practices could be seen as 
an intrusion into physicians' professional territory, no tension between the two professions 
was reported in these settings. 
Unlike other study hospitals, Klaeng and Wang Chan pharmacists had no role in AR V 
dispensing, counselling, and promoting medication adherence as these activities were carried 
out by nurses (interview D13 and D22). Similar arrangements were described in the two 
settings, i.e. the drugs were transferred from the Pharmacy Department to dispense in the 
monthly ART clinics where responsible nurses and PLWHA leaders provided treatment 
information and drug counselling. Therefore, the prescriptions and dispensed ARVs were not 
reviewed and rechecked by pharmacists. 
Importantly, nurses of all district hospitals in this study were authorised to repeat the 
prescriptions in the cases without complications (interview D02, D07, D13 and D20). Having 
screened all patients for certain signs and symptoms, only the cases with OIs or severe 
adverse drug reactions would be treated by doctors. In Phichit, since more reliance was 
placed on nurses and pharmacists, the two professions from provincial and district facilities 
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were invited to attend some continuing education and training programmes originally 
targeting doctors (interview S08). 
7.4.5 Struggling to ensure quality 
Inadequate medication adherence was a matter of great concern to ART providers in all study 
hospitals. Despite constraints, the efforts of responsible health workers to keep patients on 
lifetime therapy were strong. As nurses and pharmacists argued, they spent substantial time 
on individual and group counselling before and after treatment instigation, while their 
physician colleagues were unable to do so. 
Health workers in all study hospitals said they recognised and took into account the 
characteristics of particular patients, such as willingness to adhere to the medication, 
education level, occupation, economic status, and social environment, which might affect 
treatment administration and monitoring. Past compliance to 01 medications was regarded as 
a helpful predictor (interview D20). In all settings, ART was withheld from patients whose 
adherence was anticipated to be poor. The difficulties in providing treatment instruction to 
patients and caregivers were considerable in some cases. One example given was of a child 
with AIDS, who lived with an old, illiterate grandmother and received therapy in Phichit 
provincial hospital. 
'There was a small child ... her grandmother could not read at all. The kid took 
AZT and lamivudine syrups. As her granny could not read the figure, I put brightly 
coloured stickers on the syringes to mark the volume of drugs to be drawn. The 
granny could not read the labels on the bottles either. It took a long time to explain 
to her about the instructions - how to prepare the mixture ... when to give the drugs 
to the kid. '(interview S06) 
In addition to the counselling, adherence strategies were promoted by health workers. For 
example, they used simplified education & information, unit-dose containers, reminders via 
telephone calls, and easy-to-reach counselling services. Simple measures such as pill counting, 
assessing the improvement in CD4 cell levels, body weight, and overall physical appearance 
in the follow up were used as indicators of treatment adherence in particular patients 
(interview D20). Staff of Phichit provincial hospital claimed that techniques and pragmatic 
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lessons learned from HIV-NAT research were adapted to enhance the adherence among the 
Access to Care clients (interview S04 and S05). 
However, monitoring and encouraging adherence of clients in their communities as well as 
home visits to ART- and non-ART patients was limited. An insufficient workforce and the 
effects of stigma were two common explanations. As argued by the Sam Ngam nurse, she 
could arrange regular HIV case visits by integrating them into trips for general home 
healthcare purposes, but this action was refused by some patients who concealed their HIV 
status (interview D02). In Thapkhlo, travelling to some distant villages was difficult and time 
consuming (interview D07), and some ART clients resided outside the hospital catchment 
area (interview S04). Since adherence encouragement was considered crucial, healthcare 
providers in study settings organised home visits for disclosed patients through their networks 
in communities, especially PLWHA leaders (interview D02, D07, D13 and D20). 
Contribution of health workers at sub-district health centres in these activities was reported in 
some hospitals, for example Klaeng and Wang Chan. 
7.5 Discretion in treatment financing 
After the introduction of the health care financing reform in 2001 there were 3 health benefit 
plans existing in the country: the Civil Servant Medical Benefit Scheme for government 
workers and dependants; the Social Security Scheme for formal private sector employees and 
the UC for the rest of the population (chapter 2). The inclusion of ART and 01 medications in 
these schemes differed and changed over time. This section documents the coverage for HIV 
services by health benefit programmes and practical arrangement introduced in study 
hospitals. 
Table 7.3 summarises the rules on the finance of ART and drugs for 01 prevention and 
treatment through different schemes and practices in Phichit and Rayong provinces between 
2001 and 2004. In this period, government workers and dependants could access free HIV 
medications in any public hospital. On the other hand, those on the Social Security Scheme 
and the UC plan were covered only for 01 drugs. ART was subsidised for Social Security 
Scheme beneficiaries in late 2004. 
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Table 7.3: ART and 01 medication coverage in the three health benefit plans and national ART 
programme, and practical arrangement in study hospitals, 2001-2004 
Health benefit schemes National ART Programme 
Government Social Security UCa 
Employee Scheme (SSS)a 
Scheme 
2001 
Official ART and OJ OJ drugs 01 drugs ART 
benefits drugs 
Rayong ART and OJ ART and OJ or drugs No national programme 
practices drugs drugs implemented 
Phichit ART and or OJ drugs or drugs ART in Qrovincial hosQital for 
practices drugs PL WHA who met the enrolment 
criteria, irrespective of their domicile 
and benefit scheme entitlement 
2002 
Official ART and or or drugs 01 drugs ART 
benefits drugs 
Rayong ART and OJ ART and OJ or drugs ART for UC members and the 
practices drugs drugs uninsured 
Phichit ART and or OJ drugs 01 drugs ART in Qrovincial hosQital, and ART 
practices drugs and 01 drugs in Than Khlo hosQital 
for PL WHA who met the enrolment 
criteria, irrespective of their domicile 
and benefit scheme entitlement 
2003 
Official ART and or or drugs or drugs ART 
benefits drugs 
Rayong ART and OJ ART and or OI drugs ART for UC members and the 
practices drugs drugs uninsured 
Phichit ART and OI OI drugs OI drugs ART in Qrovincial hosQital, and ART 
practices drugs and OI drugs in ThaQ Khlo and Sam 
Ngam for PLWHA who met the 
enrolment criteria, irrespective of 
their domicile and benefit scheme 
entitlement 
2004 
Official ART and OI OI drugs, and or drugs ART 
benefits drugs ART from late 
2004 
Rayong ART and OJ ART and OI OI drugs ART for UC members and the 
practices drugs drugs uninsured 
Phichit ART and or ART and or OI drugs ART in Qrovincial hosQital, and ART 
practices drugs drugs and 01 drugs in ThaQ Khlo and Sam 
Ngam for PLWHA who met the 
enrolment criteria, irrespective of 
their domicile and benefit scheme 
entitlement 
Note: a regtstratlOn of benefic lanes to particular hospItals was reqUIred 
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The national ART initiative from its launch in 2000, established clinical and social enrolment 
criteria, but had not stated which groups of the population would be eligible for treatment 
with regard to their health schemes and dwelling (ATSI 2004a; Disease Control Office for 
Health Region 3 2004c; Disease Control Office for Health Region 9 2004a). The variation in 
HIV treatment coverage across these programmes allowed different interpretations and 
discretion in providers' practices. 
In Phichit, the three study hospitals provided ART in the national programme to all clinically-
eligible patients, without taking into consideration their health benefit entitlement (interview 
S04, D02, and D07). It was not until December 2003 - two years after the Access to Care 
Initiative was incorporated in the provincial hospital - that an official direction of the 
Regional Disease Control Office entitled Social Security Scheme members to ART in the 
national programme (interview R06). The justification of such a solution, as revealed by a 
PHO official, was that "the Ministry and provincial health office did not mind who would be 
enrolled to receive the medication ... otherwise we could not meet the target". The main 
reason then, for extending the availability of ARVs, was to meet MOPH targets. 
Another variation relating to patients' rights to inclusion was caused because ART delivered 
in the national programme in Phichit as well as other provinces in Health Region 9, was 
opened to PLWHA of all domiciles (Disease Control Office for Health Region 9 2004a). 
However, the UC and Social Security Scheme beneficiaries were entitled to the health 
services specified in the benefit package from particular hospitals, mostly located in their 
residential areas. If patients sought ART from different hospitals, and at the same time 
required other drugs such as those indicated in opportunistic infections, they had to pay for 
these drugs themselves. The provincial hospital was strict on this rule, so some patients who 
received ART freely in this setting were charged for other HIV medicines such as drugs for 
opportunistic infections and symptomatic treatment (interview S04 and S05). 
For Thapkhlo, on the other hand, the hospital's executive board decided to offer all HIV 
treatment without charge irrespective of the clients' entitlement (interview D07). The ART 
coordinator in this setting asserted that registering people to certain hospitals deployed by the 
UC and Social Security Scheme was not friendly for PL WHA since most of them were 
afflicted by stigma and discrimination so that they could not comply with, or benefit from this 
insurance management. One key informant argued: 
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'We can't counter HIV problems if we always consider whether this or that patient 
has been entitled to the services of our hospital . Working on HIVIAIDS has no 
border. Many patients came here from other districts and provinces because they 
want to hide themselves - there should be a place accepting them and offering care 
to them. Definitely, we know they are able to transmit the disease, why don't we 
keep them in our hands? Just don't let them wander uncared. '(interview DO?) 
Nevertheless, HIV medications other than ART offered in this district facility were relatively 
limited because expensive 01 drugs were not available in the hospital. In such cases, patients 
would be referred to the provincial hospital free of charge. Transactions were managed 
between the two hospitals in accordance with the UC regulations (interview D08). 
The financial arrangement for ART in Rayong was different from Phichit. In the provincial 
facility, it was the hospital's policy not to cross-subsidise therapy between health plans 
(interview S16 and S22). For the Social Security Scheme beneficiaries and government 
officials, therapy was delivered through the schemes' funding mechanisms. The drugs 
supplied by the national programme were dispensed only to the UC members and the 
uninsured. Interviewees argued that subsidising ART in the Social Security Scheme was 
fiscally feasible because the pool of over 100,000 Scheme's members registered at MOPH 
hospitals in this province was large enough to cover the costs. In Klaeng and Wang Chan, 
according to the agreement made between hospitals, all HIV patients on this plan were 
referred to receive ART and 01 drugs in the provincial hospital (interview D13 and D20). 
HIV nurses in these districts claimed that if they diverted the Social Security Scheme cases to 
the national initiative, the toll of the national programme's clients in their hospitals would 
increase to a certain extent. However, both hospitals insisted on reserving the national ART 
programme's resources for the UC beneficiaries and the uninsured. 
A common problem shared by study hospitals was that a lot of people residing in Rayong 
were migrants from other areas, thus were not eligible for the UC benefits offered in this 
province. Some were of Thai nationality, other were migrants from Cambodia and Myanmar 
and providing care was problematic (Disease Control Office for Health Region 3 2004a; 
2004c). In such cases, ART and 01 drugs were withheld. However, respective social workers 
and nurses claimed that, with their help, all Thai patients could overcome the complicated 
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bureaucratic processes48 to obtain the UC entitlement in Rayong, and access to ART and 
other HIV treatments (interview S16 and D20). For non-Thai citizens, an official resolution 
was enacted in 2004 that foreigner migrants were eligible to ART under the Access to Care 
Initiative (Disease Control Office for Health Region 3 2004a). While this could be seen as a 
strategy to boost the number of treatment enrolees, it was argued that the extension of therapy 
to this population was necessary for public health reasons because many of the migrants had 
sexual relations with or married Thais, and they were a potential source of HIV transmissions 
(interview R04). In interview, health providers emphasised that medication might help to 
encourage HIV screening and care seeking among these individuals. So from 2004, the 
Cambodian and Burmese labours were treatment eligible if they had permanent residence, 
essential for the complicated, life-time medications. Community leaders such as head of 
villages, teachers and monks helped to provide health workers with the information on 
foreign migrants' settlements. Despite the national ART programme resources sharing out, 
the Regional Disease Control Office stressed that Thais were priority for medication (Disease 
Control Office for Health Region 3 2004a). 
Another financing issue highlighted in both Phichit and Rayong was the impracticality of 
following guidelines on laboratory charges. The national ART programme did not cover 
laboratory assessment of CD4+ levels in the patients who had not met the enrolment criteria. 
PL WHA who received the tests for monitoring purposes prior to treatment instigation, and 
were found with CD4+ counts of higher than 200 cells per mm3 would be charged 200 baht 
per case (Ministry of Public Health 2001 b; 2002a; 2003b). Health workers claimed that the 
charge of this rate was unaffordable for many patients and might discourage them from 
visiting HIV clinics regularly (interview D02 and D07). Providers would miss opportunities 
to keep their clients' health status monitored and also to remind them about safe sex, self care, 
and other desirable practices. For these reasons, all study hospitals waived the laboratory 
charges, for the poor if not all cases, and subsidised them with other funds. 
7.6 The role of PLWHA in ART scaling up 
Following the national guidelines from 2002, PLWHA were recognised as partners in the 
service delivery (Ministry of Public Health 2002a; 2003b). The patterns of the non-state 
48 This administrative hurdle was diminished in 2004 when a computerised registration system had 
been established nationwide. 
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actors' involvement in Phichit's and Rayong's ART were similar. Health workers accepted 
that PLWHA significantly contributed to treatment provision (interview S04 and SI6). In all 
study hospitals where patient groups existed, the group leaders and staff were involved in 
offering essential information on the disease, 01 prevention and ART to members. An HIV 
patient argued that the activity was well-organised in Rayong provincial hospital as it was 
managed in planned sessions for clients at different stages of treatment (interview S24). In 
other settings, more casual mechanisms were deployed. For instance, in Phichit provincial 
hospital, messages were transferred through inter-personal or group conversations arranged 
while patients were waiting in front of the clinics before service time (interview S04). Apart 
from the information and education facets, monitoring and promoting adherence were other 
programme components in which PLWHA played a role (interview S04, 816,002,007 and 
020). For example, group leaders made home visits to observe drug-taking behaviour and 
provide psychological support. 
The PLWHA group management contributed to ART coverage and its quality in study 
settings in three aspects. First, the group leaders and staff facilitated the enrolment process as 
well as treatment adherence through discussions (interview S12, S24 and 011). The lay-
language used in the conversations was highlighted as a helpful element to encourage 
understanding (interview S16 and S23). New enrolees were, to some extent, informed about 
ARV-related issues at the time they started the medication. However, health providers felt 
that the patient groups' activity could not substitute for their counselling and other patient 
preparation procedures (interview 005, 007 and 009). A HIV specialist in Rayong revealed 
that in random checking, he detected occasional incorrect information provided in PL WHA-
organised education programmes (interview SI4). 
The second benefit was that patient groups' activities that included home visits were regarded 
as encouragement to keep patients adhering to treatment. Moreover, sharing of undesirable 
experience such as suffering from adverse drug reactions among ART clients and peer 
pressure were flagged as factors enhancing therapy adherence (interview S24 and 013). 
Given the workforce shortage and limitations of the bureaucratic system, the PL WHA groups 
were perceived to playa useful role. In some settings such as Thapkhlo, Klaeng and Wang 
Chan, ART service coordinators said that when patients failed to visit HIV clinics as 
scheduled, the group leaders were asked to follow up the missing cases (interview 007,013 
and 020). Furthermore, it was maintained that the home visits undertaken by lay people were 
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more appropriate than the providers since the latter's untimely or frequent visits to particular 
households would be recognised by the public which might break patients' confidentiality 
(interview S12 and D02). 
Finally, ART-experienced PLWHA in groups and individuals had a role in convincing the 
high risk and the infected persons, who had been reluctant to receive institutional care, to seek 
counselling and HIV testing (interview S12 and D09). This was because the significant 
improvement in health status of ART clients was observable and had the potential to motivate 
reluctant patients: 
'Neighbours frequently asked me how my illnesses were relieved - which kinds of 
medicines I took. They saw me getting healthier ... some of them had children or 
relatives who had the disease so they asked me for advice. They were afraid of 
visiting hospitals and seeing doctors. I told them not to worry... drugs were 
available and also we had organised as a group. It was better joining the group 
than staying desperately at home. '(interview D12) 
7.7 Summary 
This chapter suggests there was a gap between national ART policy intention and actual 
programme implementation in Phichit and Rayong, including missing provincial treatment 
targets and many discretionary practices. The disparities between policy expectation and 
reality were influenced by several factors, for example lack of accurate epidemiology 
information at local level, inadequate ART experience, administrative and management 
pressures from concomitant reforms in the health sector and public administration system, 
stigma against PL WHA and health seeking behaviour of HIV patients. 
Although both study provinces could not achieve the programme targets, the attempt made by 
sub-national health officials and health providers in integrating ART into the health delivery 
system resulted in substantial progress. As these front-line workers were motivated by clinical 
benefits of therapy, their prime concern was on service quality rather than merely meeting 
programme targets. Such interest concomitantly with treatment delivery constraints shaped 
the professional and management practice to certain extent, which varied from setting to 
setting. 
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In all district hospitals, single-handed nurses played a crucial role in service provision and 
management activities. In contrast, many more health workers were involved in provincial 
ART clinics. Despite the importance of health care staff in each setting, in this policy stage, 
there was network formation of regional and provincial MOPH offices, hospitals and civil 
society organisations including HIV NGOs and PL WHA groups as a key mechanism to deal 
with treatment impediments. As the two provinces differed in the strength and capability of 
local civil society organisations, the structure of treatment networks varied: while ART 
implementation in Rayong was encouraged by the pre-existing public-civic collaboration, 
scale-up of therapy in Phichit was enhanced through a newly-established network of MOPH 
hospitals and the Provincial Health Office. 
As argued by Marsh and Rhodes (1992), policy networks often function through resource 
sharing and collective action of network members. ART networks in two study provinces 
affected treatment integration through similar mechanisms: knowledge and experiences on 
ARV-based therapy of front-line actors were collaboratively utilised. The joint missions of 
these partnerships were facilitated by learning of both service providers and supporters, as 
well as the exchanges of information among them. Lessons drawn from research projects and 
NGO-organised services helped all members of the network to understand the crucial 
requirements of ART administration and how to assure therapy quality. In addition, transfer 
of clinical knowledge and skills from experts to general practitioners within and across 
settings and policy networks was beneficial to treatment expansion, especially in the areas 
with few HN specialists. Communicating with each other in training programmes and 
meetings to promote treatment scaling up might have been another channel for health care 
staff to exchange not only their ART experiences but also their perspectives towards the 
national programme ambition and administration. Sharing the opinions and feelings among 
treatment providers could have been an effective mechanism to cope with work-related stress 
including that stemmed from resource constraints and missing programme targets. 
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This thesis has aimed to understand the development of antiretroviral therapy (ART) policy in 
Thailand. Its objectives were to assess the roles of actors and context in agenda setting, policy 
formulation and implementation. The influence of networking and learning among policy 
participants on the policy processes was also examined. This chapter synthesises the overall 
findings and lessons concerning the introduction of antiretroviral (ARV) medication in this 
middle-income country. It also explores the strengths and drawbacks of public policy models 
employed to explain health policy development. 
8.1 Driving factors of the universal ART policy 
In Thailand, the human immune-deficiency virus (HIV) epidemic and its devastating effects 
including the growing burden of the disease on the health systems became obvious and 
recognised by policy makers from the early-1990s. However, although effective ARV-based 
therapy had been available and implemented in developed countries as well as in Brazil from 
1996, a nationwide programme to offer medication was not rolled out in Thailand until late-
2001. Like most resource-poor settings, a key impediment in therapy provision was the 
prohibitive drug costs. Thus, it is clear that the price reduction of ARVs owing to local 
generic production by the Government Pharmaceutical Organisation (GPO) was a crucial 
element of the policy shift. However, the availability of low-priced drugs could not have been 
the sole factor making ART universally available. Limited access to therapy in India and 
China - the countries with the capacity to manufacture many generic ARV s - supports this 
argument (WHO 2004a; 2004b). As suggested by the findings of this thesis, the Thai policy 
process that led to treatment scale up was facilitated through several, highly collaborative 
networks at national and provincial level, and through a policy learning environment. The 
agenda setting and policy adoption were also influenced by many contextual factors. 
8.1.1 Old and new policy networks 
Resembling the punctuated equilibrium model proposed by Baumgartner and Jones (1993), 
the dramatic po!icy change towards the universal treatment coverage developed after a decade 
of policy stability where the national treatment plan targeted only small fractions of the 
afflicted population. This study illustrates the transformation of policy networks from a 
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relatively narrow group that embraced bureaucrats and experts, to an expanded cluster of 
politicians, reformist bureaucrats, and civil society coalitions. During the policy continuity 
period of 1992 to 2000, the decisions in relation to treatment delivery in the public sector 
were dominated by officials in the Health Ministry's Disease Control Department, although 
HIV experts including researchers, clinicians and laboratory scientists had an increasing role 
when the national ART programme was replaced by a clinical trial network in 1996. By 
contrast, support for treatment extension in 2001 covered a much wider group of participants 
including the Health Minister, ART advocacy alliances, and bureaucrats responsible for the 
establishment of the Universal Health Coverage (UC) scheme. 
The civil society network comprising non-governmental organisations (NGOs), people living 
with HIV/AIDS (PLWHA), experts and other activists can be regarded as policy 
entrepreneurs who campaigned for improving ART access, and for assuring long-term service 
fmancing by including therapy in the UC plan. Employing several approaches, the coalition 
rapidly succeeded in raising the treatment scale-up issue on to the governmental agenda in the 
early 2001. It took a short time thereafter, a few months, for further policy development. 
However, without support from the Deputy Health Secretary Nitayarumphong, the policy 
might have evolved in different ways or at a slower pace. This senior official, who had long 
led the refonn of the health system, had good relationships with NGOs in the health sector, as 
discussed in chapter 5. At the same time, he was trusted by the Health Minister as can be 
seen in his appointment to lead the initiation of the UC plan, and then in his appointment in 
2003 as the first Secretary General of the National Health Security Office. However, although 
Nitayarumphong supported the NGOs' proposal to extend ART, initially he considered 
therapy should not be integrated into the UC benefit package since he felt that subsidising 
such high-cost medication might destabilise the emerging health scheme. 
8.1.2 The contextual elements 
The ART policy shift was affected by changes in the endogenous and exogenous factors in 
the health system context. The most obvious element encouraging ART policy adoption was 
the local capacity to produce generic ARVs. Another positive contextual factor was the 
relatively well-established health delivery infrastructure and management system throughout 
the country. Unlike many other countries in the South, Thailand did not face serious problems 
concerning service provision capacity. Despite no systematic assessment of the health 
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system's readiness to introduce ART nationwide, from the perspective of the Health Minister, 
health officials and NOO staff, any shortcomings and emerging requirements would be 
managed when the programme started. 
A non-health system factor that facilitated the policy change was the national political 
ideology. The universal ART policy was adopted in November 2001 - 10 months after the 
Thai Rak Thai Party cabinet took office in January. As the Health Minister argued in 
interview in 2003, the government's commitment to offer free ARV medication was in line 
with the UC plan - a major social policy pledged in the election campaign. Several populist 
programmes were instigated by this regime: the agrarian debt relief initiative, the village 
revolving fund programme, and the health benefit scheme (Phongpaichit and Baker 2004). So 
the extension of HIV treatment was not surprising in that all these projects shared one 
characteristic - large policy investments to meet with political party promises, people's 
expectations and to maintain popularity. 
Furthennore, the Thai ART policy innovation was encouraged by exogenous factors. In this 
study two fonns of international influence could be observed. First, as a member of the 
United Nations (UN) and other transnational organisations, the country took seriously its 
commitments to international agreements, treaties, and declarations decided by these 
authorities. Policy directions, technical guidance and best practice recommendations issued 
by such agencies therefore had legitimacy. Second, the infonnation about ART access and 
availability of cheap medicines elsewhere was intentionally conveyed to the government by 
treatment advocates and refonnist officials to make the policy change. It was possible that the 
infonnation also reached policy makers through other channels, for example via international 
meetings, personal communications and the media. Although there was no obligation 
imposed on the government, recognizing global efforts to facilitate treatment access might 
have inspired Thai politicians and bureaucrats to make ARVs more accessible among Thai 
PL WHA. From another angle, foreign experiences, especially the well-recognised Brazilian 
ART programme, as well as similar initiatives about to be established in many South 
American and African countries, might have pushed Thai policy makers to emulate such 
policies. For instance, a senior official admitted in interview that when NOO alliances 
campaigned for universal ART access in 2001, he infonned the Health Minister about 
treatment scaling up in other middle-income countries, and encouraged the Minister to extend 
the national programme by arguing that by not doing so, Thailand would lose its esteem in 
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the international HN arena. This can be explained by what Dolowitz and Marsh (1996:349) 
have observed: a policy implemented in other settings may be adopted 'if political actors 
perceive their country as falling behind its neighbours or competitors. ' As the country was 
lauded for its past success in HIV prevention, the perceived need among Thai policy makers 
to maintain international admiration was likely to have been a factor influencing policy 
development. 
8.1.3 How did the policy change?: the process 
Baumgartner and Jones (1993) argue that radical policy change takes place only when there is 
positive feed back in the policy subsystem, for example transformation of monopolistic policy 
networks as well as the image or deftnition given to particular proposals. In Thai ART policy, 
the shift from limited treatment programme to universally accessed medication was 
introduced by a new administration. The regime brought with it the ideology to offer 
equitable access to health care including medical services that allowed the entry of a new 
cluster of policy actors: the Health Minister, reformist bureaucrats and treatment advocates, 
all of whom shared some fundamental values in relation to equity in health. These 
participants replaced the pre-existing policy network monopolies - the Disease Control 
Department officials and HIV specialists - who had dominated the policy subsystem for a 
long period. The shared ideologies on equity and human rights among the new policy network 
members likely played a role in the policy innovation. Parallel to the actor network 
transformation, local manufacture of generic ARV products and drug price reduction resulted 
in changes in policy makers' perceptions about nationwide therapy, changing the image of the 
policy from one which was a hugely expensive service to one which was affordable. 
Kingdon (1984) explains the agenda setting process in different way, suggesting that a 
problematic issue can become agenda item at a critical moment when three independent 
streams of problems, solutions and politics come together, i.e. when particular conditions are 
recognised as problems; feasible policy solutions are available; and the political environment 
facilitates policy change. This study argues that in the Thai context, the agenda setting of the 
universal ART policy developed in the same vein. Although HIV-related problems had been 
considered signiftcant in the country since early 1990s, it was not until mid-2001 that ARV 
medication was expected to be affordable and therefore it was perceived to be feasible to 
deliver on a large scale. This window of opportunity arose when the new government came to 
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power, accompanied by substantial shifts in ideals and attitudes of politicians and bureaucrats 
involved in health policy making. The faU of drug prices as well as new groups of policy 
actors affected how nationwide ART provision was defined and interpreted. Campaigns 
organised by civil society organisations (CSOs) was political events, which also had a role in 
treatment extension. Not only was the HIV problem well recognised, but solutions to 
treatment of PL WHA became apparent, and the change in government facilitated political 
change. Furthermore, as Kingdon (1984) points out, issue defInition and policy entrepreneurs 
are two important factors in raising previously-neglected problems and corresponding 
policies on to the policy agenda. The issue was re-defmed as drug costs came down, and 
CSOs acted as entrepreneurs to accelerate change. 
It could be argued that the Thai government had anticipated the policy to offer universal 
coverage for ART before treatment advocates appealed for it, as evidenced from the request 
of the Health Minister to the GPO to speed up its research on ARV formulation as well as to 
extend the production capacity in early March 2001. However, without the civic movement, 
the government might have hesitated to hasten scaling up, especially when the UC 
bureaucrats argued that this would result in immense fmancial burden. 
The exact moment when the government began to pay serious attention to ART service is 
hard to identity. However, between March and November 2001 there were continuing 
interactions between the existing cluster of state actors and civil society alliances. Exchange 
of information drawn on treatment experience elsewhere furthered the penetration of the 
policy ideas within this informal, transient network. Assessing the benefits, political 
desirabilitY, threats and feasibility of the policy proposal in comparison to status quo, policy 
makers began to think the unthinkable: extending the national ART plan and including 
medication in the UC benefit package. 
8.1.4 Spill-over effects/policy momentum 
The rise of universal ART delivery issue on the government agenda and subsequent policy 
adoption were both a consequence of health care fInancing reforms and the launch of the DC 
plan, and were affected by those policies. Reforms had been developed and pushed by health 
officials and reformists in Thailand for more than three decades before being adopted by the 
Thai Rak Thai Party, and becoming the government's major policy in January 2001 
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(Jindawattana and Pipatrojkomol 2004). The ideology behind such policy was based on 
human rights notions, emphasising the rights to health through equitable access to essential 
health services (Leechanavanichphan 2004). The shared ideology of the UC scheme and 
universal access to ART - the two policies adopted almost in tandem - were reflected in 
many policy dialogues and statements made by NGOs and the Health Minister. 
It could be argued that the treatment policy development in Thailand during the one year of 
2001 resembled what Walker (1971) calls a momentum phenomenon. In his theory, Walker 
maintains that when there is a breakthrough in a policy domain previously neglected by the 
government, it is often followed by a surge of administrative or legislative policies in that 
domain which has persisted for a long time. An initial policy shift can have spill-over effects. 
This fits the introduction of the UC plan, followed by ART expansion. Two reasons for the 
spill-over effects can be applied to understand the mechanisms by which the consecutive 
policy shifts in the Thai health domain operated. First, exploration and consideration of the 
first issue (universal health coverage) make others (ART expansion) increasingly specified 
and well defined. Second, policy makers and interest groups working on similar problems see 
the opportunity to make themselves knowledgeable and ride on the wave of policy change 
(Nelson 1978). This study suggests an additional explanation: given that the ART policy 
proposal was deliberately labelled with the same ideology as the emerging UC scheme - one 
of the most popular policies at the time - it would have been difficult for the government to 
find a justifiable argument to reject the expansion of ART. As noted by Kingdon (1984), the 
success of policy entrepreneurs to promote spill-over in adjacent arenas can be enhanced by 
underlining similar analogy in legitimising their arguments. China offers a good illustration: 
reform of the country's disease control strategies and considerable change in AIDS policy in 
2003, could be regarded as a response to the outbreak of severe acute respiratory syndrome 
(SARS) earlier in the same year (Zhang 2004). 
8.2 Devising the nationwide ART programme 
Since ART service coverage in Thailand before 2001 was limited to small numbers of the 
population in need, national-scale treatment provision inevitably required modification and 
preparation in the central departments, sub-national health offices and health delivery 
facilities, all of which demanded the reformulation of the national programme's strategies. 
Addressing the question on how such a policy process operated, this study suggests a new 
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network of policy actors, the importance of policy learning, and imbalance of power among 
programme formulators. 
8.2.1 Policy formulation network 
A small group of actors involved in the decisions to adopt universal ART policy had a 
considerable role in policy formulation. The involvement of these participants became official 
as they were appointed by the Health Ministry to sit on Advisory Committee and Technical 
Panels. Joining with public servants from the Disease Control Department, clinicians, 
researchers and scientists in the HN field who were also assigned to work out the national 
programme's blue print, this group of policy actors characterised a policy network as defined 
by Marsh and Rhodes (1992). This policy formulation network had restricted membership 
and tight integration characteristics such as frequent meetings and sharing core values and 
interests: not only to improve equitable access to ARV medication but also to assure service 
quality. However, the stability of the network lasted over a short period, one year only. 
While members of this policy network were interdependent, each possessed different 
resources essential to formulate new strategies for ART provision. These included the 
technical expertise of HIV clinicians and laboratory scientists, administrative skills of health 
officials, and implementation experience of CSOs. As Rhodes (1988) argues, members of a 
policy network may enhance the capacity to pursue their pet proposals as well as their 
interests by sharing resources with others. In the absence of support from experts and NGOs, 
the Health Ministry bureaucrats might have foreseen difficulties in both policy formulation 
and programme implementation. At the same time, the opportunity to connect academic 
works such as research results with national policies and subsequent action could have been 
an incentive to specialists to participate in the policy process. For treatment advocacy 
members, partnership with government agencies and HN experts provided them with a 
chance to influence policy, gain more technical knowledge, and also legitimise their future 
activities. 
The features of the dominant policy network in this stage resemble what Howlett and Ramesh 
(2003: 148) have observed: the policy subsystem in which a policy is formulated, which is 
relatively closed, allowing only relevant actors with some minimal knowledge and 
experiences in the subject area to participate. This is because these actors are required to 
- 194-
CHAPTER 8: DISCUSSION AND CONCLUSIONS 
search for policy prototypes, consider and make comments on the feasibility, outcomes, and 
consequences of different policy options. Networks also provide a channel for policy transfer 
and lesson drawing (Stone 1999). Findings of this thesis suggest that information and 
experience exchange among the various Panels' members facilitated treatment programme 
reform, to the benefit of people who needed medication which was a common interest of the 
policy network members - that is, learning among network members played an important role 
in this phase. 
8.2.2 Role of policy learning in policy formulation 
Policy learning in the universal ART policy occurred at all stage of the policy process: agenda 
setting, policy adoption and formulation. The inspiration to get more PL WHA on therapy, as 
well as the discussion about feasibility and affordability of scaling up the service were in 
major part encouraged by the information circulated in the international health community. In 
the programme reformulation, members of the four Advisory Panels continued to learn and 
draw lessons about ART in several respects. 
Policy transfer models argue that the motivating factor of policy learning or voluntary policy 
transfer is the policy makers' demand for effective solutions to particular problems (Dolowitz 
and Marsh 1996; Rose 1993). To obtain such remedies, individuals and groups search for 
policy ideas or programmes established in other countries, or experiences in their own 
settings. The Ministry of Public Health (MOPH) appointed Advisory Panels comprising 
members with relevant expertise and experience to carry out the task of expanding access to 
ART. Instead of spending resources and time on conducting research to identify the most 
appropriate practices and instruments, these Panels' members devised the programme's 
features by drawing lessons from different sources, including their own experiences and some 
Thai researches. It was the expertise and experience of these actors that led to the 
examination of several policy choices in order to develop solutions pertinent to problems 
faced in the Thai context (Considine 2005). 
This study points to the many lessons drawn from domestic experience, which played a 
crucial role in the policy design. As seen in chapter 5, learning about the success and 
obstacles in earlier phases of ART provision, through public and NGO's initiatives, was 
highlighted by interviewees and also illustrated in the Panels' minutes. Such feedback was 
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prepared in the fonn of meeting documents, and then fed into the discussions by the Panel 
secretariat and, in some instance, by some members assigned by chairperson. Moreover, in 
the meetings, participants developed arguments on the basis of their direct experiences as 
treatment providers, administrators or service clients. Other than the programmes' feedback, 
findings from locally-conducted clinical trials of the first-line regimen - OPO-Vir, as well as 
other treatment protocols were raised to consideration by the Panels. 
While domestic policy learning had an important role in devising the national treatment 
programme configuration, foreign country experiences in ART service strategies were neither 
mentioned by key infonnants nor recorded in the Advisory Panels' minutes. Although policy 
transfer from abroad is difficult to trace in non-coercive cases where policy makers in 
importing countries have the liberty to adopt and adapt policies from elsewhere, it is highly 
likely that exogenous infonnation on treatment provision and programme management, either 
from the forerunners, CSOs, or international agencies, affected the decisions regarding the 
Thai ART initiative. As the Thai policy development took place while ART access in 
developing countries was strongly promoted at the global level, research results, evidence and 
other types of infonnation about what worked and what didn't in foreign settings were 
reaching and affecting Thai experts, NOOs, and health officials, all of whom had been 
interested in such issues. Training programmes, conferences, meetings, visits, collaborative 
projects and personal communications were all vehicles by which Thai policy participants 
were exposed to international lessons. 
8.2.3 Imbalance of power 
Although the universal ART programme fonnulators shared a common goal, and all 
participants actively contributed to accomplish the tasks as commissioned by the Health 
Ministry, on many occasions the Deputy Health Secretary and officials in the Disease Control 
Department dominated the policy process. On the whole, government actors controlled the 
Panels' agendas, directed the meetings or even furthered their proposals directly to the 
authorities, bypassing the discussions within the Panels. Despite the fact that, as some 
observe, the tenn 'network' refers to non-hierarchical relationships between individuals 
and/or organisations (Considine 2005), some imbalance of power among policy network 
members is not unusual. Marsh and Rhodes (1992) suggest that unequal resources and powers 
among members can be found in most policy networks. Public policy scholars have pointed 
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out that power and influence is distributed unevenly in the policy subsystems, even in tightly-
integrated networks defmed as policy communities, and that the concentration of supremacy 
in policy making is found more often in state actors than other interests (Marsh 1998a; Read 
1992). 'Governments can seize power over established institutions such as policy 
communities and networks. ' (Richardson 2000: 1009). 
However, while civil servants dominated the policy process, NOO leaders revealed that they 
felt that health officials 'knew best' about issues such as those on public programme 
administration. This indicates that the unequal information and experiences possessed by the 
two parties was a source of power differences. As Hill (1992:1-11 quoted in Howlett and 
Ramesh 2003:69) has suggested, expertise and access to knowledge and information in 
particular areas of specialisation are among policy resources commanded by technocrats and 
professionals. In ART programme renovation, the bureaucrats' influence over NOO 
representatives and scientists also had different roots. For instance, the Deputy Health 
Secretary who chaired the Panel on treatment programme management had long been 
recognised as a dedicated health system reformist. Cooperating with him in other areas of 
public health, HN NOOs had developed a sense of respect and trust for this official. This 
may have emanated from what could have been seen as the authority reflected in an 
individuals' charismatic personality (Weber 1949, quoted in Hudson and Lowe 2004:195). It 
can be speculated that owing to the influence of the Deputy Health Secretary, he was able to 
lead Panel meetings and apparently, also keep the issue of ART finance off the Panel's 
agenda without significant challenges from the treatment advocacy alliance. This was in spite 
of the fact that the alliance had strongly-promoted the proposal for including ART in the 
benefit package in the agenda-setting and policy adoption phases. 
8.2.4 Factors facilitating policy formulation 
Although the Advisory Committee and four Panels worked over only one year of 2002, these 
groups of actors made considerable changes in the National ART Programme strategy. This 
indicated a low level of conflict among policy formulators, which was unusual for 
participants with different backgrounds. Apart from the personality of the Deputy Health 
Secretary, the consensual, rapid policy development process might have been based on three 
interconnected elements: common interests; the sense of interdependency; and shared 
experiences among network members. First, the Health Ministry appointed only selected 
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individuals or groups who had similar attitudes to sit on the Panels in order to smooth the 
decision processes and therefore rapidly work out the programme configuration. Having 
worked and learned lessons together, the panel members had developed similar preferences 
towards the urgent needs for solutions and strategies. Second, one of the lessons these state-
and non-state actors might have learned interaction was that they were interdependent: neither 
MOPH, specialists, nor NGOs alone could move universal ART coverage forward in the 
absence of support from the others. And third, in addition to the direct experiences in 
treatment implementation of Panel members, the availability of research on the national ART 
initiative, feedback from treatment programme evaluation, and documented lessons on NGO-
organised service could also have facilitated policy learning and therefore policy formulation. 
8.3 Implementing universal ART policy 
With regard to the policy implementation stage, this study does not examine the programme's 
effectiveness, but analyses the factors influencing ART expansion at the provincial and 
district level. 
8.3.1 Policy implementation network 
Howlett and Ramesh (2003) point out that clusters of participants who form into networks to 
pursue their interests, can be found in every policy stage including policy execution. While 
most top-down and bottom-up theorists emphasise the interactions between government 
actors, employing the policy networks concept in this thesis helps to explain the involvement 
of non-state participants in the integration of ART into the health delivery system. In the 
study settings, policy implementation networks were dominated by bureaucrats: 
administrators and health professionals in provincial and district hospitals, who were in direct 
contact with HN-positive patients. But, in addition to creating relationships with health 
workers in other settings, these front-line bureaucrats interacted with regional and provincial 
health officials, as well as CSOs like PL WHA groups and NGOs. 
Despite sharing some characteristics, there were differences between the networks in the two 
study provinces. In both areas, the Regional Disease Control Offices and Provincial Health 
Offices provided technical and management support essential to ART provision in hospitals. 
These MOPH sub-national agencies also operated as mediators for policy communication and 
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feed back between national policy makers and the implementation units. The relationships 
between the MOPH organisations at different levels were set along the command and 
supervision lines of the public administration system. Another common feature of treatment 
implementation networks was that all patient groups were initiated and managed by hospital 
staff. 
However, the two provinces also differed. While close collaboration of providers at 
provincial and district levels was formally established in Phichit, hospital-civil society 
partnerships in Rayong seemed to be more influential than its Phi chit counterpart. 
Furthermore, to carry out some activities such as public relations about treatment availability 
and case finding, health workers sought cooperation with local organisations such as 
provincial government offices of other ministries, local administrative authorities and also 
community leaders. These partnerships developed intermittently and were contingent on 
particular settings. 
The collaboration of state- and non-state actors in ART policy execution was largely 
conditioned by the need to exchange resources among members of the networks. Obviously, 
the MOPH's hospitals had a mandate to offer medication and related care to significant 
numbers of HIV -infected patients. However, as the service was so complicated, in order to 
achieve the targets and to assure quality at the same time, the providers needed assistance 
from other public agencies and CSOs. Another reason for networking on the supply side was 
to overcome implementation constraints, as will be discussed further. Meanwhile, getting 
more PL WHA on therapy was the shared interest of NGOs, patients themselves, communities 
and the health professionals. Therefore, it could be expected that the network would benefit 
all parties involved in the treatment introduction. 
8.3.2 ART delivery constraints, discretion and context 
Although planned preparation of the health delivery system was introduced at the national 
and sub-national level alongside the ART programme scale up, many obstacles were stated by 
health providers as impeding treatment targets, and ensuring quality of care. The lack of 
reliable HIV registration, complexities of therapy, inadequately experienced staff in district 
hospitals, increasing burdens of concomitant reforms and so on were reportedly afflicting 
medication delivery. Insufficient staff may affect treatment service in different ways. In 
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addition, the additional burdens of ART introduction on health care providers would increase 
over time, since therapy improves patient survival. Experiences in Thailand and elsewhere 
suggest that long-term caring of PL WHA accompanied by high workload may cause anxiety, 
stress and burnout49 among health workers (Visintini et al. 1996; WHO-SEARO 2005). These 
psychological conditions tend to develop alongside the growing number of patients on ART 
in study context, especially in district hospitals where a single nurse ran a HIV clinic and 
prescribed medication. In fact, administrators of some settings such as Sam Ngam district 
hospital predicted such impediments, but nevertheless signed up to the national initiative 
because of the perceived pressure from Provincial Health Office and forerunner participating 
hospitals. 
To address these problems, health facilities generated different coping measures, as seen in 
chapter 7. Similar situations have been reported in other resource-poor countries, where 
health providers experience constraints to ART scale up. Example of coping solutions include 
networking with NGOs and other support groups outside the health systems, encouraging 
home-based and community-based service delivery, and introducing simplified therapy 
approaches which allow nurses and other paramedics to substitute for medical doctors 
(UNAIDS 2003c; Wendo 2005). When front-line civil servants face implementation 
constraints, ambiguous policy content, uncertainty of work environment, or work-related 
hazards, they invent several mechanisms to counter such problems (Lipsky 1980). The 
practice of government workers who directly contact with clients and beneficiaries of a public 
programme may thus deviate from the expectation of national-level policy makers. However, 
this operational discretion becomes routinised and maintained in the policy enacting units. 
Example "can be drawn on how treatment providers discretely responded to the unclear 
elements of the national ART programme. As it had not been spelled out which groups of 
patients were entitled to the service according to their health benefit plans, different 
arrangements were introduced in study hospitals: while ART in Phichit was offered to all 
clinically eligible PL WHA, in Rayong medication subsidised through the national programme 
was provided only to VC members and the uninsured (chapter 7). 
49 Burnout syndrome is defined as a loss of motivation in work, response to excessive engagement, 
dissatisfaction, psychological withdrawal interest and emotional exhaustion (Cherniss 1980 quoted in 
Visintini et al 1996: 184). 
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This thesis demonstrates that the implementation constraints and coping mechanisms in 
certain hospitals were understood in general, but were also context driven. Responses to the 
universal ART policy involved other government policies: the reforms of health financing 
and public administration system, which worsened the existing district-level workforce 
shortages among other things. However, many factors and their implications for discretionary 
practices were province-specific. An illustration can be drawn on the case of Rayong where 
the existence of a large business sector made it feasible not to provide the Social Security 
Scheme members with drugs from the national ART programme. Other factors that related to 
the particular context included the burden of HIV in comparison to other diseases; 
experiences on treatment delivery; distance between hospitals to regional laboratory; 
relationships with NGOs and surrounding communities. All these factors affected the 
decision to sign up to the initiative, allocate health personnel, and organise the service and 
related logistics. 
8.3.3 Policy learning in the implementation stage 
ART programme instigation in many countries suggests the need for capacity building and 
skill development of health workers. The literature shows that individual and organisational 
experiences on the supply side have a substantial role in assuring desirable professional 
practice and clinical outcomes (Dudley et al. 2000; Kitahata et al. 1996; Laine et al. 1998). 
The importance of substantive learning - the process by which policy actors draw lessons 
from education, observation, analysis and practice (Peterson 1997) - was observed in all 
study hospitals. This was reflected in the interviews with health workers as they discussed the 
benefits from training workshops organised by Regional Disease Control Offices; training 
programmes for new cohorts of health workers in Phichit province; training courses for 
specialists in Medicine, Infectious Diseases and Paediatric; consultation with HIV experts 
within and outside hospitals; as well as experiences on treatment delivery as part of research 
projects, Disease Control Department's earlier initiatives, and programmes previously run by 
NGOs. 
Findings of this research indicate that health professionals in study settings learned to devise 
coping strategies since they were motivated not only to achieve the national programme 
targets, but also to meet their goal: offering therapy of high quality. Knowledge about coping 
with ART service delivery - the intervention new to the hospitals and most health care 
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workers - was sought in several ways. In addition to the clinical and programme 
administration guidelines from the Health Ministry, the service providers searched for 
additional information from different sources. For instance, a HIV nurse in Thapkhlo, who 
missed the Regional Disease Control Office's training course, reported self-learning from 
textbooks and other documents, as well as from discussions with pharmacists and even 
PL WHA group leaders. Meanwhile, a doctor in Rayong provincial hospital asked for advice 
on complicated case management from HIV specialists in adjacent province of Chonburi. 
However, policy learning also has another critical role in converting policy prescriptions into 
action. According to Schofield (2004)'s model oflearned implementation, to meet new policy 
goals, street-level bureaucrats seek to obtain necessary information to guide policy execution 
as well as draw lessons from several sources. Through the learning process, there are 2 
categories of knowledge acquired by these service providers: technical and procedural 
(chapter 3). The learned implementation model suggests that procedural knowledge has an 
important role in adapting and utilising technical information, by increasing skills and 
capabilities of front-line workers to deal with impediments. This thesis argues for the 
existence and usefulness of knowledge of both types in ART scaling up. Apart from 
commanding clinical knowledge necessary for treatment administration, hospital directors 
and staff in study provinces possessed the capacity to adapt the undesirable work conditions 
that afflicted programme achievement. The self-learning of the Thapkhlo nurse and expert 
consultation by the Rayong doctor earlier mentioned in this section offer illustrations of how 
these health workers gained technical knowledge on ART administration. In contrast, lesson 
drawing on adherence promotion among health professionals in Phichit provincial hospital, 
who had participated in Clinical Research Project, could be regarded as generative learning, 
since their skills to promote patients' adherence were developed on past practices. 
Learning for policy implementation, as Schofield (2004) points out, is provoked by many 
elements. Collaboration between hospitals in Phichit offers an example as it aimed to 
facilitate the learning process through the transfer of knowledge and experiences from 
provincial experts to district-level practitioners. Other ways learning was facilitated were 
found in this study: the past experiences on ART administration and other HIV service 
provision; teamwork of health personnel in the same hospitals; support from respective 
regional and provincial offices in organising treatment networks and training courses; 
partnerships with NOOs; and accessibility to relevant information. These learning approaches 
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can be viewed as the function of policy networks by which the resources, i.e. knowledge and 
infonnation, were shared and exchanged among implementation agents. As argued by 
Schofield (2004), when service providers discover the strategies to operationalise new policy 
prescriptions, they do not hesitate to share such knowledge with others in their fonnal and 
infonnal networks - the so-called 'communities of policy learning and practice'. In Phi chit 
and Rayong, sharing lessons in relation to ART provision might have taken place in several 
occasions: for example, discussions and presentation in fonnal meetings and conferences, 
training programmes, circulation of provincial or hospital treatment guidelines, and personal 
communication. It is suggested that collective learning among service providers as members 
of policy learning networks can encourage and steer a policy through to implementation 
(Schofield 2004). 
Based on the fact that during 2002 to 2004 all study settings took part in the national ART 
programme and offered therapy to HIV patients, this thesis maintains that certain extent of 
policy learning happened among health providers and hospital administrators. However, 
different paces of learning could be anticipated. Learning in Sam Ngam and Thapkhlo 
hospitals tended to be relatively slow, as it was hindered by the lack of ART experience, 
accompanied by recent changes in HIV clinic staff, and rapid turnover of GPs (Thapkho), 
especially when they first participated in the treatment programme in 2002-2003. In contrast, 
lesson drawing to enact treatment extension in Phichit and Rayong provincial hospitals and 
Klaeng hospital was likely to develop rapidly. This was because these settings had offered 
ART through clinical trial projects and/or NGO-organised service before the national 
programme scale up. The knowledge obtained and skills developed in the previous-phase 
treatment 'were compiled in the organisations owing to the continuity of health workers 
involved in HIV care. Although some doctors recently moved to Phichit and Rayong 
provincial hospitals, they had exposed to HIV cases while there were on specialist training. 
This study also shows that policy learning among ART providers and its results, i.e. the 
invention of task completion strategies, was not only influenced by contextual elements 
including the existence of learning facilitators as above mentioned, but actors themselves 
were also crucial in the process. Despite the central department's pressure on sub-national 
offices and health facilities to meet the programme's targets, health officials, hospital 
administrators and HIV clinic staff asserted that many of their discretionary practices and 
coping strategies aimed to avoid the adverse effects of the service on enrolees and the public. 
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For instance, although a 200-baht charge was recommended in the programme management 
guidelines, all study hospitals offered free CD4+ cell assessment to PL WHA in order to 
encourage them to visit hospitals for regular follow-up. The response of the Thai health 
professionals to ART expansion is typical of the features of street-level policy inventions, 
bound to professional norms and codes of conduct, and accountable to their bureaucratic and 
personal responsibilities (Lipsky 1980; Schofield 2004). 
8.4 Potential negative outcomes of the universal treatment policy 
This thesis illustrates a satisfactorily picture of ART service in study hospitals: good attitudes 
and strong devotion of health care providers, as well as acceptable adherence, small default 
fractions, and improved quality of life among treatment enrolees. However, according to the 
existing literature, both implementation constraints and coping mechanisms invented by 
front-line civil servants may have negative implications. As Lipsky (1980:xii) suggests, in the 
worst cases, street-level bureaucrats adopt discrimination in service provision against selected 
populations: .... they give in to favouritism, stereotyping, and routinising - all of which serve 
private or agency purpose. ' In similar ways, health workers' interventions and discretionary 
behaviour in HIV care may result in unwanted effects. Poor attitudes including fear of 
occupational infections amongst health care staff and associated stigma and discrimination 
practice against HIV patients have been documented in many developed and developing 
countries (Foreman, Lyra, and Brienbauer 2003; Hsiung et al. 2001; Kermode et al. 2005). 
Also, substitution of physicians by nurses and other paramedics in ART prescription and 
monitoring could potentially impose clinical risks as studies in industrialised societies show 
that service quality and survival time of treated patients are significantly associated with 
expertise and experience of clinicians (Dudley et al. 2000; Kitahata et al. 1996; Laine et al. 
1998). 
In addition, studies on treatment extension in other Thai settings in the same period have 
suggested some sorts of poor performance such as inadequate adherence to therapy. For 
instance, Punpanich et al (2005) found that among 1,137 ART enrolees in 12 provinces, 4% 
missed at least one dose of ARVs in the last five days, and 15% had ever failed to take 
medicines on time. Regarding discrimination in health facilities, other systematic studies 
suggest the existence of poor-quality and delayed treatment delivered by Thai health 
professionals to some patients on the ground of their HIV status (Seale 2004; Stringer et al. 
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1999). Therefore, similar practices among ART providers in Phichit and Rayong cannot be 
ruled out, although such action was not captured in this thesis. 
There are three possible explanations for the underestimated problems in study provinces. 
First, during field work, the programme was in its early phase of scaling up, thus the 
undesirable effects might not have happened, or been perceived by interviewees. Second, 
without a proper study design, it is difficult to examine the causes of poor therapeutic 
outcomes and other unwanted effects, as they could be resulted from many factors. For 
instance, there were a number of deaths among patients on ART in all study hospitals, which 
might be owing to the lack of GPs' competency, nurse prescribing, insufficient information 
provided by pharmacists and counsellors, or inadequate adherence to medication and late care 
seeking of the HIV -positive individuals. The third reason involves methodological 
limitations: this part of research was based only on interview data, and triangulation between 
sources of information could not be carried out since the results of programme evaluation and 
research on ART extension in study settings were not available (see chapter 3). As most of 
the key informants were health workers, they tended not to criticise their own practices, or 
reveal their unacceptable behaviour, especially stigmatising and discriminating HIV -infected 
persons. It was also possible that PL WHA interviewed in this study dare not make frank 
comments on their service providers. However, based on empirical evidence in some study 
hospitals, for example, inaccurate information provided by PL WHA to treatment enrolees, 
and poor prescribing by inexperienced doctors, it can be anticipated that treatment quality in 
these settings may be undermined in the long run. 
8.5 Weaving the web: policy learning network 
Exploring the changes in Thailand's national ART initiative, this thesis has illustrated that 
throughout the past decade, the policy development processes were intricate and dynamic, 
governed by two integral elements: policy networks and policy learning. This section 
suggests that, in the period and context described, there were policy learning networks, and 
that treatment programme evolution was a consequence of collective learning among several 
actors as network members. 
It was the collective process of learning of policy makers, health officials, professionals, 
experts and CSOs that, in considerable part, triggered treatment extension and made such 
- 205-
CHAPTER 8: DISCUSSION AND CONCLUSIONS 
inspiration possible, by guiding the policy fonnulation as well as leading the service 
provision at the frontline. In fact, the use of knowledge and scientific evidence to infonn 
policy had been traditional, integrated in Thailand's health systems for a long time prior to 
the 2001 policy shift. Research in different disciplines of basic sciences, biomedicine, 
epidemiology, and social sciences conducted in the country were influential in many respects. 
The case of ART policy was merely one illustration afflnning the existence of a strong 
applied research environment and links to policy. 
It has been argued that owing to the research & development capacity of the government 
laboratory - ARV prices - the major barrier to therapy substantially declined. The strength of 
local generic production was complemented by clinical trials conducted by Thai experts, 
which provide the infonnation on the effectiveness and safety of several ARV regimens and 
alternative medicines. The drug testing involved not only specialists and academics but also 
health personnel in the MOPH's sub-national offices as well as health providers in district 
and provincial hospitals. Knowledge and infonnation emerging from domestic research 
greatly contributed to policy decisions and programme feasibility. Moreover, clinical and 
management experiences of health professionals obtained through taking part in study 
projects were reported in interviews as invaluable in getting policy into action. 
In collaboration with experts in academic institutes, officials in the Health Ministry usually 
integrated research into the process of programme development. The start-up of mother-to-
child HN transmission prevention in the late-1990s offers a good example. Based on a 
clinical study in the country between 1996 and 1998 which demonstrated the efficacy of 
short-course zidovudine and breast-milk substitutes in reducing perinatal infections, the 
MOPH organised operational research to assess how such interventions would work when 
delivered in a pilot programme in 1997 before scaling up nationwide in 2000 (Kanshana and 
Simonds 2002; Thaineua et al. 1998). In the same vein, when the clinical benefits of highly 
active antiretroviral therapy were proved in the developed world during the late 1990s, 
medication was provided in some hospitals through a small initiative - known as the Access 
to Care Plan, which it was intended to extend further gradually. These two HIV programmes 
demonstrate how knowledge was generated and used in policy development. Feedback from 
these operational studies encouraged policy learning among policy makers, fonnulators and 
implementers. Some have pointed out that this is a key feature and a factor of success in the 
country's HIV control policy: 
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'Rather than first drafting a comprehensive policy and then designing programmes 
accordingly, Thailand built large part of its national programme on the 
groundwork and experiences of a series of early, often province-wide initiatives. 
These were monitored and assessed, and provided relatively quick proof to policy 
makers that solutions were available. They also provided early lessons for adapting 
and improving programmes. Policies could therefore incorporate or draw on this 
accrual of learning and adaptation. ' (UNDP-Thailand 2004:31) 
By this, it does not mean that research findings and other types of scientific evidence from 
foreign settings were less important than those of domestic origins, but the existence of a 
lively research community was extremely important. 
The above discussion on policy learning networks is confined to those operating in the public 
sector. Actually, the web of actors keen to use knowledge and evidence to influence ART 
policy covered a greater range. Chapter 4 illustrates, for instance, the relationships and 
collective learning of NGOs, PL WHA, specialists, academics, lawyers, scientists of the 
government laboratory, and international AIDS relief organisations who fought against a 
trans-national company in the didanosine case. Chapter 6 portrays the partnerships of experts, 
national-local NGOs, PL WHA alliance, and health providers involved in many activities 
including in carrying out research, as well as delivering therapy such as the organisation of 
the Buyers' Club. Furthermore, some NGOs like MSF cooperated with the Health Ministry 
hospitals in doing studies on treatment regimens and patients' adherence (Frederix et al. 
2004; Petdachai and Wilson 2005). Given that these networks had existed before the 
universal ART policy adoption, and their members overlapped with those of the policy 
formulation community seen in chapter 5, it cannot be denied that the national policies were 
also influenced by actors outside the MOPH's Advisory Panels, through the transferring of 
knowledge and experiences from antecedent learning clusters. 
In addition to the complex feature of ART policy learning networks, the interrelations 
between these participants and their influence changed over time. The period of policy 
evolution saw the rise and fall of particular learning agents at the core and distant zones of the 
policy subsystem. For instance, those NGOs and PLWHA groups that previously focused 
their attention on ART provision through the Buyers' Clubs and had a minor role in the 
national policy decisions gradually moved closer to the centre of the policy-making stage 
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from early 2001, and continued their involvement in devising the universal treatment 
initiative until late 2002. State actors like the Disease Control Department officials also 
shifted within the learning network. They dominated ART policy decisions throughout the 
1990s, then their leading role was taken over by reformists who set up the UC plan in 2001. 
They eventually returned to central sphere of the subsystem where they regained their policy-
driving power from 2002 as they were appointed as members of the Health Ministry's 
Advisory Committee on ART Expansion. 
8.6 Policy learning environment 
The development of policy learning networks and their roles in the national ART policy were 
moulded by many contextual factors. One clear factor was the overall health environment 
which encouraged the use of evidence and knowledge to inform policy. It can be argued that 
in addition to the well-educated personnel and adequate financial resources, this was the 
legacy of a group of intellectual leaders in the Health Ministry and medical schools in the 
1970s that contributed notably to knowledge generation and utilisation in policy making (see 
chapter 2). The roles of research in the health system have been increasingly crucial, 
particularly in late 1990s when Prawase Wasi - a Professor of Medicine and well-respected 
reformist - suggested the integration of 3 elements: knowledge management, social 
mobilisation and political movement into a framework to drive health system reforms - the 
so-called Triangle that Moves the Mountain (Wasi 2000). This framework reflects the 
viewpoint that not only knowledge but also networks of social and political actors are key 
elements to policy change. 
The introduction of health care financing reform and the Universal Health Coverage Scheme 
in 2001 is a good illustration of knowledge-based policy that incorporates civil society and 
political involvement. Some suggest that the remarkable progress of such reforms can be 
attributed to local health system research capacity, which generated information to identify 
the weaknesses of the existing health plans and estimated resources needed for the new 
fmancing mechanisms as well as potential outcomes of different policy alternatives 
(Tangcharoensathien, Wibulpolprasert, and Nitayarampong 2004). Others emphasise the 
credibility of research and close connections between research communities, NGOs and 
policy makers as key factors encouraging research-policy integration (Alliance for Health 
Policy and Systems Research 2004; Mills 2004). Mills (2004) suggests that both research 
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capacity and good relationships including 'trust' between Thai researchers, refonnists and 
policy makers required long-tenn development. It certainly can be argued that these factors 
had been fostered systematically in the health systems by responsible organisations. For 
instance, since the Health Systems Research Institute (HSRI) was instigated as a research-
granting agency under the MOPH in 1992, one of its mandates was to facilitate health system 
refonns (Ministry of Public Health 2004b). In addition to commissioning studies, this 
Institute fonned networks with regional universities and set up many affiliated organisations 
including a programme to strengthen research capacity in related areas such as health 
economics, financing, human resources and policy analysis (International Health Policy 
Program 2003; Phoolcharoen 2002b). Research fellows in this programme were exposed to 
national-level policy making and contact with politicians and bureaucrats in order to 
understand how policies were made and what evidence was required. Introducing the 
Triangle that Moves the Mountain concept, the HSRI also held a series of consultations to 
consolidate stakeholders' opinions and mobilise people's participation as a vital part of the 
refonn process. Major issues on the HSRI's agenda included not only research to improve the 
health system's efficiency, equity and responsiveness, but also research to promote civil 
society mobilisation and empowennent (PhooIcharoen 2002a). This Institute involved policy 
makers from the initial phase of setting the research agenda to the use of research findings in 
policy fonnulation and implementation (Grant et aI. 1998; Green 2000). 
An important feature of the network for health system research in Thailand is that it involves 
researchers, experts and practitioners at all levels. Capacity strengthening programmes were 
established by many Health Ministry's departments to produce researchers with different 
expertise .. An example can be drawn from the Field Epidemiology Training Programme. 
Organised by the Bureau of Epidemiology in collaboration with the US Centre for Disease 
Control and Prevention in 1980, this training course provided health workers from all regions 
with knowledge and skills on disease investigation and surveillance (Laosiritaworn and 
Jirapongsa 2004). The Epidemiology Bureau also had a programme to support local analysis 
of surveillance data in order to infonn provincial planning and health programme evaluation 
(Thanaisawanyankoon and Sangwanloy 2005). The strength of Thailand's disease 
investigation and monitoring system as well as its contribution to the country's policy 
development is reflected in the case of HIV / AIDS control. 
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Academic institutes in Bangkok and up-country had an important role in conducting studies 
and building research capacity for the health workforce at sub-national level. The Health 
Ministry allocated annual budgets to support research projects run by its staff. Findings of 
these studies have been presented in meetings, published in journals, and disseminated 
through organisations' websites. Many studies have been accepted by international journals 
and conferences. For example, at the 2005 International Congress on AIDS in Asia and the 
Pacific, 37 studies conducted by health workers in MOPH's sub-national offices and 
hospitals 50 were presented (AIDS Society of Asia and the Pacific 2005). In addition to 
conducting research in their responsible areas, large numbers of the workforce took part in 
pilot programme assessments, routine programme monitoring and evaluation, as well as 
regular epidemiological and health-related behaviour surveillance (Poshyachinda and 
Danthamrongkul 1999). Experience on data collection, management and analysis acquired by 
these health personnel was highly likely to have been helpful in systematically drawing 
lessons from their own work. 
As a member of global health community, Thailand also gained knowledge to improve its 
health systems by learning from foreign experiences. The Thai Government and private 
organisations offered scholarships for Thai students to study in developed countries. Some 
scholarships and training opportunities were arranged under collaborative programmes jointly 
organised by the MOPH and international academic institutes. Green (2000) observes that 
some researchers and reformists who played important roles in driving health system reform 
in the 1990s maintained the connection with their post-graduate schools, mostly in Belgium, 
the Netherlands and the UK, in order to draw technical support to next-generation research 
fellows. Furthermore, Thai health officials have had many opportunities to engage with heads 
of states, health ministers, experts, programme managers and NGO representatives from 
different countries as part of international networks - at conferences and meetings. In 
addition to formal education and training programmes abroad, health officials and health 
workers had access to information on health systems and policies in different countries 
through many channels. These included worldwide media such as the Internet which can be 
connected from all district hospitals. 
50 As measured by first authors' institutes. 
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8.7 Government and civil society in the HIV arena 
This thesis shows that CSOs were among the key actors in Thai HIV policy. However, the 
civic sector was not homogeneous: the distinction between NGOs and PL WHA groups could 
be observed. In the early phase of HIV epidemic, NGOs working on HIV issues comprised 
existing associations, well-established in health and social welfare areas such as the 
Population and Community Development Association, Thai Red Cross Society and the 
Parenthood Association of Thailand (chapter 2). That these organisations had long-term, good 
relationships with the public sector allowed them to playa considerable role in the decisions 
and implementation of HIV policies. Despite collaboration with the Health Ministry and other 
government agencies, the background and involvement of these NGOs indicated that the 
voluntary sector developed independently from its public counterpart, and therefore can be 
regarded as the third sector (chapter 3). This argument is based on the fact that NGOs ran 
several campaigns to support or oppose particular policies issued by the administration. For 
example, they filed court cases against Big Pharma and the Department of Intellectual 
Property to revoke didanosine patent in late 1990s, and rallied to promote universal coverage 
for ART in 2001 (chapter 4). At peripheral level, the roles of HIV NGOs in providing 
treatment and care to the afflicted individuals were also widely acknowledged: 
.... NGOs' vitality, efficiency and unwavering commitment to social causes have 
been recognised by many members of society. Even some state officials readily 
attest to NGOs' contributions to social development in niche arenas such as health 
care for HIVIAIDS patients and their families, and policies for women and 
children. '(Vichit-Vadakan and Anukansai 2004:72-73) 
Apart from their involvement in HIV policies, in many instances these NGOs created 
partnerships with other CSOs to pursue wider interests. For example, the National Network of 
HIV NGOs and its individual members took part in a series of public fora to facilitate the 
development of the National Health Bill in early 2000s (chapter 5). The civic campaigns 
against the regime in 2006, demanding the Prime Minister's resignation and political system 
reforms in 2006 reflect the power of NGOs to make coalitions across a number of different 
sectors to demand radical political change. 
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In addition to NOOs, this thesis shows that groups of persons afflicted by the disease were 
another type of CSO participating in HIV policy process. In all study settings except Sam 
Ngam hospital, PLWHA groups had a supporting role in HIV care including ART delivery. 
Despite their contribution as self-help organisations, a common feature was that these groups 
were attached to, and organised by Health Ministry hospitals. That the national HIV 
programme demanded health facilities to foster networks with NOOs and PL WHA to 
facilitate Comprehensive and Continuum of Care including ART extension (AIDS Division 
2000; Ministry of Public Health 2002a; 2003b) might have been the reason for patient group 
formation in some settings such as Thapkhlo and Wang Chan hospitals. Meanwhile, in other 
facilities including Phichit and Rayong provincial hospitals and Klaeng district hospital, 
patients groups were established before ART scaling up. Findings of this thesis suggest that 
these groups of PL WHA were not self-reliant: they required financial, information and 
management support from health providers and local NOOs. This is what some have noted 
that in the developing world, people's responses to HIV were often led and managed by the 
'outsiders', i.e. health workers and NOOs (Seckinelgin 2002). Such development was 
contradictory to AIDS activism in Western societies where HIV-afflicted people themselves 
initiated and mobilised response. 
Although civil society is located outside the public and private sphere, the boundaries 
between the three sectors are complex and unclear (Centre for Civil Society 2004). In modem 
societies, CSOs may be set up, managed or subsidised by governments and international 
organisations for particular purposes. In many countries, governments encourage volunteering 
and charitable activities of CSOs and businesses through different enabling and enforcing 
measures (Post and Rosenblum 2002). In Thailand, an example of government-operated 
voluntary sector could be drawn on the organisation of HIV patients in MOPH hospitals. At 
the global level, CSOs have been mobilised and integrated into health and development 
frameworks of transnational agencies such as the UN systems (UNAIDS 2004a; UNDP 2002). 
Moreover, some civic advocacy is supported by for-profit corporations through their 
philanthropic divisions: for example, the Bill and Melinda Oates Foundation and some 
pharmaceutical companies. The findings of this thesis suggest that the growing need for 
networks and partnerships between government agencies and other organisations has resulted 
in increasingly blurring lines between the state, market and civil society sectors. 
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Despite the advantages of policy networks in achieving policy goals shared by government 
and non-government actors, the unequal power of network members is an important feature 
(Marsh 1998b). This thesis maintains for the health officials' superior power and dominant 
role over CSOs throughout the process of universal ART programme formulation and 
implementation. However, NGOs and PLWHA alliances at national-level were relatively well 
off as they had the ability to persuade and challenge the regime, as reflected in the 
development of many HIV policies since the epidemic began. This was totally different from 
patient groups in study hospitals. The insufficient information, low socioeconomic status, 
illnesses, stigmatisation and isolation among HIV-infected individuals might have been 
crucial factors discouraging them from confronting with health workers. Despite organising 
as groups, it was unlikely for PLWHA to guide ART introduction in order to fulfil their own 
needs. Since PL WHA volunteered to participate in groups to carry out self- help activities, 
their organisations resembled others in the civil society sector. At the same time, because of 
their dependence on resources from service providers, it could be argued that these patient 
groups acted as extended arms of government: working to achieve policy goals set by the 
state. Moreover, the involvement ofPLWHA in ART scaling up not only benefited front-line 
providers in carrying out some activities, but also legitimise the national treatment policy as a 
whole. 
8.8 Lessons learned from Thailand's universal ART policy 
The primary aim of this research was to increase understanding about the ART policy process 
through the analysis of treatment programme evolution in Thailand. It was expected that 
lessons derived from this study may be useful to inform therapy policy in other low- or 
middle-income countries, recognising that programme configuration introduced in one setting 
cannot be replicated in other societies owing to the differences in socioeconomic, political 
and health system environment. The universal coverage for ART in Brazil and Thailand, for 
example, cannot be adopted in many African settings with many fewer resources. Assuming 
the policy learning notion, however, this thesis maintains that the Thai experience can be used 
as a model for adaptation in other resource-constrained settings. This section raises some 
general issues emerging from this study. 
First, although the National ART Programme was a public policy and therefore responsible 
by government agencies, rolling out such complex therapy nationwide would have been 
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infeasible without support from NOOs and PL WHA groups. This thesis has demonstrated 
how the collaboration between state actors and civic volunteers, as members of policy 
networks, was essential in policy making and execution. Despite the fact that health officials 
and treatment providers in the public sector often command more resources than the CSOs 
counterpart, in some aspects of HIV policy decisions and service delivery, NOO staff and 
PL WHA are relevant to substitute for government workers. 
Second, ART scaling up in Thailand was facilitated by a learning environment, from which 
knowledge could be generated and used to inform policy. Treatment introduction needs 
regular monitoring and evaluation as vital elements since feedback on programme's strengths 
and weaknesses is indispensable for further improvement. To avoid and tackle unwanted 
consequences of service expansion, surveillance of sexual behaviours and drug resistance as 
well as supply side monitoring should be well operated and carried out as an integral part of 
therapy initiative. 
Third, knowledge-based policy processes existed at all levels of the health system, especially 
through collective learning of stakeholders. As the formation of a policy network is motivated 
by efficient use of resources to pursue common interests of all members, empowering CSOs 
is as crucial as strengthening the capacity of professionals, experts, bureaucrats and policy 
makers. It is noteworthy that fostering policy learning networks will not only contribute to the 
use of empirical evidence to shape policies, but also potentially to reinforcing public-civic 
unity through the collaboration of policy participants. 
Fourth, the development of ART policy and its outcomes were facilitated by policies 
implemented in other domains, either the non-health areas or health-related sectors. Thailand 
offers an illustration that it might have been infeasible to scale-up therapy to meet the 
universal access goal if HIV prevention programmes had not been in place and effectively 
translated into action when the epidemic begun in early 1990s. Moreover, the country enjoyed 
the benefits from the legacies that resulted in adequate health infrastructure and a relatively 
well-developed pharmaceutical industry. 
Finally, ART implementation requires adequate resources and proper management. This 
study suggests that although Thailand's health system was better-off compared to many 
countries in the South, the impediments in ART extension were substantial. In high HIV-
prevalent, but under-resourced settings such as some sub-Saharan African nations, the trade-
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off between rapid start-up of treatment provision to address the urgency of HIV problems, 
and service quality as well as the programme consequences should be considerate among 
local policy makers, international organisations and donors. 
8.9 Conclusions and future research 
Fieldwork for this thesis ended in December 2004. However, the National ART programme 
developed further. In April 2005, the number of PLWHA on therapy was 56,400 or 83% of 
the overall enrolees since the programme expanded in 2002 (data from Bureau of AIDS, 
Tuberculosis and Sexually-transmitted Infections). ARVs and related services including 
counselling as well as laboratory tests for CD4+ cell count, viral load and drug resistance 
were included in the universal health coverage plan in October 2005 (Sakulpanich 2005). 
Treatment offered through this scheme covered 3 categories of PL WHA: ART -naIve, 
treatment-experienced, and drug-resistant cases, who were UC beneficiaries (Matichon 2005; 
Srisamit 2006). The Disease Control Department was contracted by the National Health 
Security Office to continue its role as programme manager, providing technical and 
administration support to health providers. Meanwhile, PL WHA groups were increasingly 
involved in service delivery. The Comprehensive and Continuous Care Centres run by HIV 
patients extended from 105 hospitals in 2004 to 129 hospitals in 2005 (Sakulpanich 2005). It 
was expected that by September 2006, treatment recipients in the UC plan would amount to 
82,000, or approximately 100% of need (Srisamit 2006). 
While the numbers of Thai PLWHA on ARV medication were increasing, the learning 
networks' to improve treatment access were maintained. Apart from several ART -related 
studies including programme evaluation, the GPO's capacity was extended, resulting in the 
production of many new generic ARVs including indinavir, ritonavir and saquinavir, as well 
as other drugs in new dosage forms and fixed-dose combinations (Ake-sangsri 2005). The 
generic protease inhibitors will be beneficial for cost containment if and when first-line 
regimens are resisted in the wider population. At the same time, from 2004 civil society 
network comprising HIV NGOs, PLWHA, scientists, lawyers, and academics, most of whom 
played a vital role in the didanosine case in late 1990s (see chapter 4), campaigned against 
market exclusivity extension of pharmaceutical products, suggested by the US Government as 
part of Thai-US Free Trade Agreements (FTA) Proposal (FTA Watch Group 2006). Until 
March 2006, the two countries had not reached agreement, and the civic movement was still 
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continuing. When the people's campaign to dismiss Thaksin Shinawatra regime begun in late 
2005, the Thai-US FTA problems were among several issues raised to justify the petition 
against the Prime Minister. Certainly, CSOs in the HIV arena joined the civic coalitions in 
this political event. 
This thesis provides insights into ART policy in resource-poor countries through the literature 
review and the analysis of Thailand's national treatment programme evolution. The Thai 
experience illustrates the crucial roles of actor networks and policy learning that drove the 
universal ART proposal on to the government agenda, and thereafter, shaped the process by 
which the service strategies were devised and translated into action. In each policy stage, the 
policy process was complex and dynamic, affected by networks' features including their 
resources, the interactions between participants and context, as well as collective learning 
among network members. Over a decade of the publicly-subsidised ART programme, there 
were occasional changes in the groups of dominant actors. Although government officials 
continued to lead the policy decisions and execution, in some instances their monopolistic 
influence was shared with others, such as HIV experts, health system reformists, NGOs, 
PL WHA groups and treatment advocate individuals. The transformation of actor networks 
took place alongside the growing experiences of local and international ART introduction. At 
the same time, learning environment including knowledge generation capacity and evidence-
based policy tradition fostered the transfer of such treatment lessons. It was the common 
interests, concerted efforts, learning competence, as well as technical and practical expertise 
of multiple partners from the government and civil society sector that facilitated ART 
extension, despite significant impediments. 
This study also increases the knowledge on the introduction of policy analysis approaches 
developed in the northern hemisphere to describe the processes of health policy in the South. 
The conceptual framework drawn on these public policy models was helpful in several ways. 
First, the policy triangle backbone provided a fundamental explanation about the influence of 
actors and context on the development of the national ART policy in particular stages. Second, 
the punctuated equilibrium model could capture the dynamic features of the treatment 
programme, both in its stable phase and when the universal coverage idea was adopted, 
through the understanding of dominant actors and their perceptions towards different policy 
alternatives. Third, the integration of policy networks and policy learning concepts enhanced 
the explanatory power of the conceptual framework, as these two notions deliberately address 
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the questions on how and why state and non-state actors formed partnerships with each other, 
and drew lessons from elsewhere to inform ART policy making and executing in Thai context. 
Fourth, the bottom-up theories of policy implementation helped to figure out the process and 
motivation by which the treatment extension policy was reinvented by front-line service 
providers. Finally, the overall analytical framework reaffirmed the untidy policy process, as 
comprising intersections between policy stages: the ART policy innovation developed in 
parallel to, and was affected by the implementation of existing treatment programme. 
This thesis does not aim to appraise the national ART programme's performance and its 
consequences. Nevertheless, since knowledge-based policy making is a tradition in the 
country's health system, it is not surprising that the initiative has been systematically 
scrutinised in several facets, for example epidemiology, biomedicine, economics, and 
behaviour. However, gaps of public policy research concerning HIV and ART in Thailand 
remain. Comparative analysis of HIV interventions that succeed and fail is required. For 
instance, policy analysis would help to explain why it took only a few years to implement 
perinatal infection prevention on national scale, but by contrast, harm reduction for 
intravenous drug users has been completely neglected by the government. 
With respect to the established initiatives such as ARV medication, more attention should be 
paid on how to assure their effectiveness, encourage equitable access, and avoid negative 
impact. One of the areas of research that deserves emphasis is better understanding of health 
workers' responses to the burdens of several health policies and the implications of the street-
level practice for policy outcomes. In addition, given that ART introduction in the country 
will substantially change the face of the HIV epidemic and the demands for treatment and 
care among PL WHA, need assessments of supply and demand, and programme revision, as 
well as epidemiological projections are urgently needed. 
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APPENDIX 1: INTERVIEW GUIDES 
Note: The following questions were used as general guideline. They were subject to 
adaptation in response to particular respondents and emerging situations during interview. 
Relevant sets of questions were sent to interviewees in advance. Each questionnaire contained 
generic front page illustrating background information on project, purpose of this interview, 
confidentiality statement, and signature. 
Section 1: National-level policy process 
1. Personal background: 
• What was your background? 
• When did you first get involved in the antiretroviral treatment (ART) policy? 
Have you been continually involved? Until when? 
2. The National ART Policy before scaling-up (1992 to 2001): 
What were the key determinants of the programme development? How did these 
factors change over time? 
• Was there any attempt to expand the programme coverage? Who were the people 
who suggested the expansion? Why didn't they succeed? Was there any 
opposition to the expansion? Who were they? How did these two groups of 
people get involved in the policy? 
• What did the general public think about publicly-subsidised ART provision? (for 
or against the issue). How and why did the public opinion affect the policy? 
• What were the best and worst things about the government's ART policy during 
this phase? Why? How did you influence decisions? 
3. Agenda setting of the universal ART policy: 
. Why was the ART excluded from Universal Health Coverage (UC) benefit 
package when the scheme was first launched in March 2001? What were the 
government's reasons for the exclusion? How was the exclusion justified in the 
technical, financial and political aspects? Who was involved in the decision? How 
were they involved? 
• Why did the government adopt the policy to provide universal access to ART in 
November 2001? What were the key factors influencing policy change? What 
were the government's reasons for the new policy? How was the adoption 
justified in the technical, financial and political aspects? Who was involved in the 
decision? How were they involved? 
• At the time of policy adoption, what was the expected source of funding for the 
programme? Did the information on the establishment of Global Fund to Fight 
AIDS, Tuberculosis and Malaria affect the government's decision? 
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Who were the people inside and outside the government who advocated universal 
access to ART? How did they get involved? 
• Who outside the government was involved in campaigning for or against the 
policy? Who ran the campaign? How and why did the campaign affect the policy? 
Did the general public think about public-subsidized ART provision? Was there 
any strong public opinion for or against the policy? How and why did the public 
opinion affect the policy adoption? 
What were the barriers and opportunities the adoption of universal ART policy? 
At the time of policy adoption, was the policy feasible and sustainable? Did you 
expect any negative effect of the policy (e.g. diversion of budget from HIV 
prevention programmes, encouraging unsafe sex behaviours among PL WHA, 
increasing drug-resistant HIV strains)? 
4. Policy formulation: 
• What was the mechanism through which the policy was formulated? Were health 
care workers at the provincial and peripheral level consulted? 
• Who were the key actors in the policy formulation? How did they get involved? 
What were the particular policy components focused by each actor? What were 
their concerns? 
• What were the most controversial issues in designing universal ART programme? 
Who made the final decisions? How did s/he convince other actors involved in the 
policy making process to accept her or his ideas? 
• How were lessons drawn from the pilot ART programme in Thailand, established 
ART programmes in other countries, and international recommendations affect 
the design of universal ART programme? 
• What were the expected obstacles to implementing universal ART policy? What 
. were the measures to deal with those obstacles? 
• How did you get involved in the policy formulation? What were the best and 
worst components of the universal ART policy? At the time of policy formulation, 
what did you think about the technical feasibility and political desirability of the 
programme? 
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Section 2: Sub-national level policy process 
Questionnaire 1: Regional and provincial health officerslhospital directorslNGO staff 
(1) Personal background 
What was your background? 
• When did you first get involved in ART delivery? Have you been continually 
involved? 
• [NGO staff] When was your organisation established? Is it domestic or 
affiliation of other agency? What are the main objectives and activities? 
(2) What are the major HIV problems in this province - how have they impacted on 
your organisation? How has this changed since ART became available? 
(3) What have been the main developments in ART policy in this province? [hospital 
director] When did your hospital join the national programme - why? 
(4) What information have you received from the Disease Control Department on 
ART? How was the information conveyed? Were you consulted in the process -
how? What were your concerns? 
(5) What guidelines did you receive? What follow up support have you received - has 
it been useful? 
(6) How was the universal ART policy integrated into the provincial health delivery 
system? Was there any consultation between the Regional Disease Control Office, 
Provincial Health Office (PHO) and key stakeholders at the peripheral level, e.g. 
director of district and provincial hospitals, NGOs, PL WHA, community leaders? 
(7) What _were the implications of ART for human resources, training, drug 
distribution, treatment systems, laboratories, and fmancing in this province/your 
organisation? 
(8) What has been the outcome of the ART policy monitored: numbers on treatment, 
proportion of quota met, adherence/dropout rate, PLWHA health, quality of life, 
productivity? 
(9) What is the relationship between your organisation and others such as Regional 
Disease Control Office, PHOs, provincial hospital, district providers, NGOs, 
PLWHA groups, communities? When and how often do you meet formally? Do 
you have other informal interaction? 
(10) What have been your major constraints to scaling up ART? How have you managed 
to overcome these constraints? How will they change as the ART programme 
expands further? 
(11) What have been the positive aspects for you of scaling up ART? Why were they so 
positive? 
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Questionnaire 2: Hospital health professionals (clinicians, nurses, counsellors, 
pharmacists, laboratory scientists) 
(1) Personal background: 
APPENDIX 
• What was your background? 
• When did you first get involved in ART delivery? Have you been continually 
involved? 
(2) What have been the main developments in ART programme in this hospital? When 
did the hospital director decide to participate in the National ART Programme - why? 
Was there any consultation between the director and key stakeholders, e.g. hospital 
staff, networking health facilities (district hospitals and health centres), and NGOs? 
(3) What is your responsibility in providing HIV treatment and care - how has it changed 
with the arrival of ART? 
(4) What information and guideline have you received from the Disease Control 
Department on ART? How was the information conveyed? Have you ever been 
trained in ART delivery? What were your concerns? 
(5) What have been the complexities in ART delivery in professional/technical aspects 
(e.g. prophylaxis and treatment of opportunistic infections, promotion and assessment 
of treatment adherence, promotion of safe sex practice, home visit, counselling 
service, drug information provision, performing laboratory test, specimen 
management)? What are the hospital's measures to deal with them? How effectives 
are these measures? (if not effective) Why? 
(6) What have been your major administration constraints to deliver ART? How have you 
and your hospital managed to overcome these constraints? How will they change as 
the ART programme expands further? 
(7) What follow up support, including supervision, have you received from national, 
regional and provincial agencies - has it been useful? 
(8) What were the implications of ART for work load, case complications, management 
system in your department, risk of disease transmission to health care workers? 
(9) What support have you received from hospital director, colleagues, external experts, 
NGOs/patient networks? 
(10) What have been the positive aspects for you of scaling up ART? Why were they so 
positive? 
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Questionnaire 3: PLWHA group leaders 
(1) Have you ever sought care from other facilities? What are the supportive factors for 
you to seek care at the hospital? Have these elements been improved during the past 2 
to 3 years - in what aspects? 
(2) How did you get the information on ART provision at this hospital? What was your 
impression when you fIrst got the information? What were your concerns? Who was 
the key person encouraging you to seek the treatment? How did this person help you 
to make the decision? 
(3) How long have you taken ARVs? What is the most important support you have got 
from hospital staffs, NGOs and your colleagues that encourage the adherence? From 
your experience, what do you feel about the health effects of ART? Is there any 
signifIcant improvement or deterioration? What symptoms are serious? Have you got 
any support to manage these symptoms - from whom? 
(4) If you have a chance to talk to a friend who is HIV infected, will you recommend 
himlher to receive ARVs at this hospital- why? What information you would like to 
convey to your friend? 
(5) How long have you participated in this PLWHA group? How often the group 
meetings are organised? What are the activities carried out by group members? How 
has this group supported the members to access to treatment and care? What are the 
constraints in group management? Has your group got any support from the hospital 
director and health care staff - how? 
(6) What is the relationship between your group and others such as Regional Disease 
Control OffIce, PHOs, provincial hospital, district providers, NGOs, PLWHA groups, 
communities? Has your group got any support from them - how? 
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APPENDIX 2: LIST OF INFORMANTS 
In this thesis 80 persons were fonnally interviewed, using the semi-structured questionnaires 
as interview guide (Appendix 1). Furthennore, 22 persons were consulted by the investigator 
in order to clarify and triangulate particular points. See tables Al and A2 for lists of 
interviewees and other informants. 
Table At: List of interviewees 
No. Job title ID Interview date 
1. Health Minister NOI 26 November 2003 
2. Secretary General, National Health Security Office N02 21 January 2004 
3. Expert, Disease Control Department N03 15 January 2004 
4. Expert, Disease Control Department N04 27 November 2003 
5. Director, Thai-US Collaborating Centre for HIV/AIDS NOS 16 January 2004 
Research 
6. Director, Bureau of AIDS, Tuberculosis and Sexually- N06 6 October 2003 
Transmitted Infections 
7. Technical Officer, Bureau of AIDS, Tuberculosis and N07 5 November 2003 
Sexually-Transmitted Infections 
8. Technical Officer, Bureau of AIDS, Tuberculosis and N08 9 April 2004 
Sexually-Transmitted Infections 
9. Counsellor, Bang Rak Sexually-Transmitted Infections N09 16 December 2003 
hospital 
10. HIV specialist, Faculty of Medicine, Chulalongkorn NIO 6 February 2004 
University 
11. Director, International Health Policy Programme NIl 24 December 2003 
12. Research fellow, International Health Policy Programme N12 17 December 2003 
13. Director, Research and Development Institute, Government N13 24 December 2003 
Pharmaceutical Organisation 
14. Deputy Director, Research and Development Institute, N14 12 January 2004 
Government Pharmaceutical Organisation 
15. Director, AIDS Access Foundation N15 18 December 2003 
16. Staff, National Network for PL WHA N16 23 December 2003 
17. Director, Centre for AIDS RiAAts N17 22 January 2004 
18. Colunmist, Bangkok Post newspaper NI8 20 November 2003 
19. Associate Professor, Faculty of Pharmaceutical Science, N19 22 January 2004 
Chulalongkorn University 
20. Manager, Pond Chemicals, Co. Ltd N20 15 January 2004 
21. Manager, T.O. Chemicals, Co. Ltd N21 22 J anuarv 2004 
22. Chief, HIV and STI Division, Regional Disease Control ROI 11 June 2004 
Office, Region 9 
23. Chief, HIV and STI Division, Regional Disease Control R02 10 May 2004 
Office, Region 3 
24. HIV specialist, Cholburi provincial hospital and Regional R03 10 May 2004 
ART programme consultant, Region 3 
25. Health Official, HIV and STI Division, Regional Disease R04 10 May 2004 
Control Office, Region 3 
26. Social worker, HIV and STI Division, Regional Disease R05 17 November 2003 
Control Office, Region 11 
28. Health official, Provincial Health Office, Phichit R06 11 June 2004 
- 248 -
APPENDIX 
No. Job title ID Interview date 
29. Health official, Provincial Health Office, Rayong R07 23 April 2004 
30. Director, Camillian Social Centre, Rayong R08 23 April 2004 
31. Director, Thai Network for PL WHA, Eastern Region Office R09 23 April 2004 
32. Pharmacist, HIV and STI Division, Regional Disease RIO 10 May 2004 
Control Office, Region 3 
33. HIV Programme Manager, Holt Sahathai Foundation, R11 17 November 2003 
Southern Region Office, Nakhon Si Thammarat 
34. Head, Preventive Medicine and Community Health SOl 23 July 2004 
Department, Phichit provincial hospital 
35. Clinician, Medicine Department, Phi chit provincial hospital S02 21 July 2004 
36. Clinician, Paediatric Department, Phi chit provincial hospital S03 23 July 2004 
37. Counsellor, HIV clinic, Phichit provincial hospital S04 21 July 2004 
38. Pharmacist, Phichit provincial hospital S05 23 July 2004 
39. Pharmacist, Phichit provincial hospital S06 24 July 2004 
40. Director, Phichit provincial hospital S07 24 July 2004 
41. Nurse, Phichit provincial hospital S08 22 July 2004 
42. Nurse, Phichit provincial hospital S09 22 Julv 2004 
43. Medical scientist, Phi chit provincial hospital S10 24 July 2004 
44. Nurse, Psychiatric Department, Phi chit provincial hospital Sl1 22 July 2004 
45. Leader, PL WHA group, Phichit provincial hospital S12 21 July 2004 
46. Director, Sam Ngam hospital DOl 26 July 2004 
47. Nurse, HIV clinic, Sam Ngam hospital D02 26 July 2004 
48. Pharmacist,_ Sam Ngam hospital D03 3 August 2004 
49. Medical scientist, Sam Ngam hospital D04 27 July 2004 
50. Leader, PL WHA group, Sam Ngam hospital D05 27 July 2004 
51. Clinician, Thapkhlo hospital D06 4 August 2004 
52. Nurse, Tha~khlo hospital D07 4 August 2004 
53. Nurse, Thapkhlo hospital D08 5 August 2004 
54. Pharmacist, Thapkhlo hospital D09 4 August 2004 
55. Medical scientist, Thapkhlo hospital DI0 5 August 2004 
56. Leader, PL WHA group, Thapkhlo hospital Dl1 5 August 2004 
57. Clinician, OBGYN Department, Rayong provincial hospital S13 19 May 2004 
58. Clinician, Medicine Department, Rayong provincial hospital S14 19 May 2004 
59. Clinician, Preventive Medicine and Community Health S15 21 May 2004 
Department, Rayong provincial hospital 
60. Social Worker, Rayong provincial hospital S16 18 May 2004 
61. Nurse, Preventive Medicine and Community Health S17 18 May 2004 
Department, Rayong provincial hospital 
62. Nurse, Paediatric Department, Rayong provincial hospital S18 21 May 2004 
63. Nurse, Ante-natal Clinic, Rayong provincial hospital S19 19 May 2004 
64. Nurse, Out-Patient Department, Rayong provincial hospital S20 24 May 2004 
65. Medical scientist, Rayong provincial hospital S21 18 May 2004 
66. Pharmacist, Rayong provincial hospital S22 24 May 2004 
67. Leader, PL WHA group, Rayong provincial hospital S23 20 May 2004 
68. Leader, PL WHA group, Rayong provincial hospital S24 20 May 2004 
69. Clinician, Klaeng hospital Dl2 14 June 2004 
70. Nurse, Klaeng hospital DB 14 June 2004 
71. Pharmacist, Klaeng hospital D14 14 June 2004 
72. Medical scientist, Klaeng hospital D15 15 June 2004 
73. Medical scientist, Klaeng hospital Dl6 15 June 2004 
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No. Job title ID Interview date 
74. Leader, PL WHA group, Klaeng hospital D17 14 June 2004 
75. Director, Wang Chan hospital D18 27 May 2004 
76. Clinician, Wang Chan hospital D19 28 May 2004 
77. Nurse, Wang Chan hospital D20 28 May 2004 
78. Medical scientist, Wang Chan hospital D21 27 May 2004 
79. Phannacist, Wang Chan hospital D22 27 May 2004 
80. Leader, PLWHA group, Wang Chan hospital D23 28 May 2004 
Table A2: List of other informants 
No. Name Job title 
1. Suwit Wibulpolprasert Deputy Health Secretary, Ministry of Public Health 
2. Chaiyos Kunanusont United Nations Population Fund, Thailand office 
3. Waranya Teokul Technical Officer, Social Division, National Economics and 
Social Development Office 
4. Samrit Srithamrongsawat National Health Security Office 
5. Busaba Tantisak Technical Officer, Bureau of AIDS, Tuberculosis and 
Sexually-Transmitted Infections 
6. Peeramon Ningsanonda Technical Officer, Bureau of AIDS, Tuberculosis and 
Sexually-Transmitted Infections 
7. Taweekiat Bunyapaisal- Provincial Chief Medical Officer, Ayudhaya 
charoen 
8. Aphichart Rodsom Chief, AIDS and Sexually-Transmitted Infections Division, 
Provincial Health Office, Nan 
9. Supaporn Wattanatorn Chief, AIDS and Sexually-Transmitted Infections Division, 
Centre for Disease Control, Region 2 
10. Phanumas Yanavesakul Chief, AIDS and Sexually-Transmitted Infections Division, 
Centre for Disease Control, Region 11 
11. Patcharee Si-chapaeng Nurse, Preventive Medicine and Community Health 
Department, Phichit provincial hospital 
12. Ladda Nurse, Preventive Medicine and Community Health 
Thanompreechachai Department, Rayong provincial hospital 
13. Opas Putcharoen Clinician, Panas Nikom district hospital, Cholburi 
14. Peerachat Chantako Phannacist, Pho Prathap Chang district hospital, Phichit 
15. Surachai Pai-pan Health officer, Pho Prathap Chang district hospital, Phi chit 
16. Supornpen Aksornwong Phannacist, Nakhon Si Thammarat provincial hospital 
17. Thapanee Karikarn Nurse, HIV clinic, Nakhon Si Thammarat provincial hospital 
18. Nujaree Tulatharn Nurse, Camillian Social Centre, Rayong 
19. Churnruethai Professor, Institute for Population and Social Research, 
Kanjanachitra Mahidol University 
20. Sukontha Kongsin Associate Professor, Faculty of Public Health, Mahidol 
University_ 
21. Niyada Kiat-ying- Associate Professor, Faculty of Phannaceutical Science, 
angsulee Chulalongkorn University 
22. Jongkol Lertiendumrong International Health Policy Programme, Thailand 
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APPENDIX 3: OUTLINE OF REVIEWED DOCUMENTS 
Category Source of Information obtained 
document 
(1) Government Responsible Policy context: 
documents (e.g. agencies, • Policy-making institution: structures and procedures 
statements, libraries, • Government policy 
declarations, minutes, internet • Economic and financial status: Gross Domestic 
guidelines, notices, Product, government budget 
letters, memorandum, • The profile of health system: health administration 
reports, and database) and service delivery, health financing system, health 
expenditure and sources of finance 
• HIV epidemiology and burdens of disease 
• National HIY/AIDS policy 
• Drug regulations: drug approval, pricing, patent 
• International relations: collaboration between Thai 
Government and international agencies 
Policy content: 
• ART policy content at the national and sub-national 
level: preparatory activities, coverage of ART in 
health benefit package, drug regimens, patient 
enrolment, availability and allocation of 
fundamental resources for ART provision, drug 
management, programme evaluation and 
monitoring, expected roles of local authorities, 
private health care settings, NGOs, PL WH/ A 
networks and communities 
(2) International Responsible • State of the art of international HIY treatment 
declarations, agencies, recommendations, internationally accepted regimens 
recommendations, libraries, and experiences elsewhere 
guidelines, and internet • International collaborations and agreements in 
manuals health, HIY/AIDS, pharmaceutical, and trade 
(3) Domestic and Libraries, • State of the art of international HIY treatment 
international journals internet recommendation, internationally accepted regimens 
and experiences elsewhere 
• Efficacy, effectiveness and safety of different 
antiretroviral regimens 
(4) Books, research Responsible • Socio-cultural parameters: values, norms, and 
reports and other grey agencies, beliefs relating to PL WHA and treatments 
literature libraries, • Political situation: government status, legitimacy, 
internet and popUlarity 
• Political environment of ART policy: public opinion 
and social movements 
(5) Domestic News • Political situation: government status, legitimacy, 
newspapers clipping and popUlarity 
servIce • Political environment of ART policy: public 
opinion, social movement 
• Roles of principle actors 
Note: The actual documents are included in the Reference list. 
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